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A four component reaction involving the coupling of functionalized aldehydes, 
amines, acid chlorides, and π- and organometallic nucleophiles has been developed to 
prepare multifunctional substrates that may be employed in subsequent ring-forming 
reactions to generate diverse arrays of functionalized heterocyclic scaffolds.  Allyl 
metals, Grignard reagents, silyl ketene acetals, silyl enol ethers, and silyloxy furans have 
been utilized as the nucleophile in the four component reaction (4CR).  The 4CR has 
been sequenced with intramolecular Heck reactions, Diels-Alder and [3+2] 
cycloadditions, ring closing metathesis (RCM), and Dieckmann condensations to provide 
a number of diverse heterocyclic structures.  The practical utility of this approach to 
diversity-oriented synthesis (DOS) was further exemplified by its application to the first 
total synthesis of the isopavine alkaloid roelactamine, which was completed in only four 
steps from commercially available materials.   
 vi 
The application of this methodology towards the synthesis of the Aspidosperma 
alkaloids rosicine and pseudotabersonine is also presented.  To this end, an imine 
pentadienylation/double RCM strategy has been adopted to rapidly access the pentacyclic 
core of the aspidospermine alkaloids.  This sequence involved the use of a pentadienyl 
aluminum reagent, which was found to react with aryl imines to give branched products 
in good yields.  
 vii 
Table of Contents 
Chapter 1: Diversity Oriented Synthesis and the Applications of Multicomponent 
Reactions to the Synthesis of Diverse Heterocyclic Scaffolds .......................1 
1.1 Diversity Oriented Synthesis ....................................................................1 
1.1.1 Introduction ...................................................................................1 
1.1.2. The Pairwise Use of Complexity-Generating Reactions .............4 
1.1.3 Stereochemical Diversity ..............................................................7 
1.1.4 Skeletal Diversity via Reagent Based Differentiation Pathways ..9 
1.1.5 Skeletal Diversity via Substrate Based Differentiation ..............16 
1.1.6 Stereochemical Control of Skeletal-Diversity ............................24 
1.1.7 The Build/Couple/Pair Strategy ..................................................25 
1.2 Applications of Multicomponent reactions to the Synthesis of Diverse 
Heterocyclic Scaffolds .........................................................................31 
1.2.1 Introduction .................................................................................31 
1.2.2 Applications of the Ugi-4CR and related Isocyanide Based MCRs.
.....................................................................................................32 
1.2.2.1 Ugi/de-Boc/Cyclization ...........................................................33 
1.2.2.2 Ugi 4CR/Intramolecular Cyclization to Give Benzodiazepines37 
1.2.2.3 Ugi 4CR/Intramolecular Alkylation ........................................39 
1.2.2.4 Ugi 4CR/Intramolecular SNAr .................................................42 
1.2.2.5 Ugi-4CR/Intramolecular Knoevenagel Condensation and Horner-
Wadsworth-Emmons Olefination ...............................................48 
1.2.2.6 Tandem Ugi-4CR/1,4-Addition ...............................................53 
1.2.2.7 Sequential Ugi-4CR/Pictet-Spengler .......................................54 
1.2.2.8 Sequential Ugi 4CR/Hydroamination ......................................55 
1.2.2.9 Sequential Ugi 4CR/Radical Cyclization.................................56 
1.2.2.10 Sequential Ugi-4CR/6π-Photocyclization and Ugi-4CR/[2+2] 
Cycloaddition ..............................................................................58 
1.2.2.11 Sequential Ugi 4CR/[3+2] Cycloaddition ..............................60 
1.2.2.13 Sequential Ugi 4CR/RCM .....................................................69 
1.2.2.14 Sequential Ugi-4CR/Heck Cyclization ..................................77 
 viii 
1.2.2.15 Sequential Ugi-4CR/Intramolecular Arylation or Amidation (N-
Arylation) ....................................................................................80 
1.2.2.17 Ugi 4CR/Intramolecular Cyclization to give Benzoxazoles and 
Benzothiazoles ............................................................................85 
1.2.2.18 Applications of the Ugi-Smiles Reaction ..............................86 
1.2.3 Applications of the van Leusen 3CR ..........................................88 
1.2.4 Applications of the Aldehyde/Amide/Dienophile Reaction .......92 
1.2.5 Applications of the α,γ-Difunctionalization Reaction of β-Ketoesters 
and Amides .................................................................................94 
1.2.6 Applications of the 4-Component Triazinedione Synthesis .......96 
1.3 Conclusions .............................................................................................97 
Chapter 2: The Development of a Four Component Reaction and Its Application to 
the Synthesis of Diverse Heterocyclic Structures. ......................................100 
2.1 Introduction ..................................................................................100 
2.2.1 Investigations into Reactions Involving Allyl Nucleophiles ....105 
2.2.1.1 Three Component Reactions Designed to Identify Competent Allyl 
Nucleophiles .............................................................................105 
2.2.1.2 The 4CR Involving Allyl Nucleophiles Leading to Sequential 
4CR/RCM Sequences ...............................................................109 
2.2.1.4 Sequential 4CR/RCM/Heck Cyclization ...............................110 
Part 2.2.1.5 Sequential 4CR/RCM/Dieckmann .................................112 
Part 2.2.1.6 Attempted Sequential 4CR/Dearomatizing Intramolecular 
Enolate Alkylation. ...................................................................118 
2.2.2 Sequential 4CR/Diels-Alder Cycloadditions ............................121 
2.2.3 Sequential 4CR/Hetero Diels-Alder Reactions .........................125 
2.2.4 Sequential 4CR/[3+2] Dipolar Cycloadditions .........................127 
2.2.5 Sequential 4CR/Heck/Dieckmann Cyclization and Reactions 
Involving Silyl Ketene Acetal Nucleophiles .............................131 
2.2.5.1 Investigations into Intramolecular Heck Reactions ...............139 
2.2.4.2 Sequential 4CR/Heck Cyclizations Utilizing 4-Bromoindoles.150 
2.2.5.3 Sequential 4CR/RCM/Deickmann Cyclization Utilizing Silyl 
Ketene Acetal Nuclophiles .......................................................152 
2.2.5.4 Tandem 4CR/[3+2]Azide/Alkyne Cycloadditions ................156 
 ix 
2.2.5.5 Reactions Involving Aliphatic Aldehydes. ............................157 
2.2.5.6 Reactions Involving Vinyl Silyl Ketene Acetals ...................158 
2.2.6 Reactions Involving Silyloxyfurans Leading to 4CR/Michael 
Addition Sequences ..................................................................159 
2.2.7 General Comments Involving the Methods of Imine Formation in the 
4CR ...........................................................................................161 
2.3 Conclusion ...................................................................................162 
Chapter 3: The Isopavine and Aspidosperma Alkaloids ......................................164 
3.1 The Isopavine Alkaloids ....................................................................164 
3.1.1 Introduction ...............................................................................164 
3.1.1.1 Roelactamine..........................................................................165 
3.1.2 Synthetic Approaches to the Isopavine Alkaloids ....................165 
3.1.2.1 Double Cyclization of Benzylaminoacetaldehyde Acetals ....165 
3.1.2.2 Syntheses of Isopavines from 4-Hydroxytetrahydroisoquinoline 
Derivatives. ...............................................................................174 
3.1.2.3 Other Routes to the Isopavine Alkaloids ...............................179 
3.1.3 Conclusion ................................................................................185 
3.2 The Aspidosperma Alkaloids ................................................................186 
3.2.1 Introduction ...............................................................................186 
3.2.1.1 Rosicine..................................................................................187 
3.2.1.2 Pseudotabersonine..................................................................188 
3.2.2 Syntheses of the Aspidosperma Alkaloids ................................189 
3.2.2.1 Syntheses Involving the Stork-Dolfini Ketone ......................189 
3.2.2.2 Syntheses of Quebrachamine and Its Conversion to the 
Aspidospermine Skeleton .........................................................197 
3.2.2.3 The Ban Oxindole Approach .................................................201 
3.2.2.4 The Rearrangement of β-Carboline Derivatives ....................205 
3.2.2.5 Syntheses of Vinderosine and Vindoline ...............................206 
3.2.2.6 The Magnus Indole-2,3-quinodimethane Approach ..............212 
3.2.2.7 Application of the Aza-Cope Mannich Reaction to the 
Aspidosperma Alkaloids ...........................................................213 
3.2.2.8 Kuehne’s Biomimetic Approach to the Aspidosperma Alkaloids
...................................................................................................215 
 x 
3.2.2.9 Syntheses of Aspidosperma Alkaloids Utilizing Ring Closing 
Metathesis .................................................................................218 
3.2.3 Syntheses of Pseudotabersonine ...............................................223 
3.2.3.1 Kuehne’s Synthesis of Pseudotabersonine.............................223 
3.2.3.2 Grieco’s Synthesis of Pseudotabersonine ..............................224 
3.2.4 Conclusion ................................................................................226 
Chapter 4: Applications of the Four Component Reaction to Natural Product 
Synthesis .....................................................................................................228 
4.1 Introduction ..................................................................................228 
4.2 Application of the 4CR to the Total Synthesis of Roelactamine .229 
4.3 Applications of the 4CR Towards the Synthesis of Aspidosperma 
Alkaloids ...................................................................................237 
4.3.2 Efforts Towards the First Total Synthesis of Rosicine .............253 
4.3.3 Efforts Towards the Total Synthesis of Pseudotabersonine .....285 
4.3.4 Preliminary Studies Involving 3-Ethylpentadienyl Aluminum 291 
4.4 Conclusions ..................................................................................293 
Chapter 5: Experimental Procedures ...................................................................295 
5.1 General .........................................................................................295 




Chapter  1: Diversity Oriented Synthesis and the Applications of 
Multicomponent Reactions to the Synthesis of Diverse Heterocyclic 
Scaffolds 
1.1 DIVERSITY ORIENTED SYNTHESIS 
1.1.1 Introduction 
 As chemists and biologists search for small molecule probes for analyzing all 
aspects of protein function, cell circuitry, and animal physiology, many thousands of 
molecules are needed for testing in biological screens.  In particular, the study and use of 
small molecules as modulators of biological activity gains continued importance, as small 
molecules often exhibit many favorable properties over macromolecules and biological 
theropuetics.1, 2  Since the vast majority of these compounds are accessible only through 
chemical synthesis, a significant burden is placed on synthetic chemists to develop 
efficient methods for synthesizing these large collections of molecules.   
Of particular interest is the ability to include in these libraries compounds that 
contain natural product or drug-like scaffolds, as the use natural products and privileged 
structures3 as lead compounds for drug development, or as drugs themselves, has already 
been validated.4,5  The vast majority of natural products and biologically active molecules 
contain a heterocyclic ring system, and therefore a premium is placed on the ability of 
synthetic chemists to develop methods for the efficient synthesis of diverse heterocyclic 
compounds.   
Traditionally organic chemists have focused their synthetic efforts towards 
specific target molecules, and this process of target-oriented synthesis (TOS) has led to 
efficient syntheses of numerous natural products and biologically active molecules.  The 
target molecules are typically chosen due to their natural occurrence, structural features, 
 2 
and known biological activity, and therefore the syntheses of these molecules has led to 
many advances in the fields of chemistry and biology.  However, when a specific target 
molecule is chosen, the synthetic route is designed to access only the specific region of 
chemical space occupied by the synthetic target, and the focused nature of TOS severely 
limits the number and types of molecules that can be generated for biological screening.   
The concept of combinatorial chemistry was developed to further expand the 
number and types of targets accessible by TOS, and this synthetic strategy greatly 
increased the number of small molecules available for testing.  Combinatorial chemistry 
is a scaffold-based approach, where known scaffolds are sequentially derivatized to 
generate large libraries of compounds.  The scaffolds that are typically chosen are 
privileged structures or natural product derived, as these scaffolds are already known to 
exhibit certain biological activities.3-5  However, since combinatorial chemistry is focused 
on filling in the chemical space around known compounds with desirable structural or 
biological properties, the chemical diversity found in libraries generated by combinatorial 
chemistry is limited.6, 7  Whether the limitations of today’s libraries should be cause for 
concern is unknown, as the questions of whether or not the previously explored areas of 
chemical space are the best areas for finding new biologically active molecules and 
whether or not the unexplored regions of chemical space will lead to novel active 
compounds go unanswered.  The concept of diversity-oriented synthesis (DOS) was 
developed to provide synthetic chemists with the tools to synthesize the molecules that 
may one day answer these questions.   
The main goal of DOS is to synthesize collections of diverse molecules that 
represent every region of chemical space, so that these collections of molecules can then 
be utilized in biological assays to further knowledge about living systems.  However, 
 3 
before DOS could begin to reach this goal, a new set of synthetic strategies needed to be 
developed.   
DOS is a synthetic strategy designed to allow for the synthesis of a collection of 
structurally and stereochemically diverse molecules in a short number of steps from 
simple starting materials.  From a synthetic standpoint DOS is distinctly different from 
TOS.  The field of TOS generally focuses on the synthesis of a single target structure, 
while the goal of a DOS is to generate collections of diverse structures (Figure 1).  
Therefore, the general planning strategies for TOS and DOS are also different.8,9  While 
the strategy of retrosynthetic analysis has greatly advanced the field of TOS,10 this 
strategy is not ideal for DOS.  DOS instead relies on a forward-synthetic planning 
strategy that focuses on identifying inherent chemical reactivity in collections of 
compounds and the ability to recognize the potential for iterative pathways, wherein the 
product of one reaction becomes the starting material for the next reaction, leading to 
















The diversity of a collection of molecules arises from three main elements: the 
molecular skeleton, the appendages on the skeleton, and the relative stereochemistry of 
the substituents on the molecule.  Variations on all three of these elements are needed for 
the full potential of DOS to be realized.  Thus, it is important for synthetic chemists to be 
able to access in a stereo-controlled manner a number of different heterocyclic skeletons 
that contain a diverse array of functionalities that can be used to attach a wide range of 
differentially functionalized appendages.  While this is no small feat, a number of 
different strategies have been developed to lay the foundation for DOS, and this Chapter 
will focus on the discussion of these strategies.         
1.1.2. The Pairwise Use of Complexity-Generating Reactions 
The most straightforward approach to DOS is the pairwise use of complexity-
generating reactions. A complexity-generating reaction is a reaction that turns relatively 
simple starting materials into a more complex product.  The sequencing of these reactions 
so that the product of the first reaction becomes the substrate in a second complexity-
generating reaction can lead to very complex structures in a short number of steps.  
Schreiber has demonstrated that the pairing of two complexity-generating reactions, 
namely the tandem Ugi four component reaction (Ugi-4CR)/intramolecular-Diels-Alder 
(for more on the tandem Ugi-4CR/IMDA reaction see Section 1.2.1.6) and ring-
opening/ring-closing metathesis (ROM/RCM), can allow for rapid access to complex 
molecules (Scheme 1.1).11  Starting from the benzylamine 1.1, benzyl isocyanide (1.2), 
furfural (1.4), and the carboxylic acid 1.3 a tandem Ugi-4CR/Diels-Alder reaction 
proceeded to give the 1.5.  It was then envisioned that the strained alkene in 1.5 would 
make a suitable substrate for ring-opening/ring-closing metathesis.  However, 1.5 was not 
a suitable substrate for the ROM/RCM, and a subsequent bis-allylation was needed to 
provide 1.6.  Treatment of 1.6 with the Grubbs II catalyst in refluxing CH2Cl2 provided 
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the desired tetracycle 1.7 in 69% yield.  Thus, from four simple starting materials the 
complex 7,5,5,7-tetracyclic 1.7 could be accessed in only three steps, showing the power 
of sequencing complexity-generating reactions for the synthesis of complex molecules.  
Also, this reaction sequence resulted in the synthesis of two compounds, 1.5 and 1.7, 
which contain two distinctly different molecular scaffolds, highlighting the utility of 

































































Oikawa subsequently modified the acid and isonitrile components of the Ugi-4CR 
to develop a process whereby a selective mono-allylation of the Ugi product could be 
achieved (Scheme 1.2).12  Incorporating acid 1.9 and benzyl isocyanide into the Ugi-4CR 
gave 1.10 in 73% yield.  The p-bromoanilide could be selectively allylated with allyl Br 
and CsOH in THF at 0 ºC to give 1.11.  Since 1.11 only contains a single allyl group it 
cannot undergo the same ROM/RCM as 1.6.  However, upon adding styrene to the 
reaction, 1.11 underwent a ring-opening/cross-metathesis/ring-closing metathesis to give 
1.12 in 81% yield.  By simply switching the functionality contained in the isonitrile and 
carboxylic acid a different tricyclic scaffold, namely 1.13, could be accessed via an 
analogous reaction sequence.  In addition to being an illustrative example of the use 
complexity-generating reactions in DOS, this is also a good example of substrate based 

















































































The previous two examples demonstrate how by sequencing two complexity-
generating reactions complex substrates can be accessed in a short number of steps from 
simple starting materials, making this a useful tactic for DOS.  Additional examples 
utilizing complexity-generating reactions will be shown throughout this chapter, further 
highlighting their utility to DOS. 
1.1.3 Stereochemical Diversity 
Stereochemistry plays an important role in DOS as it determines the 3-
dimensional orientation of a molecule.  The stereochemistry of ring fusions determines 
the overall shape of a molecular skeleton, while the stereochemistry of appendages 
determines their relative orientation in space.  Both of the overall shape of a molecule and 
the orientation of its appendages can influence how a small molecule interacts with a 
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biological target, and therefore stereochemical diversity is an important aspect to consider 
in DOS.  In an ideal diversity synthesis every possible stereoisomer should be accessed; 
however, in practice this is not always possible.  Stereocontrol can be achieved by both 
substrate and reagent control, and there are numerous methodologies for stereoselective 
synthesis that can be utilized in DOS.  However, in situations where there is the 
possibility for both substrate and reagent control, it can be hard to override the inherent 
substrate control, and therefore it sometimes can be difficult, or even impossible, to 
access every possible combination of stereoisomers.     
An example of this limitation in achieving stereochemical diversity can be found 
in Schreiber’s application of the bis(oxazoline)metal Lewis acid catalyzed hetero-Diels-
Alder to DOS (Scheme 1.3).13  Starting from the resin bound E and Z enol ethers 1.14 and 
1.15, the copper bis(oxazoline) Lewis acid catalyzed the hetero-Diels-Alder with 1.16  to 
provide the dihydropyrans 1.18-1.21 with high levels of diastereo- and enantioselectivity.  
However, while the reactions showed high levels of selectivity for the endo product, this 
catalyst system did not override the inherent endo selectivity to provide the exo product.  
Therefore, only two of the possible four diastereomers could be synthesized using this 
methodology.  This reaction sequence exposes one of the current limitations of DOS, and 
the lack of general methodologies that allow for complete control of stereochemistry 
regardless of substrate influences while allowing for access to every possible 
combination of stereoisomers needs to be addressed in order for the full potential of 
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1.1.4 Skeletal Diversity via Reagent Based Differentiation Pathways 
Of the three elements of diversity, skeletal diversity has the largest impact on how 
a molecule occupies 3-dimensional space.  Therefore, this aspect of DOS has received the 
largest amount of attention from synthetic chemists, and two main approaches have been 
developed.  The first of these approaches involves using reagent based differentiation 
(Figure 1.2).  In a reagent based differentiation sequence, a single multifunctional 
compound is synthesized and subjected to a series of reactions with different reagents 
that transform the starting substrate into distinct products.  The challenge in successfully 
implementing a reagent based differentiation lies in the identification and synthesis of 








Schreiber has shown that the resin bound triene 1.22 can undergo a reagent based 
differentiation pathway leading to a library of polycyclic compounds (Scheme 1.4).14  
When 1.22 was treated with a reactive disubstituted dienophile such as maleimide 1.23, a 
double Diels-Alder reaction takes place to give tetracyclic products such as 1.24.  
However, when tri- or tetra-substituted dienophiles were utilized in the reaction, only a 
single cycloaddition occurred to give tricyclic products like 1.26.  The diene in 1.26 can 
then react with another dienophile, further increasing the diversity of the tetracyclic 


































































 Another example of reagent based differentiation from the Schreiber labs further 
exemplifies the power of this DOS strategy.15  The multifunctional amine 1.33 was 
synthesized using the Petasis 3CR16 followed by a subsequent propargylation (Scheme 
1.5).  Amine 1.33 contains both polar (the alcohol and ester) and nonpolar (the alkene and 
alkyne) functional groups, and the selective pairing (for more on functional group pairing 
see section 1.1.7) of each of these functional groups allowed for the differentiation of 
1.33 into a number of scaffolds by simply subjecting 1.33 to a variety of reaction 

































First, the nonpolar enyne functionality of 1.33 was exploited in a number of 
cyclization reactions (Scheme 1.6).  Upon treatment with the Hoveyda-Grubbs II catalyst, 
1.33 underwent an enyne RCM to give 1.34, which reacted smoothly with dienophile 
1.35 in a hetero-Diels-Alder cycloaddition to give 1.36.  Cycloisomerization of 1.33 
under Pd catalysis resulted in the formation of 1.37, while a Ru catalyzed 
cycloisomerization resulted in a [5+2] cycloaddition to give 1.38.  Finally, a cobalt 
mediated Pauson-Khand reaction yielded enone 1.39.  Thus, by pairing the nonpolar 
functional groups present in 1.33 in various different transition metal mediated reactions, 





















































































The polar functional groups in 1.33 could also be utilized in a series of reactions 
leading to a different set of compounds (Scheme 1.7).  A gold catalyzed cyclization of the 
alcohol onto the alkyne resulted in the formation of the morpholine 1.40.  Base mediated 
lactonization of 1.33 provided 1.41.   Treatment of 1.33 with mCPBA in THF resulted in 
oxidation of the amine to the N-oxide, and a subsequent rearrangement provided 1.42.  
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The enyne functionality present in 1.42 could then be utilized in an enyne RCM/Diels-
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Lactone 1.41 still contains a 1,6-enyne unit identical to that found in 1.33, and 
therefore could to undergo the same set of cyclizations to give 1.44-1.47 (Scheme 1.8).  
Substrates containing enyne functionality are particularly well suited for reagent based 
differentiation due to their ability to participate in a number of transition metal mediated 
processes, and additional examples utilizing enyne substrates will be shown throughout 
this chapter.  Additionally, the sequencing of enyne RCM and Diels-Alder reactions is a 





























































The above sequence of reactions shows how with careful planning a reagent based 
differentiation can be used to access a diverse collection of compounds in a short number 
of steps.  Amine 1.33 contains four functional handles, and each was selectively utilized 
in reactions with a predetermined set of conditions to provide different heterocyclic 
products.  However, it is still a challenge for organic chemists to design and synthesize 
multifunctional substrates that are amenable to reagent based differentiation, and as more 
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of these pluripotent substrates are identified chemists and biologists will have access to 
more diverse regions of chemical space.   
1.1.5 Skeletal Diversity via Substrate Based Differentiation 
A second method for creating skeletal diversity is by using substrate based 
differentiation.  In this approach a collection of substrates with different appendages that 
pre-encode skeletal information are subjected to a common set of reagents to generate 
compounds with varied molecular skeletons (Figure 1.3).  The appendages, which have 
been referred to as σ-elements, are strategically placed so that the functionality they 
contain can dictate the outcome of the reaction, and thus the outcome of the reaction is 








A substrate based differentiation process developed by Schreiber that utilizes the 
Achmatowicz reaction17 is representative of this approach (Schemes 1.9 and 1.10).18, 19  
First, the functionalized furans 1.49-1.51 were synthesized on solid support.  These 
furans were oxidized with NBS, and the intermediates derived there from were treated 
with acid to induce cyclization.  In the case of 1.49, the σ-element is the free hydroxyl 
group, which under acidic conditions undergoes cyclization and dehydration to give 1.52.  
In the case of 1.50, the hydroxyl group is protected, preventing any subsequent 
cyclization reactions.  Furan 1.51, with two free hydroxyl groups, can undergo an 
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intramolecular ketalization to give 1.54.  Thus, the nature of the hydroxyl groups 

































































An additional set of σ-elements can also be incorporated onto the furan ring, 
adding a second level of control to dictate the outcome (Scheme 1.10).  The bromofuran 
1.55 underwent oxidative ring expansion to provide 1.59.  Interestingly, the dehydration 
that occurred in the reaction of 1.49 did not proceed in this case. The acetate protected 
bromofuran 1.56 was found to be unreactive under these conditions.  However, acetate 
1.57, with an aryl substituent on the furan, underwent oxidation to give enedione 1.60.  
When the hydroxyl group was left unprotected as in 1.58, oxidation occurred as expected, 
but upon exposure to PPTS a ring contraction, dehydration, and rearomatization to give 
1.61.  Thus, by incorporating two σ-elements into the starting substrate, a combinatorial 
approach could be utilized to generate skeletal diversity, and in this manner a library of 





























































































An alternative approach to substrate based differentiation was developed by 
Schreiber for generating indole alkaloid-like skeletons (Scheme 1.11).20  Starting from a 
single scaffold, 1.62, functional groups amenable for a Rh(II) catalyzed [1,3]-dipolar 
cycloaddition could be iteratively appended at one of three places around the scaffold, 
leading to 1.64-1.66.  Thus, three different modes of cyclization were made available.  
An A→B cyclization mode yielded 1.67, while the A→C and C→A modes of cyclization 
yielded 1.68 and 1.69, respectively.  These examples demonstrate how moving functional 















Possible Modes of Cyclization
A → B, B → A, C → A




















































































Schreiber has also developed an oligomer-based approach to generating skeletal 
diversity.21  In this approach reactive oligomers are synthesized from functionalized 
monomers and then transformed via substrate based differentiation into distinct scaffolds 
(Scheme 1.12).  The starting monomers, allylamines 1.70 and 1.71 and propargyl amine 
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1.72, were chosen because the olefin functionalities would be suitable for generating 
heterocyclic structures via RCM.  The monomers were first coupled via a Mitsunobu 
reaction to give three linear dimers, which were then cyclized using the Grubbs I catalyst 
in refluxing benzene.  Diene 1.73 underwent a simple RCM to give 1.76, while enynes 
1.74 and 1.75 underwent enyne RCM to provide 1.77 and 1.78, respectively.  The 1,3-
dienes generated by the enyne RCM were then subjected to a subsequent Diels-Alder 





































































































































Trimers 1.81 and 1.82 could be accessed from the original monomers by two 
sequential Mitsunobu reactions (Scheme 1.13).  The addition of a third site of 
unsaturation into these oligomers allows for double RCM reactions to occur leading to bi- 
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or tricyclic substrates.  Thus, dienyne 1.81 underwent a tandem enyne RCM/RCM to 
provide the bicylcic 1.83, which could undergo a subsequent Diels-Alder with 1.35 to 
generate 1.85.  The ene-diyne 1.82 underwent a similar double enyne RCM, which was 
followed by a subsequent 6π-electrocyclic ring closure and 1,5-hydride shift to provide 
1.84.  Tricycle 1.84 also underwent an intermolecular Diels-Alder to provide the complex 
polycyclic 1.86.  
The previous examples show how substrate based differentiations can be a useful 
strategy in DOS.  The challenge for synthetic chemists is to devise different combinations 
of appendages that allow for alternative modes of reactivity to be accessed, which in turn 




















































































































1.1.6 Stereochemical Control of Skeletal-Diversity 
The use of stereochemical control is a common tactic in TOS, but its application 
to DOS has been limited.  One example developed by Schreiber utilizes the 
stereochemistry, rather than the inherent reactivity, of a σ-element to control skeletal 
diversity (Scheme 1.14).22  Following a reaction sequence similar to that shown in 
Scheme 1.1, an Ugi-4CR/DA sequence provided the tricyclic 1.89.  Subsequent 
allylation, saponification, and esterification provided the separable diastereomers 1.91 
and 1.92.  Subjecting 1.91 to 10% Grubbs II catalyst in refluxing CH2Cl2 resulted in a 
ROM/RCM sequence to provide 1.93.  However, when 1.92 was reacted under identical 
conditions, only macrocycle 1.94 was formed.  It was determined that the relative 
orientation of the phenyl group on the ester side chain was controlling the outcome of 
these reactions.  When the phenyl group is α, as it is in 1.91, the ROM/RCM pathway 
dominates, but when the phenyl group is β, as it is in 1.92, macrocyclization is the 
preferred pathway.  This example shows how subtle changes in stereochemistry can be 





































































































1. CsOH, allyl Br, THF
2. Ba(OH)2, MeOH
3. 1.90, EDC, DMAP
    separation














1.1.7 The Build/Couple/Pair  Strategy 
The previously discussed strategies for DOS focused mainly on the reagent and 
substrate controlled differentiations of substrate molecules.  However, in many of these 
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examples, an underlying synthetic approach was utilized that up until this point has not 
been discussed.  This three step approach has been called the build/couple/pair (B/C/P) 
strategy (Scheme 1.15).23   
The first step, the build step, involves the syntheses of building blocks containing 
orthogonal sets of functionality that will be exploited in the subsequent coupling and 
pairing steps.  In the couple step, an intermolecular coupling of the building blocks 
assembled during the build stage leads to more complex molecules with a range of 
functionality. In addition to building in all of the requisite functionality needed for 
subsequent cyclizations, these first two steps also enable the incorporation of any desired 
stereochemical diversity. Finally, in the pair step the functional groups that were 
incorporated in build phase are paired in intramolecular reactions leading to cyclic 
scaffolds.  This final step, known as functional group pairing,24 is where the skeletal 





















Porco has recently developed a synthetic strategy that exemplifies the B/C/P 
approach,24 and this will be discussed as a representative example; however, many of the 
examples outlined in this Chapter also utilized this approach effectively.  The starting 
materials for Porco’s approach, 1.95 and 1.96, could be readily synthesized during the 
build phase and coupled using an asymmetric Michael addition catalyzed by the modified 
Cinchona alkaloid 1.97 (Table 1).  This coupling provided the densely functionalized 
products 1.98-1.101 in moderate yields and high enantioselectivities.  These substrates 
contain nonpolar alkene and alkyne functional groups, as well as polar nitro and ester 

































Entry Yield (%) ee (%)
















H 1.99 44 90
 
The nitro group in 1.98 could be selectively paired with an alkene or alkyne in 
1,3-dipolar cycloadditions to generate isoxazole scaffolds (Scheme 1.16).  To this end, 
alkyne 1.98 was treated with phenyl isocyanate and Et3N in toluene to form an 
intermediate nitrile oxide which underwent a 1,3-dipolar cycloaddition to give 1.102 in 
74% yield.  Similarly, alkene 1.199 could be treated with Boc2O and catalytic DMAP in 
toluene at 0 ºC to provide 1.103 in 86% yield and 2.6:1 dr.  
 


























1.98 R = propargyl




By incorporating two alkenes into 1.100, a substrate amenable to RCM was 
generated (Scheme 1.17).  Thus, diene 1.100 underwent RCM upon treatment with the 
Grubbs II catalyst, and subsequent reduction of the nitro group followed by cyclization 
provided the tricyclic lactam 1.104 in 45% yield over the two steps.  The two alkenes in 
1.100 were effectively paired via RCM, while the ester and nitro group were paired via 
reduction and lactam formation.  Thus, all four of the functional groups were fully 









    CH2Cl2, µW, 50 °C
2. Zn, AcOH, THF,






As with previous examples, the alkene and alkyne in 1.102 could be effectively 
paired under a number of different reaction conditions (Scheme 1.18).  Treatment of 
1.101 with the cationic Au(I) catalyst derived from AuCl(PPh3) and AgOTf resulted in a 
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cycloisomerization to 1.105.  The reaction of 1.101 with Co2(CO)8 provided the desired 
Pauson-Khand product 1.106 in 67% yield.  Finally, 1.101 underwent an enyne 
RCM/Diels-Alder sequence to provide 1.109 in excellent yield.  This example again 
highlights the potential number of cyclization modes that are accessible by pairing an 















































    AgOTf
    toluene, 50 °C
67%
 
The B/C/P approach has a great amount of potential for DOS, and almost every 
example contained in this chapter utilizes this approach.  In fact, if proper care is taken in 
the design of the synthetic route almost any functional group can be incorporated during 
the build and couple stages for use in subsequent functional group pairing reactions.  This 
places a large burden on the coupling reactions, as they need to be efficient, high 
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yielding, and functional group tolerant.  One such strategy for the coupling stage that 
generally meets these criteria is the use of multicomponent reactions, and their 
application to DOS will be discussed herein.       
1.2 APPLICATIONS OF MULTICOMPONENT REACTIONS TO THE SYNTHESIS OF 
DIVERSE HETEROCYCLIC SCAFFOLDS 
1.2.1 Introduction 
Perhaps the most promising synthetic strategy for generating collections of 
diverse molecules is the sequencing of multicomponent reactions (MCRs) with 
subsequent transformations that lead to the generation of new compounds with increased 
molecular complexity and diversity (Scheme 1.19).25 Although this process of sequencing 
MCRs with subsequent cyclizations falls mainly under the build/couple/pair strategy of 
DOS, as evidenced by the examples shown in the previous section, MCRs are applicable 
to all of the DOS strategies.  
Multicomponent reactions are generally defined as reactions where three or more 
starting materials are allowed to react to form a product that incorporates a majority of 
the atoms contained in the starting materials.26  MCRs are by definition complexity-
generating reactions, making them ideal for use in DOS and drug discovery.27  However, 
the MCRs that are designed and implemented should be versatile so that each component 
of the MCR can incorporate a wide range of functionalities.  Then through the use of 
functional group pairing these functional groups can be selectively exploited in 
subsequent ring forming processes, leading to more diverse and complex structures.  This 
should lead to a situation where potentially any reaction can be utilized to transform the 
intermediates generated by the MCR into the target heterocyclic structures.  Additionally, 
the ring forming reactions should be chosen so that the products they generate still 
contain functional handles that can be further elaborated as needed. This combination of 
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MCRs with post-condensation modifications should then allow for access to a number of 







1.2.2 Applications of the Ugi-4CR and related Isocyanide Based MCRs. 
Since its publication in 195928 the Ugi four component reaction (Ugi-4CR) has 
become the most widely used MCR in organic chemistry.29, 30  The Ugi-4CR involves the 
combination of an aldehyde, amine, carboxylic acid, and an isocyanide and proceeds 
mechanistically as shown in Scheme 1.20.  First, the amine and aldehyde react to provide 
an imine, which is subsequently protonated under the acidic conditions to provide 
iminium ion 1.116.  The isocyanide then adds to the iminium ion to provide 1.117, and 
subsequent addition of the carboxylate ion provides 1.118.  An intramolecular acylation, 
known as the Mumm rearrangement,31 occurs as the final step to provide the desired 


























































The Ugi-4CR is very functional group tolerant and each of the four components 
can incorporate functionality for use in subsequent transformations, thus allowing for 
access to a number of cyclization manifolds.  It is then not surprising that there has been 
substantial work focused on the post condensation modifications of the Ugi-4CR,30, 32-34 
and much of this work will be described below.    
1.2.2.1 Ugi/de-Boc/Cyclization  
The incorporation of additional nitrogen functionality into the starting materials of 
the Ugi-4CR is desirable because this functionality can be utilized in subsequent steps for 
the synthesis of nitrogen containing heterocycles.  However, because primary amines are 
one of the four components of the Ugi-4CR, any additional amines that are to be 
incorporated need to be protected.  A commonly employed tactic is to Boc-protect the 
additional nitrogen for the Ugi-4CR, deprotect the resulting Ugi product, and then engage 
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the resulting free amine in a subsequent cyclization reaction.  This is commonly called 
the Ugi/de-Boc/cyclize (UDC) strategy, and has been employed in the synthesis of 
numerous heterocyclic scaffolds. 
Hulme has developed a UDC strategy that allows efficient access to 
quinoxalinone scaffolds (Scheme 1.21).35 The mono-protected phenylene diamine 1.119 
was reacted in the Ugi-4CR with a number of different aldehydes, glyoxylic acids, and 
isonitriles to give adducts 1.122.  Upon treatment with TFA in CH2Cl2 1.122 underwent 
deprotection and cyclization to give the target quinoxalinones 1.123 in good yields over 









































A similar two step procedure was later adapted for the synthesis of 
benzimidazoles (Scheme 1.22).36  However, in this case the fluorous-Boc (F-Boc) 
protecting group was utilized to allow for purification of the Ugi products by fluorous 
SPE (F-SPE).  When F-Boc protected 1.124 was utilized in the Ugi-4CR, the desired 
amides 1.126 were produced.  Subsequent deprotection and cyclization produced the 

















































A three-step route to γ-lactams utilizing a convertible isonitrile and the UDC 
strategy has also been reported by Hulme (Scheme 1.23).37 The reaction of the Armstrong 
convertible isocyanide 1.12838 and Boc-protected amino aldehydes 1.129 with carboxylic 
acids and amines formed 1.130.  Treatment of 1.130 with AcCl in MeOH/THF resulted in 
deprotection of the amine and conversion of the cyclohexenyl amide to the methyl ester, 
and subsequent base mediated lactam formation provided the desired γ-lactams 1.131.  
The yields for this sequence were not reported, and purities of the products as determined 
























    MeOH/THF
2. MP-carbonate









Habashita has demonstrated that the UDC sequence can be utilized for 
synthesizing spirodiketopiperazines that were shown to be selective CCR5 antagonists 
(Scheme 1.24).39  Boc-protected amino acids 1.133 were reacted with ketones 1.132, 
amines 1.111, and a resin bound isonitrile to give 1.135.  Boc-deprotection, acid 
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catalyzed cyclization, and resin cleavage provided the desired spirodiketopiperazines 































    2,6-lutidine
    CH2Cl2
          or
    TFA/CH2Cl2
2. AcOH  
















The UDC sequence has also been applied to the synthesis of medium sized 
lactams via a Pd catalyzed carbonylation/amidation reaction (Scheme 1.25).40  The Ugi-
4CR of amine 1.137, 2-iodobenzaldehyde (1.138), acid 1.140, and t-butyl isocyanide 
provided the Ugi adduct, which was subsequently treated with HCl in dioxane to provide 
1.141 in 69% over two steps.  When 1.141 was subjected to Pd catalyzed carbonylation 









































A variant of the Ugi-4CR that accesses tetrazoles by substituting TMSN3 for the 
normal carboxylic acid component was utilized by Hulme in a UDC pathway to access 
azepine-tetrazoles 1.148 (Scheme 1.26).41 Thus, when Boc-protected amino aldehydes 
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1.143 were reacted with secondary amines, methyl-isocyano acetates 1.144, and TMSN3 
the desired tetrazoles 1.147 could be synthesized.  A two step Boc-
deprotection/cyclization sequence provided the desired azepine-tetrazoles in moderate 











































    DMF/
   dioxane, ∆
1.147 1.14845-75%
3 steps  
The examples above show how the UDC strategy can be applied to the synthesis 
of a number of interesting nitrogen containing scaffolds.  However, this is not a 
comprehensive list, and additional examples of this reaction sequence can be found 
throughout this Chapter and in the literature.   
1.2.2.2 Ugi 4CR/Intramolecular  Cyclization to Give Benzodiazepines 
Benzodiazepines are an important class of biologically active compounds and are 
considered to be the prototypical privileged structure.3  Therefore it is not surprising that 
these molecules have attracted considerable attention from synthetic chemists.  One of 
the notable routes to benzodiazepines involves the sequencing of the Ugi-4CR with a 
subsequent cyclization, usually via amide formation.  Armstrong was the first to apply 
the Ugi reaction to the synthesis of 1,4-benzodiazepine-2,5-diones (Scheme 1.27).38, 42 
The combination of a number of amines and aldehydes with anthranilic acid derivatives 
1.151 and 1-isocyanocyclohexene (1.128) produced the desired amides 1.151 in 
reasonable yields.  Upon treatment with acid, 1.151 underwent cleavage of the 
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convertible isocyanide and cyclization to provide 1.153.  Interestingly, the anthranilic 
nitrogen atom did not need to be protected for this reaction sequence; however, it was 










































Since Armstrong’s initial report, additional approaches to benzodiazepines using 
the Ugi-4CR have been reported.  Marcaccini has developed two separate approaches 
utilizing a tandem nitro group reduction/cyclization protocol.  In the first of these 
approaches, nitro benzoic acid 1.154 and cyclohexyl isocyanide were allowed to react 
with a number of amino esters 1.155 and aldehydes to provide the desired Ugi products 
(Scheme 1.28).44 Upon treatment with iron powder in warm acetic acid the nitro group in 
1.157 was reduced, and cyclization occurred to produce the 1,4-benzodiazepine-2,5-












































The second approach developed by Marcaccini led to the synthesis of a number of 
4,5-dihydro-3H-1,4-benzodiazepine-5-ones (Scheme 1.29).45 Nitro benzoic acid 1.159 
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and phenacyl amine 1.161 was allowed to react with a number of isonitriles and 
aldehydes (or ketones) to provide the desired Ugi products in good yields.  Reduction of 
1.162 and subsequent cyclization provided the desired benzodiazepines 1.163 in 













































1.2.2.3 Ugi 4CR/Intramolecular  Alkylation 
When the starting materials for the Ugi-4CR contain appropriately disposed 
leaving groups, substrates can be synthesized that are suitable for cyclization via 
intramolecular substitution reactions leading to a number of different sized heterocycles.  
Marcaccini has developed an approach to β-lactams and succinimides that utilizes an 
intramolecular enolate alkylation (Scheme 1.30).46, 47 The reaction of cinnamaldehyde 
(1.164), chloroacetic acid (1.165), cyclohexyl isonitrile (1.156), and amines 1.149 yielded 
the Ugi adducts 1.166 in good yields.  Upon treatment with KOH in MeOH 1.166 
underwent deprotonation and cyclization to give β-lactams 1.167.  However, when R1 is 
an electron-poor aromatic group, the β-lactam undergoes a subsequent rearrangement 















































When aromatic aldehydes were utilized in the Ugi-4CR with chloroacetic acid, 
the resulting Ugi adducts 1.170 could be cyclized upon treatment with KOH to provide 
diketopiperazines 1.171 (Scheme 1.31).48 Thus, by changing the nature of the aldehyde, 
the selectivity of the deprotonation changed allowing for a different cyclization manifold 
to be accessed.  However, it should be noted that Ugi products generated from aliphatic 

































When the carboxylic acid is changed from chloroacetic acid to trichloroacetic acid 
the previously described pathway can allow for access to hydantoin ring systems 
(Scheme 1.32).49  In this case nucleophilic attack on the trichloroacetamide carbonyl and 
displacement of CCl3- occurs preferentially to the intramolecular alkylation.  Thus, when 
Ugi product 1.173 was treated with NaOEt in EtOH cyclization occurred to give 1.174.  
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The previous three examples are nice representatives of a substrate based differentiation 
pathway where by simply altering the nature of two of the four components control over 































The related three component Passerini reaction (P-3CR)50 can also be utilized for 
the synthesis of β-lactams (Scheme 1.33).51  The reaction of α-chloroketones 1.175 with 
carboxylic acids 1.112 and isocyanides 1.113 provided the Passerini adducts 1.176 in 
good yields. Upon treatment with CsF and a phase-transfer catalyst in THF, 1.176 
underwent cyclization to give the desired β-lactam 1.178.   When KOH was employed as 










































Riva has recently shown that incorporating an allylic leaving group into one of the 
Ugi starting materials led to substrates that can undergo intramolecular SN2’ reactions to 
generate 2-vinyl pyrrolidines.52, 53 When allylic carbonate 1.179 was incorporated into the 
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Ugi-4CR a substrate amenable to Pd catalyzed allylic amination was generated (Scheme 
1.34).  Treatment of 1.182 with catalytic Pdº resulted in ionization of the allylic carbonate 
and cyclization to give 1.183.  It should also be noted that the corresponding allylic 
alcohols can be cyclized using Pd(II) catalysis, but the yields for this reaction were 











































dr up to 89:11
 
1.2.2.4 Ugi 4CR/Intramolecular  SNAr  
The sequencing of the Ugi-4CR and with nucleophilic aromatic substitution 
reactions (SNAr) has been shown to provide rapid access to a number of benzo-fuzed 
heterocyclic scaffolds.  Tempest and Hulme were the first to exploit the utility of this 
reaction sequence for the synthesis of benzodiazepines and benzoxazepines.54  When 
mono Boc-protected diamines 1.185 were used in conjunction with benzoic acid 1.184 a 
UDC sequence could be set up to provide the desired benzodiazepines (Scheme 1.35).  
The Ugi 4CR of 1.184, 1.185, and aldehydes 1.110 and isonitriles 1.126 produced the Ugi 
products in good yields.  Subsequent treatment of 1.186 with TFA cleaved the Boc group 
and treatment with resin bound morpholine induced the SNAr reaction providing 1.187.  
 
 









































    CH2Cl2
2. PS-morpholine
    DMF
1.187
30-76% 
3 steps  
Hulme and Tempest later showed that by incorporating Boc-protected amino 
aldehydes 1.143 a different set of functionalized benzodiazepines could be accessed 
(Scheme 1.36).55  The Ugi-4CR of aldehyde 1.143, acid 1.184, amines 1.111 and 
isonitrile 1.121 provided the Ugi adduct 1.188.  Deprotection of 1.188 with TFA 
provided the corresponding amine, which was treated with resin bound morpholine to 













































    DMF
44-72%
3 steps  
When amino alcohols 1.190 were used as the amine inputs, access to aryl ethers 
could be could be achieved (Scheme 1.37).54 The Ugi adducts obtained from acid 1.184, 
amino alcohol 1.190, and various aldehydes and isonitriles were treated with a resin 
bound amine base to promote cyclization and provide 1.192 in moderate yields over the 







































TBD = 1,5,7-triazabicyclo[4.4.0]dec-5-ene  
 45 
Access to benzothiazepines via sequential Ugi-4CR/SNAr has also been reported 
by Marcaccini (Scheme 1.38).56  For example, the chloroacetamide 1.194 was accessed in 
a straightforward manner using the Ugi-4CR. Treatment of 1.194 with thiourea in acetone 
provided an isothiouronium salt which reacted with KOH in EtOH to generate the desired 























    acetone
2. KOH













Access to the dibenz[b,f][1,4]oxazepine scaffold can be accomplished via an Ugi-
4CR/SNAr sequence when phenols are incorporated as one of the starting inputs.  Dai has 
shown that the Ugi product generated from aminophenol 1.196, bromobenzaldehyde 
1.197, nitrobenzoic acid 1.198, and isocyanides 1.199 can undergo a nucleophilic 
aromatic substitution upon heating with aq. K2CO3 in MeOH at 100 ºC in a microwave 
reactor (Scheme 1.39).57  The dibenzoxazepines thus formed could then undergo a Pd 































































Zhu has applied this tactic for biaryl ether synthesis to the preparation of a 
number of natural product-like macrocycles (Scheme 1.40).58-60  The Ugi-4CR of acids 
1.1203, isonitriles 1.204, aldehydes 1.110, and amines 1.111 proceeded in the presence of 
NH4Cl in toluene at elevated temperatures to provide the 1.205 in moderate yields.  When 
treated with K2CO3 in DMF, compounds 1.205 underwent macrocyclization to give the 





















































Up to this point all of the sequential Ugi-4CR/SNAr sequences that have been 
discussed have utilized heteroatom nucleophiles.  However, Ivachtchenko has recently 
published a method for the synthesis of isoxindoles that utilizes a carbon nucleophile in a 
SNAr reaction (Scheme 1.41).61  The reaction of cyclohexylisocyanide (1.156), p-
methoxybenzyl amine (1.87), nitrobenzoic acids 1.184 or 1.198, and aldehydes 1.110 
provided the desired cyclization precursor 1.207.  Upon treatment with Et3N in DMF the 











































X = F or Cl  
1.2.2.5 Ugi-4CR/Intramolecular  Knoevenagel Condensation and Horner-
Wadsworth-Emmons Olefination  
The starting inputs of the Ugi-4CR can be functionalized such that the products 
can undergo intramolecular Knoevenagel condensations leading to a number of 
interesting structures.  Marcaccini has shown that by starting from a glyoxal and a 
carboxylic acid with an electron-withdrawing group in the α-position, substrates are 
generated that undergo an intramolecular Knoevenagel condensation and methylation 
leading to pyrroles (Scheme 1.42).62 Utilizing a three component Ugi reaction glyoxal 
imine 1.209 was reacted with cyanoacetic acid (1.210) and isonitrile 1.199 to provide the 
1.211.  Upon treatment with Et3N in MeOH cyclization occurred to give the resulting 


































    CHCl3/Et2O
1.211 1.21229-49%3 steps  
The P-3CR reaction can also be utilized in an analogous sequence leading to tetra-
substituted furans (Scheme 1.43).63, 64  The Passerini adduct obtained from aryl glyoxal 
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1.213, carboxylic acids 1.210 or 1.214, and isocyanide 1.199 could be cyclized upon 
treatment with Et3N, providing butenolides which underwent methylation with 
diazomethane to provide the desired furans.  This reaction sequence provides an 















































1.210 X = CN
1.214 X SO2Ar1  
When 2-nitrophenylacetic acid (1.218) was used as the acid input in the P-3CR 
the desired product 1.220 could be cyclized to give butenolide 1.221 (Scheme 1.44).65 
Reduction of the nitro group in 1.221 with Fe/AcOH gave the desired aniline which 



























































Access to quinolin-2-(1H)-ones can be achieved by an Ugi/Knoevenagel sequence 
when phenylketones are incorporated into one of the starting inputs (Scheme 1.45).  
Aminoketone 1.223 reacted smoothly with aldehyde 1.169, cyclohexyl isocyanide and a 
variety of carboxylic acids to generate 1.225.66 When the EWG was a nitrile or ester, 
spontaneous cyclization occurred to provide 1.226 in one step.  However, when the EWG 
was a sulfone, the addition of NaOMe was necessary to facilitate cyclization.  Thus, in 
one pot a number of quinolin-2-(1H)-ones could be accessed using this reaction 





































1.210: EWG = CN
1.214: EWG = SO2Ar1
1.224: EWG = CO2Et  
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The Ugi/Knoevenagel sequence can also be utilized for the synthesis of 2-
pyridone derivatives (Scheme 1.46).67 The incorporation of cinnamaldehyde and 
phenylglyoxylic acid (1.227) into the Ugi-4CR resulted in the formation of 1.228 in good 
yields.  Upon treatment with KOH in MeOH 1.228 underwent cyclization and 





































Diarylglyoxal monohydrazones can participate in the Ugi-4CR as the amine 
component, and when reacted in a Ugi/Knoevenagel sequence they can give rise to 
pyridazinone scaffolds (Scheme 1.47).68 Thus, the reaction of hydrazone 1.230 and 
cyanoacetic acid (1.210), with aldehydes and isonitriles gives rise to intermediate 1.231, 











































Similar to the Ugi/Knoevenagel sequence, the Ugi/Horner-Wadsworth-Emmons 
(HWE) sequence can be utilized to access nitrogen containing heterocyclic scaffolds.  
Dömling has shown that phosphonoacetic acid 1.233 is a viable input for the Ugi 
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reaction, thus allowing access to substrates amenable to HWE chemistry.69  
Phosphonoacetic acid 1.233 is advantageous over the cyanoacetic acids and malonic 
acids previously utilized in Ugi/Knoevenagel sequences because it offers the ability to 
incorporate a wider range of functional groups (R3 in 1.233) that cannot accessed 
otherwise.   
By incorporating phosphonoacetic acid 1.233 and glyoxal 1.218 into the Ugi-
4CR, 1.234 could be readily accessed (Scheme 1.48).  Upon treatment of 1.234 with Et3N 
and LiCl in THF the intramolecular HWE reaction took place to generate pyrrolidone 
1.235.  Phosphonoacetic acid 1.233 could also be utilized in an analogous P-3CR/HWE 
sequence giving rise to butenolides.70  Dihydropyridones 1.240 can also be accessed in 
good yields by incorporating β-ketoaldehyde 1.236 into the Ugi/HWE sequence (Scheme 



















































































The sequential Ugi/Knoevenagel and Ugi/HWE reaction pathways have proven 
themselves to be efficient methods for generating a number of five- and six-membered 
nitrogen containing heterocycles.  Similarly, by sequencing the P-3CR with these two 
post condensation reactions a number of functionalized butenolides and furans can be 
accessed.           
1.2.2.6 Tandem Ugi-4CR/1,4-Addition  
Andreana has recently developed a cascade sequence involving a tandem Ugi-
4CR/1,4-addition sequence (Scheme 1.50).71 The reaction of substituted benzylamines 
1.241 with fumaric acid 1.242, aldehydes 1.110, and isonitriles 1.126 proceeded in protic 
solvents under microwave heating to give the intermediary Ugi adduct 1.243.  When p-
methoxybenzyl amine (X = OMe, Y = H) was employed as the amine component, 1.243 
underwent an 1,4-addition reaction to provide the diketopiperazine 1.244.  However, 
when X = OH, an intramolecular 1,4-addition took place to give the spirocyclic 1.245.  
Interestingly, these subsequent cyclizations only took place when protic solvents were 
used.  When aprotic solvents like CH2Cl2 were used, the linear Ugi adduct 1.243 was the 























































up to 20:1 dr
50-95%
 up to 3:1dr
 
1.2.2.7 Sequential Ugi-4CR/Pictet-Spengler  
The sequencing of the Ugi-4CR with a Pictet-Spengler reaction has shown to be a 
useful method for the generation of tricyclic diketopiperazines (Scheme 1.51).72  By 
incorporating an electron rich aromatic as part of the isonitrile input, in conjunction with 
a glyoxylic acid, access to Ugi adducts 1.248 could be achieved.  Upon treatment of with 
TFA the Pictet-Spengler reaction took place to give 1.249.  While the yields for this two 
step sequence were acceptable, there was virtually no diastereoselectivity, and the 
diastereoselectivity for this process would need to be improved in order for this to 










































1.2.2.8 Sequential Ugi 4CR/Hydroamination 
Gold catalysis has in recent years received an increasing amount of attention 
amongst synthetic chemists.73  Therefore, it is not surprising that gold catalysis has been 
used in conjunction with the Ugi-4CR for heterocycle synthesis.  Dyker has exploited the 
ability of gold(III) to activate alkynes for nucleophilic attack in the synthesis isoindoles 
and isoquinolines (Scheme 1.52).74  The Ugi 5-center-4CR of aldehyde 1.250, valine 
(1.251), t-BuNC (1.139), and MeOH yielded 1.252 in 71% yield and 5:1 dr.  Treatment 
of 1.252 with AuCl3 in refluxing CH3CN resulted of the formation of isoquinoline 1.253 
in 35% yield and isoindole 1.254 in 38% yield.  Unfortunately the lack of regioselectivity 
















































1.2.2.9 Sequential Ugi 4CR/Radical Cyclization 
Although radical cyclizations have found widespread use in heterocycle synthesis, 
their use in conjunction with the Ugi reaction has been limited.  El Kaïm has utilized a 
two step Ugi-4CR/xanthate ester formation sequence to access substrates suitable for 
radical cyclization (Scheme 1.53).75  The Ugi product formed from allylamine, 
chloroacetic acid, aldehydes 1.110 and isocyanide 1.126 was treated in situ with 
potassium O-ethyl xanthate to provide the desired xanthate ester 1.257.  Treatment of 
1.257 with catalytic dilauroyl peroxide provided the γ-lactams 1.258 in good yields.  The 
six and seven membered lactams 1.259 and 1.260 could also be accessed by simply 































































More recently El Kaïm has developed a radical cascade for synthesizing indanes 
from Ugi products (Scheme 1.54).76  The reaction of 1.263 with β-ketoester 1.264 in the 
presence of Mn(OAc)3 provided the indane products 1.265 in moderate yields over the 
two steps. Interestingly, in this reaction the isocyanide functionality was completely lost 
in the cyclization product. The authors propose that this reaction occured via addition of 
radical 1.266 to 1.263 to give 1.267, which underwent an 1,4-aryl shift to give 1.268.  
Radical 1.268 is further oxidized by Mn(OAc)3 to give 1.239, which is then hydrolyzed 
to give 1.270.  Further oxidation of 1.270 by Mn(OAc)3 and cyclization provides indane 







































































































1.2.2.10 Sequential Ugi-4CR/6π-Photocyclization and Ugi-4CR/[2+2] Cycloaddition 
Djuric and co-workers have developed two approaches to heterocyclic scaffolds 
by using the Ugi-4CR in conjunction with photochemical cyclizations.  The first of these 
approaches utilizes a [2+2] ene-enone photocycloaddition (Scheme 1.55).77  The 
representative [2+2] cycloaddition precursor 1.274 was synthesized from allylamine, i-
PrNC, acetone and carboxylic acid 1.273 in 39% yield.  Upon exposure to hν in MeOH 
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the desired [2+2] cycloaddition took place to give 1.275 in 84% yield. Using this reaction 





































The second of these approaches involves a 6π-photocyclization that gives access 
to 3,4-dihydroquinolin-2(1H)-ones (Scheme 1.56).78  The desired cyclization precursors 
were readily accessible in good yields from aldehydes 1.110, aniline 1.276, 
benzylisonitrile, and acrylic acid 1.277.  Upon irradiation in acetonitrile the 6π- 
photocyclization took place to provide the desired quinolines 1.279 in low yields, but 


















































1.2.2.11 Sequential Ugi 4CR/[3+2] Cycloaddition 
A number research groups have reported the use of the Ugi-4CR for synthesizing 
substrates amenable to [3+2] dipolar cycloadditions.  In the course of investigating the 
mechanism of cleavage of the 1-isocyanocyclohexene convertible isocyanide (1.128) 
Armstrong found that an intermediate münchone 1.281 was formed from 1.280 upon 
treatment with acid (Scheme 1.57).38 In the presence of dipolarophiles such as DMAD, 
the münchone 1.281 could be trapped in a [3+2] dipolar cycloaddition to give the bridged 


















































Djuric and co-workers have shown that nitro groups incorporated into the Ugi 
products can be utilized in subsequent intramolecular nitrile oxide cycloadditions to 
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generate isoxazoles and isoxazolines (Scheme 1.58).79 The Ugi product 1.286, generated 
from propargyl amine, acid 1.285, aldehydes 1.110, and isonitriles 1.126, reacted with 
POCl3 and Et3N to generate the insipient nitrile oxide, which underwent a [3+2] dipolar 




































When azides were incorporated into the Ugi inputs, structures could be generated 
that were suitable for intramolecular azide-alkyne cycloadditions (Scheme 1.59).80 
Propargyl amine reacted smoothly with benzaldehyde, azido-acid 1.289, and cyclohexyl 
isocyanide to provide 1.290 in 65% yield.  Heating 1.290 in refluxing benzene provided 
the desired triazole 1.291 in 86% yield.  In this example the amine and acid inputs were 
paired in the cycloaddition; however, structures like 1.292 could be synthesized by 
pairing the amine and aldehyde inputs, and scaffolds similar to 1.293 could be accessed 






























































El Kaïm has published a route to indolizine scaffolds utilizing a sequential Ugi-
4CR/[3+2] cycloaddition (Scheme 1.60).81 The pyridinium salt 1.295, formed by reacting 
pyridine with Ugi adduct 1.294, underwent a Sonogashira reaction with a number of aryl 
iodides to provide a more reactive alkyne which underwent spontaneous cyclization 

















































In the demonstration of a new DOS folding pathway (see Scheme 1.14) Schreiber 
exploited the Ugi-4CR to generate a substrate suitable for reaction under Rh(II) catalyzed 
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1,3-dipolar cycloaddition conditions (Scheme 1.61).20 Carboxylic acid 1.297 reacted with 
indole carboxaldehyde 1.298, amine 1.87, and t-BuNC to provide 1.299 in 61% yield and 
1:1 dr.  After the reaction of the Ugi adduct 1.299 with 1.300 and subsequent separation 
of the diastereomers, diazetination provided the cyclization precursor 1.301 in excellent 
yield over the two steps.  The treatment of 1.301 with Rh2(O2CC7H15)4 in benzene at 50 
ºC resulted in the formation of the carbonyl ylide which underwent cyclization with the 



























































    PhMe, ∆
2. MsN3, Et3N










1.2.2.12 Tandem Ugi-4CR/Diels-Alder  Cycloaddition 
As previously shown in Section 1.1.2 the tandem Ugi-4CR/Diels-Alder (Ugi-
4CR/DA) is a powerful complexity generating reaction that has numerous uses in DOS.  
This tandem sequence was first reported by Paulvannan, who in 1999 showed that the 
Ugi products generated from furfural, benzyl aminde, benzyl isocyanide, and maleic or 
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fumaric acid derivatives underwent a spontaneous intramolecular furan Diels-Alder to 
provide oxa-bicyclic structures similar to 1.306 in good yields and with good levels of 
diastereoselectivity (Scheme 1.62).82 This method was later extended to include the use 




















1.306: X=O  70%, 92:8 dr










In their development of a cascade sequence involving a tandem Ugi/1,4-addition 
sequence (Scheme 1.52), Andreana discovered that thiophenes could also be diene 
partner in a Ugi-4CR/DA sequence (Scheme 1.63).71  When thiophene-2-carboxaldehyde 
(1.308) reacted with p-methoxybenzyl amine, benzyl isocyanide, and fumaric acid 1.242 
under the conditions of microwave heating the desired Diels-Alder adduct 1.309 could be 

































The ability of the Ugi-4CR/DA sequence to synthesis diverse heterocyclic 
structures can be further increased by carrying out a sequential ring opening reactions on 
the oxa-bridged bicycle.  As previously described ROM/RCM can be utilized when 
additional olefins are appended to the Diels-Alder adduct (see Section 1.1.2).  
Ivachtchenko has found that the Ugi-4CR/DA adduct 1.312 undergoes a ring 











































When acetylenic acids 1.314 are input into the Ugi-4CR, the adducts that are 
produced are isolable and do not under spontaneous cyclization (Scheme 1.65).85  
However, upon heating in toluene to 200 ºC the desired intramolecular cycloaddition 
occurs to provide 1.316 in good yields.  The Diels-Alder adducts then could be ring 
opened and aromatized to isoindolinones upon treatment with Yb(OTf)3 in refluxing 

















































The analogous Passerini adducts derived from furfural, acetylenic acid 1.314, and 
isocyanide 1.199 were also found to undergo an intramolecular Diels-Alder cycloaddition 
(Scheme 1.66).85  Although attempts to perform the Diels-Alder reaction of 1.318 under 
thermal conditionals were unsuccessful due to its instability, it was found that the 
Me2AlCl catalyzed cycloaddition proceeded in good yields at -78 ºC.  Interestingly, all 




























-78 °C → rt
68-77%
1.319  
The Ugi-4CR/DA sequence has been applied to the synthesis of a number of 
indole, benzofuran, and benzothiophene scaffolds (Scheme 1.67).86 The Ugi reaction of 
aldehydes 1.320, acetylenic acids 1.314, anilines 1.321, and isonitriles 1.199 provided 
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Ugi adducts 1.322.  The heating of 1.322 in xylenes at 140 ºC induced the desired Diels-
Alder reaction, and oxidation with DDQ provided the desired heteroaromatics 1.323 in 

































   140 °C
2. DDQ
    CH2Cl2, ∆




Zhu has developed a three-component variant on the Ugi-4CR involving the 
reaction of amines, aldehydes, and α-isocyano acetamides that generates oxazoles in 
good yields.87  When allylamine 1.324 was utilized as the amine input, a spontaneous 
intramolecular 4+2 cycloaddition occured between the oxazole 3.326 and the pendant 
alkene leading to 1.327 (Scheme 1.68).88 The oxa-bridged 1.327 underwent ring-opening 
and aromatization upon treatment with TFA in MeOH to provide pyridines 1.321.  This 
3CR was later applied to the synthesis of a number of oxa-bridged tetracyclic 
tetrahydroisoquinolines89, 90 and to the core structure of the alkaloid natural product 

























































This reaction was also expanded to a four component reaction by including the 
addition of an acid chloride (Scheme 1.69).87, 92  Thus, the reaction of primary amine 
1.149, aldehyde 1.150, and isonitrile 1.329 provides oxazole 1.330, which can be reacted 
in situ with acid chloride 1.331 to provide after ring opening and aromatization the 
pyrrolopyridine 1.332 in moderate yields over the two steps.  In contrast to the previous 
example which retained the morpholine ring during ring opening and aromatization under 







































As evidenced by the examples shown in this section and in Section 1.1.2 the 
tandem Ugi-4CR/DA is a powerful complexity-generating reaction that can be utilized to 
access a diverse collection of heterocyclic scaffolds.  These Diels-Alder adducts can also 
be elaborated to allow access to even more types of scaffolds, further showing the 
synthetic power of this reaction sequence.     
1.2.2.13 Sequential Ugi 4CR/RCM 
Ring-closing metathesis (RCM) has in recent years shown itself to be a powerful 
method for the synthesis of heterocyclic structures.93  When used in conjunction with the 
Ugi-4CR, access to diverse functionalized heterocyclic structures can be achieved in as 
little as two steps.  The first use of RCM in conjunction with the Ugi-4CR was reported 
by chemists at Amgen and Array BioPharma in 1999 for the synthesis of Freidinger 
lactams (Scheme 1.70).94 The solid phase synthesis of 1.337 was carried out using a 
cinnamyl amine resin 1.333 as the amine input, which allowed for cleavage of the resin 
during the RCM step.  The Ugi-4CR of 1.333, isobutyraldehyde (1.336), isocyanide 
1.334, and Boc-protected dipeptide 1.335 proceeded smoothly to give 1.337.  Treatment 
of 1.337 with 5% of the Grubbs I catalyst in DCE at 80 ºC provided the desired seven-
membered lactam, which was deprotected to provide 1.339 as a mixture of diastereomers 











































































Banfi has reported the use of an Ugi/RCM sequence for accessing 9-membered 
lactams (Scheme 1.71).95-97 Starting from imine 1.340, the Ugi-3CR with isonitrile 1.341 
and acid 1.112 provided the desired Ugi adduct 1.342 in good yields.  Diene 1.342 
underwent RCM with the Grubbs I catalyst to provide lactam 1.343.  Lactam 1.343 was 



































Westermann has applied the Ugi/RCM sequence to the synthesis of bicyclic 
lactams (Scheme 1.72).98 Utilizing a 3-component-4-centered Ugi reaction 1.346 could 
be synthesized from ketone 1.344, allylamine, and butylisocyanide in 57% with no 
diastereoselectivity.  The RCM of 1.346 proceeded smoothly using the Grubbs I catalyst 


























Westermann also found that diallyl ketone 1.348 could also be utilized in a Ugi-
4CR leading to tetraene 1.351 (Scheme 1.73).  The tetraene 1.351 is functionalized to 
undergo a double RCM, with two potential modes of cyclization being possible.  Upon 
treatment with the Grubbs I catalyst, 1.351 underwent double RCM to provide a mixture 
(1:1) of 1.352 and 1.353 in only 34% yield over the two steps.  The formation of a 
mixture of products was in agreement with the results seen by Ma, who has shown that 
the outcome of related RCM reactions is highly dependent on whether a quaternary or 
tertiary stereogenic center is formed, with quaternary centers leading to equal mixtures of 






































Martin has recently shown that ketone 1.354 could be employed in the Ugi-4CR 
reaction as a masked equivalent of divinyl ketone.100  However, it was found that pre-
formation of imine was necessary prior to addition of the carboxylic acid and isonitrile 
(Scheme 1.74).  Thus, from allylamine, t-butyl isocyanate, ketone 1.354, and crotonic 
acid, Ugi adduct 1.355 could be formed.  A two step oxidation/elimination sequence 
provided tetraene 1.356 in 86% yield.  When treated with the Grubbs II catalyst, 1.56 
underwent RCM to give 1.357.  Interestingly, none of the double RCM product or lactam 
































     -78 → -20 °C
2. p-xylene, pyr



















A number of approaches to macrocyclic structures have been reported utilizing 
both the Passerini101 and Ugi reactions.12, 102-104 An example of an Ugi-4CR/RCM 
sequence leading to 16-membered macrocycles developed by Kazmaier is shown in 
Scheme 1.75.102, 104 By incorporating alloc-protected amino acids 1.358 and allyl 
isocyanoacetate 1.359 into the Ugi-4CR, substrates amenable to RCM leading to 
macrocyclic structures could be generated.  In the event, the Ugi-4CR of amine 1.360 and 
isobutyraldehyde with 1.358 and 1.359 generated 1.361 in good yields and high levels of 
diastereoselectivity. The subsequent RCM with Grubbs I proceeded to provide 


























































Guanti and co-workers have reported on the use of optically pure bicyclic amino 
acid derivatives as chiral auxiliaries in the Ugi 5-center-4-component reaction.105 In 
addition to this, they have found that when using the N-allylated bicyclic amino acid 
1.366 substrates are generated that can undergo ROM/RCM to generate optically pure 
fused polycyclic scaffolds (Scheme 1.76).106 The reaction of 1.363 with aldehydes and 
isocyanides in MeOH provided the desired Ugi products 1.364 in moderate to good yields 
as a single diastereomer.  The ROM/RCM proceeded without incident using the Grubbs 


































An analogous reaction sequence could also be performed using the 
propargylamine 1.366 (Scheme 1.77). The U-3CR of 1.366 provided the desired 1.368, 
which could undergo a ROM/enyne RCM to give 1.369.  As previously shown, the 
products of enyne RCM reactions are suitable substrates for subsequent Diels-Alder 
reactions, and 1.369 was reacted with 1.370 and 1.372 to give the tricyclic 1.371 and 






















































































The previous examples have shown that by incorporating appropriately disposed 
olefins into the Ugi inputs, substrates suitable for RCM can be generated. The Djuric 
research group at Abbott Laboratories has shown that if an aryl halide input is 
incorporated, in addition to the olefin inputs required for RCM, that products are 
generated that can under an Ugi/RCM/Heck reaction sequence leading to bridged bicyclic 
lactams (Scheme 1.78).107  Thus, the Ugi-4CR of allylamine, i-PrNC, 2-
iodobenzaldehyde, and unsaturated acid 1.374 provided 1.375 in 84% yield.  Amide 
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1.376 then underwent a two step RCM/Heck reaction sequence to give bicyclic amide 
1.376 in good yield.  Using this three step reaction sequence a number of other bridged 
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1.2.2.14 Sequential Ugi-4CR/Heck Cyclization 
As shown in the previous Ugi/RCM/Heck cyclization sequence, aryl halides can 
be incorporated into the Ugi inputs leading to structures that can undergo Heck 
cyclizations leading to interesting heterocyclic scaffolds. The first example of sequencing 
the Ugi-4CR with an intramolecular Heck reaction was reported in 2004 by Yang and co-
workers, who demonstrated a two step synthesis of isoquinolines utilizing this reaction 
sequence (Scheme 1.79).108 The desired Heck precursor 1.381 could be isolated in good 
yields by reacting allylamine with benzaldehydes 1.379, isonitriles 1.199, and 
iodobenzoic acids 1.380.  Subsequent Heck cyclization of 1.81 provided 1.382 or 3.383 
in good yields.  Isoquinoline 1.382 resulted from an iodobenzoic acid input, while 1.383 
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was formed from a starting iodobenzaldehyde. In both cases the exocyclic double bond 













































X = H or I
or
 
Shortly after the report of Yang, Djuric and co-workers reported a similar 
Ugi/Heck sequence leading to isoquinolines.109 However, in addition to isoquinoline 
scaffolds, seven-membered lactams were also shown to be accessible (Scheme 1.80).  
The Ugi-4CR of amino ester 1.384 with benzaldehyde, 2-iodobenzoic acid, and benzyl 
isocyanate proceeded in almost quantitative yield to give 1.386.  The Heck reaction of 




































Additionally, Umkehrer and co-workers have shown the Ugi/Heck sequence can 
be used to access indole110 and oxindole scaffolds.110, 111  Access to indole scaffolds could 
be readily accomplished by incorporating a 2-bromoaniline as the amine input along with 
a cinnamaldehyde as the aldehyde input (Scheme 1.81).  Thus, the reaction of 
bromoaniline 1.388 with cinnamaldehydes 1.389, acids 1.112 and isonitriles 1.113 
provided the Heck reaction precursor.  It was found that the nature of the carboxylic acid 
input greatly influenced the outcome of the Heck reaction.  When R3 = methyl or phenyl, 
the desired Heck reaction proceeded to provide 1.391 in moderate yields over the two 
steps.  However, when R3 = H, the resulting Heck product underwent formamide 






















































Access to oxindoles could also be achieved using an analogous reaction sequence 
with acrylic acid inputs incorporating the requisite olefin (Scheme 1.82). 111  Thus, the 
Heck cyclization precursor 1.394 was synthesized and subjected to the Heck reaction 




































1.2.2.15 Sequential Ugi-4CR/Intramolecular  Arylation or  Amidation (N-Arylation) 
The aryl halides that are incorporated in the Ugi reaction can also be utilized in 
intramolecular arylation or amidation (N-arylation) reactions.  The research groups of 
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Yang and Zhu have independently developed routes to functionalized 
dihydrophenanthridines by utilizing a Ugi-4CR/intramolecular arylation sequence 
(Scheme 1.83).112, 113  The Ugi-4CR of iodobenzaldehydes 1.396, anilines 1.286, benzoic 
acids 1.397, and isonitriles 1.126 provided the arylation precursors 1.398 in good yield.  















































Zhu has also developed a tandem intramolecular arylation/amidation sequence 
that has led to the synthesis of a number of benzodiazepines (Scheme 1.84).114, 115 To 
perform this tandem reaction, the di-aryliodide 1.401 was first synthesized from 
aldehydes 1.110, amines 1.111, isonitrile 1.400, and iodobenzoic acid 1.385.  Upon 
treatment with Pd(OAc)2 and KOAc in DMSO at 120 ºC amide 1.401 underwent double 
cyclization to give 1.402 in good yields.  It was later found that the tandem 
arylation/amidation substrates 1.401 could undergo a tandem amidation/intermolecular 
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Heck reaction sequence.116  When a coupling partner such as dihydrofuran was 
introduced to the reaction, the desired amidation/intermolecular Heck reaction proceeded 
to give 1.403 in variable yields. Interestingly, the intermolecular Heck reaction out 
competes the intramolecular arylation, even under reaction conditions that were identical 
to those used in the arylation/amidation protocol.  Other coupling partners such as methyl 
















































It was subsequently found that when a copper-based catalyst system was utilized 
with these systems that only the amidation reaction occurred, and after some optimization 
this was developed into a general method for the synthesis of benzodiazepines (Scheme 
1.85).115  The Ugi-4CR proceeded smoothly to provide the desired cyclization precursors 
1.405.  Upon treatment with catalytic CuI and thiophene carboxylic acid in the presence 
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of K2CO3 in DMSO at 110 ºC, 1.405 underwent the desired amidation to provide 1.407 in 








































In 2006 Kalinski and Zhu independently reported the synthesis of oxindoles 
utilizing a Pd catalyzed N-arylation.  Kalinski’s approached utilized aryl bromides, and 
the yields for the cyclization were only modest at best (Scheme 1.87).117  Zhu was able to 
achieve much higher yields (60-99%) for the cyclization by utilizing aryl iodides and 
microwave heating.118  However, Kalinski did demonstrate that using a 2-bromoaniline or 
2-bromobenzoic acid, quinoxalin-2-ones 1.411 and benzodienzepines 1.412 could be 
































































Dai has developed an interesting tandem Ugi-4CR/O-alkylation/amidation 
sequence (Scheme 1.88).119  The Ugi product of 2-bromobenzaldehyde, amino phenol 
1.196, bromoacetic acid 1.413, and isonitrile 1.121 was treated in situ with K2CO3 to 
provide the phenolic ether 1.414.  Subsequent Cu(I) catalyzed amidation provided the 











































1.2.2.17 Ugi 4CR/Intramolecular  Cyclization to give Benzoxazoles and 
Benzothiazoles 
Benzoxazoles and benzothiazoles are important classes of compounds found in 
both natural products and drug like molecules.  Hence, efforts have been made to 
synthesize libraries of these compounds using the Ugi-4CR.  Spatz has reported a two 
step procedure for accessing both benzoxazoles and benzothiazoles that utilizes a Ugi-
4CR followed by a Cu(I) catalyzed cyclization (Scheme 1.89).120  The reaction of amines 
1.180 and aldehydes or ketones 1.160 with bromophenylisocyanate 1.416 and either 
carboxylic acid 1.181 or thienoic acids 1.417 provided the desired cyclization precursors 
in variable yields.  Subjection of 1.418 to the Cu catalyzed cyclization conditions 
provided the desired benzoxazoles and benzothiazoles in up to 99% yields.  It should also 
be noted that aryl chlorides and fluorides could also be utilized in the synthesis of the 





































1.181: X = O




Zhu has recently shown that the Ugi-4CR can be utilized to synthesize substrates 
that are amenable for an oxazole formation/C-H activation sequence (Scheme 1.90).121 
Thus, the Ugi adduct 1.421 containing two aryl iodides was synthesized from amine 
1.149, aldehyde 1.150, iodobenzoic acid 1.385, and iodophenylisocyanate 1.420 in 
moderate to good yields.  First, 1.421 underwent a Cu(I) catalyzed cyclization to form the 
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desired benzoxazoles in variable yields.  The benzoxazoles were then reacted in the Pd 


















































1.2.2.18 Applications of the Ugi-Smiles Reaction 
In 2005 El Kaïm reported a variation of the Ugi-4CR that incorporates electron 
deficient phenols in place of the usual carboxylic acid input.122 Mechanistically, the 
reaction differs from the Ugi-4CR in that the reaction proceeds via a Smiles 
rearrangement123 instead of the normal Mumm rearrangement (Scheme 1.91), and 




























































The Ugi-Smiles reaction works with a variety of electron deficient phenols, 
including functionalized heterocyclic phenols such as pyrimidines 1.430 (Scheme 1.92).  
By incorporating different functional handles into 1.430, a variety of different cyclization 
modes could be accessed.  When an allyl group was incorporated in 1.430 (X = allyl) the 
products of the Ugi-Smiles reaction could undergo RCM and double bond isomerization 
to give 1.433.124  By incorporating an iodide into 1.430 (X = I) an Ugi-Smiles/Heck 
cyclization pathway was accessible to access pyrrolo-pyrimidine 1.434.125 Currently 
these are the only two examples of post-condensation modifications of Ugi-Smiles 
products, however, the potential exists for sequencing the Ugi-Smiles with other 


































1.431: X = allyl













The above examples demonstrate why the Ugi-4CR has become the benchmark 
MCR for synthesizing diverse heterocyclic scaffolds.  The functional group tolerance of 
the U-CR has allowed for it to be sequenced with a large number of subsequent 
cyclization reactions, each leading to a distinct scaffold.    Although a large volume of 
work has been completed with the Ugi-4CR, as chemists continue to devise new 
cyclization manifolds to sequence with MCRs the Ugi-4CR will continue to remain an 
important reaction in the synthetic community.   
1.2.3 Applications of the van Leusen 3CR 
Polycyclic imidazole containing scaffolds are found in a number of natural 
products and biologically active compounds, making them attractive targets for synthetic 
chemists. The van Leusen imidazole synthesis combines aldehydes, amines, and 
substituted TosMIC reagents to provide substituted imidazoles in pot.126  Researchers at 
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Abbott Laboratories have shown that by incorporating the appropriate functionalized 
starting materials, the van Leusen 3CR can be sequenced with a number of ring forming 
reactions leading to polycyclic imidazole scaffolds, which are prevalent in a number of 
natural products and biologically active compounds.127-129 
Unsaturated amines and aldehydes can readily be input into the van Leusen 3CR 
leading to substrates suitable for subsequent RCM130 and enyne RCM131 (Scheme 1.93). 
Thus, the reaction of 4-pentenal (1.435) with allylamine and phenyl TosMIC (1.436) 
provided 1.437, which underwent RCM upon treatment with the Grubbs II catalyst to 
provide bicyclic imidazole 1.438.  Enyne RCM precursor 1.440 could be accessed simply 
by changing the amine component from allylamine to the propargyl amine 1.439.  Upon 
treatment with the Grubbs II catalyst, the enyne RCM occurred smoothly to provide 1.433 
in good yields for the two steps.  For both of these RCM reactions it was necessary to 
protonate the imidazole with TsOH prior to adding the Grubbs catalyst, thus preventing 


























i. TsOH, CH2Cl2, ∆
ii. 10% Grubbs II





















i. TsOH, CH2Cl2, ∆
ii. 5% Grubbs II




Aryl halides can also be incorporated into the van Leusen 3CR for use in 
subsequent Heck cyclizations (Scheme 1.94). 133, 134 Aryl bromide 1.443 could be 
accessed in one step from bromobenzaldehyde 1.197, homoallylamine, and phenyl 
TosMIC. Upon treatment with Pd(0) in acetonitrile under conditions of microwave 


























It was also discovered that in the absence of a pendent alkene, the aryl halides 
could undergo an intramolecular C-arylation reaction (Scheme 1.95). 135  The requisite 
arylation substrate 1.447 could readily be accessed from phenethyl amine 1.445, 
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isovaleraldehyde (1.446), and phenyl TosMIC. The subsequent arylation was found to 
proceed under conditions utilizing catalytic Pd(OAc)2 and stoichiometric CuI to generate 






























A tandem van Leusen 3CR/azide-alkyne cycloaddition sequence leading to fused 
triazolo-imidazole scaffolds has also been demonstrated (Scheme 1.96).136  The reaction 
of propargylamine with azidobenzaldehydes 1.449 and ayrl TosMIC reagent 1.436 
generated an intermediary azide that underwent a 3+2 dipolar cycloaddition to provide 




















The van Leusen 3CR has initially shown considerable promise for synthesizing 
diverse collections of imidazole containing scaffolds.  However, to date only a handful of 
ring forming reactions have been utilized in conjunction with the van Leusen 3CR and 
further efforts are needed to expand this reaction sequence to other cyclization manifolds 
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leading to additional imidazole scaffolds.  Additionally, to date there has only been one 
published example where the TosMIC input contained functionality amenable for a 
subsequent cyclization,130 and the expansion of this methodology to include more 
examples with functional handles on the TosMIC derivative would further expand the 
scope of accessible scaffolds.   
1.2.4 Applications of the Aldehyde/Amide/Dienophile Reaction 
Beller has developed a novel MCR that involves the coupling of an amide, 
aldehyde, and dienophile (the AAD reaction)137 that has been shown to generate 
structures amenable to post-condensation modification.138-140 The AAD reaction of amide 
1.451 with crotonaldehyde and maleimide 1.452 provided the desired enyne 1.454 in 
71% yield.  Methylation of 1.454 with MeI provided 1.455 (Scheme 1.97).138, 139  As 
previously discussed in this Chapter, enyne substrates such as 1.455 are amenable to 
reagent based differentiations leading to a number of different scaffolds.  In this case it 
was shown that enyne 1.455 could undergo a Ru catalyzed Pauson-Khand reaction to 




































































Alternatively, the amide input can be functionalized with an aryl halide leading to 
structures amenable for subsequent Heck cyclizations (Scheme 1.98).140  Phenanthridone 
1.458 could be synthesized from acrylonitrile (1.455), amide 1.456, and crotonaldehyde 
via a two step AAD/Heck reaction sequence.  The phenanthridone core structure is found 
in a number of alkaloid natural products,141 highlighting the ability of this method for 


































1.2.5 Applications of the α,γ-Difunctionalization Reaction of β-Ketoesters and 
Amides  
Rodriguez has reported the multicomponent synthesis of α,γ-difunctionalized β-
ketoesters and amides starting from aldehydes, alkyl halides, and β-ketoesters or 
amides.142 More recently Rodriguez has shown that this 3CR can be sequenced with a 
number of transition metal catalyzed ring-closing reactions that lead to the generation of 
spiroheterocyclic scaffolds.143    
β-Ketoester 1.462 or amide 1.463 can undergo reaction with furfural and either 
allyl bromide or propargyl bromide 1.464 leading to 1.465 or 1.467, respectively 
(Scheme 1.99).  Diene 1.465 could undergo RCM with Grubbs II to generate the 
























































1.462: Z = CH2, Y = O
1.463: Z = S, Y = NMe
 
Additional spriocyclic structures could be accessed by utilizing allyl bromide 
1.470 as the alkylating agent, thus generating substrates suitable for Pd catalyzed 
couplings (Scheme 1.100).  The vinyl bromide present in 1.471 underwent a Pd catalyzed 
amidation to give lactam 1.472.  With the incorporation of an additional olefin into 1.473, 
a Heck cyclization was possible to give diene 1.474, which was reacted with DMAD in a 




































































1.2.6 Applications of the 4-Component Tr iazinedione Synthesis 
Orru has recently developed a 4CR of a phosphonate, nitrile, aldehyde, and two 
equivalents of an isocyanate gives rise to the triazinane diones.144  Triazinane diones 
represent a relatively unexplored class of compounds, and this methodology should 
provide access to a number of scaffolds based on this core structure.  While it has not 
been shown that the triazinane dione products themselves can be directly manipulated 
into other more complex heterocycles, by performing an additional alkylation step 
substrates suitable for further cyclization can be generated (Scheme 1.101).145 
The 4CR of phosphonate 1.476, benzonitrile, benzaldehyde, and phenyl 
isocyanate yielded 1.479 (R1 = Ph) in 91% yield.  Allylation of 1.479 gave a substrate 
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which underwent RCM to provide 1.481 in 31% yield over the two steps.  Similar use of 
2-furonitrile in the 4CR gave 1.480 (R1 = furyl), which upon alkylation with allyl 


















1.479: R1= Ph    91%
1.480: R1= furyl  49%
1. allyl Br
    NaH, DMF
2. Grubbs II




































As chemists and biologists search for novel active compounds for use in 
modulating biological function, the question arises as to whether or not the collections of 
molecules that have been synthesized and screened in biological assays represent the best 
of the best in terms of their chemical and biological properties.  It is quite possible that a 
number of as of yet unknown compounds will display biological activities that are 
superior to any known drug.   Thus, there is a need for chemists to the synthesize an 
optimal screening library, which is a library of compounds that contains molecules 
representative of every possible combination of chemical structure and property, and 
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includes both structures that have been previously studied and those that are currently 
unknown.   
The concept of DOS was developed to provide chemists with a strategy for 
rapidly and efficiently accessing these unexplored regions of chemical space.  To this 
end, a number of synthetic tactics for DOS have been developed.  One of the most 
promising of these strategies is the sequencing of MCRs with subsequent cyclization 
reactions that lead to diverse heterocyclic scaffolds.  To date a number of different MCRs 
have been developed and sequenced with multiple ring forming reactions leading to 
numerous heterocyclic scaffolds.  In particular, the Ugi-4CR has proven to be a work-
horse in this field, and hundreds of diverse scaffolds have been synthesized by combining 
the Ugi-4CR with subsequent ring forming reactions.  Other MCRs, like the van Leusen 
3CR, have shown promise in this area, but to date have not been as extensively explored 
as the Ugi-4CR.     
However, the synthetic methodologies known today are not without their 
limitations, and if every conceivable type of compound is to be synthesized, new 
synthetic methods and strategies will need to be developed.  There is still a great need for 
synthetic chemists need to develop new MCRs on par with the Ugi-4CR in terms of their 
synthetic utility, but complimentary to the Ugi-4CR in that the scaffolds they can access 
are distinctly different.  This in turn will allow for all areas of chemical space to be 
targeted in an efficient matter.     
While the underlying questions in DOS still remain unanswered, the synthetic 
methods developed thus far have provided chemists and biologists with a starting point 
for answering these questions.  Hopefully in time the synthetic methods will allow for the 
synthesis of the optimal screening library, so that every biological pathway and receptor 
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can be studied and then adequately drugged, thus creating a perfect world where no 





















Chapter  2: The Development of a Four  Component Reaction and Its 
Application to the Synthesis of Diverse Heterocyclic Structures. 
2.1 Introduction 
Diversity-oriented synthesis (DOS) continues to grow as an area of importance in 
both the fields of organic synthesis and chemical biology.9, 146-148 The main goal of 
DOS is the synthesis of structurally and stereochemically diverse collections of 
molecules for evaluation in biological systems, with the hypothesis being that a broader 
spectrum of diversity in the chemical library will lead to the generation of more 
information from biological screens.  Of particular interest is the ability to synthesize 
compounds that possess a skeleton found in natural products or drug-like molecules.4, 
149  Since the vast majority of natural products and drug-like compounds possess a 
heterocyclic structure, having the ability to synthesize diverse heterocyclic compounds 
efficiently becomes all the more important.     
As discussed in the previous Chapter, the success of DOS still relies squarely on 
the shoulders of the synthetic methods used to generate these small molecules.  Perhaps 
the most promising synthetic strategy for generating these collections of molecules is the 
sequencing of multicomponent reactions (MCRs) with subsequent ring-forming 
transformations that lead to the generation of new compounds with increased molecular 
complexity and diversity.26, 30 This process of sequencing MCRs with subsequent 
cyclizations falls under the build/couple/pair strategy of DOS.23 
Ideally, the MCRs that are designed and implemented should be versatile so that 
each component of the MCR can incorporate a wide range of functionalities.  Then 
through the use of functional group pairing,24 these functional groups can be selectively 
exploited in subsequent ring forming processes.  Ideally, this should lead to a situation 
where potentially any known synthetic reaction can be utilized to transform the 
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intermediates generated by the MCR into the targeted heterocyclic structures.  
Additionally, the ring forming reactions should be chosen so that the products they 
generate still contain functional handles that can be further derivatized as needed. This 
combination of MCRs with post-condensation modifications should then allow for access 
to a number of functionalized heterocyclic scaffolds in a short number of steps.   
While the strategy of sequencing MCRs with subsequent ring-forming processes 
is seemingly ideal for DOS, the implementation of this strategy has been limited.  The 
venerable Ugi four component reaction (Ugi-4CR) has proven to be ideal for this 
application, and a large number of reactions have been sequenced with the Ugi-4CR, 
leading to a vast collection of diverse heterocycles.  Outside of the Ugi-4CR, there have 
been only a handful of MCRs that have been successfully sequenced with multiple ring 
forming reactions, and in all of these examples the number of subsequent ring-forming 
reactions performed was limited.25  Thus, there is a need for the development of new 
MCRs that are sufficiently versatile so that they can access substrates amenable to a wide 
range of cyclization manifolds, allowing for the synthesis of diverse libraries of 
compounds.                            
To this end, we have set out to develop a four component Mannich-type reaction 
capable of generating highly functionalized products that can be transformed into 
interesting heterocyclic structures (Scheme 2.1).150  Previously the Martin group has 
exploited the vinylogous Mannich reaction as a key construct in the syntheses of 
numerous alkaloid natural products.151  Drawing on this background in vinylogous 
Mannich chemistry, it was envisioned that this three component reaction (3CR) of an 
imine, acid chloride, and a nucleophile could be readily adapted into a novel four 
component reaction (4CR) by utilizing an aldehyde and a primary amine to form the 
imine in situ. Thus, the sequential combination of a primary amine 2.1, aldehyde 2.2, acid 
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chloride 2.3, and a nucleophile 2.4 would allow access to functionalized amides 2.5, 





























Operationally, aldehyde 2.2 and amine 2.1 react to form an imine (2.7), which can 
then undergo one of two reactions (Scheme 2.2).  In the first pathway (Path A), the imine 
2.7 can react with acid chloride 2.3 to form a reactive N-acyl iminium ion (2.8), which 
can then be trapped by the nucleophile to give 2.5.  In an alternative pathway (Path B), 
imine 2.7 and the nucleophile 2.4 react first to give an amine, which can then undergo N-
acylation to give the desired amide product.  This experimental flexibility together with 
the ready availability of numerous reactants 2.1–2.4 allows for the incorporation of high 
levels of functional and structural diversity into the MCR products, so that a number of 


















































A key feature to this design is the number different functional groups that can be 
incorporated into the 4CR products allowing for a number of cyclization modes and 
potential targets to be accessed.  Aiding the utility of this 4CR is the fact that all of the 
four components are readily available with a number of different inherent functionalities, 
and it was envisioned that by incorporating various olefins, carbonyl groups, and aryl 
halides into the starting inputs, substrates amenable to ring closing metathesis (RCM), 
Heck reactions, Diels-Alder cycloadditions, [3+2] dipolar cycloadditions, and Dieckmann 
cyclizations could be accessed.  Both N-acyl iminium ions152-161 and imines162 are 
known to react with a number of different nucleophiles under a variety of reaction 
conditions, and allyl metals, silyl enol ethers, silyl ketene acetals, silyloxy furans, and 
other organometallic reagents could all be potential nucleophiles in the 4CR.  This allows 
for high levels of variability in choosing a nucleophile and therefore great variability in 
the functional groups that are incorporated into the 4CR adduct.  Also, when one 
considers the numerous methods for the enantioselective addition of nucleophiles to C=N 
double bonds,162 there is a potential to access amides 2.5 in enatioenriched form.    
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The initial experiments towards the goal of developing a 4CR and applying it to 
the synthesis of diverse heterocyclic scaffolds is discussed herein.  Because these were 
the preliminary investigations into this project, much of the focus is on general reactivity 
and substrate scope, so that an idea could be generated as to what types of inputs could be 
utilized and how the functional groups contained in these inputs could be exploited in 
subsequent ring forming reactions.    
While in the course of our investigations, Zhao and co-workers reported on a 
related 4CR.163  Their reaction involved the use of a solid supported Yb catalyst that was 
used to catalyze the 3CR of an aldehyde, primary amine, and allyl tributylstannane.  The 
resulting amine was then acylated in situ to provide the desired amide product.  This 
reaction is an example of the reaction pathway outlined in path B in Scheme 2.2.  In one 
lone example, it was shown that by incorporating furfural as the aldehyde input products 
could be generated that could undergo an intramolecular furan Diels-Alder leading to 
2.15 and 2.16.  Otherwise, no attempts to further modify the 4CR adducts have been 











































9%        
2.2.1 Investigations into Reactions Involving Allyl Nucleophiles 
The use of allyl nucleophiles in the 4CR is desirable because the olefin that is 
incorporated into the products of the 4CR can then be utilized in a number of subsequent 
ring forming reactions including RCM, intramolecular Heck reactions, and a number of 
different cycloadditions.  There is also ample precedent for the addition of a number of 
different allyl metal species to imines and N-acyl iminium ions,152-155 making this a good 
starting point for investigations into the 4CR. 
2.2.1.1 Three Component Reactions Designed to Identify Competent Allyl 
Nucleophiles  
Our initial investigations began with a model three component reaction (3CR) 
consisting of imine 2.17, acetyl chloride and allyltrimethylsilane (2.18). However, the 
only isolable products from this reaction were amide 2.22 and benzaldehyde (Scheme 
2.4).  The formation of amide 2.22 suggests that the reaction of imine 2.17 with acetyl 
chloride takes place to form N-acyl iminium 2.20, which is expected to be in an 
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equilibrium favoring 2.21,164, 165 and that allyltrimethylsilane is unreactive towards both 
2.20 and 2.21.  Amide 2.22 and benzaldehyde would then arise from the hydrolysis of 
2.20 and 2.21 upon aqueous work up.  Attempts to generate a more electrophilic N-acyl 
iminium ion by using benzyl chloroformate as the acylating agent were unsuccessful, as 
too were attempts to increase the nucleophilicity of allyltrimethylsilane by adding 






































  There are numerous reports of Lewis acid mediated additions 
allyltrimethylsilane to N-acyl iminium ions,153, 155 so investigations were undertaken 
on this front. Yamaguchi has reported on using catalytic triflate salts to promote the 
addition of allyltrimethylsilane to quinolines and isoquinolines that have been acylated by 
chloroformate esters,166 and these studies led us to try AgOTf and TMSOTf in the MCR.  
It has been postulated that the triflate salts promote the reaction by replacing the chloride 
counter ion with the less nucleophilic triflate, thus enhancing the electrophilicity of the N-
acyl iminium.166 Adding AgOTf or TMSOTf, in either stoichiometric or catalytic 
amounts, to the model 3CR resulted in formation of the desired product in low yields 
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(<30%).  Although the yields using AgOTf and TMSOTf were similar, TMSOTf became 
the Lewis acid of choice due to its lower cost and relative ease of handling.  BF3·OEt2 
was also tried as the Lewis acid, but the yields were inferior to those obtained with 
TMSOTf.  The yields of the reactions were almost identical when stoichiometric or 
catalytic amounts of Lewis acid were used, and thus catalytic TMSOTf was utilized 
throughout.  Switching to the less polar solvent toluene showed little improvement in 
yield.  The more polar solvent acetonitrile provided the desired amide 2.19 in 61% yield 
(Scheme 2.5).   




CH3CN   61%











Satisfied that reasonable conditions had been found for the 3CR of imine 2.17 
with acetyl chloride and allyltrimethylsilane, investigations were then turned to more 
functionalized substrates suitable for subsequent cyclization reactions.  The reaction of 
imine 2.24 with acetyl chloride and allyltrimethylsilane would lead to a substrate 
amenable to cyclizations via RCM and Dieckmann reactions.  However, the acylation of 
imine 2.24 with acetyl chloride in the presence of allyltrimethylsilane and catalytic 
TMSOTf resulted in only 17% of the desired amide 2.25 being produced (Scheme 2.6).  
The low yield may be caused in part by the Lewis basic ester in 2.24 or 2.25 that can 
coordinate with the Lewis acid and shut down the reaction.  These unpromising results 
led to investigations of the use of more nucleophilic allylating reagents. 
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Since the use of allyltrimethylsilane as the nucleophile proved to be useful in only 
a handful of cases, investigations were made into using allyl tributylstannane as the 
nucleophile.  Allyltributylstannane is ~104 times more nucleophilic than 
allyltrimethylsilane,167 and should readily attack the acyl iminium ion in the absence of 
Lewis acids.  When imine 2.17 was treated with allyltributylstannane and acetyl chloride, 
amide 2.19 was formed in good yield; however, the product was contaminated with 
tributyl tin impurities (Scheme 2.7).   
Scheme 2.7 
SnBu3












The more functionalized amide 2.25 was attained in 77% yield from imine 2.24; 
however, repeated chromatography was needed to remove the tin impurities (Scheme 
2.8).  In order to avoid the difficulties associated with the purification of the allyl 
tributylstannane reactions, allyl zinc reagents were investigated.  After some 
optimization, it was found that by reacting imine 2.24 with acetyl chloride for 1 h prior to 
the addition of allylzinc bromide the desired amide 2.25 could be obtained in 78% yield.  
Thus, allylzinc bromide was identified as the optimal allyl nucleophile for the 4CR as it 
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provided the desired levels of reactivity without the need for the tedious purification that 



















2.2.1.2 The 4CR Involving Allyl Nucleophiles Leading to Sequential 4CR/RCM 
Sequences  
The first step of the MCR is the formation of an imine from an amine and an 
aldehyde.  Although this reaction is normally rapid and facile, the side product of the 
reaction, water, can react with acid chlorides and hydrolyze N-acyl iminium ions.  Thus, 
some method for the removal of water from the reaction medium is necessary.  The first 
attempts at performing the 4CR using molecular sieves to dry the reaction worked, but 
the yields were low (<35%). Since in most cases the corresponding 3CRs where the 
imine was isolated proceeded uneventfully, the low yields in these reactions were 
attributed to the inability of the molecular sieves to effectively remove water from the 
reaction.  While it was later discovered that satisfactory yields could be obtained by 
utilizing properly activated molecular sieves, the initial investigations focused on 
utilizing alternative methods for generating imines without generating water.   
Morimoto has reported on the TMSOTf catalyzed formation of imines from 
bis(silyl)amines and aldehydes or ketones.168 These reactions result in the rapid formation 
of an imine, but the benign side product TMS2O is generated instead of water.  This is an 
attractive approach because TMSOTf had already been shown to be a catalyst for the 
previously discussed 3CRs; and therefore can be used to catalyze both steps of the MCR.  
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Utilizing this approach the commercially available N,N-bis(trimethylsilyl)allylamine 
(2.26) was reacted with benzaldehyde in the presence of TMSOTf.  Imine formation was 
complete in less than 30 min and the resulting imine was reacted with Cbz-Cl and 
allyltrimethylsilane to produce the desired carbamate 2.27 in 77% yield (Scheme 2.9).  
Although homoallylic amine 2.27 is not of direct interest, this method provides a facile 
approach to homoallyic amines, which are commonly used intermediates in alkaloid 







0.1 eq. TMSOTf, CH2Cl2
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2.2.1.4 Sequential 4CR/RCM/Heck Cyclization 
By removing the formation of water from the reaction the goal of a four 
component reaction was finally realized.  However, homoallylic amine 2.27 did not meet 
the requirement of having functionality amenable to subsequent cyclization reactions 
incorporated into each of the four components.  So again we turned our attention to more 
functionalized substrates suitable for elaboration into heterocyclic scaffolds.  To meet this 
goal, bis(trimethylsilyl)allylamine 2.26, 2-bromobenzaldehyde, acryloyl chloride, and 
allylzinc bromide were incorporated into the 4CR to generate products such as 2.29 that 
are amenable to both RCM and intramolecular Heck reactions (Scheme 2.10).  The 4CR 
proceeded smoothly using allylzinc bromide as the nucleophile to provide amide 2.29 in 
81% yield.  When the less reactive allyltrimethylsilane was used as the nucleophile in this 












ii. acryloyl Cl, 0°C → rt





One of the major drawbacks to using bis(silyl)amines to generate imines is lack of 
available bis(silyl)amines.  In light of this problem, investigations into finding methods 
for removing water from the reaction were on going.  It was discovered that the key to 
drying the reaction was properly activating the molecular sieves.  By heating the 
molecular sieves to ~250 °C under high-vac for extended periods, the sieves became 
sufficiently activated, and 4CRs were found to proceed smoothly.   Using this method of 
imine formation, amide 2.29 could be prepared from bromobenzaldehyde 2.28 and 
allylamine in 77% yield (Scheme 2.11).  Thus, two complimentary methods for imine 
formation were developed that could be used as needed in the optimization of subsequent 









4 Å MS, CH2Cl2
ii. acryloyl Cl, 0°C → rt






Having developed a method for preparing the highly functionalized amide 2.29, 
the next step was to complete the RCM and Heck reaction leading to tricycle 2.33 
(Scheme 2.12).  Treatment of 2.29 with Grubbs I or Grubbs II catalyst in CH2Cl2 at room 
temperature (rt) or reflux resulted in the formation of piperidine 2.31, along with 
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appreciable amounts of lactam 2.32.  In order to investigate the nature of this product 
distribution, 2.31 and 2.32 were independently treated with Grubbs II in refluxing CH2Cl2 
under an atmosphere of ethylene, and no interconversion between the two products was 
observed, suggesting that the two products do not interconvert.  Crotonoyl chloride was 
incorporated into the 4CR in hopes that the added substitution on the acrylamide double 
bond might inhibit the formation of lactam 2.32.  However, this additional substitution 
did not improve the results, and a negligible increase in the product ratio was observed.  
The Heck cyclization of 2.32 appeared to proceed smoothly using 10% Pd(OAc)2 and 
20% PPh3 with Et3N in CH3CN, however, the product 2.33 was not stable to isolation, 


















Grubbs I 8% 74%
















Par t 2.2.1.5 Sequential 4CR/RCM/Dieckmann  
Having found reaction conditions for the successful execution of the 4CR 
reactions, attention was then turned to the one pot synthesis of 2.25 (Scheme 2.13).  
Methyl 2-formylbenzoate (2.34) was condensed with allylamine and the resultant imine 
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was sequentially treated with acetyl chloride and allylzinc bromide to provide 2.25 in 
82% yield.  Reaction of 2.25 with the Grubbs II catalyst provided 2.35, which underwent 
a Dieckmann cyclization to give benzazepine 2.36 in 70% yield over the two steps.  It is 
worthy to note that in the synthesis of 2.36 a high level of functionality has been 
maintained in the product and that 2.36 possesses three sites for potential elaboration: the 
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Substrates amenable to enyne RCM were next synthesized by incorporating 
propargyl amine into the 4CR.  To this end, enyne 2.38 was synthesized in 63% yield 
following the standard procedure (Scheme 2.14).  During course of experimentation, it 
was found that consistently higher yields (76% vs. 63%) could be obtained if the 
intermediary imine was isolated prior to acylation and allylation.  The reason for this 
discrepancy in yield is not known, and this phenomenon was not observed in the 
synthesis of 2.25.  Enyne 2.38 proved to be a poor substrate for the enyne RCM, and poor 
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One possibility for improving the enyne RCM was to perform the Dieckmann 
cyclization first in hopes that constraining the alkene and alkyne would facilitate the 
RCM (Scheme 2.14).  Of the conditions tried, the treatment of 2.38 with NaHMDS in 
ether gave the best results, with the desired Dieckmann product 2.40 being isolated in 
55% yield.  Lower yields were obtained when THF or DMF were used as solvent, and 
using KHMDS as base did not generate any product.  Treatment of 2.38 with NaOMe in 
methanol using conventional or microwave heating also did not provide 2.40, and 2.38 
could be recovered in good yields.  Despite this poor yield for the Dieckmann cyclization, 
enough material could be obtained to carry out studies on the enyne RCM.  The bicyclic 
enyne 2.40 underwent the desired enyne RCM in the presence of the Hoveyda-Grubbs II 
catalyst170 and ethylene to generate the tricyclic 2.41 in moderate yield.  Upon 
concentrating 2.41 after chromatography, an insoluble material was produced, and one of 
the potential reasons for the moderate yield may be instability of 2.41.  
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If the low yields for the above enyne RCM are indeed due to product instability, it 
may be possible to circumvent this problem by performing a tandem enyne RCM/cross 
metathesis (RCM/CM).  By including a cross metathesis partner in the reaction, a fifth 
component is added to the reaction sequence, adding an additional site for the 
incorporation of functionality. 
Initial investigations into a tandem enyne RCM/CM were performed with methyl 
acrylate as the CM partner.  Unfortunately, these reactions were plagued by low mass 
recovery and incomplete conversion to the cross metathesis product, regardless of the 
catalyst used.  When styrene was used as the CM partner, the yields were greatly 
improved, but the cross metathesis still did not go to completion, and enyne RCM 
product 2.39 was still isolated in appreciable amounts.  During the course of these 
investigations it was discovered that operationally it was best to purify the metathesis 
product via filtration through a plug of silica and immediately subject it to the Dieckmann 
cyclization.  After some optimization, it was found that by treating 2.38 with 10 eq. of 
styrene and 10% of the Hoveyda-Grubbs II catalyst in refluxing CH2Cl2 or benzene at a 
concentration of 0.03 M, followed immediately by the Dieckmann cyclization, 2.42 and 
2.41 was obtained as an inseparable mixture (18:1) in a 58% yield for the two steps 
(Scheme 2.15).  Increasing the concentration did not increase the ratio of products, but 
did result in decreased yields.  Using a larger excess of styrene also did not improve the 
ratio of products.  Heating the reaction to 100 °C using microwave heating resulted in 
2.42 and 2.41 being formed in a ~1:1 ratio.  Despite efforts to drive the reaction CM to 
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Although the tandem enyne RCM/CM had been optimized to a satisfactory level, 
the use of CM partners other than styrene that contain more desirable functionality were 
investigated.  Allyltrimethylsilane, methyl vinyl ketone, and allyl alcohol were examined 
as CM partners; however, none of these CM partners provided acceptable results.  These 
substrates suffered from poor conversions to the CM product, and in all cases 2.33 could 
be isolated as the major product.  No effort was made to optimize these preliminary 
experiments, and given that these cross metathesis partners have been shown to work in 
related reactions171 it is reasonable to expect that with some additional optimization these 
results can be improved upon.              
Enyne 2.43 was synthesized following standard procedures in order to determine 
the feasibility of performing a selective RCM or enyne RCM (Scheme 2.16).  If a 
selective enyne RCM could be achieved, the aryl bromide and the additional olefin could 
undergo a Heck cyclization following the enyne RCM.  However, this goal could not be 
realized as attempts to perform a selective enyne RCM were met with limited success.  
When the Grubbs II catalyst was used in refluxing CH2Cl2 under an ethylene atmosphere, 
starting material was never consumed, and the desired product 2.44 was formed in low 
yields.  Attempts to perform a standard diene RCM on 2.43 with the Grubbs I or Grubbs 
II catalyst in the absence of ethylene gas were also unsuccessful.  When styrene was 
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added to the reaction as a CM partner the desired 2.45 was produced in 52% yield along 
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Since conditions for a successful enyne RCM on 2.43 could not readily be found, 
it was decided to continue investigations using the simplified substrate 2.47.  Enyne 2.47 
was synthesized in excellent yield using standard procedures (Scheme 2.17).  However, 
changing to the acetamide did not result in improved yields for the enyne RCM and the 
desired product 2.48 could only be isolated in 20% yield after treatment with the Grubbs 
II catalyst in refluxing methylene chloride under an ethylene atmosphere.  Using the 
Hoveyda-Grubbs II catalyst under identical conditions led to no improvement.  Greater 
levels of success were achieved when styrene was added, and an enyne RCM/CM 
sequence could be achieved.  However, as seen previously with 2.38, the cross metathesis 
reaction did not go to completion and 2.48 could be isolated along with the desired 2.49. 
Enyne 2.47 is also a suitable substrate for a Pauson-Khand reaction (PKR); however, 
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preliminary attempts to carry out a PKR on 2.47 were met with limited success.  When 
either NMO or DMSO was utilized as the promoter, the desired product 2.50 was only 
formed in low yields.  Optimization studies beyond this point were not undertaken, and it 
is still unknown whether or not the PKR can be successfully utilized to manipulate 4CR 
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Par t 2.2.1.6 Attempted Sequential 4CR/Dearomatizing Intramolecular  Enolate 
Alkylation. 
In order to further expand the scope of the type of heterocyclic structures that can 
be accessed using the sequential 4CR/cyclization strategy, we began to look for 
additional reactions that could be performed on the 4CR adducts.  One potentially 
interesting possibility was found in a recent report of a dearomatizing cyclization of 
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enolates derived from N-nicotinoyl glycine derivatives by Clayden and co-workers 
(Scheme 2.18).172  When N-nicotinoyl glycine compounds such as 2.51 were treated with 
base and methyl chloroformate, the dihydropyridine 2.52 was formed in good yields.  The 
authors proposed that the reaction proceeds first through deprotonation of the ester, 
which is followed by selective acylation of the pyridine nitrogen, and subsequent 
cyclization of the enolate onto the N-acyl pyridinium salt provides the desired 2.52.  To 
avoid any problems associated with the oxidation 2.52, it was immediately subjected to a 







































    -20 °C → rt
 
Our first explorations into utilizing this dearomatizing cyclization were focused 
on the synthesis and subsequent cyclization of 2.56.  Although there was no precedent for 
use of compounds similar to 2.56 in this chemistry, the ease in which 2.56 could be 
synthesized led us to try 2.56 in the reaction.  Imine 2.55, readily available from the 
reaction of allylamine and pyridine-3-carboxaldehyde, was sequentially treated with allyl 
Grignard and acetyl chloride to give 2.56 in an unoptimized 50% yield (Scheme 2.19).  It 
is interesting to note that this reaction must be sequenced in this order because if the 
acylation is performed first, competitive acylation of the pyridine nitrogen atom becomes 
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a problem.  When 2.56 was treated with base followed by the addition of methyl 
chloroformate, the only isolable product 2.57 was the result of the acylation of the 
resulting amide enolate.  This is not completely unexpected, as the enolate of 2.56 is 
significantly less hindered and more reactive than the substituted ester enolate utilized by 




 THF,  0 °C






  THF, 0 °C 
ii. MeO2CCl










Undeterred by these results, focus was turned to synthesizing a substrate more 
similar to the N-nicotinoyl glycine derivative 2.51.  Substrates of this nature can readily 
be obtained from imine 2.58 (Scheme 2.20).  Treatment of 2.58 with allylzinc bromide 
followed by crotonoyl chloride provided the aimde 2.59 in 54% yield.  In this example, 
the use of allylzinc bromide is necessary as the analogous reaction with allyl Grignard 
was not clean due to competitive nucleophilic attack on the ester.  Moreover, crotonoyl 
chloride gave substantially higher yields compared to acryloyl chloride, and the extra 
methyl group could be removed during a subsequent RCM.  When 2.59 was treated with 
NaHMDS and methyl chloroformate in THF at 0 °C, the reaction quickly consumed 
starting material and went to one major less polar spot by TLC, presumably the desired 
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product 2.60.  Attempts to isolate 2.60 were unsuccessful and were presumably this is 
due to the ability of 2.60 to readily oxidize to pyridinium salt 2.61.  Investigations into 
methods for effecting the oxidation of 2.62 along with concurrent removal of the methyl 
carbamate to regenerate the pyridine ring are needed to make this a viable sequence.   
Scheme 2.20 
N
N CO2Me i. 
 THF,  -78 °C
ii. crotonyl Cl








  THF, 0 °C 
ii. MeO2CCl

















2.2.2 Sequential 4CR/Diels-Alder  Cycloadditions 
The intramolecular Diels-Alder reaction has been previously exploited in the 
Martin group as a method for the synthesis of members of the yohimbine and 
heteroyohimbine family of alkaloids.173-178 It has also been shown by Yamaguchi that 
isoquinolines and carbolines can react with acryloyl chloride and pentadienyltributyltin to 
generate products that undergo a spontaneous [4+2] cycloaddition reaction at room 
temperature.  This reaction was used in the syntheses of berbane and yohimbane 
alkaloids.179 Thus it was envisioned that by incorporating a diene into the 4CR, substrates 
amenable to intramolecular Diels-Alder reactions could be generated leading to scaffolds 
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with core structures similar to that found in the yohimbine180 and berbane alkaloids 




























 It was envisioned that by using pentadienylsilane 2.67 as the nucleophile a diene 
would be generated in the 4CR product that could then undergo a [4+2] cycloaddition 
with a pendent dienophile (Scheme 2.21).  To this end, when the imine derived from 
bromobenzaldehyde 2.28 and bis(trimethylsilyl)allylamine 2.26 was treated in a one pot 
fashion with acryloyl chloride and pentadienylsilane 2.67 in the presence of 10 mol % 
TMSOTf, and the intermediate adduct underwent a Diels-Alder cyclization to generate 
the hydroisoquiniline 2.69 in good yield as a single diastereomer. The scope of this 
reaction was expanded to include differently functionalized benzaldehydes, with 4-
bromobenzaldehyde (2.65) and 3,4-dimethoxybenzaldehyde (2.66) reacting smoothly to 
give the desired cycloadducts 2.70 and 2.71 in good yields and diastereoselectivities.  In 
order to determine the relative stereochemistry of the Diels-Alder adducts, 2.71 was first 
reduced with LiAlH4, giving 2.72 as a single detectable diastereomer in 76% yield.  
Attempts to obtain X-ray quality crystals from the HCl salt of 2.72 failed, but the 
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methiodide salt 2.73 gave x-ray quality crystals upon crystallization from benzene 
(Figure 2.2).   
Scheme 2.21   
i.
N(TMS)2









2.69: R = 2-Br        69% >19:1 dr
2.70: R = 4-Br        76% 6.5:1 dr  







2.28: R = 2-Br
2.65: R = 4-Br






























Figure 2.2: ORTEP drawing of 2.73  
  
Another alternative for incorporating a diene into the 4CR adduct is by utilizing 
furfural as the aldehyde component, thus generating products that are set up to undergo 
intramolecular furan Diels-Alder reactions (IMDAF)182 to generate epoxy-isoindolones.  
To this end, furfural was allowed to react with bis(trimethylsilyl)allylamine 2.26, and the 
resulting imine was treated with acryloyl chloride and the silyl enol ether 2.74 to generate 
2.75 in only 27% yield.  It was apparent by TLC that the product was not stable on silica 
gel, and the Diels-Alder reaction appeared to proceed slowly at room temperature.  In 
order to avoid these complications, the reaction was telescoped, and the Diels-Alder 
reaction was run without purification of 2.75.  Thus, when the 4CR was complete, the 
reaction mixture was subjected to an aqueous work-up, concentrated, and then heated 
under reflux in toluene to effect cyclization (Scheme 2.21).  By avoiding the purification 
of 2.75, the major diastereomer 2.76 could be isolated in 49% yield, along with ~19% of 
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an unclean diastereomer believed to be 2.77.  The major product 2.76 has been tentatively 
assigned by 2D NMR to be the product resulting from the exo mode of cyclization to 
generate the trans ring fusion, and the pertinent NOE correlations are shown in Scheme 
2.22. Previous literature examples show that for intramolecular furan Diels-Alder 


































2.2.3 Sequential 4CR/Hetero Diels-Alder  Reactions 
Previous work in the Martin group has shown that 1-silyloxybutadienes are 
reactive nucleophiles in the vinylogous Mannich reaction.151 The α,β-unsaturated 
aldehydes generated from these reactions can then react in a subsequent hetero Diels-
Alder (HDA) reaction, and this reaction sequence was used in the synthesis of several 
natural products.183-189  Based on this precedent, the use of 1-trimethylsilyloxybutadiene 
as the nucleophile in the 4CR and the subsequent HDA reaction were investigated.   
Trimethylsilyloxybutadiene (2.78) proved to be a good nucleophile in the 4CR, 
and 2.79 was generated in good yield from bromobenzaldehyde 2.28 (Scheme 2.23).  The 
α,β-unsaturated aldehyde 2.79 is nicely disposed to undergo a hetero Diels-Alder 
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reaction, and after some experimentation, the desired product 2.80 was obtained upon 
heating 2.79 to 200 °C in toluene in a sealed tube.  Refluxing 2.79 in tetrachloroethane or 
mesitylene did not result in the formation of any desired product.  The overall yield and 
diastereoselectivity in this HDA reaction are low, and the low yield has been attributed to 
the stability of 2.79, both to the reaction conditions and in general.  Upon standing 2.79 
will turn into an insoluble polymer-like material and under the reaction conditions a 
significant amount of insoluble material was formed.  It was thought that by limiting the 
amount of handling of 2.79 the yields for the reaction could be increased, but when crude 
reaction mixture containing 2.79 was subjected immediately to the Diels-Alder 
conditions, a similar yield over the two steps was obtained.  The use of microwave 
heating in this reaction also did not result in an increase in yield.     
Scheme 2.23 
i.
0.1 eq TMSOTf, CH2Cl2






















In the previously mentioned syntheses from the Martin group that employed a 
similar HDA reaction the dienophile was derived from crotonoyl chloride.183-190 
Accordingly, it was thought that a way to improve the 4CR/HDA sequence would may be 
to incorporate crotonoyl chloride into the 4CR in place of acryloyl chloride. In practice, 
the use of crotonoyl chloride in the 4CR reaction provided the desired product 2.81 in 
only 36% yield (Scheme 2.24).  The reason for the reduced yield as compared to acryloyl 
chloride is not known.  When 2.81 was heated at 200 °C in a microwave reactor, very 
little reaction took place.  Upon heating this reaction for 30 minutes at 215 °C, the hottest 
temperature attainable for this reaction in the microwave reactor, the desired product 2.82 
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could be isolated in 51% yeild, along with 24% recovered starting material.  This reaction 
was much cleaner and the diastereoselectivity was improved compared to 2.80.  Heating 
the reaction for longer times should further increase the yield, but this study has not been 
undertaken.  The electron rich aldehyde 2.66 was also compatible with this reaction 






200 °C, 30 min;
~215 °C, 30 min
51% dr = 6:1
+ 24% RSM
i.
0.1 eq TMSOTf, CH2Cl2













2.81: R = 2-Br         36%















2.2.4 Sequential 4CR/[3+2] Dipolar  Cycloadditions 
As demonstrated in the above synthesis of 2.77, the silyl enol ether 2.74 is a 
competent nucleophile in the 4CR.  It was envisioned that the aldehyde functionality 
formed from the reaction of 2.74 could be utilized in the generation of 1,3-dipoles that 
could undergo [3+2] dipolar cycloadditions with appropriately disposed dipolarophiles.  
To this end, aldehyde 2.86 was synthesized from bromobenzaldehyde 2.28, 
bis(trimethylsilyl)allylamine 2.26, acetyl chloride, and 2.74 (Scheme 2.25).  
Condensation of 2.86 with sarcosine in refluxing toluene resulted in the formation of an 
intermediary azomethine ylide which cyclized onto the pendent alkene to give 2.89 in 
65% yield.   Similarly, aldehyde 2.86 could be condensed with N-methylhydroxylamine 
 128 
to generate a nitrone which underwent cyclization to give 2.91 in 87% yield.  The relative 
stereochemistry of 2.89 was established by correlating its NMR spectra with those of the 
corresponding aryl iodide 2.90, which was prepared in similar yields using an identical 
sequence and whose structure was established by X-ray analysis of its hydrochloride salt 
(Figure 2.3).  The relative stereochemistry of 2.91 was determined from the X-ray 
analysis of its hydrochloride salt (Figure 2.3). Both 2.89 and 2.91 are functionalized to 
undergo an intramolecular enolate arylation, but studies carried out in the Martin group 
by Dr. Chris Dockendorff proved this to be a problematic reaction.191  A number of 
conditions were screened, and in the best cases the desired product was formed along 





































2.28: X = Br
2.85: X = I 2.86: X = Br   77%
2.87: X = I      71%
2.89: X = Br   65%





Figure 2.3: ORTEP drawing of 2.90·HCl. 
 
Figure 2.4: ORTEP drawing of 2.91·HCl. 
 
Although 2.86 and 2.87 could be synthesized in good yields using the 
bis(silyl)amine method, it is desirable to be able to access these compounds from 
allylamine.  To this end, the 4CR of aldehyde 2.28, allylamine, acetyl chloride, and silyl 
enol ether 2.74 was investigated under a number of different reaction conditions (Scheme 
2.26).  When the 4CR was run in CH2Cl2, none of the desired 2.86 was observed.  When 
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the solvent was changed to CH3CN, 2.86 was isolated in 16% yield.  These yields are 
drastically lower than the yields obtained using the bis(silyl)amine method, and it was 
thought that the main reason the bis(silyl)amine method gave higher yields was the 
presence of TMSOTf.  Thus, benzaldehydes 2.28 and 2.85 were condensed with 
allylamine, and the intermediary imine was treated with acetyl chloride, 2.74 and a 
catalytic amount of TMSOTf to give 2.86 and 2.87 in only 34% and 9% yields, 
respectively.  Although the exact reason for the low yields in these reactions is not 
known, one possibility is that the molecular sieves and TMSOT react with each other, 
effectively removing the Lewis acid from the reaction.  Support for this hypothesis comes 
from the fact that good yields of 2.86 can be obtained if the molecular sieves are removed 
by filtration prior to the addition of the second set of reactants.  Thus, by simply 
modifying the procedure to include a filtration step, 2.86 was synthesized in good yields 
from the corresponding aldehydes and allylamine.       
Scheme 2.26 
ii. 0.1 eq. TMSOTf 
   AcCl, 2.74
O
X
2.28: X = Br
2.85: X = I
2.86: X = Br   34%
2.87: X = I      9%
ii.  AcCl, 2.74
i.  
   
   4 Å MS 










i. 2.30, 4 Å MS
   CH2Cl2
 
In the interest of accessing additional heterocyclic scaffolds the bromopyridine 
2.92192 was utilized in a similar reaction sequence (Scheme 2.27).  In the event, 
bromopyridine 2.92 was treated with bis(trimethylsilyl)allylamine 2.26 in the presence of 
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a catalytic amount of TMSOTf, and the resulting imine was then reacted with acetyl 
chloride and 2.74 to provide 2.93 in 56% yield.  Aldehyde 2.93 was reacted with 
sarcosine in refluxing toluene to provide 2.94 in only 26% yield.  One reason for the low 
yield is that 2.93 readily undergoes elimination of the amide under the reaction 
conditions, and aldehyde 2.95 is a major side product of this reaction.  This side reaction 
was also observed in the synthesis of 2.89, although it did not occur to a significant 

































2.2.5 Sequential 4CR/Heck/Dieckmann Cyclization and Reactions Involving Silyl 
Ketene Acetal Nucleophiles 
Silyl ketene acetals are highly reactive π-nucleophiles that have been shown to 
react with N-acyl iminium ions under a number of different reaction conditions153-155 
and therefore should be viable as a component in the 4CR.  Silyl ketene acetals react with 
N-acyl iminium ions to generate products that contain ester functionalities, and it was 
envisioned that this functionality could be readily exploited in post condensation 
reactions leading to cyclic structures.  One reaction that particularly attracted our interests 
was the Dieckmann cyclization.  By carefully selecting an appropriate acid chloride, it 
was envisioned that products could be accessed where the amide and ester in 2.99 could 
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be reacted with one another (Scheme 2.28).  If the functional groups contained in the 
amine and aldehyde components were appropriately paired, a second cyclization could 
then be induced leading to tricyclic scaffolds.    This short sequence could provide access 
to functionalized benzo[a]quinolizine ring systems, which are found in a the berberine181 
and emetine193 classes of natural products, as well as in biologically active compounds 



















































Preliminary investigations into the use of silyl ketene acetals were undertaken to 
ascertain the general reactivity of these nucleophiles in our system (Scheme 2.29). When 
imine 2.17 was treated in situ with silyl ketene acetal 2.103 and acetyl chloride in CH2Cl2 
2.104 was produced in 21% yield.  When a catalytic amount of TMSOTf was added to 
the reaction, 2.104 was isolated 52% yield.  Although the reaction involving the use of 
TMSOTf is not a true 4CR, these results do suggest that the addition of TMSOTf to 
reactions involving silyl ketene acetals can have a beneficial effect similar to that seen 

















 Attention was then turned to incorporating aldehydes with additional 
functionality and finding optimal conditions for running a one pot reaction.  Since the 
previous results suggested that TMSOTf was needed for optimal yields with silyl ketene 
acetal nucleophiles, and since reactions with silyl enol ether 2.74 involving TMSOTf in 
the presence of molecular sieves proved to be low yielding, it was decided to pursue the 
bis(silyl)amine method for forming the imine.  The treatment of bromobenzaldehyde 2.28 
and bis(trimethylsilyl)allylamine 2.26 with a catalytic amount of TMSOTf in CH2Cl2 
resulted in the rapid formation of the imine, and subsequent addition of 2.103 and acetyl 
chloride provided the desired amide 2.106 in only 32% yield (Scheme 2.30).  When the 
more reactive trimethylsilyl ketene acetal 2.105 was used in the reaction, the desired 
product could be isolated in 65% yield.  Switching the solvent to CH3CN further 
increased the yield of 2.106 to 78%.  When the reaction was run generating the imine 
from allylamine and bromobenzaldehyde 2.28 in the presence of activated 4 Å molecular 
sieves the desired amide 2.106 could only be isolated in 16% yield, again showing the 













 Nu        Solvent   Yield
2.103      CH2Cl2     32%
2.105      CH2Cl2     65%
2.105      CH3CN     78 %
i.
N(TMS)2
ii. AcCl, 2.103 or 2.105












Amide 2.106 is functionalized to undergo subsequent Heck and Dieckmann 
cyclizations to give functionalized benzo[a]quinolizine ring systems.  In working with 
2.104 it was found that under a variety of reaction conditions the only products formed 
from the attempted Dieckmann reaction were methyl cinnamate (2.107) and 2.22 
(Scheme 2.31).  These products arise from deprotonation occurring α to the ester group 
followed by an elimination of the amide anion.  Even thought the protons α to the amide 
are more sterically accessible, the most acidic protons in 2.104 should be those α to the 
ester (pKa of esters = 29 versus 34 for amides in DMSO195), so this result is not 
















There are two potential scenarios whereby this problem might be avoided.  The 
most direct method for eliminating this side reaction is by incorporating substitution α to 
the ester, thereby blocking the pathway for elimination.  To this end, the substituted silyl 
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ketene acetal 2.108 was employed as the nucleophile in the 4CR (Scheme 2.32).  
Formation of the imine from bromobenzaldehyde 2.28 and bis(trimethylsilyl)allylamine 
2.26 proceeded smoothly, and upon addition of 2.108 and acetyl chloride the desired 
amide 2.109 could be isolated in 59% yield.  Upon treatment with excess NaHMDS in 
refluxing THF, amide 2.109 underwent the Dieckmann cyclization to form 2.110 in 80% 
yield.  The incorporation of the gem dimethyl group solves the elimination problem 
associated with the unsubstituted substrate, but at the same time it is also limiting in that 






























In order to expand on the number and types of aldehydes utilized in the 4CR, 
investigations into using substituted pyridine carboxaldehydes as were undertaken 
(Scheme 2.33).  Treatment of 3-formyl-2-bromopyridine (2.92) with bis(trimethylsilyl)-
allylamine 2.26 and TMSOTf in CH2Cl2 for 3 h gave the desired imine, which was 
treated with acetyl chloride in the presence of silyl ketene acetal 2.108 to give the 
substituted pyridine 2.111 in 69% yield.  Treatment of 2.111 with NaHMDS in THF 




























However, when 3-bromo-4-formylpyridine (2.113)192 was used as the aldehyde in 
the 4CR, the desired pyridine 2.114 was not isolated (Scheme 2.34). Instead, 
dihydropyridine 2.115 was isolated in 49% yield.  This product arises from the N-
acylation of the pyridine followed by nucleophilic attack of the silyl ketene acetal on the 
acyl pyridinium ion.  This side reaction shows the limitations encountered when using 
pyridine carboxaldehydes in the 4CR.  If the pyridine nitrogen is not sterically hindered, 
as it is in 2.92, then the pyridine can be competitively N-acylated in the presence of the 
imine.   






















0.1 eq TMSOTf, CH2Cl2
2.26
 
The second scenario in which the above elimination reaction might be avoided 
involves increasing the acidity of the protons α to the amide.  If the protons α to the 
amide carbonyl can be rendered more acidic than those α to the ester, then a selective 
deprotonation of the more acidic protons should occur to give rise to the desired 
Dieckmann product.  This tactic is also a more desirable solution to the problem, as it 
avoids the need for incorporating geminal substitution α to the ester and potentially 
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increases the number of scaffolds accessible using the 4CR/Dieckmann cyclization 
reaction sequence.  
By incorporating methyl malonyl chloride (2.116) into the 4CR, access to 
compounds containing a β-dicarbonyl functional group can be obtained.  The protons of 
the β-dicarbonyl moiety are significantly acidic to be selectively deprotonated in the 
presence of the ester, thus removing any potential for the elimination reaction to occur.  
The additional ester incorporated in the acid chloride can be then kept as an additional 
functional handle, or it can be removed by a subsequent decarboxylation if desired.  
Preliminary results show that this is potentially a viable option (Scheme 2.35).  
Formation of the imine from bromobenzaldehyde 2.28 and bis(trimethylsilyl)allylamine 
2.26, followed by the addition of silyl ketene acetal 2.105 and methyl malonyl chloride 
provided a complex reaction mixture from which the desired amide 2.117 could be 
isolated in 39% yield.  Lower yields 2.117 (15%) were obtained when the imine was 
formed in situ from allylamine in the presence of molecular sieves.  Treatment of 2.117 
with excess NaOMe in refluxing THF provided the desired Dieckmann product 2.118 in 
81% yield.  While utilizing methyl malonyl chloride as the acid chloride effectively 
solved the problems associated with competitive elimination during the Dieckmann 
cyclization, the low yields for the 4CR present a major drawback to this sequence that to 










































Another alternative for increasing the acidity of the protons alpha to the amide 
that has shown promise is the use of the acid chloride 2.119 (Scheme 2.36).  Acid 
chloride 2.119 incorporates masked β-dicarbonyl functionality into the 4CR that can then 
later be unmasked under mild conditions.  Thus, when the imine derived from 
bromobenzaldehyde 2.28 and bis(trimethylsilyl)allylamine 2.26 was reacted acid chloride 
2.119 and silyl enol ether 2.74 in CH3CN, 2.121 was isolated in 56% yield.  When 
CH2Cl2 was used as the solvent the yield dropped to 20% for the aryl bromide 2.121 and 
24% for the aryl iodide 2.120.  When 2.120 was treated with a catalytic amount of HCl in 
aqueous THF the hydrolysis of the ketal was accompanied by an intramolecular 
Knoevenagel condensation to give 2.122 in 53% yield.  Although this reaction sequence 
has not been optimized, it shows that acid chloride 2.119 may be a useful alternative to 



















2.120:  X = I    CH2Cl2 = 24%
2.121: X = Br  CH2Cl2 = 20%









2.28: X = Br
2.85: X = I 2.122
i.
N(TMS)2




2.2.5.1 Investigations into Intramolecular  Heck Reactions 
By incorporating an aryl halide and an appropriately disposed olefin into the 4CR, 
substrates can be generated that are set up for an intramolecular Heck reaction.  By 
looking at the number of structures that can readily be accessed via the 4CR with this 
pairing of functional groups, one can easily see that the Heck reaction could potentially 
be a very valuable reaction to sequence with the 4CR.  Thus, studies were undertaken to 
access the viability of this reaction sequence.  
When amide 2.106 was heated under reflux in CH3CN in the presence of 0.1 eq. 
Pd(OAc)2, 0.2 eq. PPh3, > 2 eq. Et3N the reaction did not go to completion, and 38% of 
the starting material was recovered.  In order to drive the Heck reaction to completion, 
the reaction was run in a microwave reactor, which is known to accelerate Heck 
reactions.196, 197  When the reaction was heated to 100 °C for 80 minutes, the reaction still 
did not completely consume starting material.  Increasing the temperature to 125 °C 
provided complete conversion in one hour and gave an inseparable mixture (1:1) of 
compounds 2.123 and 2.124 in 72% yield along with 22% of 2.125, which was the 
separable (Scheme 2.37).  The endocyclic olefin product 2.125 was presumably formed 
as a result of the Pd-H species that is generated during the course of the reaction further 
reacting with 2.123 via a hydropallidation/β-hydride elimination pathway to give rise to 
the isomerized the olefin.198 When 2.106 was heated in DMF at 125 °C and the reaction 
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was stopped after 5 h, the reaction did not go to completion and 20% of the starting 
material could be recovered, along with 60% of a ~2:1 mixture of 2.123 and 2.124 and 
10% of 2.125.  When the reaction was run in refluxing toluene the reaction only 
proceeded to 50% conversion with a similar product distribution.   
Scheme 2.37 
10% Pd(OAc)2 













CH3CN        88                        42                         ~1:1               n.d.             38
CH3CN        µW,125               72                            1:1               22                0
DMF            125                      60                           2:1               10               20
Toluene       110                      36                           1:1               10               49
2.123 2.124
2.125










While the combined yield for the above Heck reaction was excellent, there is 
almost no selectivity in the product distribution.  In order to improve this ratio the use of 
silver salts in the reaction was investigated, because silver salts have been shown to 
decrease the amount of double bond isomerization.198 The silver salts work by 
sequestering halides from palladium, which in turn increases the acidity of the Pd-H 
species, making it more susceptible to deprotonation and less apt to reinsert into and 
isomerize the reaction products.  Unfortunately, the addition of Ag2CO3 to the reaction, 
both as the base and as an additive, had little influence in supressing double bond 
isomerization (Scheme 2.38).  However, the addition of Ag2CO3 did have a small 
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influence on the relative amount of 7-membered ring product 2.124 generated in the 
reaction, with a greater preference towards the 6-membered ring products being shown.  
When AgNO3 was used as an additive, no reaction occurred.  If the silver salts are indeed 
sequestering halide from the reaction, this suggests that there may be a halide effect on 






2.5 eq. Et3N, 0.7eq Ag2CO3


























Base 2.123 & 2.124 (2.123:2.124) 2.125 RSM
 
In order to further investigate the possible influence of the halide on the Heck 
cyclization, the aryl iodide 2.126 was synthesized from iodobenzaldehyde 2.85 (Scheme 
2.39).  Subjecting 2.126 to the standard Heck reaction conditions in refluxing acetonitrile 
provided a mixture (~2:1) of 2.123 and 2.124 in 59% yield along with 30% of 2.125.  
Unlike the aryl bromide 2.106, the aryl iodide 2.126 readily reacted in refluxing CH3CN 
and did not need microwave heating to drive the reaction to completion.  The ratio of 6:7 
membered ring products also increased, indicating the halide may indeed play a role in 

















0.1 eq TMSOTf, CH2Cl2
ii. AcCl, 2.105 
   0 °C → rt
2.17
60%





















 Recently it has been shown that the combination Pd(OAc)2, 
tricyclohexylphosphine (PCy3), and N-methyldicyclohexylamine (MeNCy2) is an 
effective catalyst system in dimethyl acetamide (DMA) for performing intramolecular 
Heck reactions to generate the 6-membered ring exclusively with complete double bond 
isomerization (see Chapter 1.2.2.14).108 Following these conditions, the aryl iodide 2.126 
was reacted at 60 °C in DMA generating 2.124 and 2.125 in 32% and 54% yields, 
respectively (Scheme 2.40).  When DMF was used as solvent, isomerization to the 6-
membered endocyclic double bond was not complete, and the exocyclic olefin product 
2.123 was also isolated.  The ratios of 6:7-membered ring formed were similar for both 
DMA and DMF.  While these conditions were successful in generating only a single 
double bond isomer, the ratio of 6:7-membered ring was not improved, and this remains 

























The previously discussed Heck reactions were all run on substrates where the 
Heck reaction was performed prior to the Dieckmann cyclization.  However, with the 
analogous gem-dimethyl compounds the reaction sequence can be reversed.  To this end, 
amide 2.127 was synthesized so that the effects of resequencing the Heck and Dieckmann 
reactions could be investigated (Scheme 2.41).  Amide 2.127 was readily synthesized 
from iodobenzaldehyde 2.85 in good yield. When 2.127 was heated in the presence of 0.1 
eq. Pd(OAc)2, 0.2 eq. PPh3, > 2 eq. Et3 in CH3CN at 100 °C using the microwave reactor, 
the reaction produced an inseparable mixture (10:1) of 2.128 and 2.129 in 80% yield 
along with 8% of the isomerized 2.130 in only 10 min.  Alternatively, 2.127 underwent a 
Dieckmann cyclization to give 2.131 in 91% yield.  Subjecting 2.131 to the Heck reaction 
conditions in refluxing CH3CN generated an inseparable mixture (10:1) of 2.132 and 
2.133 in 65% yield along with 10% of 2.134, which was separable.  These results show 
that the sequencing of the Heck and Dieckmann reactions has no effect on the product 




























0.1 eq TMSOTf, CH2Cl2
ii. AcCl, 2.108














































Since aryl iodide 2.131 showed a greater preference (~11:1) for the formation of 
the 6-membered ring products, it was hoped that by reacting 2.131 with the 
Pd(OAc)2/PCy3/MeNCy2 catalyst system that complete double bond isomerization would 
occur to generate 2.134 as the major product.  When 2.131 was subjected to the Heck 
reaction, all three of the possible products were formed, and the ratio of 6:7-membered 
rings was only ~2:1 (Scheme 2.42).  The analogous aryl bromide 2.110 was found to 
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show a greater selectivity (~6:1 versus ~2:1) for the 6-membered ring, contradicting the 
earlier results that showed that aryl iodides gave better selectivity for the 6-membered 
ring. Interestingly, complete isomerization to the endocyclic olefin did not occur in either 
case.  Aryl bromide 2.110 did show a greater extent of double bond isomerization; 
however, this may be attributed to the longer reaction time needed for 2.110 versus aryl 
iodide 2.131.  In both cases it is possible that increased reaction times could lead to 






















        2.132 + 2.133      2.132:2.133          2.134
               48%                    3:2                  16%
               22%                    3:2                  43%
2.110: X = Br




Previous work from the Martin group had shown that selectivity for 6- versus 7-
membered rings could be achieved under reductive Heck reaction conditions.199, 200 To 
investigate the use of a reductive Heck cyclization in our system, aryl halides 2.137 and 
2.138 were synthesized using from propargyl imines 2.135 and 2.136 (Scheme 2.43).  
Attempts to synthesize 2.137 via a 4CR were low yielding, and the desired product could 
was isolated in <10% yield when the imine was made in situ from propargyl amine and 
the appropriate halobenzaldehyde.  Using the bis(silyl)amine approach was also 
unsuccessful due to difficulties that were encountered in the synthesis and isolation of 















2.136: X=I 2.137: X=Br  74%
2.138: X=I     58%
2.105
 
The initial studies into the reductive Heck cyclization were made using aryl 
bromide 2.137.  Reacting 2.137 under our previously utilized Heck reaction conditions 
(10% Pd(OAc), 20% PPh3, Et3N, CH3CN, µW, 125 ºC), with formic acid added as a 
terminal reductant, provided a mixture (1:1:1) of 2.123, 2.124, and 2.125 in only 21% 
yield (Table 1, entry 1).  This result was not an improvement.  Hence, the reaction 
conditions developed for the synthesis of methyl lysergate were explored.  Namely, 2.137 
was subjected to the catalyst system of Pd(PPh3)4, tetrabutylammonium chloride (TBAC), 
formic acid, and either tetra- or pentamethylpiperidine (TMP or PMP) in refluxing 
acetonitrile.199, 200  When TMP was used as the base, 2.123 and 2.125 were isolated in 
25% and 6% yields, respectively, with no 7-membered ring products being detected 
(entry 2).  Switching the base to PMP resulted in a significant increase in overall mass 
recovery, but four reaction products were generated, with 2.123, 2.124, and 2.125 being 
produced along with the reduced 2.106 (entry 3).  By adding the formic acid at 75 °C, the 
overall yield for the reaction could be increased, but this came at the price of reduced 
selectivity towards the 6-membered ring products when TMP was used (entry 4).  The 
selectivity towards the 6-membered ring did increased when PMP was used as base and 
the formic acid was added at elevated temperatures (entry 5), however, this increase in 
selectivity was accompanied by an increase in the amount of 2.106 formed.  Running the 
reaction at lower temperatures also improved the selectivity towards the 6-membered 
 147 
ring, but a substantial amount of the reduced product 2.106 was generated (entry 6).  The 
addition of tetrabutylammonium iodide (TBAI) instead of TBAC was detrimental to both 
the yield and selectivity (entry 7).  Using triethylsilane (Et3SiH) as the reductant 
increased the selectivity towards the 6-membered ring, and no reduced or 7-membered 





























1 10% Pd(OAc)2, 20% PPh3, Et3N, HCO2H
CH3CN, µW 125 °C
21% 2.123:2.124:2.125 (1:1:1)
2 10% Pd(PPh3)4, TBAC, 3 eq. TMP, 2 eq. HCO2H
CH3CN, ∆, 4.5h
25% 2.123,  6% 2.124
3 10% Pd(PPh3)4, TBAC, 3 eq. PMP, 2 eq. HCO2H
CH3CN, ∆, 1.5h
25% 2.106:2.125 (3:1) 
58% 2.123:2.124 (1:1)
4 10% Pd(PPh3)4, TBAC, 3 eq. TMP, 2 eq. HCO2H*
CH3CN, ∆, 40 min
66% 2.123:2.124 (1:1)
6% 2.125
10% Pd(PPh3)4, TBAC, 3 eq. PMP, 2 eq. HCO2H*
CH3CN, ∆, 1h
5 38% 2.106, 30% 2.123
trace 2.125




8 10% Pd(PPh3)4, TBAC, 3 eq. PMP, 2 eq. Et3SiH
CH3CN, ∆
18% 2.123, 6% 2.125






















In all of the above cases the reactions suffered from poor yields, poor selectivity, 
or both.  While switching to the reductive Heck conditions did improve selectivity for the 
6-membered ring, the 7-membered ring was still frequently formed.  A potential reason 
for this is that the alkyne reacts to give exclusively the 6-membered ring, while the 7-
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membered ring is formed from the alkene, which is formed by reduction of the alkyne 
under the reaction conditions.  These reaction conditions are similar to conditions 
reported for the reduction of alkynes to alkenes,201, 202 and as shown in entries 3,5,6, and 
7, the alkene could indeed be isolated from these reactions, further lending support to the 
hypothesis that the 7-membered ring was formed exclusively from the alkene.  When 
Et3SiH was used as the terminal reductant, no alkene or 7-membered ring were isolated, 
lending some support to this argument.  Additionally, in almost all cases partial 
isomerization of the 6-membered ring product double bond occurred, further 
complicating the reaction mixtures.   
The preceding experiments revealed that the nature of the aryl halide affected the 
both the rate and selectivity of the Heck reaction, and it was hoped that by switching to 
aryl iodide 2.138 the yields and product distributions of could be improved.  In a 
preliminary experiment, the aryl iodide 2.138 was treated with Pd(PPh3)4, TBAC, formic 
acid, and PMP at 60 °C in acetonitrile, the isoquinoline derivative 2.123 was isolated in 
40% yield as the only detectable product (Scheme 2.44).  The aryl iodide again showed 
better results as compared to the analogous aryl bromide.  This is presumably due to the 
increased reactivity of aryl iodides, which in turn allows for milder reaction conditions 
and shorter reaction times and limits the formation of the potential side products.  The 
yield for this reaction is still low and extensive optimization may be needed to further 


















A radical cyclization of aryl bromide 2.137 could also provide 2.123 (Scheme 
2.45).  To this end, 2.137 was treated with AIBN and tributyltinhydride in refluxing 
benzene to give an inseparable mixture (~1.2:1) of 2.123 and 2.125 in only 35% yield.  
The low yield and selectivity for this reaction was rather discouraging, and additional 


















2.137 2.123 2.125  
The Heck cyclization of compounds such as 2.106 and 2.137 has proven to be 
somewhat troublesome.  In most cases, multiple products are formed in poor ratios, while 
in other cases yields were low. It may be possible to improve these results, but when one 
considers the number of variables that might need to be changed to optimize a Heck 
reaction, it was deemed that the effort that may be required to perform such an 
optimization was not worthwhile.  These results can be looked upon as preliminary 
results that show the 4CR can be sequenced with Heck reactions that lead to scaffolds 
that may potentially be of interest to the scientific community.      
2.2.4.2 Sequential 4CR/Heck Cyclizations Utilizing 4-Bromoindoles. 
In order to expand the scope of aldehydes that could be used in the 4CR 
investigations, indole 3-carbaldehyde derivatives were next examined.  One derivative of 
particular interest was the 4-bromoindole-3-carboxaldehyde 2.139, as the aryl bromide 
could be readily exploited in a subsequent Heck reaction, providing an approach to 
polycyclic indole scaffolds (Scheme 2.46).  Treatment of 2.139203, 204 with 
bis(trimethylsilyl)allylamine 2.26 in the presence of a catalytic amount of TMSOTf 
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provided the imine, which could then be acylated and reacted with silyl ketene acetal 
2.105 to give 2.140 in 72% yield.  Unlike other examples of the 4CR employing silyl 
ketene acetal 2.105, substantially higher yields were obtained in CH2Cl2 instead of 
acetonitrile.  Upon subjecting 2.140 to standard Heck conditions with microwave heating, 
two separable indoles, 2.141 and 2.142 were generated in 83% and 12% yields, 
respectively.  The structure of 2.141 was conclusively determined by X-ray 
















































Figure 2.5: ORTEP drawing of 2.141. 
 
2.2.5.3 Sequential 4CR/RCM/Deickmann Cyclization Utilizing Silyl Ketene Acetal 
Nuclophiles 
By substituting 2-vinylbenzaldehyde for 2-bromobenzaldehydes in the 4CR 
substrates that are functionalized to undergo a subsequent RCM are generated.  When 2-
vinylbenzaldehyde is used in conjunction with allylamine, and an appropriate acid 
chloride and silyl ketene acetal, products could be accessed that can undergo sequential 
RCM and Dieckmann cyclization to generate a pyrido-benzazepine ring structure 2.145 
(Scheme 2.47).  Compounds containing this scaffold have been studied, and structures 









































To this end, vinyl benzaldehyde 2.143 was treated with allylamine in the presence 
of molecular sieves.  After imine formation was complete, silyl ketene acetal 2.105 and 
acetyl chloride were added, and 2.147 could be isolated in 31% yield (Scheme 2.48).  
Upon treatment of 2.147 with the Grubbs II catalyst in refluxing CH2Cl2 the desired 
azepine 2.124 was isolated in 88% yield.  When 2.124 was treated with NaHMDS in 
THF, none of the desired 2.148 was produced.  The overall mass recovery for this 



































Attention was then turned to substituted silyl ketene acetal 2.108 as products 
derived from 2.108 had been shown to be substrates for the Dieckmann cyclization 
(Scheme 2.49).  Vinyl benzaldehyde 2.143 was condensed with 
bis(trimethylsilyl)allylamine 2.26 in the presence of a catalytic amount of TMSOTf to 
provide the desired intermediary imine.  When silyl ketene acetal 2.108 and acetyl 
chloride were added at 0 °C and the reaction was warmed to room temperature, the 
desired product 2.149 was isolated in 68% yield.  When the addition was done at room 
temperature the yield was increased to 80%.  Switching solvents to acetonitrile provided 






CH2Cl2  =  80%











Treatment of 2.149 with 5% Grubbs II catalyst in refluxing CH2Cl2 provided the 
desired azepine 2.129 in 94% yield (Scheme 2.50).  Attempts to cyclize 2.129 via a 
Dieckmann reaction were met with limited success.  No reaction occurred when 2.129 
was treated with NaH in refluxing THF.  When NaHMDS was used as the base, the 
desired product 2.133 was isolated in only 8% yield, along with equal amounts of the 
isomerized product 2.150.  This problem was readily avoided by resequencing the 
Dieckmann and RCM reactions.  Namely, treatment of 2.149 with NaHMDS provided 
2.151 in 87% yield, and the RCM reaction of 2.151 proceeded smoothly in refluxing 





































 While the synthesis of the tricycle 2.133 had proceeded uneventfully, this is only 
made possible by the presence of the gem dimethyl group.  It would be advantageous to 
be able to access compounds without this substitution, and investigations into using 
methyl malonyl chloride as the acylating agent in this reaction sequence were undertaken 
(Scheme 2.51).  In the event, the imine derived from vinyl benzaldehyde 2.143 and 
bis(trimethylsilyl)allylamine 2.26 was treated with methyl malonyl chloride and ketene 
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acetal 2.92 to provide 2.152 in 34% yield along with 43% of indane 2.153.  Indane 2.153 
presumably arose from an intramolecular attack of the styrene onto the N-acyl iminium 
ion and subsequent elimination to reform the double bond.  This side reaction was 
problematic in a number of reactions employing 2.116, and therefore this sequence was 























2.2.5.4 Tandem 4CR/[3+2]Azide/Alkyne Cycloadditions 
The incorporation of nitrogen functionality into the aldehyde component of the 
4CR is desirable because this functionality can then be used to generate additional 
heterocyclic rings.  Investigations into the use of 2-azidobenzaldehyde (2.154)208 were 
undertaken, as it was thought that this would be a desirable starting material since the 
azide could be easily engaged in a subsequent cycloaddition reaction leading to scaffolds 
containing a triazole motif (Scheme 2.52).  When the imine derived from 2.154 and 
propargyl amine in acetonitrile was treated with acetyl chloride and silyl ketene acetal 
2.105, the adduct thus formed underwent a spontaneous [3+2] cycloaddition to give 
triazole 2.155 in 75% yield.  A limited number of attempts to carry out a Dieckmann 
cyclization on 2.155 were unproductive, and in the best case a 5% yield of tetracycle 






























An attempt to circumvent the problematic Dieckmann cyclization of 4.155 was 
made by replacing the acetyl chloride used in the synthesis of 2.155 with methyl malonyl 
chloride.  The use of methyl malonyl chloride as the acylating reagent in the 4CR has 
proven to be problematic, and in this case the desired triazole 2.157 was only isolated in 
25% yield (Scheme 2.53).  Due to the low yield in this 4CR further investigations into the 




















2.2.5.5 Reactions Involving Aliphatic Aldehydes. 
Up until this point all of the examples shown have involved the use of aromatic 
aldehydes.  The use of aliphatic aldehydes is also highly desirable because they would in 
turn allow access to scaffolds that cannot be synthesized from an aromatic aldehyde.  
Aliphatic aldehydes present potentially major problem that is not encountered with 
aromatic aldehydes, which is the presence of enolizable α-protons.  When an imine 
derived from an aliphatic aldehyde is reacted with an acid chloride, the resulting N-acyl 
iminium ion can be readily quenched by loss of a proton to give an enamide.  If loss of a 
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proton is faster than the trapping of the N-acyl iminium ion by an external nucleophile, 
the 4CR will fail.  In practice, this concern was a valid one and when the imine derived 
from propionaldehyde and allylamine was treated with acetyl chloride and 2.103, the 
desired 2.159 could be isolated in 8% yield while enamide 2.160 was the major product 
from the reaction and was isolated in 53% yield (Scheme 2.54). 













  4Å MS, CH2Cl2
NH2
ii. AcCl, 2.103






2.2.5.6 Reactions Involving Vinyl Silyl Ketene Acetals 
The use of vinyl silyl ketene acetals in the 4CR is desirable because the products 
produced from this nucleophile contain α,β-unsaturated ester, which can potentially be 
utilized in subsequent ring forming transformations.  To answer the question of whether 
or not these nucleophiles can be utilized in the 4CR, preliminary investigations were 
undertaken. In a 3CR with imine 2.17 and acetyl chloride, ketene acetal 2.161 was found 
to give a mixture (3:2) of the separable products 2.163 and 2.164, slightly favoring the γ-
addition product 2.163 (Scheme 2.55).   When the bulkier nucleophile 2.162 was used in 
the reaction the γ-addition product 2.165 was obtained in 31% yield as the only detectable 
product.  Presumably, the increased steric interactions that occur between the N-acyl 
iminium ion and the t-butyl group in 2.162 make γ addition the preferred mode of attack.  
Although the yield for this reaction was low, the high level of selectivity makes this 



















2.163: R = Me  30%
2.165: R = t-Bu 31%
N
2.17
2.164: R = Me  20%
2.166: R = t-Bu 0%
 
2.2.6 Reactions Involving Silyloxyfurans Leading to 4CR/Michael Addition 
Sequences   
Methyl malonyl chloride has been used as the acylating agent in the 4CR to 
generate products that can undergo Dieckmann cyclizations. Alternatively, if methyl 
malonyl chloride were used in conjunction with a silyloxy furan nucleophile, a product is 
generated that is set up for an intramolecular Michael reaction to generate the bicyclic 
























2.168 2.169  
Initial investigations into this reaction were made using imine 2.170 (Scheme 
2.57).  When 2.170 was treated with methyl malonyl chloride and the TIPS-silyloxyfuran 
2.171, 2.172 was produced in good yield as an undetermined mixture of stereoisomers.  
Upon treatment of 2.172 with either NaH or NaOMe in THF cyclization occurred to 
generate 2.173, again as an uncharacterized mixture of diastereomers.   
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In order to generate a product functionalized to undergo a sequential 
intramolecular Michael reaction followed by a Heck cyclization iodobenzaldehyde 2.85 
and allylamine were chosen as components along with methyl malonyl chloride and 
trimethylsilyloxy furan 2.174 (Scheme 2.58).  The aldehyde and amine were condensed 
in CH2Cl2, and the intermediate imine was treated in situ with methyl malonyl chloride 
and 2.174 to generate the butenolide 2.175 as separable mixture (1.3:1) of diastereomers 
in a combined 28% yield.  Similar low yields were obtained when the imine was 
generated via the bis(silyl)amine method and when the TIPS-silyloxyfuran 2.171 was 
utilized as the nucleophile.  Subsequent treatment of the major diastereomer with NaOMe 































The work on this project involving silyl ketene acetals has shown that in general 
low yields are obtained for reactions involving methyl malonyl chloride.  For this reason 
the use of acetyl chloride as the acylating agent was investigated in conjunction with 
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TIPS-silyloxyfuran 2.171 in order to determine if there were unseen issues involving the 
silyloxyfuran that were contributing to the low yield in the above reaction (Scheme 2.59).  
When the imine formed in situ from the condensation of bromobenzaldehyde 2.28 and 
bis(trimethylsilyl)allylamine 2.26 in the presence of catalytic TMSOTf was treated with 
acetyl chloride and silyloxyfuran 2.171, 2.177 was isolated in 62% yield as a 1.4:1 
mixture of diastereomers.  The increase in yield for this reaction as compared to the 
yields obtained for the synthesis of 2.176 suggests that the low yields obtained in the 




















The limited work done with silyloxyfurans has shown that they can be utilized in 
the 4CR to generate products that can be further elaborated into heterocyclic structures.  
The yields and diastereoselectivities for these reactions are still modest at best, and 
optimization would be needed in order for these sequences to be generally useful.   
2.2.7 General Comments Involving the Methods of Imine Formation in the 4CR 
    Throughout this Chapter two methods were routinely utilized for synthesizing 
imines, and it is worth mentioning the merits of each of these methods in the 4CR.  All of 
the imines utilized in this work can be cleanly accessed in virtually quantitative yields by 
the traditional method of condensing an aldehyde and an amine in the presence of 
molecular sieves, and if one desires, the crude imine can be isolated by filtering off the 
molecular sieves and concentrating the reaction mixture.  The crude imine thus obtained 
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can then be utilized directly in subsequent 3CRs.  However, when this method for imine 
formation is utilized in the 4CR, the yields of the reactions have been shown to be 
substrate dependent.  In general, highly reactive nucleophiles like allylzinc bromide react 
under these conditions to provide the desired products in good yields, while subpar yields 
are generally obtained when less reactive nucleophiles like silyl enol ether 2.74 or silyl 
ketene acetal 2.105 are employed in the 4CR.   
It is for these weaker nucleophiles that the bis(silyl)amine methodology routinely 
out performs the traditional method for imine formation.  The higher yields in the 
reactions utilizing bis(silyl)amines can be attributed to the presence of TMSOTf, which 
serves to catalyze both the imine formation and the nucleophilic addition to the N-acyl 
iminium ion.  While this leads one to believe that the low yielding 4CRs that involve the 
traditional method of imine formation being used in conjunction with nucleophile 2.74 or 
2.105 can be improved upon by simply adding TMSOTf to reaction, preliminary results 
show that the addition of TMSOTf to reactions containing molecular sieves does not 
drastically improve yields (see Scheme 2.26).  This problem can be easily remedied by 
removing the molecular sieves from the reaction mixture prior to the addition of the 
second set of reactants, and thus the use of bis(silyl)amines is not a requirement for these 
reactions. However, in cases where allylamine is used in conjunction with a silyl enol 
ether or silyl ketene acetal, the use of the commercially available 
bis(trimethylsilyl)allylamine 2.26 provides an operationally simple and high yielding 
alternative.       
2.3 Conclusion 
In an effort to develop new strategies for the rapid synthesis of diverse collections 
of heterocyclic compounds a four component reaction of aldehydes, amines, acid 
chlorides and π- and organometallic nucleophiles has been developed.  By incorporating 
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the appropriate functional groups into each of the four inputs of the 4CR, one gains 
access to highly functionalized adducts that can be readily transformed into heterocyclic 
scaffolds in a short number of steps.  The 4CR has been shown to be compatible with a 
number of differentially functionalized aryl and heteroaryl aldehydes, and allylzinc 
bromide, silyl enol ethers, silyl ketene acetals, and silyloxy furans have all been shown to 
be competent nucleophiles.  The scope of the amine and acid chloride components have 
been explored to a lesser extent, but a number of functionalized examples of each have 
been reported.  Thus, by selecting the four inputs carefully, structures were generated 
containing various aryl halides, olefins, and carbonyl groups that were then exploited in 
intramolecular Heck reactions, Diels-Alder and [3+2] cycloadditions, RCM, and 
Dieckmann condensations leading to a diverse collection of heterocyclic scaffolds.  
Additionally, the scaffolds generated using this strategy contain orthogonal functionality 
that can be further elaborated into more focused libraries, and work in this area is 
currently underway in the Martin group.    
The 4CR is very well suited for DOS, as it is sufficiently versatile such that a 
wide range of functional groups can be incorporated for use in subsequent reactions.  We 
have demonstrated that a number of different reactions can be sequenced with the 4CR, 
and one can envision numerous other possibilities that could further expand the scope of 
this process.  A number of the scaffolds accessed by this strategy are found in both 
natural products and other biologically active compounds, further illustrating the utility of 
this process.  The 4CR is also amenable to the synthesis of a variety of alkaloid natural 





Chapter  3: The Isopavine and Aspidosperma Alkaloids 
3.1 THE ISOPAVINE ALKALOIDS 
3.1.1 Introduction 
The isopavine alkaloids are a small family of tetracyclic tetrahydroisoquinoline 
natural products that are characterized by a doubly benzannulated 
azabicyclo[3.2.2]nonane core structure (Figure 1). 209, 210  Although the structure of 
synthetic isopavine (3.4) was first determined in 1958,211 the first isolation of an 
isopavine alkaloid from natural sources did not occur until amurensine (3.1) was isolated 
from Papaver nudicaule var. amurense in 1960.212  Since then members of this family 
have been isolated from numerous species of plants in the Papaveraceae family, as well 
as from plants in the Ranunculaceae family.209, 210  Both natural and unnatural members 
of the isopavine family have been shown to possess interesting biological properties 
useful for the treatment of nerve system disorders like Alzheimer’s disease, Parkinson’s 
disease, and Hungtington’s chorea, as well as the genetic disorder Down’s syndrome.213, 
214 Synthetic isopavines have also been shown to be potent morphinomimetics215 and are 
strong binders of the PCP receptor.216, 217  The interesting aza-bridged bicyclic structure 
and biological profiles have made this family of natural products an attractive target for 


























































(-)-Roelactamine (3.7) was isolated in 1992 by Gözler and Hesse from Roemeria 
refracta DC. (Papaveraceae). 218  It is the first and only known natural isopavine alkaloid 
that possesses a lactam functional group.    The structure of 3.7 was assigned on the basis 
of its 1H-NMR, IR, and mass spectral data, as well as through its conversion to (-)-
reframidine (3.6) by reduction with LiAlH4.  There have been no reported biological 
studies for roelactamine, as well as no reported total syntheses. 
3.1.2 Synthetic Approaches to the Isopavine Alkaloids 
3.1.2.1 Double Cyclization of Benzylaminoacetaldehyde Acetals 
The first synthesis of the isopavine core was performed by Guthrie in 1955 
(Scheme 3.1).219  However, Guthrie erroneously assigned the structure of the compound 
obtained by treating aminoacetal 3.8 with H2SO4 to be the pyrrolidine 3.9.  The correct 
structure of the product of this reaction was later determined by Battersby and Yoewell to 
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be 3.4, which was given the name isopavine.211  This structural assignment was also 

























  The acid catalyzed double cyclization reaction of benzylaminoacetaldehyde 
dialkyl acetals similar to 3.10 has since become the classical approach to the isopavine 
skeleton and has been utilized in a number of syntheses.  Mechanistically, this reaction is 
thought to proceed as shown in Scheme 3.2.  Hydrolysis of the acetal gave an 
intermediary aldehyde, which undergwent nucleophilic addition to provide the 4-
hydroxytetrahydroisoquinoline 3.12.  From 3.12 two reaction pathways are possible, 
leading to one of two isomeric products.  The first pathway involves a dehydration to the 
1,2-dihydrotetraisoquinoline 3.13.  Subsequent protonation generates iminium ion 3.14, 
which undergoes cyclization to give the pavine skeleton.  The alternative pathway 
involves ionization of the alcohol to give 3.16, and subsequent cyclization affords 
isopavine 3.17.  Evidence for this proposed mechanism has been provided by the 
isolation of intermediate 3.12 from the reaction medium.221-223  4-
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Hydroxytetrahydroisoquinolines have been suggested as intermediates in the biosynthesis 
of pavine and isopavine alkaloids,224, 225 but no concrete evidence establishing the 
























































The nature of the reaction conditions control which of the two mechanistic 
pathways is followed.  At elevated temperatures, mixtures of isopavines and pavines are 
usually formed, while at room temperature the isopavines are formed almost 
exclusively.210  The nature of the acid has also been shown to influence the product 
distribution.226      
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In order to exploit this double cyclization, a number of different routes to the key 
aminoacetal intermediates have been developed.  One of the most common synthetic 
approaches involves the reductive amination of an appropriately substituted 
deoxybenzoin, and a representative example of this is outlined in Scheme 3.3.225  The 
desired deoxybenzoin 3.20 was obtained in 74% yield from a Friedel-Crafts acylation of 
veratrole (3.18) with acid chloride 3.19.  The condensation of 3.20 with 
aminoacetaldehyde diethyl acetal (3.21) afforded an imine, which was subsequently 
reduced with NaBH4 to provide 3.22.  The double cyclization of 3.22 proceeded in 
concentrated HCl/EtOH (10:1), and reductive amination with formaldehyde yielded (±)-
reframine (3.3) in 40% yield over the two steps.  Similar synthetic sequences have been 
reported in the syntheses of (±)-amurensinine (3.1),224, 227 (±)-O-methylthalisopavine 





































    EtOH (10:1)
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A number of alternative routes to the key benzylaminoacetaldehyde dialkyl 
acetals have also been reported.  Dyke has shown that aminoacetal 3.27 can be accessed 
via a Strecker/aminonitrile alkylation sequence (Scheme 3.4).229  The condensation of 
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benzaldehyde 3.23 with amine 3.24 in the presence of KCN provided aminonitrile 3.25.  
Alkylation of 3.25 with piperonyl chloride (3.26) and subsequent removal of the cyano 
group gave aminoacetal 3.27, which was contaminated with a small quantity of the 
unalkylated amine.  It was found that this impurity was more readily removed after the 
cyclization reaction.  Upon treatment with 6N HCl, 3.27 underwent a double cyclization 
to deliver (±)-reframoline (3.28) in 8% yield over the four steps, along with 2% of the 
pavine alkaloid caryachine (3.29).  The formation of 3.29 as a side product presumably 
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A third approach utilized by Dyke and co-workers has allowed for access to 
enantiomerically enriched isopavine alkaloids (Scheme 3.5).230  Thus, imine 3.30 was 
deprotonated with NaH, and the resulting anion was alkylated with 3.26 to give 3.31 in 
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75% yield after hydrolysis of the imine.  The direct methylation of 3.31 was 
unsuccessful, so a two step acylation/reduction sequence was utilized to yield 3.32.  The 
secondary amine 3.32 was then resolved with (+)-dibenzoyltartaric acid to provide (+)-
3.32.  Subsequent alkylation with bromoacetal 3.33 and double cyclization afforded (-)-
reframoline (3.28) and (-)-caryachine (3.29) in low yields.  This synthesis was used to 
confirm the absolute configuration of the naturally occurring isopavines, and verified the 
results of Shamma and Nakanishi, who had previously determined the absolute 
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A number of more modern approaches to the isopavine alkaloids that utilize a 
double cyclization have also been reported.  The first of these routes was reported in 1996 
by Badía and Domínguez, and constituted a concise approach to chiral isopavines of both 
natural and unnatural origin (Scheme 3.6).232  Their synthesis of (-)-amurensinine began 
with the condensation of piperonal (3.34) with (S)-(+)-phenylglycinol (3.35) to provide 
imine 3.36.  The addition of benzyl Grignard reagent 3.37 to the imine afforded the 
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desired secondary amine 3.38 in good yield with excellent levels of diastereoselectivity.  
The chiral auxiliary could then be removed by hydrogenolysis, and the resulting primary 
amine was alkylated with 3.33 to furnish 3.39 in 57% yield over the two steps.  The 
double cyclization of amine 3.39 occurred upon treatment with conc. H2SO4 in acetic 
acid, and subsequent reductive amination delivered (-)-amurensinine in excellent yields 
over the two steps.  Then, by simply altering the substitution pattern on the starting 
aldehyde and Grignard reagent, the syntheses of (-)-O-methylthalisopavine and other 
unnatural isopavines could be achieved in an analogous fashion.         
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Ellman has reported an enantioselective synthesis of the isopavine skeleton 
utilizing a resin bound chiral sulfinamide (Scheme 3.7).233  Imine formation between the 
resin bound t-butansulfinamide 3.40 and aldehyde 3.41 provided 3.42.  Imine 3.42 was 
then treated with Grignard reagent 3.43 to yield 3.44.  N-Allylation and oxidation of 3.44 
delivered 3.45, which underwent subsequent dihydroxylation and oxidative cleavage to 
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give aldehyde 3.46.  Upon treatment with formic acid in CH2Cl2, aldehyde 3.46 
underwent a double cyclization to generate the isopavine core, and resin cleavage 
provided 3.47 in 47% yield and 86:14 er over 8 steps.  Although this route has been 
shown to give access to enantiomerically enriched isopavine scaffolds, its application to 
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eight steps   
The above routes to the isopavine alkaloids employ an aminoacetal similar to 3.10 
in an acid catalyzed double cyclization.  Alternatively, Sano has shown that the 
Pummerer reaction can be employed in a similar cyclization that led to the synthesis (±)-
O-methylthalisopavine (3.52) (Scheme 3.8).234  The reductive amination of deoxybenzoin 
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3.48 with 2-phenyl-thioethylamine (3.49) afforded an intermediary amine, which was 
formylated with formic acid/Ac2O to give 3.50 in 91% yield.  The thioether group in 3.50 
was then oxidized with NaIO4 in MeOH to give sulfoxide 3.51 in 94% yield.  The 
treatment of 3.51 with trifluoroacetic anhydride (TFAA) in benzene initialized a 
cyclization via a Pummerer reaction to provide a mixture of 3.53 and 3.54, which was 
treated in situ with BF3·OEt2 to furnish the N-formylisopavine.  Subsequent reduction of 
the formyl group with LiAl4 gave (±)-O-methylthalisopavine in 46% yield over the two 
steps.  The Pummerer reaction is a milder alternative to the acid catalyzed double 
cyclization, but the lack of regiocontrol in the first cyclization limits its application to 
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3.1.2.2 Syntheses of Isopavines from 4-Hydroxytetrahydroisoquinoline Der ivatives. 
The second common approach to the isopavine alkaloids involves the synthesis 
and subsequent cyclization of 4-hydroxytetrahydroisoquinoline derivatives.  The 
synthesis of (±)-O-methylthalisopavine (3.52) by Dyke in 1971 was the first to utilize this 
approach,225 and Dyke later used this strategy in establishing the structure of (±)-
amurensine via its total synthesis (Scheme 3.9).225, 235  A Ressiert reaction of the known 
isoquinoline 3.55 with benzoyl chloride and KCN furnished 3.56.  Alkylation of 3.56 
with benzylchloride 3.57 and subsequent de-acylation afforded isoquinoline 3.58.  
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Methylation of 3.58 and reduction with LiAlH4 generated a 1,2-dihydroisoquinoline, 
which underwent a subsequent hydroboration/oxidation to yield the 4-
hydroxytetrahydroisoquinoline 3.59.  Acid catalyzed cyclization provided (±)-amurensine 
(3.1), thus establishing the position of the phenolic-OH in the natural product.  A similar 
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A more commonly utilized approach to 4-hydroxytetrahydroisoquinoline 
derivatives involves the regioselective benzylic oxidation of an appropriate 
tetrahydroisoquinoline.  The application of this tactic to the isopavine alkaloids was first 
reported by Umezawa and co-workers in 1973 (Scheme 3.10).237, 238  The oxidation of 6-
hydoxytetrahydroisoquinoline 3.60 with Pb(OAc)4 in chloroform furnished the 4-
acetoxytetrahydroisoquinoline 3.61 in 60% yield.  Upon treatment with conc. HCl in 
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ethanol, 3.61 underwent cyclization to give reframoline (3.28) in 90% yield.  Methylation 






































 3.3   
A similar oxidative approach has been utilized by Rice in the synthesis of (-)-
thalidine and (-)-O-methylthalisopavine (Scheme 3.11).239, 240  Rice’s synthesis began 
with the condensation of phenethylamine 3.62 and acid 3.63 to give the amide 3.64 in 
90% yield.  Cyclization of 3.64 with POCl3 and reduction of the resulting 
dihydroisoquinoline with NaBH4 provided racemic N-norreticuline (3.65), which was 
purified via crystallization of its tosic acid salt.  N-Norreticuline could be easily resolved 
by treating with 2’-bromotartranilic acid in ethanol, and upon treatment with HCl in 2-
propanol the hydrochloride salt of (+)-3.65 could be isolated with >99% optical purity.   
With optically pure (+)-3.63 in hand, attention was then turned towards the 
completion of the synthesis.  Acylation of (+)-3.63 with ethyl chloroformate and 
subsequent oxidation with 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) provided 3.64 
in 97% over the two steps.  The cyclization of 3.66 proceeded smoothly in the presence 
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of methanesulfonic acid, and a borane reduction delivered (-)-thalidine (3.67).  
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Another oxidative approach to the isopavine skeleton has been reported by 
Meyers, who applied the chiral formamidine auxiliary to the asymmetric syntheses of (-)-
O-methylthalisopavine and (-)-reframoline (Scheme 3.12).241, 242  The synthesis began 
with the attachment of the chiral auxiliary to the tetrahydroisoquinoline 3.68, which was 
accomplished in 90% yield by heating 3.68 and 3.69 in toluene.  Deprotonation of 3.70 
with t-butyllithium and trapping with the appropriate benzyl bromide at -100 ºC provided 
3.71 in good yields.  The O-benzyl group was then removed by hydrogenolysis, and the 
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resulting phenol oxidized with Pb(OAc)4 to give an intermediate quinol acetate which 
was cyclized into (-)-reframoline (3.28) upon  treatment with concentrated HCl.  The 
enantiomeric purity of 3.28 was found to be 98-99% based on its optical rotation. The 
yield for this last sequence was poor, but the authors commented that no efforts to 
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One of the few syntheses of a lactam containing isopavine was achieved by Elliot 
in his route to (±)-O-methylthalisopavine (3.52) (Scheme 3.13).228  Treatment of acid 3.72 
with polyphosphoric acid resulted in the formation of ketoacid 3.73 in 60% yield.  
Heating 3.73 with methylamine in diethylene glycol yielded an intermediary enamide, 
which was hydrogenated over PtO2 to produce 3.74.  The yields for these steps were not 
reported.  Upon treatment with VOF3 in acetonitrile, isoquinolone 3.74 underwent 
oxidation and cyclization to give a lactam that was reduced with borane to give the 
natural product in only 5% yield.    
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3.1.2.3 Other  Routes to the Isopavine Alkaloids 
 Kamenti has developed a novel approach to the isopavine skeleton involving the 
ring expansion of an aziridinium ion (Scheme 3.14).243  The synthesis began with the 
condensation of 3.75 with hydroxyl amine, and subsequent reduction with Raney nickel 
furnished the requisite primary amine 3.76.  A three step formylation, reduction, and 
formylation sequence provided formamide 3.77 in 58% yield.  A Bischler-Napieralski 
cyclization afforded the desired dihydroisoquinoline, which was treated with methyl 
iodide in diethyl ether to generate iminium ion 3.78.  When 3.78 was treated with ethereal 
diazomethane, the desired aziridinium salt 3.79 was formed in high yield.  The crude 3.79 
was treated immediately with 6N HCl to give reframidine (3.28) in 20% yield over the 
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Jung has developed an expedient approach to the isopavine skeleton that was 
utilized in the synthesis of isopavine itself (Scheme 3.15).244  The trimethylsilyl iodide 
catalyzed dimerization of phenylacetaldehyde 3.41 generated 3.80 in quantitative yield.  
Upon treatment with n-BuLi in THF, 3.80 underwent ring opening to yield 3.81.  Alcohol 
3.81 was then converted to azide 3.82 upon treatment with NaN3 and H2SO4 in refluxing 
benzene.  Thermolysis of azide 3.82 in mesitylene at 160 ºC gave the dehydroisopavine 
3.87 in 63% yield over the two steps.  The authors propose that this reaction proceeds via 
the nitrene intermediate 3.83, which aziridinates the proximal olefin to generate 3.84.  
Subsequent ring opening of the aziridine and attack by the aromatic ring afforded 3.86, 
which underwent a ring opening to give imine 3.87.  Reduction of 3.87 with NaBH4 













































































The Stevens rearrangement has also been successfully applied to the synthesis of 
a number of isopavines.  In 1978 Takayama reported the syntheses amurensinine (3.2) 
and reframine (3.3) using the Stevens rearrangement to construct the isopavine core 
(Scheme 3.16).245  The aminoacetal 3.88 was cyclized under acidic conditions to give 
azocine 3.89.  Formation of the quaternary ammonium salt with methyl iodide provided 
3.90.  Upon treatment with KOt-Bu in dioxane at 80 ºC, 3.90 underwent the desired 
rearrangement to provide a mixture (1.8:1) of 3.2 and 3.3 in 85% yield.  The lack of 
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selectivity in this reaction detracts from what is otherwise a concise approach to the 
isopavine alkaloids, thereby limiting use of this approach to the synthesis of symmetrical 
isopavines.  Hanessian has since applied this approach to the synthesis of a number of 
unnatural isopavine analogues similar to 3.91 and 3.92 that have been shown to be potent 
morphinomimetics.215, 246, 247  











































The most recently reported synthetic effort towards this family of alkaloids was 
the total synthesis of (+)-amurensinine by Stoltz in 2006.248  This synthesis featured the 
aryne acyl alkylation249 and oxidative kinetic resolution250 methodologies previously 
developed in the Stoltz group.  The synthesis began with the four step homologation of 
acid 3.72 into β-ketoester 3.93 (Scheme 3.17).  The diazo transfer reaction of 3.93 
 183 
proceeded in almost quantitative yield to give 3.95.  Upon treatment with Rh2(OAc)4 in 
1,2-dichloroethane, 3.95 reacted to form 3.96 selectively in 96% yield.  With 3.96 in hand 
the key aryne acyl alkylation could be attempted.  β-Ketoester 3.96 and 3.97 were treated 
with CsF in acetonitrile at 80 ºC to provide 3.98 in 57% yield.  Mechanistically the 
reaction proceeds through aryne 3.100, which reacts with 3.99 to yield cyclobutane 
3.101.  Ring expansion of 3.101 proceeds to afford 3.98.  Thus, the complete carbon 
framework for amurensinine had been assembled and all that remained was the 
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The completion of the synthesis commenced with a diastereoselective reduction 
of ketone 3.98 with L-selectride to give 3.102 (Scheme 3.18).  The methyl ester was then 
reduced with LiAlH4, and the resulting primary alcohol protected as its TIPS-ether.  
Alcohol (±)-3.103 then underwent the oxidative kinetic resolution to provide (-)-3.103 in 
47% yield and >99% ee.  Conversion of the secondary alcohol to the azide and removal 
of the TIPS-ether afforded 3.104 in 62% yield.  Two step oxidation of alcohol 3.104 to 
the corresponding carboxylic acid proceeded smoothly, and subsequent hydrogenation of 
the azide provided lactam 3.105.  It is worthy to note that the reduction of the ester 3.102 
and its later re-oxidation was necessary, as efforts to install the azide on the 
enantioenriched form of 3.102 resulted in substantial epimerization at C-5.  From lactam 
3.105, (+)-amurensinine could be obtained in 52% after LiAlH4 reduction and 
methylation.  The lengthy sequence of reactions required to convert 3.98 into the natural 
product without the loss of enantiopurity makes this synthesis the longest of all the 
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Although the isopavine alkaloids are a small family of natural products, a number 
of syntheses of these alkaloids have been reported.  The classic approach to the isopavine 
core is the acid catalyzed double cyclization of benzylaminoacetaldehyde dialkyl acetals 
similar to 3.10.  The route developed by Badía and Domínguez utilizes this approach,232 
and is arguably one of the best methods for synthesizing natural and unnatural isopavines 
in enantioenriched form.  The second most commonly utilized approach is the cyclization 
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of 4-hydroxytetrahydroisoquinoline derivatives, and a number of approaches to the 
isopavines have been developed utilizing this approach.  The most notable of these 
approaches are the those of Rice240 and Meyers241 that allow for the enantioselective 
syntheses of the isopavine family.   
Notably lacking is a synthesis of roelactamine, which is the only known naturally 
occuring lactam containing isopavine alkaloid.  Only two syntheses of lactam containing 
isopavines have been reported, and these lactams were accessed as intermediates in 
routes to other isopavine alkaloids.  The first of these was by Elliot, who utilized a low 
yielding vanadium mediated oxidation and cyclization of isoquinolone 3.72 to form a 
lactam that was subsequently reduced (Scheme 3.13).  The second lactam containing 
isopavine was synthesized by Stoltz in route to (+)-amurensinine.  Although both of these 
routes could potentially be applied to the synthesis of roelactamine, neither is readily 
amenable to the synthesis of roelactamine analogues that could be utilized in biological 
assays.  The route developed by Stoltz is too lengthy to be of practical use is this arena, 
while the route developed by Elliot would need to be modified to access anything other 
than symmetrically substituted isopavines.  Due to the interesting biological activities 
shown by other members of this family, it is desirable for chemists to develop an efficient 
route to roelactamine that is also amenable to the synthesis of unnatural analogues, so 
that the biological properties of these lactam containing isopavines can be studied.    
3.2 THE ASPIDOSPERMA ALKALOIDS 
3.2.1 Introduction 
The Aspidosperma family of alkaloids is one of the largest families of indole 
alkaloids known, and over 250 unique alkaloids have been isolated from numerous plant 
sources.251-253  The aspidospermine alkaloids are characterized by a pentacyclic 
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framework, which is exemplified by the structure of aspidospermidine (3.106) (Figure 
3.2).  The vast majority of the members of this family contain substitution at C20, usually 
in the form of an angular ethyl substituent.  Exceptions to this are few, with the most 
notable being the pseudoaspidospermidine-pandoline group, represented by 
pseudoaspidospermine (3.107).  Also included in this class of natural products is the 
quebrachamine group, exemplified by quebachamine itself (3.108).  Members of the 
aspidospermine family have been shown to display a number interesting biological 
activities.  Of particular interest are the bisindole alkaloids related to vinblastine (3.111), 
which is currently used as an antitumor drug.254           


























































Rosicine (3.112) was isolated in 1984 from Catharanthus roseus and is one of the 
rare Aspidosperma alkaloids lacking the angular C20-ethyl group.255  The structure of 
rosicine was determined on the basis of its 1D and 2D-NMR, IR, and mass spectral data.  
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Rosicine is thought to arise from epimisiline (3.113) via oxidation and subsequent 
fragmentation of iminium 3.114 (Scheme 3.19).255  There have been no reported 


































Pseudotabersonine (3.115) was first in isolated in 1975 from Pandaca 
caducifolia.256 Prior to that, 3.115 had been known as a product of the acid catalyzed 
rearrangements of caranthanine (3.116),257-260 and as a product of the acid catalyzed 
dehydration of pandoline (3.118)261 (Scheme 3.20).  To date there have been two reported 
total syntheses of (±)-pseudotabersonine.  The first of these was reported by Kuehne in 
1992,262 and was followed a year later Grieco’s elegant synthesis263 (see Section 3.2.3).  







































3.2.2 Syntheses of the Aspidosperma Alkaloids 
Due to their interesting structural features and biological activities, the 
aspidospermine alkaloids have attracted an extraordinary amount of attention from the 
synthetic community.251-253, 264  The first total synthesis of a member of this family was 
Stork and Dolfini’s synthesis of aspidospermine (3.128) and quebrachamine in 1963.265  
Since then over 50 different research groups have reported syntheses of various members 
of the aspidospermine alkaloids.  The remainder of this Section will focus on describing 
some of the work in this field as an overview of the more commonly utilized approaches 
to the Aspidosperma alkaloids.   
3.2.2.1 Syntheses Involving the Stork-Dolfini Ketone  
Stork and Dolfini completed the first total synthesis of aspidospermine (3.128) 
and quebrachamine (3.108) in 1963.265, 266 Their synthetic route focused on the use of 
enamine chemistry to synthesize ketone 3.125, which has since been named the Stork-
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Dolfini ketone (Scheme 3.21).  Enamine 3.119, readily available from the condensation 
of pryrrolidine and butyraldehyde, was reacted with methyl acrylate to give aldehyde 
3.120 in 67% yield.267  The enamine of 3.120 was formed by condensation with 
pyrrolidine and subsequently reacted with methyl vinyl ketone to generate a keto-
aldehyde that underwent an aldol condensation in refluxing acetic acid to provide 
cyclohexenone 3.121 in 48% yield over the three steps.  The ketone in 3.121 was then 
protected as its ketal, and the methyl ester was converted to the primary amide with 
aqueous ammonia.  The amide was then reduced to the primary amine with LiAlH4, and 
after hydrolysis of the ketal and treatment with base, the hydroquinoline 3.122 was 
formed.  The conversion of 3.122 into the tricyclic amide 3.124 was achieved in two 
steps by the acylation of 3.122 with chloroacetyl chloride and treatment of the resulting 
amide 3.123 with KOt-Bu to provide tricycle 3.124.  Selective reduction of the amide in 
3.124 was achieved through a three step sequence that involved the protection of the 
ketone as its ketal, reduction of the amide with LiAlH4, and hydrolysis to give the key 
aminoketone 3.125.  Fisher indole synthesis with hydrazine 3.126 afforded indolenine 
3.127, which could be reduced with LiAlH4 and acylated to provide (±)-aspidospermine 
(3.128).  Alternatively, the Fisher-indole synthesis with phenylhydrazine gave an 
intermediate indolenine 3.129 that could undergo reductive cleavage with KBH4 to 
generate (±)-quebrachamine (3.108).  Thus, Stork’s syntheses of aspidospermidine and 
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After Stork’s initial synthesis, ketone 3.125 became a popular target for synthetic 
chemists.  However, Stork had originally assigned the structure of 3.125 to be that of the 
trans-fused 3.130.  This error did not become apparent until after Ban completed a 
synthesis of aspidospermidine in 1965.268  Ban’s route was conceptually very similar to 
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that of Stork’s, but due to differences in the stereochemistry of the intermediates did not 
actually intercept any of Stork’s intermediates (Scheme 3.22).   
Ban’s synthesis began with the double conjugate addition of 2-pentanone (3.131) 
to acrylonitrile to provide 3.133.  Methyl ketone 3.133 was partially hydrolyzed and 
cyclized in 80% H2SO4 at elevated temperatures to give the unsaturated ketoamide 3.134 
in 80% yield.  Hydrogenation of 3.134 under basic conditions generated the saturated 
ketoamide, which was reduced with LiAlH4 to provide amino alcohol 3.135 in 64% yield 
over the two steps.  Alcohol 3.135 then underwent an Oppenauer oxidization with KOt-
Bu in cyclohexanone to give ketone 3.136.  From aminoketone 3.136 the synthesis of 
aspidospermine was completed using Stork’s previously reported route.  However, Ban’s 
intermediates were trans-fused, as opposed to Stork’s cis-fused intermediates.  
Interestingly, Ban was also able to isolate indole 3.138 as a side product from the Fisher 
indole synthesis, and later commented on the formation in this reaction of an isomer of 
deacetylaspidospermine with a trans-CD ring fusion.269   It is noteworthy that Ban had 
also originally incorrectly assigned the structure of 3.130 and initially believed that the 
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 Upon comparison of the physical and spectral data for 3.137 and 3.130 to Stork’s 
intermediates 3.124 and 3.125, it was apparent that the compounds synthesized with these 
two routes were not identical.  In order to garner more evidence towards the proper 
structures of tricyclic ketones 3.125 and 3.130, additional studies were undertaken by the 
Ban group.  After preliminary investigations involving model compounds lacking the 
C20 ethyl group showed that compounds such as 3.125 and 3.130 could epimerize under 
the conditions of the ketal hydrolysis, the relative stereochemistry of these compounds 
was called into question.270  The A/B trans-aminoketone 3.137 was independently 
synthesized, and subjected to the reaction sequence shown in Scheme 3.23.271  The 
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reduction of 3.137 with NaBH4 gave an alcohol that was subsequently reduced with 
LiAlH4 to give aminoalcohol 3.140.  Oxidation of 3.140 with chromic acid yielded 
ketone 3.130, which was then reduced with LiAlH4 to provide the diastereomeric alcohol 
3.141.  Because the structures of 3.140 and 3.141 were different, it was concluded that an 
epimerization must have occurred under the acidic conditions of the oxidation.  Both 
3.140 and 3.141 exhibited Bohlmann bands in their respective IR spectra, indicating that 
A/B ring fusion was in fact trans.  Aminoketone 3.130 was identical with the one 
previously utilized in the Ban’s synthesis of aspidospermidine, thus establishing the 
correct structure for Ban’s proposed intermediate 3.139.  This also meant that the 































While the stereochemistry present in Ban’s aminoketone 3.130 is different from 
that found in the natural product, it eventually led to the natural product.  This meant that 
during the course of the Fisher indole synthesis Ban’s intermediate 3.130 had to undergo 
an epimerization.  Stork, initially thinking he had made 3.130, proposed two possible 
mechanisms for this epimerization (Scheme 3.24).266  The first explanation is that the 
final intermediate in the Fisher indole synthesis, 3.142, undergoes a fragmentation to give 
3.144, which would cyclize to give the more stable cis-indoleine 3.127.  This pathway 
could presumably be lower in energy than the elimination pathway leading to the strained 
trans-indolenine.  The second possible pathway for epimerization arises from the fact that 
under the conditions of the Fischer indole synthesis, the initially formed trans-indolenine 
 195 
3.142 can undergo a retro-Mannich process, also leading to iminium ion 3.144.  Thus, 
regardless of whether or not the proposed fragmentation occurs, the cis-indolenine should 
still be the major product of the reaction.  However, as previously mentioned Ban was 
able to isolate the deacetylaspidospermine with a trans-CD ring fusion, indicating that the 






























Since the pioneering works of Stork and Ban a number of different routes to 
3.125, or compounds related to 3.125 have been developed.  Martin reported an approach 
to 3.125 that utilizes an intramolecular Diels-Alder cycloaddition to construct the cis-
fused tricyclic framework (Scheme 3.25).272  The synthesis began with the acylation of 
3,4,5,6-tetrahydropyridine 3.145 with acid chloride 3.146, which provided enamide 3.147 
in 57% yield.  The use of the 2,5-dihydrothiophene-1,1-dioxide as a masking group for 
the requisite diene was necessary as attempts to acylate 3.145 with 3,5-hexadienoyl 
chloride were unsuccessful.  The thermolysis of 3.147 at 600 ºC resulted in the 
cheleotropic extrusion of SO2 to give triene 3.148, which underwent a [4+2] 
cycloaddition to provide the cis-fused tricycle 3.149.   The oxidation of 3.149 with SeO2 
in AcOH and subsequent hydrolysis of the allyl acetate gave an allylic alcohol, which 
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was oxidized with pyridinium chromate to give ketoamide 3.150.  Hydrogenation of the 
double bond in 3.150 provided 3.125 in 98% yield, thus completing the formal synthesis 
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The first asymmetric synthesis of the Stork-Dolfini ketone was reported by 
Meyers in 1989.273  Meyers utilized the chiral bicyclic lactam 3.151 as a chiral auxiliary 
for establishing the stereochemistry of the C20 ethyl group (Scheme 3.26).  The 
sequential alkylation of 3.151 with ethyl iodide and allyl bromide afforded 3.152 in 69% 
yield with greater than 25:1 diastereoselectivity.  Cleavage of the auxiliary with Red-Al 
provided a keto-aldehyde, which was cyclized to cyclohexenone 3.153 upon treatment 
with mild acid.  The olefin in 3.153 was successfully converted to a carboxylic acid in 
good yield by a sequence of hydroboration/oxidation and Jones oxidation.  Carboxylic 
acid 3.154 was then converted to primary amide 3.155 via its acid chloride.  Amide 3.155 
was cyclized upon treatment with TsOH in benzene, and subsequent addition of ethylene 
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glycol to the reaction mixture furnished ketal 3.156 as a single diastereomer in 85% yield.  
Reduction of the amide moiety and hydrolysis of the ketal provided an aminoketone 
which was acylated with chloroacetyl chloride to give (+)-3.123, which is the 
enantioenriched form of Stork’s intermediate.  Although a formal synthesis had been 
completed at this point, (+)-3.123 was further elaborated into the enantioenriched version 
of the Stork-Dolfini ketone (3.125), thus completing the formal synthesis of the (+)-
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3.2.2.2 Syntheses of Quebrachamine and Its Conversion to the Aspidospermine 
Skeleton 
As shown in Storks synthesis of aspidospermine, 1,2-dehydroaspidospermine 
derivatives can be converted to the quebrachamine ring system via reduction under acidic 
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conditions.  The reverse of this transformation is also known, and the oxidation of 
quebrachamine derivatives to iminium ions such as 3.157 has been used numerous times 
for the conversion of quebrachamine derivatives into the aspidospermine skeleton 
(Scheme 3.27).  Thus, any approach to the quebrachamine alkaloids can be utilized to 



















In 1966 Kutney reported a total synthesis of quebrachamine that focused on the 
synthesis of tetracycle 3.160, which could be converted into quebrachamine via the 
ammonium salt 3.161.258, 274-278 This approach has since become the most commonly 
utilized approach to the quebrachamine family of alkaloids.  Kutney later modified this 
approach to allow for the synthesis of (±)-vincadifformine (3.164) and minovine (3.165). 
(Scheme 3.28).279  Starting from the known ethyl ester 3.158, alkylation with allyl 
bromide and subsequent oxidative cleavage of the olefin provided aldehyde 3.159.  
Aldehyde 3.159 was then reacted with tryptamine in a Pictet-Spengler reaction to give an 
intermediary lactam, which was reduced with LiAlH4 and deprotected to furnish 3.160 in 
good yield.  Alcohol 3.160 was then treated with methanesulfonyl chloride in 
triethylamine to give the quaternary mesylate 3.161.  Reacting 3.161 under either 
dissolving metal conditions or with LiAlH4 generated quebrachamine in moderate yields.  
Alternatively, 3.161 could be ring opened with potassium cyanide in DMF to give 3.162.  
Subsequent hydrolysis of the nitrile and esterification of the intermediate acid with 
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diazomethane provided 3.163, which could be cyclized to vincadifformine using either 
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(±)-vincadifformine (3.164) R = H





   
Since Kutney’s original report, other similar routes to quebrachamine utilizing the 
intermediacy of compounds similar 3.161 have been reported by Takano,280-284 
Wenkert,285 Ziegler,286-288 Fuji,289, 290 and Asaoka and Takei.291  In addition to these 
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reports, a number of other routes to quebrachamine have also been reported.  One of the 
more interesting of these routes is the enantioselective synthesis of (+)-quebrachamine 
reported by Hoveyda in 2008.292, 293  The key step in this synthesis was the asymmetric 
ring closing metathesis (ARCM) of prochiral triene 3.174 (Scheme 3.29).  The synthesis 
began with a deacylative diazo transfer that afforded 3.167 in 66% yield from the 
commercially available lactone 3.166.  The synthesis of cyclopropene 3.169 was 
accomplished by the slow addition of 3.167 to a solution of Rh2(OAc)4 in 
trimethylsilylacetylene, and subsequent de-silylation provided 3.169 in 59% yield over 
the two steps.  The requisite divinyl functionality was then installed via a ring opening-
cross metathesis reaction of 3.19 with the Hoveyda-Grubbs II catalyst under an 
atmosphere of ethylene gas.  The lactone 3.170 was opened with the magnesium anion of 
N-methyl-O-methyl hydroxylamine, and Swern oxidation of the resulting alcohol gave 
aldehyde 3.171.  Aldehyde 3.171 was then reacted with tryptamine in a Pictet-Spengler 
reaction to yield a tetracyclic lactam, which was reduced with LiAlH4 to provide 3.172 in 
good yields.  Ring opening of the β-carboline was achieved by sequentially treating 3.172 
with allyl chloroformate and NaCNBH3.  The key ARCM substrate 3.174 could then be 
accessed through a palladium mediated decarboxylative allylation, which proceeded in 
88% yield.  With 3.174 in hand, attention was turned to the ARCM.  After screening 
several chiral catalysts, it was found the molybdenum catalyst 3.175 could produce the 
desired ARCM product 3.176 in good yield with excellent levels of enantiocontrol.  The 
final hydrogenation of 3.176 proceeded without incident to furnish (+)-quebrachamine in 
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3.2.2.3 The Ban Oxindole Approach 
Although Ban had previously completed a successful synthesis of 
aspidospermine, the problematic Fisher indole synthesis utilized in this route caused Ban 
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to develop a second approach to the aspidospermine alkaloids.  This was approach was 
built around the synthesis and manipulation of spiroxindole 3.180 (Scheme 3.30).294-296  
Following a general protocol developed by Harley-Mason,297 spiroxindole 3.179 was 
synthesized from 2-oxytryptamine (3.177) and aldehyde 3.178.  The amine was then 
acylated, and the ketal hydrolyzed to provide 3.180.  When 3.180 was treated with ethyl 
triethyloxonium tetrafluoroborate, an imidate was formed that was heated with NaH in 
DMSO to give the tetracycle 3.181 as the major product.  The vinylogous amide moiety 
in 3.181 was then reduced to the amino-alcohol with NaBH4, and selective tosyl 
protection of the aniline nitrogen and cleavage of the acetamide yielded 3.182.  The 
installation of the D ring began with the acylation of secondary amine 3.182 with acid 
chloride 3.183, and subsequent elimination generated acrylamide 3.184.  The secondary 
alcohol was then re-oxidized to the ketone with Jones reagent, and upon treatment with 
triethyloxonium tetrafluoroborate in refluxing dichloroethane the desired pentacycle 
3.185 was formed in 16% yield.  The ketone was then removed by forming the dithiane 
and reduction with Raney nickel.  Reduction of the amide with LiAlH4 proceeded with 
concurrent removal of the tosyl protecting group, and subsequent acylation provide N-
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While Ban never utilized the oxindole approach for the synthesis of 
aspidospermine alkaloids containing a C20 ethyl group, Le Man was able to demonstrate 
its application to the synthesis of aspisospermidine and vincadifformine (3.164) (Scheme 
3.31).298  By starting with aldehyde 3.188, Le Man was able to assemble the D and E 
rings in a single step.  Thus, 2-oxotryptamine was treated with aldehyde 3.188 in 
refluxing benzene to afford 3.189 as mixture (6.2:1) of diastereomers in a combined 70% 
yield.  For the synthesis of aspidospermidine, the major diastereomer, 3.189, was treated 
with polyphophoric acid at 125 ºC to produce 3.191 in 68% yield.  The reduction of 3.191 
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with LiAlH4 gave aspidospermidine in 70% yield.  For the synthesis of vincadifformine, 
a slightly longer reaction sequence was needed.  To this end, 3.189 was treated with 
triethyloxonium tetrafluoroborate to generate an imidate that was heated with NaH in 
DMSO to provide a mixture of the methyl and ethyl esters 3.192 and 3.193, which were 
used in the next step without separation.  The lactam group could then be selectively 
reduced in the presence of the ester by conversion to the thioamide and reduction with 
Raney nickel, thus completing the synthesis of vincadifformine (3.164).  Interestingly, 
the authors made no attempt to convert the undesired ethyl ester 3.194 into the natural 
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3.2.2.4 The Rearrangement of β-Carboline Der ivatives 
One alternative approach to the aspidospermine skeleton involves the synthesis of 
an octahydroindolo[2,3-a]quinolizine via a Pictet-Spengler reaction, followed by a 
subsequent rearrangement of the quinolizine to provide the aspidospermine skeleton 
(Scheme 3.32).  This approach was first applied to the synthesis of aspidospermidine by 
Harley-Mason in 1965.299, 300  Since then, Rapoport has utilized a similar approach to 
synthesize vindoline,301, 302 and Fuji has exploited this tactic in the enantioselective 
synthesis of (-)-aspidospermidine.289, 290  Langlois has also utilized a similar 
rearrangement of an indolo[2,3-a]quinolizine in the syntheses of vindoline and 
vinderosine.  However, Langlois accessed the requisite quinolizine via a hetero Diels-
Alder reaction instead of the more commonly used Pictet-Spengler approach.303, 304   
The Harley-Mason synthesis is representative of this approach, and is outlined in 
Scheme 3.32.  Starting with the aldehyde 3.120, previously prepared by Stork,267 enamine 
formation and alkylation with allyl bromide provided 3.195.  The aldehyde was then 
protected as its dimethyl acetal, and ozonolysis of the alkene moiety followed by sodium 
borohydride reduction gave alcohol 3.196.   Acetal 3.196 was then reacted with 
tryptamine in boiling acetic acid to generate 3.197.  Upon heating to 100 ºC in 40% 
H2SO4 or BF3·OEt2, 3.197 reacted to give 3.198, which underwent a retro-
Mannich/Mannich sequence to give 3.200.   Indolenine 3.200 was then reduced with 




























































3.2.2.5 Syntheses of Vinderosine and Vindoline 
Vindoline (3.110) is perhaps the most sought after of the Aspidosperma alkaloids 
due to its inclusion as a subunit in the oncolytic alkaloid vinblastine (3.111).  Therefore, a 
substantial amount of effort has been made towards the syntheses of vindoline and its 
demethoxy analogue, vinderosine (3.208).  The first synthesis of vinderosine was 
reported by Buchi in 1971,305 and was followed by a synthesis of vindoline in 1975.306  
Buchi’s route focused on the sequential construction of the C, D, and E rings onto an 
indole nucleus, with the C and E rings being formed in a single operation (Scheme 3.33).  
Buchi’s elegant synthesis began with the reaction of tryptamine with vinylogous 
acid chloride 3.202, which provided a vinylogous amide that was N-acylated to give 
3.203.  Upon heating in BF3·OEt2 at 90 ºC the desired double cyclization occurred to give 
3.204 in 35% yield after cleavage of the acetamide.  Amino-ketone 3.204 was then 
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reacted with acrolein in NaOMe/MeOH to give a mixture of ketols, which were 
dehydrated with BF3 in acetic acid to form the pentacyclic core of the natural product.  
The C20 ethyl group was then installed in 44% yield by alkylation with ethyl iodide.  The 
next step of the synthesis focused on installing the requisite functionality at C16.  The 
methyl ester was installed first by treating 3.206 with NaH in dimethyl carbonate, and the 
resulting β-ketoester was treated with KOt-Bu and hydrogen peroxide under an oxygen 
atmosphere to afford 3.207 in 31% yield over the two steps.  The ketone was then 
selectively reduced with LiAlH4 in THF at -70 ºC, and the resulting secondary alcohol 
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 3.208      
Since Buchi’s first synthesis of vindoline a number of other approaches to ketones 
3.204 and 3.206 have been developed.  The syntheses of vindoline by Langlois and 
 208 
Rapoport were briefly discussed in the previous section.  A number of other routes to 
vindoline and vinderosine have also been developed.  The first asymmetric synthesis of 
these two alkaloids was reported by Kuehne in 1987.307  This approach was an extension 
of their previous synthesis of (-)-tabersonine (see Scheme 3.41), and was similar to that 
originally used by Danieli for the conversion of tabersonine into vinderosine.308   
A conceptually different approach to the vindoline ring system has been 
developed by Padwa.309, 310  In this approach, a tandem cyclization/cycloaddition reaction 
of a rhodium carbenoid was exploited to assemble the pentacyclic skeleton of vindoline 
(Scheme 3.34).  Starting from the known piperidone 3.209, the homologation of the acid 
to β-ketoester 3.211 could be accomplished in two steps and 58% yield.  Acylation of the 
amide in 3.211 with acid chloride 3.212 proceeded in moderate yield, and diazo transfer 
proceeded in excellent yield using standard conditions.  With the requisite diazo 
compound 3.213 in hand, the tandem cycloaddition could be attempted.  In the event, the 
treatment of 3.213 with a catalytic quantity of Rh2(OAc)2 in benzene at 50 ºC provided 
the desired carbonyl ylide 3.214, which underwent a spontaneous [3+2] dipolar 
cycloaddition with the indole double bond to provide the pentacyclic 3.215 in excellent 
yield.  Pentacycle 3.215 contains all of the requisite oxygenation found in vinderosine, 
but it is noticeably lacking the C14-C15 double bond.  Pentacycle 3.212 was further 
progressed into intermediate 3.216, which could in principle be elaborated into 
vinderosine following protocols developed by Kutney for the synthesis of vindoline.311  
To date, Padwa has not reported on the completion of the total synthesis of vinderosine; 
however, the rhodium catalyzed [3+2] cycloaddition has been utilized in the successful 
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Boger has developed an elegant approach to the aspidospermine alkaloids that 
utilizes a [4+2]/[3+2] cycloaddition cascade sequence to assemble the pentacyclic core 
(Scheme 3.35).314  This approach has been utilized in the syntheses of minovine315 and 
vindoline.316 The synthesis of vindoline began with the reaction of tryptamine 3.217 with 
carbonyl diamidazole (CDI), to generate an intermediate that was reacted with hydrazine 
3.218 to give 3.219 in 71% yield over the two steps.  The treatment of 3.219 with tosyl 
chloride and trimethyl amine resulted in the formation of oxadiazole 3.220 in 81% yield.  
Oxadiazole 3.220 was then coupled with acid 3.221 to form the cycloaddition precursor 
3.222.  Upon heating in 1,3,5-triisopropylbenzene at 230 ºC 3.222 first underwent a [4+2] 
cycloaddition to yield 3.223, which upon extrusion of N2 generated carbonyl ylide 3.224.  
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The carbonyl ylide then underwent a [3+2] cycloaddition with the indole double bond to 
generate 3.225 in 53% yield.  Note that the [3+2] cycloaddition utilized here by Boger is 
similar to that previously utilized by Padwa, but that the entry to these cycloadditions is 
very different.   
From 3.225, four main transformations were needed to complete the total 
synthesis: the reduction of the amide, the installation of the C14-C15 double bond, the 
ring opening of the oxabicycle, and the conversion of the C16 benzyl ether to its 
corresponding acetate.  To this end, the amide in 3.225 was deprotonated with LDA and 
trapped with (TMSO)2 to generate an alkoxide, which was in situ protected as its TIPS 
ether to give 3.226 in 64% yield.  The amide was then converted to the corresponding 
thioamide, which was reduced with Raney nickel.  This step also resulted in the cleavage 
of the benzyl ether, and the resulting secondary alcohol was converted to its acetate to 
afford 3.227 in 62% yield over the three steps.  Ring opening of oxabicycle was achieved 
under hydrogenation conditions, and subsequent removal of the TIPS ether and 
elimination secondary alcohol provided (±)-vindoline in 65% yield over the three steps.  
It was also demonstrated that product of the tandem cycloaddition reaction, 3.225, could 
be easily resolved using chiral HPLC, thus allowing access to both enantiomers of the 
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 212 
3.2.2.6 The Magnus Indole-2,3-quinodimethane Approach 
Magnus has developed a concise approach to the aspidospermine alkaloids that 
proceeds through a transient indole-2,3-quinodimethane that undergoes a spontaneous 
intramolecular Diels-Alder cycloaddition leading to the stereoselective formation of the C 
and D rings (Scheme 3.37).317-319  Magnus’ synthesis of aspidospermidine began with the 
condensation of the sulfonyl protected indole-3-carboxaldehyde 3.228 with amine 3.48, 
which provided the imine 3.229 in quantitative yield.  The imine 3.229 was reacted with 
mixed anhydride 3.230 in chlorobenzene at 135 ºC to generate the intermediate 
quinodimethane 3.231, which cyclized under the reaction conditions to give 3.232.  The 
cis-ring fusion was formed exclusively, and this has been rationalized by the exo-E 
transition state represented in 3.231.  With 3.232 in hand, all that remained was the 
installation of the E ring, which was easily accomplished utilizing the Pummerer reaction.  
Oxidation of the sulfide in 3.232 afforded a sulfoxide, which was treated with 
trifluoroacetic anhydride to produce 3.233 in 81% yield over the two steps.  The thioether 
was cleaved with Raney nickel, and subsequent treatment with LiAlH4 gave (±)-
aspidospermidine.  Magnus has since utilized a chiral auxiliary in this approach that 
allowed for the enantioselective synthesis of both enantiomers of 11-methoxytabersonine 
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3.2.2.7 Application of the Aza-Cope Mannich Reaction to the Aspidosperma 
Alkaloids  
Overman has elegantly applied the aza-Cope-Mannich reaction developed in his 
laboratories to the synthesis of the Aspidosperma alkaloids 11-methoxytabersonine 
(3.247),321 and deoxoapodine, and to the related Melodinus alkaloid meloscine.322  The 
synthesis of 3.247 is exemplary of this approach, and began with the synthesis of ketone 
3.238 (Scheme 3.38).321  The known silyl enol ether 3.234323 was alkylated with α-
chlorosulfide 3.235 in the presence of ZnBr2 to provide 3.236 in 84% yield.  Chloride 
3.236 was then converted to the primary iodide, which was reacted sequentially with 
ammonia and methyl chloroformate to provide enecarbamate 3.237.  Epoxidation of the 
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enamide moiety in 3.237 occurred with concurrent oxidation of the sulfide to the 
sulfoxide, and upon heating of the intermediate epoxide to 165 ºC in the presence of 
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3.238     
With ketone 3.238 in hand, attention was then turned to the synthesis of 3.241 
(Scheme 3.39).  The synthesis of 3.241 began with the addition of cyanohydrin 3.239 to 
ketone 3.238, which produced oxazolidine 3.240 in 80% yield after basic hydrolysis.  
Methylenation of 3.240 and subsequent hydrolysis of the oxazolidine and Boc-protecting 
groups provided the aza-Cope-Mannich substrate 3.241.  In the event, 3.241 was treated 
with paraformaldehyde in toluene to initially afford N,O-acetal 3.242.  Upon heating, 
3.242 underwent ring opening to give iminium ion 3.243, which underwent the aza-Cope-
Mannich sequence and cyclization to give 3.246 in 71% yield.  Although 3.246 could be 
isolated in good yields, in practice the crude material was treated with LDA, and the 
metalloenamine was trapped with methyl chloroformate to furnish (±)-11-
methoxytabersonine (3.247) in 32% yield over the two steps, along with an almost equal 
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3.2.2.8 Kuehne’s Biomimetic Approach to the Aspidosperma Alkaloids 
Secodine (3.249) and its derivatives have been proposed as intermediates in the 
biosynthesis of the aspidospermine and ibogamine-catharanthine families of alkaloids.324  
Secodines are generally fugitive intermediates that readily dimerize or cyclize, and it is 
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proposed that the intramolecular [4+2] cyclization of these derivatives is involved in the 
biosynthetic pathway (Scheme 3.40).  Thus, the variously unsaturated secodine 
derivatives 3.250-3.252 can be envisioned to give rise to the depicted natural products. 
Although secodine has itself has been synthesized twice,325, 326 it usually prepared as a 






















































The Kuehne research group has reported a substantial portion of the work related 
to the biomimetic syntheses of the aspidospermine alkaloids, and in doing so has 
developed a number of elegant syntheses.262, 307, 327-340  Kuehne’s approaches have 
focused on the in situ preparation and cyclization of an appropriate secodine derivative.  
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Representative of this approach is the synthesis of (-)-tabersonine (3.107), which 
proceeded through the intermediary hydroxysecodine derivative 3.260 (Scheme 3.41).307, 
337, 339   
Kuehne’s approach began with the Pictet-Spengler reaction of tryptamine 
hydrochloride and pyruvate 3.254 to give 3.255 in 74% yield.  Upon heating in pyridine, 
3.255 reacted to form an aziridine, which underwent ring expansion to generate an 
intermediate vinylogous carbamate that was reduced with NaCNBH3 to provide azepine 
3.256 in 58% yield over the two steps.  Azepine 3.256 was then reacted with lactol 3.257 
in presence of catalytic boric acid in refluxing methanol to initially produce 3.258 as the 
product of a Pictet-Spengler reaction.  A subsequent intramolecular alkylation furnished 
ammonium salt 3.259, which fragmented to give the hydroxysecodine 3.260.  The 
hydroxysecodine then underwent a spontaneous intramolecular Diels-Alder reaction to 
afford 3.261 in 61% yield as a mixture (4:1) of diastereomers.  Elimination of the alcohol 
in 3.261 afforded (-)-tabersonine in 71% yield.  Interestingly, only the major 
diastereomer underwent elimination, and the minor diastereomer reacted under these 
conditions to form an aziridinium, which underwent ring opening to give a D-ring 



















































































As mentioned previously, tabersonine and 11-methoxytabersonine, which was 
prepared by an analogous route, could then be converted into vinderosine and vindoline, 
respectively, thus completing the first asymmetric syntheses of these natural products.307  
Kuehne has also utilized this, or very similar approaches, in the syntheses of a number of 
other aspidosperma alkaloids.  A handful of other groups have also reported syntheses 
involving the formation of transient secodine intermediates.341-346 
3.2.2.9 Syntheses of Aspidosperma Alkaloids Utilizing Ring Closing Metathesis 
In addition to Hoveyda’s application of ARCM to the synthesis of (+)-
quebrachamine, there have been two other syntheses of aspidospermine alkaloids that 
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have utilized RCM.  The first of these syntheses was the total synthesis of (±)-tabersonine 
reported by Rawal in 1998.347   Rawal’s approach utilized a stereoselective Diels-Alder 
reaction to form the C ring, and a RCM to close the D ring.  The Diels-Alder 
cycloaddition was later made enantioselective, allowing for the gram scale synthesis of 
(+)-tabersonine (Scheme 3.42).348  
Rawal’s synthesis began with the addition of carbamate 3.263 to acetal 3.262.  
The resulting enamine was then converted to silyl enol ether 3.264.  The reaction of 3.264 
with 2-ethylacrolein in CH2Cl2 at -40 ºC in the presence of Jacobsen’s Cr-salen catalyst 
3.265349 proceeded in 91% yield with high  levels of enantioselectivity.  With 3.266 in 
hand, the D ring was then closed via a two step Wittig olefination/RCM protocol to 
provide 3.267.  The initial attempts to install the indole ring onto 3.267 were met with 
some difficulty. The Gassman indole synthesis with 3.267 was unsuccessful, and the 
Fisher indole synthesis on the ketone derived from 3.267 was plagued by the formation of 
mixtures (~1:1) of regioisomers.  Thus, an alternative strategy was developed for the 
installation of the indole ring.  It was found that the reaction of 3.267 with (o-
nitrophenyl)phenyliodonium fluoride (3.268) proceeded smoothly to give 3.267 in good 
yield, and subsequent reduction of the nitro group afforded the desired indole 3.270.  The 
E ring was then installed via a three step protocol.  Deprotection of the amine with 
trimethylsilyliodide provided a secondary amine that was alkylated with 2-bromoethanol 
to give 3.271.  The primary alcohol in 3.271 was then converted to its mesylate, and upon 
the addition of KOt-Bu the desired spirocycle was formed.  In an improvement of 
Overman’s procedure,321 indolenine 3.272 was selectively C-acylated by deprotonation 
with LDA in THF at -78 ºC and trapping with Mander’s reagent.  Thus, the synthesis of 
(+)-tabersonine was completed in 12 steps from ketone 3.262.  Rawal also utilized this 
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route for the syntheses of (+)-16-methoxytabersonine, (+)-aspidospermidine, and (-)-
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   In 2003 Shishido reported a lengthy synthesis of (-)-aspidospermidine that 
utilized a diastereoselective RCM reaction to establish the stereochemistry of the C20 
ethyl group (Scheme 3.43).350  The synthesis began with the addition of the 3-(t-
butyldimethylsilyloxy)propyllithium to the amide 3.273 to afford a ketone that was 
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subsequently olefinated with 3.274 to give 3.275 in 61% yield over the two steps.  
Reduction of the ester with diisobutylaluminum hydride delivered an alcohol, which was 
converted to enol ether 3.276.  The enol ether 3.276 underwent a Claisen rearrangement 
and subsequent reduction upon treatment with tri-i-butylaluminum, and elimination of the 
resulting alcohol and TBS-deprotection provided 3.277 in 72% yield over the six steps.  
With the pro-chiral divinyl moiety installed, attention was then turned to the installation 
of the third olefin required for the diastereoselective RCM.  
The primary alcohol was oxidized to the aldehyde, and Wittig olefination yielded 
an α,β-unsaturated ester that was reduced to the primary alcohol 3.278.  Sharpless 
asymmetric epoxidation produced the desired epoxide with >99% enantioselectivity, and 
subsequent iodination and Boord elimination yielded allylic alcohol 3.279.  With the 
requisite triene in hand the key RCM could be attempted.  After some experimentation, it 
was found that the best results were obtained when the alcohol was protected as its TMS-
ether.  Thus, the RCM of the TMS-protected analogue 3.279 proceeded to provide 3.280 
in 85% yield as a mixture (87:13) of separable diastereomers after hydrolysis of the silyl 
protecting group.  A four step reaction sequence was used to convert 3.280 into amide 
3.282, which wsas cyclized and protected using Meyers’s procedure.273  Hydrogenation 
of the olefin over PtO2 gave 3.283, which is an intermediate first accessed by Stork in 
racemic form and is the enantiomer of Meyers intermediate 3.156.  Although this 
completed a formal synthesis, the authors followed Stork’s protocols and completed the 
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3.2.3 Syntheses of Pseudotabersonine 
3.2.3.1 Kuehne’s Synthesis of Pseudotabersonine 
  The first total synthesis of pseudotabersonine was reported by Kuehne in 1992, 
and utilized an approach that was slightly modified from Kuehne’s previously discussed 
biomimetic syntheses (see Section 3.2.3.7).262  The synthesis began with the 1,4-addition 
of enamine 3.119 to methyl acrylate to give 3.120 in 67% yield.  The aldehyde in 3.120 
was then protected as its acetal, and a two step reduction/oxidation protocol gave 3.285.  
Aldehyde 3.285 was then reacted with azepine 3.256 (see Scheme 3.44 for its synthesis) 
to give 3.286 in 84% yield.  The quaternary ammonium salt of 3.286 was formed by 
reacting 3.286 with benzyl bromide in refluxing ether, and upon heating this salt with 
triethylamine in MeOH, a fragmentation occurred to provide 3.287, which spontaneously 
cyclized under the reaction conditions to give 3.288 in 79% yield.   Note that the 
stereochemistry for what will become the C/D ring fusion generated in this reaction is 
trans, and an epimerization at a later stage would be needed. The benzyl group was then 
removed under hydrogenation conditions, and after hydrolysis the desired enamine 3.289 
was formed in 98% yield.  The oxidation of enamine 3.289 to a 1,2-dihydropyridine was 
accomplished with dibenzoyl peroxide, and subsequent reduction with NaBH4 afforded 
the natural product in only 12% yield over the two steps.  Thus the synthesis of 
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3.2.3.2 Gr ieco’s Synthesis of Pseudotabersonine 
In 1993 Grieco published his biomimetic approach to pseudotabersonine (Scheme 
3.45).263  Grieco’s synthesis began with the condensation of oxindole with 2-hexenal 
(3.290) to afford 3.292 in 65% yield.  Treatment of 3.292 with potassium 
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diisopropylamide (KDA) in THF at -78 ºC followed by addition of azidinium triflate 
3.293 gave 3.294 in 53% yield.  The oxindole was then N-benzylated to yield 3.295.  
Upon treatment with BF3·OEt2 in toluene at 100 ºC, 3.295 underwent a retro [4+2] 
cycloaddition to genreate 3.296, which subsequently underwent an intramolecular aza-
Diels-Alder to give spiroxindole 3.297 as an inconsequential mixture (1.5:1) of 
diastereomers.  The addition of 2-lithio-1,1-diethoxy-2-propene (3.298) to the oxindole 
provided 3.299 in  excellent yield.  The N,O-hemiacetal 3.299 was treated with tosic acid 
in aqueous acetone, and upon completion of the acetal hydrolysis, acetonitrile and 
triethylamine were added and the reaction was heated at 80 ºC to afford 3.301 in 50% 
yield via the secodine like intermediate 3.300.  Thus, the pentacyclic core of 
pseudotabersonine had been assembled in short order, and attention was turned to the 
conversion of 3.301 into the natural product.   
All that remained for the completion of the synthesis was the oxidation of 
aldehyde 3.301 to the methyl ester and removal of the benzyl protecting group.  
However, all attempts to oxidize 3.301 were unsuccessful, and an alternative strategy was 
adopted.  The deformylation of 3.301 was accomplished by heating 3.300 to 120 ºC in 2 
N HCl, and subsequent removal of the benzyl group provided 3.302.  Following 
Overman’s procedure,321 3.302 was C-acylated to give pseudotabersonine in 35% yield.  
No comment was given as how much N-acylated product was formed in the reaction.  
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Since Stork’s pioneering synthesis of aspidospermine and quebrachamine in 1963, 
the Aspidosperma alkaloids have attracted an enormous amount of attention from 
synthetic chemists.  A number of conceptually different approaches to the pentacyclic 
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core structure have been developed, allowing for access to virtually every member of this 
family of alkaloids.  Despite the considerable effort put forth towards this family of 
alkaloids, the aspidospermine alkaloids still attract the attention of contemporary organic 
chemists.  The interest in the aspidospermine alkaloids persists for two main reasons: the 
pentacyclic aspidospermine scaffold remains to this day to be a challenging target 
suitable for the development and testing of new synthetic methodologies and because 
there has not been a synthesis of these molecules that cannot be improved upon.  Due to 
the interesting biological properties displayed by members of this family of alkaloids, the 
desire to develop more concise and efficient syntheses still exists, so that members of this 
family can be accessed in quantity in a rapid fashion for use in various biological settings.  
Our interest in the aspidospermine and isopavine alkaloids came from the desire 
to apply our previously developed four component reaction (see Chapter 2) to natural 
product synthesis.  It was envisioned that if the appropriate functional handles could be 
incorporated into the 4CR, that the core structures of these two families of natural 
products could be readily accessed using our 4CR/cyclization strategy.  Not only would 
the application of the 4CR to these two families of natural products highlight its utility in 
synthesizing natural product-like libraries, but it could also potentially lead to some of the 
shortest syntheses of both the isopavine and aspidospermine alkaloids to date.  The 
results of the endeavors into the arena of natural product synthesis are presented in the 







Chapter  4: Applications of the Four  Component Reaction to Natural 
Product Synthesis 
4.1 Introduction 
In Chapter 2 we discussed the development of a four component reaction (4CR) 
for the generation of highly functionalized amides that can be transformed into 
heterocyclic scaffolds in a short number of steps (Scheme 4.1).150  Although this 4CR 
was originally developed for use in diversity oriented synthesis (DOS), its applications to 
natural product synthesis would further showcase its utility as a synthetic strategy.  Also, 
when one considers the emphasis that is placed on synthesis of natural product like 
libraries,351-353 and on the natural products themselves,5, 354 in drug discovery, the 

























To this end, we undertook the task of identifying classes of natural products that 
could potentially be accessed utilizing this methodology.  Two families of natural 
products that specifically caught our attention were the isopavine and Aspidosperma 
alkaloids.  Both of these families of alkaloids have interesting heterocyclic scaffolds, and 
both contain members that display a range of useful biological activities, making them 
ideal targets for applying the 4CR.  If the 4CR can provide an efficient route to the 
functionalized skeletons contained in these natural products, it stands to reason that in 
addition to completing their total syntheses, a number differentially functionalized 
analogues could be generated for testing in biological assays.      
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4.2 Application of the 4CR to the Total Synthesis of Roelactamine 
As discussed in Chapter 3 the isopavine alkaloids are a small family of tetracyclic 
tetrahydroisoquinoline natural products that are characterized by a doubly benzannulated 
azabicyclo[3.2.2]nonane core structure (see roelactamine (4.11), Scheme 4.2).209, 210  
Both natural and unnatural members of the isopavine family have been shown to posses 
interesting biological properties for the treatment of Alzheimer’s disease, Hungtington’s 
chorea, and Parkinson’s and Down’s syndromes.213, 214  For this reason we thought that 
this family of natural products would be a good target to access via the 4CR.  
Specifically, we targeted roelactamine (4.11), which was isolated in 1992 from Roemeria 
refracta DC. (Papaveraceae) and is the first isopavine alkaloid known that possesses a 
lactam.218  There has been no reported biological activity for roelactamine, as well as no 
reported total syntheses.   
We envisioned that a 4CR of piperonal (4.6), methylamine, organometallic 
reagent 4.8, and an appropriately functionalized acid chloride 4.9, would provide amide 
4.10, which could undergo a double cyclization to give 4.11 (Scheme 4.2).  All four 
starting materials are readily available, and the double cyclization is a classical approach 
to this family of natural products, so this synthetic strategy should allow for quick access 







































(±)-roelactamine (4.11)  
Previously, the only nucleophiles used in the 4CR were silyl ketene acetals, silyl 
enol ethers, and allylzinc bromide, so we first turned our attention to testing whether or 
not a benzyl organometallic reagent would be a compatible in the 4CR.  After some 
experimentation, it was found that the benzylzinc bromide 4.14 could be prepared by 
slow addition of a solution of piperonyl bromide (4.12)355 in THF to a suspension of zinc 
in THF at 0 °C (Scheme 4.3).  In a modification of the literature procedure,356 the 
corresponding Grignard reagent 4.15 could be prepared in a identical manner from 
piperonyl chloride (4.13).357 With methods to prepare both the required organozinc and 
Grignard reagent in hand, the next step was to employ these nucleophiles in the 







4.12: X = Br








4.14: MX = ZnBr
4.15: MX = MgCl  
To test the viability of these nucleophiles in the 4CR, a model three component 
reaction (3CR) was first examined (Scheme 4).  Starting from imine 4.16, a stepwise 
addition of acetyl chloride and either organozinc reagent 4.14 or Grignard reagent 4.15 
provided the desired amide 4.17 in moderate yields.  These results show that the use of a 
benzyl organometallic in the 4CR was possible, and that our route to (±)-roelactamine 
















-78 °C → rt MX = ZnBr   ~70% (yield based on [4.14])





The next step was then to find an appropriate acid chloride that would work in 
both the 4CR and the subsequent double cyclization.  Our initial efforts focused on 
diethoxyacetyl chloride (4.20), as this was a known compound that had previously been 
made from sodium diethoxyacetate and thionyl chloride in refluxing ether.358 However, 
attempts to prepare and isolate 4.20 using this method were unsuccessful, as were 
methods using oxalyl chloride.  Synthesizing 4.20 directly from diethoxyacetic acid was 
also unsuccessful.  Although it was troublesome that 4.20 could not be isolated, the acid 
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chloride had been previously made and used in situ,358 so this approach was attempted 
(Scheme 4.5).  Acid chloride 4.20 was prepared from both thionyl chloride and oxalyl 
chloride, and the reaction mixture was added directly to a solution of imine 4.16 in 
CH2Cl2.  In both cases the reaction immediately turned an opaque, dark reddish orange 
color, and upon addition of zinc reagent 4.14 or Grignard reagent 4.15 none of the desired 
product was formed. With this approach being unsuccessful, the next move was to 












































By performing the nucleophilic addition to the imine instead of the N-acyl 
iminium ion, the reaction can be run stepwise, and the intermediary secondary amine can 
be isolated prior to acylation, which helps to ensure that each individual step of the 
reaction sequence is working.  To this end imine 4.16 was treated with Grignard reagent 
4.15 in refluxing THF to provide 4.22 in an unoptimized 53% yield (Scheme 4.6).  
Heating the reaction at reflux was necessary in order to drive the reaction to completion 
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within a reasonable time period (24 h).  Following literature conditions,358 acid chloride 
4.20 was prepared using thionyl chloride.  A solution of 4.22 in benzene/pyridine (2:1) 
was then added to the crude 4.20 and the reaction heated to 50 °C to produce the desired 
amide 4.21 in 17% yield.  When 4.21 was treated with H2SO4 in AcOH232 the desired 
natural product was produced in 30% yield.  Although this route did lead to the synthesis 
of (±)-4.11, the stepwise nature of the route along with the low yields led to the pursuit of 
other acid chlorides for use in the synthesis, because it was believed that the problems 
were associated with the synthesis of acid chloride 4.20 and not with the underlying route 


























One possibility for an alternate acid chloride is the use of dichloroacetyl chloride, 
which would provide 4.24, a substrate suitable for a double Friedel-Crafts cyclization.  
Treatment of 4.22 with dichloroacetyl chloride and Et3N in CH2Cl2 provided 4.24 in 88% 
yield (Scheme 4.7).  Amide 4.24 was then treated with a variety of Lewis acids in 
CH2Cl2.  Although in all cases the starting material was consumed, none of the desired 
product was produced.  These unpromising results led us to investigate the use of other 





























Lewis Acids tried: SnCl4, AlCl3, ZnCl2, FeCl3
4.23
 
Diacetoxyacetyl chloride (4.25) was chosen next as it can easily be made in gram 
quantities from glyoxylic acid.359  The increased stability of 4.25 over 4.20 would 
presumably make 4.25 easier to handle and employ in the 4CR.  The ability to distill 4.25 
would also ensure that the reactions could be run with pure acid chloride, something that 
was in question when using 4.20.  Indeed, the use of diacetoxyacetyl chloride eventually 
allowed for the synthesis of (±)-4.11 to be completed as originally designed.   
The first attempts employing acid chloride 4.25 were made in the 3CR using the 
zinc reagent 4.14 (Scheme 4.8).  When imine 4.16 was treated sequentially with 4.25 and 
4.14 in CH2Cl2, the desired product 4.26 was produced in 40% yield.  One possibility for 
the low yield is that the N-acyl iminium ion did not form completely, but stirring the 
imine and acid chloride for 7 h instead of 2 h before adding the benzyl zinc reagent 
actually resulted in a reduced yield.  Attempts to improve this yield by using Grignard 
4.15, in either CH2Cl2 or THF, were completely unsuccessful and none of the desired 































In parallel with these reactions we were also examining running the reactions via 
a nucleophilic addition/acylation strategy, and since these reactions showed more 
promise focus placed on them.  The initial investigations into running the 4CR using an 
addition/acylation strategy were made on the preformed imine 4.16 (Scheme 4.9).  After 
some experimentation, it was found that the reaction of imine 4.16 and Grignard reagent 
4.15 would only consume starting material (as determined by TLC) when the imine was 
treated with 2 eq. of Grignard reagent in refluxing THF.  Upon cooling the reaction to -78 
°C and adding 4.25 the desired product 4.26 could be isolated in 70% yield.  Addition of 
the acid chloride at higher temperatures resulted in drastically reduced yields.  With good 
results for the 3CR in hand, attention was then turned to the 4CR and the completion of 
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When the imine formed in situ from the reaction of piperonal and methylamine 
was treated sequentially with Grignard reagent 4.15 and acid chloride 4.25, 4.26 was 
produced in 61% yield (Scheme 4.10).  Interestingly, imine formation occurred only 
when 3 Å pellet type molecular sieves were used.  None of the desired imine was isolated 
using 3 Å powdered sieves or 4 Å sieves.  When 4.26 was treated with conc. HCl/MeOH 
(2:1) the desired double cyclization occurred and (±)-4.11 was isolated in 71% yield, thus 
completing the synthesis.  One source of material loss is from competitive elimination of 
the amide side chain.  To prevent this side reaction from occuring, the double cyclization 
was attempted with BF3·OEt2 in CH2Cl2, which gave none of the desired product, and 
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(±)- roelactamine  
(4.11)
4.26  
The first total synthesis of (±)-roelactamine has been completed in four steps from 
commercially available materials.  This synthesis highlights the utility of the 
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4CR/cyclization strategy that we had previously developed for DOS.  Additionally, this 
route could be adapted to make a library of isopavines simply by adding additional 
functionality to any of the four components.    
4.3 Applications of the 4CR Towards the Synthesis of Aspidosperma Alkaloids  
As discussed in Chapter 3, the Aspidosperma alkaloids are a large family of 
alkaloids characterized by a pentacyclic skeleton, of which aspidospermidine (4.27) is the 
prototypical member (Figure 4.1).252  Their interesting structural features and biological 

























It was envisioned that by carefully selecting the inputs of the 4CR we could 
generate substrates that could be readily transformed into the aspidospermine skeleton, 
thus allowing for a quick entry to this class of natural products (Scheme 4.11).  The 
condensation of allyl amine 4.30 with an appropriately functionalized 3-
indolecarboxaldehyde 4.31 would provide an imine, which could then be allowed to react 
with acid chloride 4.32 and an appropriate pentadienyl metal to give 4.34.  Compound 
4.34 is functionalized to undergo a double ring closing metathesis (RCM) followed by a 
spirocyclization to give 4.35.  Depending on the nature of R1, R2, and R3, 4.35 could be 
further elaborated into any number of alkaloids in the Aspidosperma family, as well as 
unnatural analogues.  This route allows for explorations into the pentadienylation of 
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imines and N-acyl iminium ions, and it provides a potential opportunity to further 
































4.3.1 The Pentadienylation of Imines Leading to Branched Products 
The viability of this route falls to a large extent on finding a pentadienyl metal 
4.33 that will react with either an imine or N-acyl iminium ion to selectively generate the 
branched pentadienylation product 4.34.  Fortunately, a significant amount of work has 
been done in the area of carbonyl pentadienylation, providing sufficient precedent for us 
to believe that this could indeed be a viable approach. For example, pentadienyl Li, Mg, 
Zn, Al, Ti, Si, Sn, and In reagents have been synthesized and their reactivity with 
carbonyl compounds studied.179, 200, 361-371 While the vast majority of the work in this field 
has been focused on the pentadienylation of aldehydes and ketones, a few reported 
examples involving the pentadienylation of imines,365 N-sulfonyl imines,365, 366 1,2-
diimines,367 iminium salts,368 N,O-acetals,200, 369 α-chloroformamides,370 and N-acyl 
iminium ions150, 179 exist in the literature.   
However, of the reports on the pentadienylation of imines or imine surrogates 
only a handful of examples involve conditions that lead selectively to the branched 
product.  Miginiac has shown that pentadienyl zinc bromide (4.37) can react with α-
chloroformamide 4.36 to provide a mixture (2.5:1) of branched and linear products 
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favoring the branched product (Eq. 4.1).370  Similar results have been obtained by Dr. 
Jason Deck when bis-pentadienyl zinc (4.41) was reacted with N,O-acetal 4.42 (Eq. 
4.2).200  Savoia and co-workers have shown that glyoxal derived 1,2-diimine 4.44 can 
react with pentadienyl zinc bromide to give the branched product exclusively (Eq. 4.3).367  
Finally, Nishigaichi has shown that N-sulfonyl imines react with pentadienyltin in the 
presence of InCl3 or ZnCl2 to give only branched products (Eq. 4.4).365  Interestingly, 
when BF3OEt2 is used as the Lewis acid in this reaction, the linear isomer becomes the 
major product. From this precedent it is apparent that a good general method for the 
pentadienylation of imines that provides high levels of selectivity towards the branched 
product does not exist, and it was hoped that a suitable solution to this problem could be 
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We have previously shown that our 4CR can be run using a number of different 
experimental protocols, and we hoped that this experimental flexibility could be exploited 
here.  It is generally accepted that the branched product arises in the pentadienylation of a 
carbonyl compound from a Zimmerman-Traxler transition state 4.51,361, 364, 365, 371 while 
the linear product can arise from a less favorable eight membered transition state 4.53 or 
through an open transition state 4.55 (Scheme 4.12).  Traditionally, the 4CR is run using 
a nucleophilic addition to an N-acyl iminium ion protocol, but N-acyl iminium ions have 
no vacant coordination sites on the nitrogen atom to create a transition state like 4.51.  
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This inability to coordinate a metal could potentially lead to a situation where the 
branched product is a minor product in the pentadienylation, if it is formed at all.  
However, since the 4CR can also be performed using a nucleophilic addition/acylation 
protocol, and the Lewis basic imine nitrogen can be utilized to coordinate a pentadienyl 
metal and therefore enable the desired 6-membered ring transition state, hopefully 
leading to higher levels of selectivity towards the branched product.  Since previous 
precedent suggests that the coordination of the pentadienyl metal by the carbonyl 
compound is important for selectivity, it was decided that our initial investigations should 

































Pentadienyl metals 4.50 can be formed by a variety of methods, and we chose to 
use 1,4-pentadiene (4.55) as our starting material.  1,4-Pentadiene is readily deprotonated 
by BuLi and transmetalated to a number of other metals by addition of the corresponding 
metal halide salt (Scheme 4.13).  For the case of ZnBr2 and InCl3, the salts were added to 
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a solution of the pentadienyl lithium as a solution in THF.  However, for AlCl3 the use of 
Et2O was necessary, as AlCl3 rapidly reacts with THF.  These protocols allowed for easy 
access to 4.37, 4.57, and 4.58 and became the standard procedure that was followed for 
all studies discussed herein.  
Scheme 4.13 
nBuLi, THF







1 eq. ZnBr2 or
InCl3 in THF
4.55 4.56 4.37: MXn = ZnBr
4.57: MXn = InCl2
4.58: MXn = AlCl2  
Previous work from the Martin group200 and the literature367, 370 suggested that 
pentadienyl Zn shows high levels of selectivity for branched products and therefore was 
chosen as our starting point (Scheme 4.14).  Treatment of imine 4.59 with 4.37 at -78 ºC 
resulted in consumption of the starting material at -78 ºC, and upon warming to room 
temperature the linear product 4.61 was isolated as the major product in 71% yield.  
When the reaction was run at room temperature, both the yield and selectivity for the 
linear isomer 4.61 were increased.  While the levels of selectivity where good, the linear 
product 4.61 was not the desired regioisomer, and therefore studies of other pentadienyl 
























Both pentadienyl Li and In showed selectivity similar to Zn, forming 4.61 as the 
major product (Scheme 4.15).  In both cases the overall reactivity was lower, and neither 
reaction consumed starting material.  In the case of pentadienyl Li, one possible reason 
for the low conversion to product is that 4.44 might react with the CH2Cl2 faster than the 
imine, effectively quenching the reagent.  This could be prevented by switching to a 
solvent like THF, but since the overall selectivity for the branched product in this 








For 4.56: ~30% conv. 1:3 4.60:4.61
For 4.57: ~50% conv. 1:4 4.60:4.61
4.56 or 4.57
 
In our search for other metals that might react selectively with imines to give 
branched products, it was found that Miginiac had observed increased selectivities 
(versus pentadienyl Zn, Li, or Mg) for branched products when pentadienyl aluminum 
was used in reactions with aldehydes and ketones.362 Based on this precedent; we decided 
to investigate the reactivity of pentadienyl Al reagent 4.47 (Table 4.1).  When a freshly 
prepared solution of 4.58 in Et2O/hexane/THF was added to a solution of imine 4.59 in 
CH2Cl2 the starting material was consumed at -78 ºC, and upon warming to room 
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temperature both 4.60 and 4.61 were isolated in almost equal amounts (entry 1), already a 
vast improvement over the zinc reagent.   When the addition was done at room 
temperature, the reaction was done in <10 min, and the ratio of branched to linear 
products improved slightly (entry 2).  It was subsequently discovered that longer reaction 
times greatly improved the selectivity for the branched product (entries 3 and 4), and it 
was found that after 18 h the ratio of 4.60 to 4.61 increased to 7.5:1, and 4.60 could be 
isolated in 70% yield.  Further heating this reaction to reflux did not improve the ratio 
(entry 5). When the reaction was run with 0.33 eq. of AlCl3 in an effort to make a 
trialkylaluminum reagent,372 the yield and conversion dropped substantially (entry 6).  
THF was found to be necessary for the lithiation of 1,4-pentadiene, as no reaction 
occurred when Et2O was substituted for THF (entry 7).  The use of the non-coordinating 
solvent CH2Cl2 was also critical for selectivity, because when THF was used instead a 
dramatic drop in the selectivity for the branched product was observed, even when the 





















2h 100  31%/37%
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a Determined by NMR of crude rxn mixture. b Used 0.33 eq AlCl3.  
c Et2O used instead of THF. dTHF used instead of CH2Cl2.
nd = not determined
4.58
8d 60 °C 24h 1.2:1 100 nd
7c rt 24h nd 0 nd
 
The fact that the ratio of branched to linear product improved as the temperature 
was increased from -78 ºC to room temperature and as the reaction times increased 
suggests that the branched product might be the thermodynamic product under these 
reaction conditions.  However, the evidence from the literature and from the above 
experiments using pentadienyl ZnBr suggests that the exact opposite is true. It is known 
that under basic conditions that the allylation and pentadienylation of imines is reversible 
and that the branched product can be interconverted to the linear product.373 However, the 
interconversion of linear products to branched products has not been reported in the 
literature, and in our system it appears that this interconversion of linear to branched 
product is occurring.  Therefore, it can be concluded that the aluminum must be playing 
an important role in making 4.60 the major product.  
A possible explanation for this is the fact amines 4.49 and 4.50 are not the 
products of this reaction, and are only formed upon hydrolysis of a stable aluminum 
chelate after aqueous work up.  Aluminum is a strong Lewis acid that can coordinate with 
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both amines and olefins and indeed a strongly basic work up (1 M NaOH) was required 
to isolated 4.60 and 4.61.  When a slightly acidic work up was performed (sat. NH4Cl) 
good crude mass recovery was obtained after work up; however, the 1H NMR of the 
crude reaction mixture showed only trace amounts of the desired products, along with 
signals that presumably corresponded to the aluminum complex.  If the pathway leading 
towards the branched product does go through a 6-membered transition state similar to 
4.51 leading to an aluminum chelate similar to 4.62 or 4.63 (Figure 4.2), then perhaps 















Possible Branched Complexes Possible Linear Complex
 
To this point it has been shown that pentadienyl aluminum reagent provides good 
yields of branched products when reacting with imine 4.59, but there was still interest in 
the reactivity of 4.58 with N-acyl iminium ions (Scheme 4.16).  To this end 4.59 was 
sequentially treated with acetyl chloride and 4.58 at room temperature in CH2Cl2 to 
provide a ~1:1 mixture of 4.66 and 4.66 in good yield.  This product ratio was found to 
be insensitive to reaction time. Miginiac has studied the pentadienylation of α-
chloroformamides and found that with Li, Mg, Zn, and Al the linear product is the major 
product and that aluminum gave the best selectivity towards linear products.370 Assuming 
that imine 4.59 and acetyl chloride react to give an N-acyl iminium ion, which is in 
equilibrium with a α-chloroamide, which is structurally similar to Miginiac’s examples, 
















Confident in the pentadienylation conditions we had developed for imine 4.59, we 
then ventured to apply these conditions to a system that could be further elaborated into 
the aspidospermine skeleton.  To do this we would need a functionalized indole such as 
4.70.  Indole 4.70 is known in the literature374 and it, or a differentially protected 2-
vinylindole-3-carboxaldehyde, would fit our needs nicely.  Indole 4.70 was previously 
synthesized from 2-chloroindole-3-carboxaldehyde (4.67)375 via a two step 






















It has been reported that attempts to perform a reductive amination on 4.70 with 
allylamine and NaBH(OAc)3 did not give the desired secondary amine, but rather gave γ-
carboline 4.72 in high yields (Eq. 4.5).376 Mechanistically this reaction is thought to 
proceed through a reversible 1,6-addition to the terminal olefin, followed by cyclization 
onto the aldehyde and reduction.  This problem could be avoided by changing the 
protecting group from an electron withdrawing group to a group that is electronically 
neutral, and MOM-protected 4.73 underwent reductive amination to give 4.74 in 65% 
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yield (Eq. 4.6).  Based on this precedent it was decided that aldehyde 4.70 was not a good 




























Since the above precedent showed that MOM-protected 4.73 could undergo a 
reductive amination, we thought that this would be a good protecting group to employ in 
our system (Scheme 4.18).  The benzyl protected indole 4.78 was also investigated in 
parallel in case any unforeseen problems arose with the MOM group.  To this end, 4.75 
and 4.76 were synthesized in good yields and subjected to the Suzuki coupling to give 
4.74 and 4.78, also in high yields.  With 4.74 and 4.78 in hand, investigations into 

















4.75: Pg = MOM  81%









When 4.74 and 4.78 were treated with allylamine in CH2Cl2, no reaction occurred, 
even when 10 equivalents of allylamine were used (Scheme 4.19).  Using more forcing 
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conditions (neat allylamine or allyl HMDS with TMSOTf), provided the desired imines; 
however, these conditions did not provide clean product, and in all cases substantial 
quantities of side products were formed.  This provided us with a minor setback that 
would require us to pursue a route with an alternative strategy for installation of the C-2 














4.74: Pg = MOM
4.78: Pg = Bn
4.80: Pg = Bn








In order to access the aspidospermine core structure we had planned to perform a 
double RCM on a substrate such as 4.34 (Scheme 4.11), and for this transformation a 
vinyl group at the 2-position of the indole is required.  Up until this point we had only 
investigated pathways that led to the vinyl group being installed before the imine 
formation and subsequent pentadienylation.  It is also possible to install the vinyl group 
after the pentadienylation, and this could potentially avoid the previously discussed 
problems.   
Since we had already synthesized a number of protected 2-chloroindoles, it was 
thought that this would be a good starting material as the chloride could potentially be 
converted into a vinyl group or utilized in a Heck cyclization that could be performed in 
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place of the double RCM.  Towards this end, imines 4.83-4.85 were synthesized and 
subjected to the previously developed pentadienylation conditions using 4.58 (Scheme 
4.20).  When 4.83 was allowed to react with 4.58 at -78 ºC or at room temperature, the 
linear 4.89 was formed as the major product in modest yields.  The benzyl protected 4.84 
also reacted with 4.58 to give the linear 4.90 as the major product.  Unlike for the 
pentadienylation of 4.59, longer reaction times slightly increased the amount of linear 
product formed.  The MOM-protected 4.85 gave the best results, with linear product 
being only slightly favored as the major product.  These results are substantially worse 
than those seen with model imine 4.59, and the poor levels of selectivity may be 
attributed to the increased steric hindrance due to the chlorine atom at indole C-2.  The 
decrease in the overall reactivity of 4.84 and 4.85 as compared to the Boc-protected 4.83 
is most likely due to the nature of the indole protecting group.  The electron withdrawing 
nature of the N-Boc-group should significantly enhance the electrophilicity of imine 4.83 
as compared to the N-Bn and N-MOM analogs 4.84 and 4.85, respectively.  The levels of 
selectivity for the linear product in these examples suggest that the pentadienylation 
reaction is sensitive to steric factors and that the pentadienylation would need to be 
carried out on an unsubstituted indole, with functionalization of indole C-2 being 












4.82: Pg = Boc
4.76: Pg = Bn
4.75: Pg = MOM
NH2





4.83: Pg = Boc
4.84: Pg = Bn















4.86: Pg = Boc
4.87: Pg = Bn
4.88: Pg = MOM
4.89: Pg = Boc
4.90: Pg = Bn
4.91: Pg = MOM

























a Determined by NMR of crude rxn mixture.  nd = not determined
Branched (B):
Linear (L)a




To investigate the effects of having no substitution at C-2, imine 4.93 was 
synthesized and subjected to the pentadienylation conditions (Scheme 4.21).  By 
removing the indole C-2 substitution, the selectivity towards the branched product was 
restored.  However, the yields for the reaction were low, and the free indole 4.96 was 
isolated as the major product.  The instability of the Boc-group towards the reaction 
conditions probably also contributed to the low overall yields seen with imine 4.83.  
However, a simple switch to a more robust protecting group should eliminate any side 


































Tosyl protected indoles are generally more robust than their corresponding Boc-
protected analogs,377 and the tosyl protected 4.98 was synthesized in order to investigate 
compatibility with the pentadienylation conditions (Scheme 23). When imine 4.98 was 
subjected to the pentadienylation conditions the desired branched product 4.99 could be 
isolated in 78% yield along with 5% of the separable linear product 4.100.  Thus, a set of 
conditions were found for the successful pentadienylation of 4.98 leading to the branched 

































4.3.2 Effor ts Towards the First Total Synthesis of Rosicine 
Having found conditions suitable for providing a branched pentadienylation 
product amenable for elaborating into the aspidospermine skeleton, we then turned our 
attention to the synthesis rosicine (4.28).  Rosicine was isolated in 1984 from 
Catharanthus roseus and is one of the rare Aspidosperma alkaloids lacking an angular 
ethyl group.255  To our knowledge there are no reported syntheses of rosicine, and for this 
reason we thought it would be suitable target to initiate our studies into the 
aspidospermine alkaloids.      
Having already developed a route to amine 4.99, we envisioned that a sequence 
similar to that shown in Scheme 4.23 would lead to rosicine.  Alkylation of 4.99 with the 
appropriately protected ethanol derivative would provide 4.101.  Lithiation at the C-2 
position of the indole 4.101, followed trapping with methyl oxalate would give a ketone 
that could then be olefinated to give 4.102.  Alternatively, lithiation of 4.101 followed by 
trapping with methyl pyruvate would provide an alcohol that could be dehydrated to 
provide 4.102.  Double RCM followed by selective reduction of the electron deficient 
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olefin would give 4.103.  From 4.103, deprotection and cyclization would give a 








































    methyl pyruvate
2. elimination
 
Analysis of the later steps of the synthesis led us to the conclusion that a silyl 
group might be a good choice for protection of the primary alcohol.  A TBS ether should 
be stable to the conditions required for the remaining steps of the synthesis and could 
potentially be removed sequentially with the tosyl group when required.  The known silyl 
ethers 4.105 and 4.106378 were thus prepared for their use in the alkylation of 4.99. 
Attempts to N-alkylate 4.99 under a variety of conditions with 4.105 or 4.106 were 
generally unsuccessful (Scheme 4.24).  At temperatures below 100 ºC, starting material 
was recovered in good yields, and at higher temperatures decomposition to unidentified 
side products occurred.  It was found that when 4.99 was treated with 10 equivalents of 
4.106 in DMSO at very high concentration (e.g. greater volume of 4.106 than DMSO) 
and elevated temperatures, 4.104 could be isolated in 38% yield.  In a model system, 
attempts to perform an in situ alkylation of the aluminum amide resulting from the 
pentadienylation of 4.59 also failed, and the secondary amine 4.60 was the only 
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observable product (Scheme 4.25).  Attempts to further optimize the alkylation of 4.99 
were not made as investigations into other methods for synthesizing compounds related 


















                Other Conditions Tried
4.105, K2CO3, KI, acetone ∆, or DMF 80 → 120 °C
4.106, K2CO3, DMF or DMSO 60 → 120 °C
4.106, CsCO3, DMF 80 → 100 °C
4.106, NaH, DMF

















The TBS-protected chloro and iodoethanol derivatives are not good electrophiles, 
and it was thought that by changing the starting amine and alkylating agent a more 
favorable sequence could be achieved.  This could be made possible by starting from a 
protected ethanolamine and performing a subsequent allylation instead (Scheme 4.26).  
Thus, imine 4.108, synthesized from aldehyde 4.97 and the protected ethanolamine 
4.107,379 was subjected to the pentadienylation conditions to provide the branched adduct 
4.109 in 41% yield along with substantial quantities of the desilylated side product 4.111.  
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This is not too surprising, as TBS ethers are known to be moderately unstable to AlCl3.377  
The allylation of 4.109 with allyl bromide gave the desired 4.104 in 48% yield, along 
























































Because the TBS ether was not stable to either the pentadienylation or allylation 
conditions, a more robust protecting group was chosen (Scheme 4.27).  We also began to 
investigate the use of an N-benzenesulfonyl protecting group for indole, as during the 
lithiation step there is the potential for competitive lithiation of the toslyl methyl group.380 
Imines 4.116 and 4.117 were synthesized from the corresponding aldehydes and 
ammonium salt 4.115.  Subjecting 4.116 and 4.117 to the pentadienylation conditions 
provided 4.118 and 4.119 in 69% and 72% yields, respectively, along with small amounts 
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of the separable linear isomers.  Allylation of 4.118 and 4.119 proceeded uneventfully to 






























4.97: Pg =Ts 
4.114: Pg = SO2Ph
4.118: Pg =Ts          69%
4.119: Pg = SO2Ph  72%
4.120: Pg =Ts          7%
4.121: Pg = SO2Ph  9%
4.122: Pg =Ts          83%
4.123: Pg = SO2Ph  82%
4.115
4.116: Pg =Ts 




Although the syntheses of 4.122 and 4.123 proceeded in good yields, the use of 
the TBDPS protecting group is not ideal due to its relative size and mass compared to the 
rest of the molecule.  Accordingly, studies were ongoing to develop a more efficient route 
to the TBS protected 4.127 (Scheme 4.28).  After some optimization, it was found that 
the crude pentadienylation product 4.125 could be reacted with ethylene oxide in MeOH 
at 60 ºC in a sealed tube to provide the desired alcohol 4.126 in 71% yield over the two 
steps.  The TBS protection of 4.126 using standard conditions provided 4.127 in 96% 
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yield.  Thus, a more efficient route to 4.127 was developed that allowed for us to avoid 









































   
Efforts to further shorten the route to 4.127 were unavailing.  A one pot 
pentadienylation/ethylene oxide opening was attempted; however, when the crude 4.125 
was treated in situ with ethylene oxide, a mixture (~1:1) of 4.125 and 4.126 was obtained.  
The treatment of 4.125 with ethylene oxide in the presence of TBSCl in hopes of 
performing a one pot alkylation/protection was also unsuccessful. In most cases no 
reaction occurred, and 4.125 could be recovered quantitatively.  It should be noted that 
the direct application of the 4CR to the synthesis of 4.127 was not pursued because the 
4CR would provide an amide that would most likely need to be immediately reduced in 
order to perform the required lithiation of indole C-2.         
With viable routes to the differentially protected indoles 4.122, 4.123, and 4.127 
in hand, attention was turned to the functionalization of indole C-2.  The C-2 lithiation of 
indoles is well known, and there exist several reports of lithiation at the C-2 position of 
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indoles and the subsequent trapping with dimethyl oxalate.381-385  We began our studies 
on this reaction by looking at the conversion of 4.122 into 4.129 (Table 4.2).  It was 
found that the treatment of 4.122 with LDA or n-BuLi/TMEDA for 2 h at -78 ºC, 
followed by the addition of a solution of methyl oxalate in THF provided the desired 
product 4.129 in low yields, along with substantial quantities of recovered starting 
material (entries 2 and 5).  Similarly, the use of 2 eq. of LiTMP and warming the 
lithiation to 0 ºC provided the desired product in 29% yield with 23% recovered starting 
material (entry 6). Under the conditions shown in entries 1, 3, and 4, none of the desired 
product was produced, and the reaction returned varying amounts of 4.122.  It was 
observed, however, that upon warming these reactions above 0 ºC substantial 
decomposition occurred, and it is possible that in these cases the product was formed but 
was not stable to the reaction conditions when warmed to room temperature.  The more 
relevant issues relate to the fact that starting material was never consumed, and in most 

































Time % RSM % Yield
1.1 eq LDA 67-78, 1h 0
1.3 eq sBuLi -78, 1h 46 0
1.1 eq BuLi -78, 2h → 0, 3h 20 0
1.3 eq LDA -78, 2h 19 39
Entry
1*




5 1.3 eq BuLi/TMEDA -78, 2h 15 47
*Reaction warmed to rt before quenching.
4.122
4.129
6 2 eq LiTMP -78 → 0, 2h 23 29
4.128
 
To further investigate the origin of these low conversions, a deuterium-quench 
study was undertaken (Scheme 4.29).  The TBS protected 4.104 was chosen as the 
substrate because the aromatic proton signals from the TBDPS group in the 1H NMR 
spectrum of 4.122 overlapped with the indole C-2 signal preventing any easy 
determination of % deuterium incorporation.  Treatment of 4.104 with s-BuLi, followed 
by the addition of CD3OD resulted in no detectable deuterium incorporation.  This is in 
agreement with the results shown in Table 4.1.  When LDA was used as base, 60% 
deuterium incorporation was observed.  More concerning than the low levels of 
deuterium incorporation was the fact that for both cases the mass recovery was only 
~50% after an aqueous work up.  This indicates the 4.104 and 4.122 may not be stable to 
strongly basic conditions.  For this reason more forcing conditions (more equivalents of 








i. Base, THF 






sBuLi   ~50% recovery, <10% D incorporation
LDA     ~50% recovery, 60% D incorporation
ii. CD3OD
  -78 °C → rt
 
As previously mentioned, one potential drawback to using the tosyl protecting 
group for this lithiation is that it is known that the methyl on the tosyl group itself can be 
deprotonated under conditions similar to those used for the lithiation of indoles.380 In 
some cases this did indeed seem to be a problem, and compounds were occasionally 
observed that had resonances in their 1H NMR spectra that were consistent with 
functionalization of the methyl group.  For this reason, the corresponding 
benzenesulfonyl protected indole 4.123 was also synthesized, under the assumption that it 
should be compatible with more forcing deprotonation conditions.  The studies on the 
lithiation of 4.123 and subsequent trapping with dimethyl oxalate are summarized in 
Table 4.3.  When 4.123 was deprotonated with LDA at -78 ºC, the desired product was 
isolated in 57% yield along with 13% recovered starting material (entry 1).  Increasing 
the number of equivalents of LDA showed little improvement (entry 2), as did warming 
to 0 ºC or room temperature during the lithiation step (entries 3-5, 8).  Heating 4.123 
under vacuum to remove any water that may have been present did not improve the yield 
(entry 6).  However, it was found that increased yields were obtained when the reaction 
was maintained at colder temperatures after the addition of dimethyl oxalate.  Thus, when 
the reaction was warmed to -55 ºC after the addition of dimethyl oxalate, 4.131 could be 
isolated in 78% yield (entry 7).  LiTMP was found to give similar yields (entry 9).  The 
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more nucleophilic base LiNEt2 reacted with 4.123 to give products resulting from 
sulfonyl group cleavage.  No reaction occurred when MeMgBr was used as base, and no 
desired product could be isolated when s-BuLi was used. Overall, the best results for this 
reaction were obtained when LDA was used as the base, and the benzesulfonyl protected 
4.123 proved to be a much better substrate than the tosyl protected 4.110 for this reaction.  




















Time % RSM % Yield
1.2 eq .LDA 13-78, 4h 57
1.2 eq. LDA -78 → 0, 2h 47 42
1.2 eq. sBuLi -78, 4h 28 0






-78 → 0 °C
4.123 4.131
2 eq. LDA -78 → 0, 2h 12 63
4eq. LDA -78 → 0, 2h 22 58
1.2 eq. LDA -78 → rt, 2h 56 15
1.2 eq. LDA -78 → -10 50 34
2. eq. MeMgBr -78, 2h 85 0
2 eq. LDA -78 → 0, 2h 12 78
2 eq. LiTMP -78 → 0, 2h 13 65









1 SM dried at 120 °C under vacuum
2 RXN only warmed to -55 °C after dimethyl oxalate added
4.128
 
A few examples of the Wittig olefination of compounds such as 4.131 exist in the 
literature,386, 387 and these served as a starting point for developing conditions for the 
olefination of 4.131 (Scheme 4.30).  When 4.131 was allowed to react with the ylide 
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generated from PPh3MeBr and n-BuLi, the desired product 4.132 was formed in low 
yield, and amine 4.133 was also be isolated as the major product of the reaction.  The low 
yield of 4.132 and the formation of 4.132 are primarily due to the sterically hindered 
nature of the ketone in 4.132, which prevents nucleophilic addition of the ylide to the 
ketone and allows for competitive elimination to occur.  For this reason attention was 
turned to conditions more amenable to the olefination of hindered ketones.     























The Peterson olefination has been shown to work well on hindered ketones,388 and 
therefore it was examined for the olefination of 4.131 (Scheme 4.31).  The addition of 
TMS-methyl Grignard into 4.134 at 0 ºC provided the desired alcohol 4.135.  When the 
elimination was attempted under Lewis acidic or under basic conditions niether the 
desired product nor any other identifiable products were isolated.  With both the Wittig 
and Peterson olefinations failing to provide good yields of 4.120, attention was then 































A number of different transition metal mediated olefinations of ketones have been 
reported in the literature, and a few of the more promising conditions were tried for the 
olefination of 4.131 and 4.136 (Scheme 4.32).  When 4.131 was subjected to standard 
Takai olefination conditions (CH2CI2/CrCl2),389 starting material was consumed, but none 
of the desired product was observed.  Similar results were obtained utilizing the 
CH2I2/Zn/TiCl4 system developed by Takai.390  Treatment of 4.136 with the Petasis 










CH2I2, Zn, PbCl2, THF, then TiCl4, 0 °C






4.132: Pg = TBDPS
4.137: Pg = TBS
X
conditions
4.131: Pg = TBDPS
4.136: Pg = TBS
 
Ketone 4.131 proved to be very resistant to olefination, and an alternative 
approach to 4.132 and 4.137 was developed.  It has been shown in the literature that 
benzenesulfonyl protected indoles lithiated at C-2 can be trapped with methyl pyruvate, 
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and the resulting alcohol can undergo a subsequent elimination leading to the desired 
unsaturated ester.392-394 This approach was successfully applied to the synthesis of 4.132 
and 4.137 (Scheme 4.33).  The TBDPS- and TBS-protected alcohols 4.123 and 4.127 
were deprotonated at C-2 using the previously optimized conditions, and the anions thus 
formed were trapped with methyl pyruvate to give the desired alcohols 4.138 and 4.139 
moderate yields.  After some experimentation it was found that the treatment of 4.138 or 
4.139 with MsCl and Hunig’s base in CH2Cl2 at 0 ºC provided the highest yields of the 
desired elimination products.  Similar yields for the elimination could be obtained by 
using POCl3 in pyridine.393  When SOCl2 was used in conjunction with Hunig’s base, the 
desired product was formed as a mixture with what appeared to be the alkyl chloride.  A 
major issue with these eliminations was that 4.132 and 4.137 could never be isolated 
cleanly, and the 1H NMR spectrum always contained ~5-10% of an unknown impurity.  
The purification of 4.132 and 4.137 was complicated by the fact that neither were stable 
to silica gel, and chromatography on basic alumina could not provide clean product.  
Even when 4.137 was purified via preparatory HPLC, the product still contained this 
minor impurity.  Since 4.132 and 4.137 could not be obtained in pure fashion, they were 


















i. 2 eq. LDA, THF
   -78 → 0 °C, 2 h
ii. methyl pyruvate
   -78 → 0°C
4.123: Pg = TBDPS







4.132: Pg = TBDPS












MsCl, i-Pr2NEt, CH2Cl2, 0°C
POCl3, pyr
SOCl2, i-Pr2NEt, CH2Cl2
MsCl, i-Pr2NEt, CH2Cl2, 0°C








~25% + 38% RSM
RSM      
When 4.132 and 4.137 were subjected to a number of RCM conditions none of 
the desired double RCM product 4.140 or 4.141 were formed (Scheme 4.34). Under all of 
the conditions tried, the major isolable products for these reactions were 4.142 or 4.143, 
and at best these products could only be isolated in yields up to 50%.  Attempts to drive 
the reaction to completion by heating to higher temperatures utilizing a microwave 
reactor were also unsuccessful.  When the reactions were heated to 120 ºC, a major, but 
as of yet unidentified side product could be isolated.  Even the Grubbs-Stewart catalyst, 
which is known to show increased reactivity towards sterically hindered olefins,395 was 
unsuccessful in closing the second ring. The inability to close the second ring via RCM is 
not surprising as the α,β-unsaturated ester is expected to be a poor metathesis partner.  
Electron deficient olefins are known to react more slowly in metathesis reactions, and the 
fact that it is also a 2,2-disubstituted olefin further attenuates its reactivity due to sterics.  
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A potential difficulty in this transformation is that the bezenesulfonyl group and the 
methyl ester must become co-planer for the desired product to form, and in doing so there 
is buildup of a substantial steric interaction between these two groups.  All of these 
factors contribute negatively to the RCM.  Hence, to circumvent these issues, a number 













                     Conditions
Grubbs I, benzene,  µW, 80 °C
Grubbs II, CH2Cl2, ∆
Grubbs II, benzene, µW, 80 or 120 °C
Hoveyda-Grubbs II, benzene, µW, 120 °C






























Grubbs I Grubbs II
Ph
Ph
4.132: Pg = TBDPS 
4.137: Pg = TBS
4.142: Pg = TBDPS 





4.140: Pg = TBDPS 




One strategy for enabling this difficult RCM involved the removal of the indole 
protecting group, in order to eliminate steric interactions between the protecting group 
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and the methyl ester.  A second alternative was to perform a relay RCM,396 which should 
help to overcome the unreactive nature of the α,β-unsaturated ester by providing a 
pathway for the RCM catalyst to load onto the electron deficient olefin.  A final 
alternative is to attempt the RCM on the allylic alcohol instead of the α,β-unsaturated 
ester, as the allylic alcohol should be a more reactive RCM partner.     
The first of these alternate strategies that was investigated was the relay RCM 
(Scheme 4.35).  To this end the synthesis of 4.146 was undertaken.  Ketone 4.123 was 
reacted with Grignard reagent 4.144 to give the desired addition product 4.145 in 
moderate yield.  Elimination of the alcohol in 4.145 with MsCl and Hunig’s base 
provided 4.146 in ~50% yield.  The purification of 4.146 also proved to be problematic 
and although 4.146 could never be isolated cleanly; it was subjected to the relay RCM 
with the Grubbs II and the Hoveyda-Grubbs II catalysts.  However, only the 
monocyclized 4.147 and the macrocyclic 4.148 were formed.  Despite efforts to enable 
the loading of the RCM catalysts onto the α,β-unsaturated ester, this olefin still proved to 
be unreactive under the RCM conditions.  Attention was then turned to the synthesis and 




































benzene, 80 °C, µW
or
10% Hoveyda-Grubbs II



















In order attempt the RCM on the unprotected indole, an appropriate deprotection 
strategy was needed.  The initial attempts to deprotect a number of uncyclized 
compounds related to 4.127 were unsuccessful due to the fact that the free indole readily 
undergoes elimination of the amine side chain (Scheme 4.36).  Also, in the case of 4.132 
conjugate reduction of the α,β-unsaturated ester could be observed.  For this reason it 
was decided that the best approach would be to perform an RCM on 4.139, which would 
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effectively tether the amine side chain and possibly prevent the elimination from 





Mg, NH4Cl,  MeOH


























Pg = TBS or TBDPS
R = H,                   or
 
The RCM of 4.139 proceeded in 79% yield utilizing 10% of the Grubbs II catalyst 
in benzene at 80 ºC (microwave heating) (Scheme 4.37).  The subsequent deprotection of 
4.152 with lithium naphthalenide provided 4.153, which was subjected without 
purification to the elimination conditions.  Both MsCl and Tf2O were effective in 
promoting the elimination, but in both cases the yields of 4.154 were poor.  However, this 
route did provide enough material to attempt the RCM.  When 4.154 was treated with 
20% of the Grubbs II catalyst at 80 ºC (microwave heating), no reaction occurred.  When 
the Grubbs-Stewart catalyst was used, no reaction occurred at 80 ºC, and upon heating to 
























































20% Grubbs II, benzene, µW, 80°C






With the double RCM of esters 4.137 and 4.154 being unsuccessful, attention was 
then turned towards the synthesis and cyclization of allylic alcohol 4.159 (Scheme 4.38).  
The first approach to 4.159 involved the deprotonation of 4.127 with LDA and 
subsequent trapping with hydroxyacetone 4.156.  When this reaction was run with or 
without added CeCl3, only starting material was recovered.  The second approach to 
4.159 involved a Negishi coupling with vinyliodide 4.158.397  Deprotonation of 4.127 
with n-BuLi and subsequent transmetalation with ZnCl2 presumably formed an 
organozinc compound, which was treated with 4.158 and Pd(PPh3)4 to provide 4.159 in 
9% yield.  The double RCM was then attempted, but when 4.159 was treated with the 













i. 2 eq. LDA, THF
   -78 → 0 °C, 2 h
  with or w/o CeCl3
ii. 
      














TBSOi. 1.3 eq. nBuLi, THF
   -78 → 0 °C
ii.  ZnCl2
     0 °C → rt

















Despite our best efforts, the double RCM could not be achieved.  While these are 
undoubtedly challenging RCM reactions, the complete inability to generate any of the 
desired products highlights the current limitations of metathesis chemistry and 
underscores the need for more active catalysts for challenging RCM reactions such as 
these.  The failures of these reactions also necessitated a modification to our synthetic 
strategy and led us to adopt a strategy involving the double RCM of 2-vinylindole 4.162 
(see Table 4.4) and installation of the methyl ester at a later stage of the synthesis.     
The deprotonation of various indoles at the 2-position and subsequent trapping of 
the anion with acetaldehyde is known to proceed in good yields.398-406  Thus, it was 
envisioned that the vinyl group could be installed onto 4.127 via a two step protocol 
similar to the sequence used in the synthesis of 4.137 (see Scheme 4.33).  When 4.127 
was deprotonated with LDA, and the resulting anion trapped with acetaldehyde, the 
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desired 4.161 was isolated in 63% yield along with appreciable amounts of recovered 
4.127 (Scheme 4.39).  When n-BuLi was used as base the desired product was formed in 
only 45% yield.  Similar yields of 4.161 could be obtained using PhLi as base, but the 
yield of recovered starting material was greatly reduced.  Adding the acetaldehyde at 0 ºC 
also resulted in both a lower yield and lower overall mass recovery.  It is not known at 
this point whether the recovered starting material is the result of incomplete 
deprotonation of 4.127, or if the hindered nature of 4.127 allows for proton transfer from 










i. 2 eq. LDA, THF
   -78 → 0 °C, 2 h
ii. acetaldehyde
    -78 → 0 °C
4.127
4.161
63% + 21% 4.127 Me
HO
i. 1.5 eq n-BuLi, 
   THF, -78 → 0 °C
ii. acetaldehyde
   -78 → 0 °C
45% + 8% 4.127
i. 3 eq. PhLi, THF
   -78 → 0 °C
ii. acetaldehyde
   -78 → 0 °C
61% + 6% 4.127
33% + 36% 4.127
i. 2 eq. LDA, THF
   -78 → 0 °C
ii. acetaldehyde, 0 °C
Other Conditions Tried Result
 
With alcohol 4.161 in hand attention was then turned to the elimination reaction.  
Although this is seemingly a straightforward transformation, a number of side reactions 
were encountered (Scheme 4.40).  Under the optimal conditions alcohol 4.161 was 
treated sequentially with Tf2O and Hunig’s base at -78 ºC in CH2Cl2 to provide 4.162 in 
66% yield along with a number of side products.  The first of these side products is 
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aldehyde 4.163, which presumably is formed via a pathway similar to that shown in 
Scheme 4.41.  The structure of the second side product has not conclusively been 
determined, but the spectral evidence suggests that it arises from an intramolecular 
cyclization of 4.161.  At low temperatures, aldehyde 4.163 is formed in significant 
quantities, and 4.164 is only formed in trace amounts.  At room temperature the 
distribution of these side products is flipped, and the aldehyde is not formed while 4.164 
becomes a more substantial side product.  Since 4.162 and 4.164 are not completely 
separable by chromatography, the reaction was run at low temperatures to prevent the 
formation of 4.164.   
In order to prevent the formation of these side products, a number of other 
reaction conditions were investigated.  Screening different bases or solvents did not 
improve the yields of the desired product or eliminate the formation of side products.  
Although some the other conditions tried were successful in eliminating the undesired 
side products, none of them came close to matching the 66% yield that could be obtained 
with Tf2O and Hunig’s base.  Interestingly, the reactions involving MsCl or Burgess 
reagent were the only conditions tried that did not provide any of the desired product.  
Thus, despite considerable effort, the elimination of 4.161 could only be optimized to 













































































With the requisite tetraene 4.162 in hand the double RCM was attempted (Table 
4.4).  Heating 4.162 with 10% Grubbs II catalyst in benzene provided the desired 4.169 
in 68% yield.  The use of microwave heating accelerated the reaction, but it did not 
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improve the overall yields.  In order to increase the efficiency of this reaction, lower 
catalyst loadings were investigated.  At 5% catalyst loadings with the Grubbs II catalyst 
in refluxing benzene or toluene, the RCM would not proceed to completion, and the 
crude reaction mixture had to be re-subjected to the reaction conditions in order to drive 
the reaction to completion.  As a result of this, 4.169 was isolated in only 54% yield.  
When a second portion of catalyst was added, the reactions still did not proceed to 
completion.  It was found that lower catalyst loadings could be achieved by employing 
the Hoveyda-Grubbs II catalyst, and when 4.162 was heated with 5% of this catalyst in 
















10% Grubbs II, benzene, ∆
10% Grubbs II, benzene, µW, 80 °C
5% + 5% Grubbs II, benzene, ∆
5% + 5% Grubbs II, toluene, ∆
5% Hoveyda-Grubbs II, benzene, µW, 80 °C











It should be noted that the RCM gave exclusively the trans-fused product as 
determined by the large coupling constant (J = 16.5 Hz) for the ring fusion protons.  A 
couple of possibilities for these high levels of selectivity for the trans-fused product can 
be envisioned.  The first possible explanation is that the stereochemical outcome of the 
double RCM reaction of 4.162 is determined in the first of the two RCM reactions.  The 
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1H NMR data taken from reaction mixtures where the double RCM had not proceeded to 
completion showed that the piperidine ring is closed first.  Of the two potential products 
of this RCM, one would expect that the trans-configuration of the indole and vinyl 
substituents in 4.170 would be preferred as these two groups can both be placed in an 
equatorial position in transition state leading to 4.170.  This pathway leading to 4.170 
would presumably be lower in energy than the pathway that leads to 4.171, which 
requires that one of the substituents on the piperidine ring is placed in an axial orientation 
in the transition state.  An alternative explanation stems from the fact that the RCM is run 
under conditions in which the products of the reaction can potentially epimerize.  Thus, 
the double RCM reaction could initially provide a mixture of 4.169 and its cis-fused 
isomer 4.172.   The cis-fused product could then fragment to give 4.173, which could 
reclose to give the trans-fused 4.169.  This assumes that the trans-fused product is the 
thermodynamically more stable product, but further modeling studies would be needed to 



























It should be noted that the Aspidosperma alkaloids all contain a cis-ring fusion, 
and therefore an epimerization will be necessary.  Fortunately, there are two 
intermediates, 4.180 and 4.182, at the end of the synthesis that can potentially undergo a 
retro-Mannich/Mannich sequence that should provide the desired cis-ring fusion 
stereochemistry and render the stereochemical outcome of the RCM inconsequential.   
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With tetracycle 4.169 in hand, we then turned or attention to the introduction of 
the methyl ester and formation of the pentacyclic core.  Our first plan for introducing the 
methyl ester was the direct functionalization of the C16-C17 double bond.  This could 
potentially be accomplished via a directed lithiation of the double bond or through a 
transition metal mediated hydrocarboxylation.  Both of these methods for installing the 
methyl ester were lacking good precedent, and therefore they were investigated in 
parallel. 
It was first postulated that the N-benzenesulfonyl group might be able to direct 
deprotonation to the vinylic proton at C-16.  Alternatively, it is known that deprotonation 
may occur at C-12 and this competing pathway may prevail.  To investigate the 
feasibility of deprotonating the vinyl group, 4.169 was treated with n-BuLi or LDA in 
THF at -78 ºC.  The reactions were then warmed to 0 ºC before quenching with MeOH-d4 
or AcOH-d4.  In both cases no deuterium incorporation was observed, and the only 
isolated product was the free indole 4.174 (Scheme 4.42).  These preliminary results 
indicate that the direct deprotonation route may not be a viable method for the installation 
of the methyl ester, and due to the successes of alternate routes an exhaustive screen of 
conditions was not undertaken. 















i. nBuLi or LDA
   THF, -78 → 0 °C
ii. CD3CO2D





In addition to the directed lithiation studies, efforts the feasibility of performing a 
hydrocarboxylation on 4.169 was investigated.  The hydrocarboxylation of styrenes has 
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been studied,407 but little work has been reported on the hydrocarboxylation of vinyl 
indoles.  If this reaction could successfully be applied to 4.169, it would provide us with a 
method for installation of the methyl ester with concurrent reduction of the double bond.  
To this end, preliminary experiments were run utilizing a couple of the more promising 
conditions (Scheme 4.43).  The first of the conditions attempted was the nickel catalyzed 
hydrocarboxylation reaction recently developed by Rovis.408  However, attempts to 
convert 4.169 into 4.176 using this procedure gave only 4.175 and various compounds 
that appeared to arise from double bond isomerizations of 4.169.  When 4.169 was 
allowed to react under palladium catalyzed hydrocarboxylation conditions409 no 
identifiable products could be isolated from the reaction.  Carriera has recently reported a 
procedure for the hydrocyanation of alkenes,410 and when 4.169 was reacted under a 
slightly modified version of these conditions a number of new products were formed by 
TLC.  Mass spectrometry indicated the presence of the desired product, but attempts to 
isolate and identify any of the desired product were unsuccessful.  There are numerous 
things that could be attempted to optimize these reactions, but the success of the late 
stage installation of the ester via lithiation and acylation of 4.180 (Scheme 4.45) made 


























































Because the C16-C17 olefin is not needed for the natural product an alternative 
approach was explored that involves the selective reduction of this olefin and installation 
of the methyl ester after spirocyclization.  To this end, 4.169 was treated with Pd/C in 
MeOH or EtOAc under an atmosphere of H2, but no selectivity was observed in the 
reduction.  However, it was found that the selective hydrogenation could be achieved by 
first removing the indole protecting group (Scheme 4.44).  The benzenesulfonyl group 
could be easily removed using Mg/MeOH or Li naphthalenide to provide 4.174.  The 
more electron rich olefin in 4.174 was then selectively reduced with Pd/C in MeOH, and 
upon completion of the reduction, the addition of HCl cleaved the TBS group to provide 
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4.179.  The free alcohol 4.179 could then be cyclized to pentacycle 4.180 using 
conditions developed by Rawal;348 whereby the alcohol was first treated with MsCl and 
Et3N in CH2Cl2 to provide the primary mesylate, which was treated in situ with a solution 
of KOt-Bu in THF to provide the desired pentacycle 4.180 in 35% yield over three steps 
from 4.169 without the need for purifying of any of the intermediates.  It should be noted 
that the reduction of 4.174 was finicky, and in almost all cases the starting material 
needed to be re-subjected to the reaction conditions one or two times before the reaction 
would proceed.  Presumably this was due to sulfur containing impurities from the 
deprotection step that poisoned the catalyst and shut down the hydrogenation.     



































   CH2Cl2, -10 °C
ii. KOt-Bu in THF
   -10 → 0 °C
4.18035% from 4.169   
With pentacycle 4.180 in hand, efforts were made to find optimal conditions for 
the requisite epimerization (Table 4.5).  Pentacycle 4.180 was found to be stable in 
refluxing toluene, but when p-toluenesulfonic acid was added in stoichiometric amounts, 
the starting material was consumed, and a compound presumed to be 4.181 was formed 
upon refluxing in toluene for ~20 h.  The mass recovery for this reaction was low, and 
4.181 was isolated in only 9% yield after chromatography. A substantial amount of 
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insoluble material was formed during the course of the reaction, and it was thought that 
more polar solvents could be utilized to prevent this from occurring.  Indeed, the 
formation of the insoluble material could be avoided by heating the reaction in DMF, but 
the overall mass recovery for this reaction was still low.  It was also found that BF3·OEt2 
could promote the epimerization in refluxing dichloroethane, but again the overall mass 
recovery was low.  At this time the exact structure of 4.181 is not known, and given the 
results obtained in the attempted synthesis of pseudotabersonine (see Scheme 4.50) it is 













TsOH•H2O, CH3CN, ∆, 18h
TsOH•H2O, DMF, 120 °C, 20h
BF3•OEt2, CH2Cl2








     
In conjunction with the epimerization studies, efforts were also made to install the 
methyl ester onto 2.180 to give 2.182, as this intermediate could also potentially undergo 
an epimerization.  There have been numerous methods reported for the installation of the 
C-16 methyl ester onto the pentacyclic aspidospermine skeleton.411-413  The most direct 
method was first reported by Overman and involved the deprotonation of a pentacyclic 
imine similar to 4.181 with LDA and subsequent trapping of the metalloenamine thus 
formed with methyl chloroformate to provide a mixture (1:1) of N- and C-acylated 
products.412  This procedure was later improved upon by Rawal, who reported obtaining 
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exclusively the C-acylation product in good yield by utilizing methyl cyanoformate as the 
acylating agent.347, 348  Following Rawal’s conditions, 4.180 was treated with LDA in 
THF at -78 ºC, and the resulting metalloenamine was acylated with methyl cyanoformate 
to give the separable C- and N-acylated products 4.182 and 4.183 in 30% and 21% yields, 
respectively (Scheme 4.45).  These results are in stark contrast to those reported by 
Rawal, and the reason for the lack of selectivity for the C-acylated product in this 
reaction is not known.  One attempt has been made to epimerize 4.182, but upon heating 
in refluxing toluene no reaction occurred, and the addition of acids to the reaction will 






  -78 °C
ii. methyl 
    cyanoformate















With the methyl ester successfully installed all that remained to be completed is 
the epoxidation of the isolated olefin, a seemingly straightforward transformation that is 
complicated by the presence of the vinylogous carbamate.  When compounds such as 
tabersonine (4.184) are treated with DMDO or m-CPBA under a variety of conditions a 
number of different reactions can occur (Scheme 46).414, 415  Under neutral conditions the 
tertiary amine is oxidized to the N-oxide, and in the presence of excess oxidant the 
vinylogous carbamate is selectively oxidized to give 4.85.  The formation of the N-oxide 
can easily be avoided by running the reaction under acidic conditions so that the amine is 
protected via protonation.   However, epoxidation of the vinylogous carbamate still 
occurs preferentially, and under the acidic conditions the epoxidized product rearranges 
to the eburnane skeleton 4.186.  Thus, 4.182 cannot be directly transformed into rosicine 
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and an alternative epoxidation strategy is needed.  A five step protocol has been 
developed to circumvent this problem,180, 414 but we hoped that a more direct solution 



































It was hypothesized protecting the vinylogous urethane nitrogen in 4.182 with an 
electron withdrawing group would render it unreactive to the epoxidation conditions.  To 
this end the protection of 4.182 was undertaken (Scheme 4.47).  Attempts to install a 
carbomethoxy group onto the nitrogen atom by treating 4.182 with NaH and methyl 
chloroformate were unsuccessful, and none of the desired product was obtained.  
Attention was then turned to the installation of a Boc group. The Boc protection of 
tabersonine (4.184) had been previously reported in the literature,416 but when a slightly 
modified version of these conditions was applied to 4.182 the Boc-protected 4.187 could 





























       
This is where the efforts towards the synthesis of rosicine currently stand.  Two 
major unresolved issues need to be addressed in order to complete the synthesis.  The 
first of these issues is that optimal conditions need to be found for epimerizing 4.180.  
The second issue is that it is not known if the strategy of protecting the vinylogous 
carbamate will indeed be successful in tempering its reactivity, and the epoxidation of 
4.187 needs to be attempted to test this hypothesis.  The efforts towards rosicine still 
stand as an excellent model system and the many lessons that have been learned here 
have been applied to the synthesis of pseudotabersonine and can be applied to future 
synthetic efforts towards other members of the aspidospermine family.   
4.3.3 Effor ts Towards the Total Synthesis of Pseudotabersonine 
The efforts described above towards the synthesis of rosicine had shown that we 
can apply our imine pentadienylation/double RCM strategy to access the pentacyclic core 
of Aspidosperma alkaloids.  We thus turned our attention to the synthesis of 
pseudotabersonine (4.29).  Following the synthetic plan outlined for rosicine in Scheme 
4.23, pseudotabersonine should be accessible simply by starting from 2-ethylallylamine 
instead of allylamine. 
The synthesis of pseudotabersonine began from the commercially available 2-
ethylacrolein (4.189) (Scheme 4.48).  Reduction of the aldehyde with NaBH4 provided 
alcohol 4.190,417 which was converted to the allyl bromide 4.191 with PBr3.  Allyl 
bromide 4.191 was then reacted with LiHMDS in refluxing hexane to provide the crude 
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bis(silyl)amine, which was treated with methanolic HCl to provide the desired 2-


















Condensation of amine 4.192 with aldehyde 4.114 provided imine 4.193, which 
was subjected to the pentadienylation conditions to give the branched product 4.194 in 
greater than 10:1 regioselectivity (Scheme 4.49).  The crude 4.194 was then treated with 
ethylene oxide in MeOH to provide alcohol 4.195 in 60% yield over the two steps.  
Interestingly, alcohol 4.195 is a solid while the corresponding linear isomer is not, and 
separation of the two can easily be obtained by the crystallization of 4.195 from 
methanol.  Protection of 4.195 proceeded without incident to give 4.196 in 87% yield.  
Deprotonation of 4.196 with LDA and subsequent addition of acetaldehyde following the 
previously developed conditions (see Scheme 4.40) provided the desired alcohol 4.197 in 
55% as a mixture (2.2:1) of separable diastereomers.  Dehydration of 4.193 using Tf2O 
and Hunig’s base gave the RCM precursor 4.198.  Treatment of 4.198 with 5% Hoveyda-
Grubbs II in refluxing toluene provided the trans-fused double RCM product 4.199 in 
54% yield.  The low yield for the RCM is due apart to the fact that 4.199 can aromatize 
under the reaction conditions.      
The additional substitution on the C15-C20 double bond of 4.199 made it possible 
to perform the selective reduction on the protected indole.  To this end, 4.199 was treated 
with Pd/C in EtOH under an atmosphere of H2, and when the reduction was complete 
HCl was added to cleave the TBS group to provide 4.200 in 52-62% yield.  Then, 
following a procedure developed by Bosch and Rubiralta,418 4.200 was treated with 2 eq. 
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KOt-Bu in THF to provide the desired pentacycle 4.201.  Upon treatment with LDA and 
addition of methyl cyanoformate the desired C-acylated 4.202 could be isolated in 42% 
yield along with 30% of the N-acylated product.  This completed the synthesis of epi-


































































    -78 → 0 °C
ii. acetaldehyde




































































  -78 → -20 °C
ii. methyl
   cyanoformate









With 4.202 in hand, attention was then turned to the epimerization.  Kuehne has 
reported on the attempted epimerization of 4.203, and has shown that the trans-fused 
4.203 does not undergo epimerization when heated at 200 ºC in acetic acid.340  With these 
results in mind, the attempted epimerization of 4.202 was undertaken with hopes that 
more forcing conditions might be found under which 4.202 can be epimerized.  To this 
end, 4.202 was treated with a number of protic or Lewis acids at elevated temperatures 
(Table 4.6).  When 4.202 was heated in acetic acid at 220 ºC in a microwave reactor, no 
reaction occurred.  When anhydrous p-toluenesulfonic acid was added to the reaction, an 
unidentified side product that appeared to arise from the decarboxylation of 4.202 was 
formed.  When 4.202 was heated in trifluoroacetic acid, imine 4.201 was formed in good 
yield.  The decarboxylations seen in these reactions presumably arise from adventitious 
water present in the reaction medium.  BF3·OE2 and TMSOTf were also unsuccessful in 
epimerizing 4.202, with BF3·OE2 returning only starting material and TMSOTf giving an 


























AcOH, µW, up to 220 °C RSM
TFA, µW, 150 °C imine
AcOH, TsOH, µW, 200 °C ??
BF3•OEt2, µW, 100 °C RSM








Since 4.202 proved to be resistant to all epimerization attempts, efforts were then 
turned to the epimerization of 4.201 (Scheme 4.50).  When 4.201 was heated with TsOH 
in DMF at 120 ºC a product initially believed to be 4.204 was formed in moderate yield.  
However, when 4.204 was subjected to the acylation conditions, none of the desired 
natural product was produced.  The reaction did provide a currently undetermined 
product in good yield, and the 1H NMR spectra of this compound suggests that a methyl 
carbamate was formed in the reaction.  Further studies are needed at this time to ascertain 
the correct structures of 4.203, and to figure the product of this attempted acylation.  
These results also call into question the structure of 4.180, and its structure will also need 



















  -78 → -20 °C
ii. methyl
   cyanoformate










4.3.4 Preliminary Studies Involving 3-Ethylpentadienyl Aluminum 
The vast majority of the Aspidosperma alkaloids contain an angular ethyl group at 
C-20.  In order to access these natural products via our pentadienylation/double RCM 
strategy, a 3-substituted pentadienyl metal reagent would be needed for the 
pentadienylation.  The added substitution at the 3-position of the pentadienyl metal could 
potentially alter the selectivity of the pentadienylation.  The terminal olefin is not 
substituted and steric factors may cause attack to occur preferentially at the terminal 
carbon, which would give rise to the linear product.  To test whether the increased steric 
bulk around the 3-position would alter the selectivity of the pentadienylation, 3-ethyl 
pentadienyl aluminum was synthesized and employed in the pentadienylation reaction 
with 4.124 (Scheme 4.50).   
Treatment of methyl propionate with 2 eq. of vinyllithium provided the tertiary 
alcohol 4.208, which was converted to primary bromide 4.209 with PBr3.  The Grignard 
reagent 4.210 was made from 4.209 and Mg in Et2O at 0 ºC and subsequently 
transmetalated to aluminum with AlCl3.  The pentadienyl aluminum reagent was then 
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added to a solution of imine 4.124 in CH2Cl2 to provide the desired branched product 
4.211 in 33% yield along with 24% of the linear product 4.212 and 16% of recovered 




























i. AlCl3 in Et2O
   0 °C
















The overall conversion and selectivity for the branched product in this reaction 
were modest at best, but the fact that the branched product was still favored shows some 
promise.  The conditions for this reaction varied greatly from the standard conditions that 
are commonly employed for the pentadienylation.  The first major difference is that the 
3-ethylpentadienyl aluminum reagent was prepared from the Grignard instead of from the 
organolithium reagent.  It is not known at this time if the presence of these magnesium 
salts had any influence on the outcome of the pentadienylation.  The second major 
difference was in the solvent system and concentration.  The above pentadienylation was 
run in a 2:1 ether/CH2Cl2 solvent system instead of the normally used 4:2:1:1 
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CH2Cl2/Et2O/hex/THF mixture, and the reaction was also run at a lower concentration.  
These differences were necessitated by the fact that the Grignard reagent was formed at a 
relatively low concentration in ether in an effort to prevent the dimerization of 4.209 and 
4.210.  Hopefully, by finding an alternative way to access the 3-ethylpentadientyl 
aluminum reagent, which is more in line with the conditions previously developed for the 
unsubstituted reagent 4.58, the selectivity for the branched product can be improved so 
that additional aspidospermine alkaloids can be accessed.         
4.4 Conclusions 
In order to further demonstrate the synthetic utility of the 4CR we have applied it 
to the synthesis of members of the isopavine and Aspidosperma alkaloid families.  The 
application of the 4CR to the isopavine alkaloids has resulted in the first synthesis of 
roelactamine in only 4 steps from commercially available materials.  In addition, the 
concise nature of the route and the flexibility of the 4CR make this approach to the 
isopavine alkaloids amenable to the synthesis of a collection of unnatural isopavines for 
use in biological testing.    
 In our efforts towards the synthesis of the Aspidosperma alkaloids, we have 
adopted a pentadienylation/double RCM strategy to access the pentacyclic core of these 
natural products.  This sequence involved the use of a pentadienyl aluminum reagent, 
which was found to react with aryl imines to give branched products in good yields.  The 
application of this strategy to the synthesis of rosicine resulted in the synthesis of 
pentacycle 4.180, which is only two transformations and an epimerization away from the 
natural product.  All that remains for the synthesis of rosicine is to find optimal 
conditions for the epimerization of 4.180, and to find a protocol suitable for the 
epoxidation of 4.182.  The synthetic strategy developed for the synthesis of rosicine was 
then applied to the synthesis of pseudotabersonine. To this end, we have been successful 
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in synthesizing epi-pseudotabersonine in 13 steps from commercially available materials. 
Unfortunately, up to this point attempts to epimerize either 4.201 or 4.202 have been 
unsuccessful.  While the successful epimerization of 4.202 at this point seems unlikely, 
there is still hope that with further studies the epimerization of 4.201 can be achieved.    
We have also demonstrated in preliminary experiments that 3-ethylpentadienyl 
aluminum can react with imine 4.124 to give rise to the branched product as the major 
product.  Although the yield and selectivity in this transformation were low, it is believed 
that with some optimization this reaction will provide us with a viable entry to the rest of 
the aspidospermine family of alkaloids.  If this route does prove to be successful, it would 
be one of, if not the shortest synthetic route to the Aspidosperma alkaloids. Currently, 













Chapter  5: Exper imental Procedures 
5.1 General 
Unless noted all solvents and reagents were used without further purification.  
Methylene chloride, diisopropylamine, triethylamine, and pyridine were distilled from 
calcium hydride prior to use.  THF and Et2O were passed through two columns of 
activated neutral alumina prior to use.  Toluene was passed through a column of Q5 
reactant and a column of activated neutral alumina.  Acetonitrile, diemethyl formamide, 
and methanol were passed through two columns of activated molecular sieves.  Benzene 
was distilled from the sodium benzophenone ketyl.  TMSOTf, BF3·OEt2, styrene, and 
benzaldehyde were distilled from CaH2 under reduced pressure.  Acetyl chloride and 
triflic anhydric were freshly distilled from P2O5 immediately prior to use.  Hunig’s base 
was distilled from KOH prior to use.  Acryloyl chloride and crontonyl chloride were 
distilled immediately prior to use.  Allyl bromide was dried with MgSO4 and distilled.  
Zinc and magnesium metal was activated by washing with 1 M HCl.  AlCl3, ZnBr2, and 
KOt-Bu were sublimed under reduced pressure.   All air and moisture sensitive reactions 
were run under a positive pressure of N2 or argon gas in glassware that had been oven or 
flame dried.  4 Å powdered molecular sieves were activated under vacuum at ~ 250 °C 
for at least 6 h prior to use.  Thin-layer chromatography (TLC) was performed on EM 
250 micro silica gel plates, and plates were visualized using UV detection and para-
anisaldehyde (PAA), potassium permanganate (KMnO4), or dinitrophenyl hydrazine 
(DNP) stain.  Flash chromatography was performed with ICN Silica gel 60.  Microwave 
reactions were performed using a CEM Discover Labmate microwave synthesizer, and 
the reactions were programmed to run utilizing as much power as neccessary to maintain 
the desired reaction temperature, as measured by the internal infrared detector. 
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  1H NMR chemical shifts are reported in parts per million (ppm) downfield from 
tetramethylsilane (TMS) and for CDCl3 are referenced to an internal TMS standard (δ 
0.00) and for DMSO-d6 are referenced to the residual solvent peak (δ 2.05).  
13C NMR 
chemical shifts are reported in ppm relative to the center line of the multiplet for 
deuterium solvent peaks (δ 77.0 for CDCl3 and  δ 39.5 for DMSO-d6).   Coupling 
constants for all spectra are reported in Hertz (Hz).  The abbreviations s, d, t, q, p, m, 
comp, and br stand for the resonance multiplicities singlet, doublet, triplet, quartet, 
pentuplet, multiplet, complex, and broad, respectively.  Infrared (IR) spectra were 
recorded as films on sodium chloride plates and reported as wavenumbers (cm-1).   














N-Allyl-N-(1-phenylbut-3-enyl)acetamide (2.19). (JDS-170a).  Acetyl chloride 
(0.10 mL, 110 mg, 1.41 mmol) was added to a solution of imine 2.17 (166 mg, 1.14 
mmol) and allyltrimethylsilane (0.55 mL, 395 mg, 3.46 mmol) in CH3CN (3 mL) at  −20 
°C.  The reaction was stirred for 15 min at −20 °C, the cold bath was then removed and 
the reaction was stirred for 30 min at room temperature.  TMSOTf (22 µL, 27 mg, 0.12 
mmol) was added and the reaction was stirred at room temperature for 40 h.  The reaction 
was partitioned between CH2Cl2 (5 mL) and saturated aqueous NaHCO3 (5 mL).  The 
organic phase was removed, and the aqueous phase was extracted with CH2Cl2 (3 x 5 
mL).  The combined organics were dried (MgSO4), filtered, and concentrated under 
reduced pressure. The residue was purified by flash chromatography eluting with 
EtOAc/Hexane (1:3) to give 159 mg (61%) of 2.19 as a yellowish oil.  1H NMR (500 
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MHz, DMSO, 100 °C) δ 7.36-7.31 (comp, 4 H), 7.27-7.24 (m, 1 H), 5.80-5.72 (m, 1 H), 
5.65 (br, 1 H), 5.52 (ddt, J = 16.3, 10.5, 5.4 Hz, 1 H), 5.12 (d, J = 7.2 Hz, 1 H), 5.02 (d, J 
= 10.5 Hz, 1 H), 4.98-4.46 (comp, 2 H), 3.75 (dd, J = 16.8, 5.1 Hz, 1 H), 3.7 (m, 1 H), 
2.80-2.67 (comp, 2 H), 2.05 (s, 3 H); 13C NMR (125 MHz, DMSO, 100 °C) δ 169.4, 
139.4, 134.9, 134.8, 127.7, 127.4, 126.7, 116.4, 115.3, 55.1, 46.2, 34.3, 21.4;  IR (neat) 
3077, 2978, 2930, 1644, 1407, 917, 701 cm-1; mass spectrum (CI) m/z 230.1547 
[C15H19NO (M+1) requires 230.1545].   
NMR Assignments. 1H NMR (500 MHz, DMSO, 100 °C) δ 7.36-7.31 (comp, 4 
H, C6-H, C7-H, C9-H, & C10-H), 7.27-7.24 (m, 1 H, C8-H), 5.8-5.72 (m, 1 H, C3-H), 
5.65 (br, 1 H, C1-H), 5.52 (ddt, J = 16.3, 10.5, 5.4 Hz, 1 H, C12-H), 5.12 (d, J = 7.2 Hz, 1 
H, C4-H), 5.02 (d, J = 10.5 Hz, 1 H, C4-H), 4.98-4.46 (comp, 2 H, C13-H), 3.75 (dd, J = 
16.8, 5.1 Hz, 1 H, C11-H ), 3.7 (m, 1 H, C11-H), 2.80-2.67 (comp, C2-H), 2.05 (s, 3 H, 
C15-H); 13C NMR (125 MHz, DMSO, 100 °C) δ 169.4 (C14), 139.4 (C5), 134.9 (C3 or 
C12), 134.8 (C3 or C12), 127.7 (C6 & C10 or C7 & C9), 127.4 (C6 & C10 or C7 & C9), 






















Methyl 2-(1-(N-allylacetamido)but-3-enyl)benzoate (2.25). (JDSIII-264a) A 
mixture containing freshly distilled methyl formyl benzoate (2.34)419 (135 mg, 0.83 
mmol), allylamine (0.06 mL, 46 mg, 0.80 mmol) and activated 4 Å molecular sieves 
(~500 mg) in CH2Cl2 (2.6 mL) was stirred for 12 h at room temperature. Freshly distilled 
acetyl chloride (0.06 mL, 66 mg, 0.84 mmol) was added, and the reaction was stirred for 
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1 h. The reaction was then cooled to –78 °C, freshly prepared allylzinc bromide (2.1 M in 
THF, 0.5 mL, 1.05 mmol) was added, and the reaction was stirred for 1.5 h. The dry ice 
bath was removed, and the reaction was filtered through a Celite pad that was washed 
with CH2Cl2 (3 x 5 mL). The combined filtrate and washings were washed with saturated 
aqueous NH4Cl (10 mL). The aqueous phase was backwashed with CH2Cl2 (2 x 5 mL), 
and the combined organics were dried (MgSO4), filtered, and concentrated under reduced 
pressure. The residue was purified by flash chromatography eluting with EtOAc/hexanes 
(2:3) to give 193 mg (84%) of amide 2.25 as a viscous colorless oil. 1H NMR (500 MHz, 
DMSO, 130 °C) δ 7.62 (d, J = 7.5 Hz, 1 H), 7.60 (d, J = 7.5, 1 H), 7.52 (t, J = 7.5 Hz, 1 
H), 7.37 (t, J = 7.5 Hz, 1H), 5.99 (t, J = 7.4 Hz, 1 H), 5.73 (dddd, J = 17.1, 10.2, 6.6, 6.6, 
1 H), 5.51-5.43 (m, 1 H), 5.09 (d, J = 17.1 Hz, 1 H), 5.00 (d, J =10.2, 1 H), 4.91-4.88 
(comp, 2 H), 3.81 (s, 3 H) 3.82-3.68 (comp, 2 H), 2.79-2.69 (comp, 2 H), 2.00 (s, 3 H); 
13C NMR (125 MHz, DMSO, 130 °C) δ 169.3, 167.6, 138.1, 134.7, 134.5, 132.0, 130.2, 
128.4, 127.7, 126.7, 116.3, 114.9, 54.0, 51.3, 45.8, 35.3, 21.1; IR (neat) 1722, 1649, 
1405, 1270, 918, 749, cm-1; mass spectrum (CI) m/z 288.1601 [C17H22NO3 (M+1) 
requires 288.1600]. 
NMR Assignments. 1H NMR (500 MHz, DMSO, 130 °C) δ 7.62 (d, J = 7.5 Hz, 
1 H, C7 or C10-H), 7.60 (d, J = 7.5, 1 H, C7 or C10-H), 7.52 (t, J = 7.5 Hz, 1 H, C8 or 
C9-H), 7.37 (t, J = 7.5 Hz, 1H, C8 or C9-H), 5.99 (t, J = 7.4 Hz, 1 H, C1-H), 5.73 (dddd, 
J = 17.1, 10.2, 6.6, 6.6, 1 H, C3 or C12-H), 5.51-5.43 (m, 1 H, C3 or C12-H), 5.09 (d, J = 
17.1 Hz, 1 H, C4 or C13-H), 5.00 (d, J =10.2, 1 H, C4 or C13-H), 4.91-4.88 (comp, 2 H, 
C4 or C13-H), 3.81 (s, 3 H, C17-H) 3.82-3.68 (comp, 2 H, C11-H), 2.79-2.69 (comp, 2 
H, C2-H), 2.00 (s, 3 H, C15-H); 13C NMR (125 MHz, DMSO, 130 °C) δ 169.3 (C14), 
167.6 (C17), 138.1 (C-Ar), 134.7 (C3 or C12), 134.5 (C3 or C12), 132.0 (C-Ar), 130.2 
(C-Ar), 128.4 (C-Ar), 127.7 (C-Ar), 126.7 (C-Ar), 116.3 (C4 or C13), 114.9 (C4 or C13), 
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54.0 (C18), 51.3 (C1), 45.8 (C11), 35.3 (C2), 21.1 (C15); IR (neat) 1722, 1649, 1405, 






















Benzyl allyl-1-phenylbut-3-enylcarbamate (2.27). (JDSI-141a). TMSOTf (40 
µL, 49 mg, 0.22 mmol) was added to a solution of benzaldehyde (0.20 mL, 209 mg, 1.97 
mmol) and bis(trimethylsilyl)allylamine (0.49 mL, 400 mg, 1.98 mmol) in CH2Cl2 (4 
mL), and the reaction was stirred for 5 h at room temperature. The reaction was cooled to 
-78 ºC and allyltrimethylsilane (1 mL, 719 mg, 6.29 mmol) and Cbz-Cl (0.31 mL, 370 
mg, 2.17 mmol) were then added, and the reaction was stirred for 20 min at -78 ºC.  The 
cold bath was then removed and the reaction was stirred for 22 h at room temperature. 
The reaction was partitioned between CH2Cl2 (5 mL) and saturated aqueous NaHCO3 (5 
mL). The organic phase was removed, and the aqueous phase was extracted with CH2Cl2 
(3 x 5 mL). The combined organics were dried (MgSO4), filtered, and concentrated under 
reduced pressure.  The residue was purified by flash chromatography eluting with 
EtOAc/Hexane (1:19) to give 488 mg (77%) of 2.27 as a yellowish oil.  1H NMR (500 
MHz, DMSO, 100 °C) δ 7.36-7.25 (comp, 10 H), 5.75 (dddd, J = 17.0, 10.2, 6.6, 6.6 Hz, 
1 H), 5.59 (dddd, J = 16.5, 10.3, 5.9, 5.9 Hz, 1 H), 5.22 (t, J = 7.8 Hz, 1 H), 5.12 (comp, 
2 H), 5.12- 5.07 (comp, 1 H), 5.02-4.89 (comp, 3 H), 3.75 (dd, J = 16.1, 5.9 Hz, 1 H), 
3.69 (dd, J = 16.1, 5.9 Hz, 1 H), 2.78-2.74 (comp, 2H); 13C NMR (125 MHz, DMSO, 100 
°C) δ 155.1, 139.5, 136.5, 134.7, 134.7, 127.7, 127.7, 127.2, 127.1, 126.9, 126.8, 116.5, 
115.4, 65.9, 58.5, 45.9, 34.6; IR (neat) 3065, 3030, 2937, 2248, 1951, 1810, 1696, 1406, 
 300 
1232, 915, 733, 698 cm-1;  mass spectrum (CI) m/z 322.1799 [C21H22NO2 (M+1) requires 
322.1807].   
NMR Assignments. 1H NMR (500 MHz, DMSO, 100 °C) δ 7.36-7.25 (comp, 
10H, aromatic-H), 5.75 (dddd, J = 17.0, 10.2, 6.6, 6.6 Hz, 1 H, C3-H), 5.59 (dddd, J = 
16.5, 10.3, 5.9, 5.9 Hz, 1 H, C12-H), 5.22 (t, J = 7.8 Hz, 1 H, C1-H), 5.12 (comp, 2 H, 
C15-H), 5.12- 5.07 (comp, 1 H, C4 or C13-H), 5.02-4.89 (comp, 3 H, (C4 & C13-H), 
3.75 (dd, J = 16.1, 5.9 Hz, 1 H, C11-H), 3.69 (dd, J = 16.1, 5.9 Hz, 1 H, C11-H), 2.78-
2.74 (comp, 2 H, C2-H);  13C NMR (125 MHz, DMSO, 100 °C) δ 155.1 (C14) , 139.5 
(C3 or C12), 136.5 (C3 or C12), 134.7 (C5 or C16), 134.7 (C5 or C16), 127.7 (C6 & C10 
or C7 & C9) , 127.7 (C6 & C10 or C7 & C9), 127.2 (C18 & C20), 127.1 (C8 or C19), 
126.9 (C17 & C21), 126.8 (C8 or C19), 116.5 (C4 or C13), 115.4 (C4 or C13), 65.9 

















N-Allyl-N-(1-(2-bromophenyl)but-3-enyl)acrylamide (2.29).  (JDSI-235a).  
TMSOTf (15.5 µL, 19 mg, 0.086 mmol) was added to a solution of 2-
bromobenzaldehyde (0.10 mL, 158 mg, 0.86 mmol) and bis(trimethylsilyl)allylamine 
(0.23 mL, 188 mg, 0.93 mmol) in CH2Cl2 (2 mL) and  the reaction was stirred for 1 h at 
room temperature. The reaction was then cooled to 0 °C and freshly distilled acryloyl 
chloride (85 µL, 95 mg, 1.05 mmol) was added and the reaction was stirred for 10 min at 
0 ºC.  The ice bath was then removed and the reaction stirred for 40 min at room 
temperature.  The reaction then was cooled to −78 °C and freshly prepared allylzinc 
bromide (2.31M in THF, 0.55 mL, 1.27 mmol) was then added and the reaction was 
stirred for 2.5 h at -78 ºC.  The ice bath was then removed and the reaction was warmed 
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to room temperature. The reaction was partitioned between CH2Cl2 (5 mL) and saturated 
aqueous NH4Cl (5 mL).  The organic phase was removed, and the aqueous phase was 
washed with CH2Cl2 (3 x 5 mL).  The combined organics were dried (MgSO4), filtered, 
and concentrated under reduced pressure.  The residue was purified by flash 
chromatography eluting with EtOAc/Hexane (1:9) to give 224 mg (82%) of amide 2.29 
as a viscous yellowish oil. 1H NMR (500 MHz, DMSO, 130 °C) δ 7.63-7.59 (comp, 2H), 
7.40 (t, J = 7.6 Hz, 1H), 7.23 (dt, J = 1.6, 7.6 Hz, 1H), 6.68 (dd, J = 16.7, 10.5 Hz, 1H), 
6.13 (dd, J = 16.7, 2.4 Hz, 1H), 5.73 ( ddt, J = 17.0, 10.2, 6.6 Hz, 1H), 5.67 (t, J = 7.5 Hz, 
1H), 5.63 (dd, J = 10.5, 2.4 Hz, 1H), 5.48 (ddt, J = 15.9, 10.7, 5.5 Hz, 1H), 5.10 (dd, J = 
17.0, 1.8, Hz, 1H), 5.00 (d, J = 10.2 Hz, 1H),  4.90-4.86 (comp, 2H), 3.82 (d, J = 5.5 Hz, 
2H), 2.86-2.73 (comp, 2H);  13C NMR (125 MHz, DMSO, 130 °C) δ 165.3, 137.1, 134.2, 
133.9, 132.4, 129.6, 129.0, 128.8, 126.7, 125.6, 124.6, 116.5, 115.0, 57.2, 45.0, 34.9;  IR 
(neat) 3477, 3077, 2979, 2929, 2359, 2241, 1926, 1842, 1651, 1614, 1416, 919, 753 cm-1;  
mass spectrum (CI) m/z 320.0636 [C16H18BrNO (M+1) requires 320.0650] 322.0612. 
NMR Assignments. 1H NMR (500 MHz, DMSO, 130 °C) δ 7.63-7.59 (comp, 
2H, C7 & C10-H), 7.40 (t, J = 7.6 Hz, 1H, C8 or C9-H), 7.23 (dt, J = 1.6, 7.6 Hz, 1H, C8 
or C9-H), 6.68 (dd, J = 16.7, 10.5 Hz, 1H, C15-H), 6.13 (dd, J = 16.7, 2.4 Hz, 1H, C16-
H), 5.73 (ddt, J = 17.0, 10.2, 6.6 Hz, 1H, C3-H), 5.67 (t, J = 7.5 Hz, 1H, C1-H), 5.63 (dd, 
J = 10.5, 2.4 Hz, 1H, C16-H ), 5.48 (ddt, J = 15.9, 10.7, 5.5 Hz, 1H, C12-H), 5.10 (dd, J 
= 17.0, 1.8, Hz, 1H, C4-H), 5.00 (d, J = 10.2 Hz, 1H, C4-H),  4.90-4.86 (comp, 2H, C13-
H), 3.82 (d, J = 5.5 Hz, 2H, C11-H), 2.86-2.73 (comp, 2H, C2-H);  13C NMR (125 MHz, 
DMSO, 130 °C) δ 165.3 (C14), 137.1 (C5), 134.2, 133.9, 132.4, 129.6, 129.0, 128.8, 
126.7, 125.6, 124.6, 116.5 (C4 or C13), 115.0 (C4 or C13), 57.2 (C1), 45.0 (C11), 34.9 
(C2).   
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Alternative procedure for  amide (2.29). (JDSI-236d) A mixture containing 2-
bromobenzaldehyde (0.11 mL, 174 mg, 0.94 mmol), allylamine (0.07 mL, 53 mg, 0.94 
mmol) and activated 4 Å molecular sieves (~500 mg) in CH2Cl2 (2.5 mL) was stirred for 
16 h at room temperature.  The reaction was cooled to 0 ºC and freshly distilled acryoyl 
chloride (85 µL, 95 mg, 1.05 mmol) was added, and the reaction was stirred for 10 min at 
0 ºC. The ice bath was then removed and the reaction was stirred for 1 h at room 
temperature.  The reaction was then cooled to –78 °C, freshly prepared allylzinc bromide 
(2.31 M in THF, 0.55 mL, 1.27 mmol) was added, and the reaction was stirred for 2 h at -
78 ºC. The dry ice bath was then removed, and the reaction was warmed to room 
temperature.  The reaction was filtered through a Celite pad that was washed with CH2Cl2 
(3 x 5 mL). The combined filtrate and washings were washed with saturated aqueous 
NH4Cl (10 mL). The aqueous phase was backwashed with CH2Cl2 (2 x 5 mL), and the 
combined organics were dried (MgSO4), filtered, and concentrated under reduced 
pressure. The residue was purified by flash chromatography eluting with EtOAc/hexanes 



















(JDSI-223a).  Grubbs II  catalyst (13 mg, 0.0.15 mmol) was added to a solution of amide 
2.29 (86 mg, 0.27 mmol) in 10 mL CH2Cl2.  The reaction was heated under reflux for 1 h.  
The reaction was cooled to room temperature and concentrated under reduced pressure.  
The residue was purified by flash chromatography eluting with EtOAc/Hexane (1:3) to 
give 56 mg (72%) of dihydropyridine 2.32 and 6 mg (7%) of 2.31 as a yellowish gums.  
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2.32:  1H NMR (500 MHz, DMSO, 100 °C) δ 7.59 (dd, J = 7.7, 1.3 Hz, 1H), 7.31 (td, J = 
7.7, 1.3 Hz, 1H), 7.24, (dd, J = 7.7, 1.7 Hz, 1H), 7.18 (td, J = 7.7, 1.7 Hz, 1H), 6.62 (dd, J 
= 16.7, 10.6 Hz, 1H), 6.04 (dd, J = 16.7, 2.3 Hz, 1H), 5.94-5.90 (m, 1H), 5.85-5.81 (m, 
1H), 5.71 (br, 1H), 5.63 (dd, 10.6, 2.2 Hz, 1H), 4.33 (ddt, J = 18.4, 3.2, 2.6 Hz, 1H), 3.90 
(d, J = 18.4 Hz, 1H), 2.74-2.68 (dddd, J = 17.4, 6.2, 2.9, 2.9 Hz, 1H), 2.45 (dd, J = 17.4, 
6.2 Hz, 1H); 13C NMR (125 MHz, DMSO, 100 °C) δ 165.0, 141.0, 132.4, 128.6, 128.4, 
127.6, 127.0, 126.2, 124.1, 122.6, 121.5, 51.2, 41.5, 28.0;  IR (neat) 3438, 3043, 2894, 
2847, 2359, 1922, 1660, 1651, 1614, 1417, 1026, 751, 668 cm-1;  mass spectrum (CI) m/z 
292.0337 [C16H18BrNO (M+1) requires 292.0337] 294.0318. 
NMR Assignments. 2.32:  1H NMR (500 MHz, DMSO, 100 °C) δ 7.59 (dd, J = 
7.7, 1.3 Hz, 1H, C8-H), 7.31 (td, J = 7.7, 1.3 Hz, 1H, C10-H), 7.24, (dd, J = 7.7, 1.7 Hz, 
1H, C11-H), 7.18 (td, J = 7.7, 1.7 Hz, 1H, C8-H), 6.62 (dd, J = 16.7, 10.6 Hz, 1H, C13-
H), 6.04 (dd, J = 16.7, 2.3 Hz, 1H, C14-H), 5.94-5.90 (m, 1H, C3 or C4-H), 5.85-5.81 
(m, 1H, C3 or C4-H), 5.71 (br, 1H, C1-H), 5.63 (dd, 10.5, 2.2 Hz, 1H, C14-H), 4.33 (ddt, 
J = 18.4, 3.2, 2.6 Hz, 1H, C5-H), 3.90 (d, J = 18.4 Hz, 1H, C5-H), 2.74-2.68 (dddd, J = 
17.4, 6.2, 2.9, 2.9 Hz, 1H, C2-H), 2.45 (dd, J = 17.4, 6.2 Hz, 1H, C2-H); 13C NMR (125 
MHz, DMSO, 100 °C) δ 165.0 (C12), 141.0, 132.4, 128.6, 128.4, 127.6, 127.0, 126.2, 





















Methyl 2-(1-acetyl-1,2,3,6-tetrahydropyridin-2-yl)benzoate (2.35). (JDSIII-
224a).  Grubbs II catalyst (4 mg, 0.0053 mmol) was added to a solution of 2.25 (152 mg, 
0.53 mmol) in CH2Cl2 (20 mL) and the reaction was heated under reflux for 3 h.  The 
reaction was cooled the rt and concentrated under reduced pressure.  The residue was 
purified by flash chromatography eluting with EtOAc/Hexane (1:1) to give 129 mg 
(94%) of amide 2.35 as a tan solid, mp 104–106 °C.  1H NMR (500 MHz, DMSO, 130 
°C) δ 7.70 (d, J = 7.6, 1.4 Hz, 1 H), 7.46 (t, J = 7.6 Hz) 7.33 (t, J = 7.6 Hz, 1 H), 7.25 (d, 
J = 7.6 Hz, 1H), 6.11 (br, 1 H), 5.88-5.83 (m, 1 H), 5.81-5.77 (m, 1 H) 4.23 (dd, J = 18.4, 
2.3 Hz, 1 H), 3.86 (s, 3 H), 3.82 (d, J = 18.4 Hz, 1 H), 2.74-2.68 (m, 1 H), 2.34 (dd, J = 
17.5, 6.2 Hz, 1 H), 1.97 (m, 3 H); 13C NMR (125 MHz, DMSO, 130 °C) δ 168.8, 167.2, 
142.8, 130.5, 129.1, 128.9, 130.2, 126.1, 126.0, 123.8, 122.5, 51.2, 48.2, 41.4, 29.1, 20.7;  
IR (neat) 1722, 1649, 1405, 1270, 918, 749, cm-1; mass spectrum (CI) m/z 260.1291 
[C15H18NO3 (M+1) requires 260.1287]. 
NMR Assignments. 1H NMR (500 MHz, DMSO, 130 °C) δ 7.70 (d, J = 7.6, 1.4 
Hz, 1 H, C8-H), 7.46 (t, J = 7.6 Hz, C10-H) 7.33 (t, J = 7.6 Hz, 1 H, C9-H), 7.25 (d, J = 
7.6 Hz, 1H, C11-H), 6.11 (br, 1 H, C1-H), 5.88-5.83 (m, 1 H, C3 or C4-H), 5.81-5.77 (m, 
1 H, C3 or C4-H) 4.23 (dd, J = 18.4, 2.3 Hz, 1 H, C5-H), 3.86 (s, 3 H, C15-H), 3.82 (d, J 
= 18.4 Hz, 1 H, C5-H), 2.74-2.68 (m, 1 H, C2-H), 2.34 (dd, J = 17.5, 6.2 Hz, 1 H, C2-H), 
1.97 (m, 3 H, C13-H); 13C NMR (125 MHz, DMSO, 130 °C) δ 168.8 (C14), 167.2 (C16), 
142.8, 130.5, 129.1, 128.9, 130.2, 126.1, 126.0, 123.8, 122.5, 51.2 (C17), 48.2 (C1), 41.4 




















1,12b-Dihydrobenzo[c]pyrido[1,2-a]azepine-6,8(4H,7H)-dione (2.36).  
(JDSIII-196a).  NaHMDS (1.85 M in THF, 0.93 mL, 1.72 mmol) was added to a 
solution of 2.35 (179 mg, 0.69 mmol) in THF (30 mL) and the reaction was stirred for 2 h 
at rt.  Saturated aqueous NH4Cl (10 mL) was then added.  The organic layer was removed 
and the aqueous layer was backwashed with CH2Cl2 (2 x 5 mL).  The organics were 
combined and dried (MgSO4), filtered, and concentrated under reduced pressure.  The 
residue was purified by flash chromatography eluting with EtOAc/Hexane (1:1) to give 
106 mg (67%) of amide 2.36 as a tan solid, mp 151.5–153 °C.  1H NMR (400 MHz, 
CDCl3) δ 7.95 (dd, J = 7.7,  1.4 H, 1 H), 7.50 (td, J = 7.7, 1.4 Hz, 1 H), 7.38 (td, J = 7.7, 
1.1 Hz, 1 H), 7.28 (d, J = 7.7 Hz, 1H), 6.15-6.11 (m, 1 H), 5.87-5.82 (m, 1 H), 5.69 (d, J 
= 5.6 Hz, 1 H), 4.43 (d, J = 17.3 Hz, 1 H), 4.19-4.12 (m, 1 H), 3.79 (d, J = 17.3 Hz, 1 H), 
3.55-3.47 (m, 1 H), 2.95-2.86 (m, 1 H), 2.82 (dd. J = 17.4, 5.6 Hz, 1 H); 13C NMR (100 
MHz, CDCl3) δ 192.1, 169.8, 142.2, 136.5, 134.1, 131.3, 129.2, 126.0, 124.5, 122.6, 
54.7, 51.6, 41.6, 26.0;  IR (neat) 2906, 2853, 1681, 1650, 1409, 1248, 1137, 923, cm-1; 
mass spectrum (CI) m/z 228.1027 [C14H14NO2 (M+1) requires 228.1025]. 
NMR Assignments. 1H NMR (400 MHz, CDCl3) δ 7.95 (dd, J = 7.7,  1.4 H, 1 H, 
C10-H), 7.50 (td, J = 7.7, 1.4 Hz, 1 H, C8-H), 7.38 (td, J = 7.7, 1.1 Hz, 1 H, C9-H), 7.28 
(d, J = 7.7 Hz, 1H, C7-H), 6.15-6.11 (m, 1 H C1-H), 5.87-5.82 (m, 1 H, C3 or C4-H), 
5.69 (d, J = 5.6 Hz, 1 H, C3 or C4-H), 4.43 (d, J = 17.3 Hz, 1 H, C13-H), 4.19-4.12 (m, 1 
H, C5-H), 3.79 (d, J = 17.3 Hz, 1 H, C13-H), 3.55-3.47 (m, 1 H, C5-H), 2.95-2.86 (m, 1 
H, C2-H), 2.82 (dd. J = 17.4, 5.6 Hz, 1 H, C2-H); 13C NMR (100 MHz, CDCl3) δ 192.1 
(C12), 169.8 (C14), 142.2 (C11), 136.5 (C6), 134.1, 131.3, 129.2, 126.0, 124.5, 122.6, 



















Methyl 2-(1-(N-(prop-2-ynyl)acetamido)but-3-enyl)benzoate (2.38).  A 
mixture containing freshly distilled methyl formyl benzoate (2.34) (146 mg, 0.89 mmol), 
propargyl amine (0.06 mL, 48 mg, 0.87 mmol) and activated 4 Å molecular sieves (~ 500 
mg) in CH2Cl2 (2.2 mL) was stirred for 12 h.  Freshly distilled acetyl chloride (65 µL, 72 
mg, 0.91 mmol) was added, and the reaction was stirred for 1 h.  The reaction was then 
cooled to –78 °C, freshly prepared allyl ZnBr (2.2 M in THF, 0.46 mL, 1.01 mmol) was 
added, and the reaction was stirred for 1 h.  The dry ice bath was removed, and the 
reaction was filtered thru a Celite pad that was washed with CH2Cl2 (3 x 5 mL). The 
combined filtrate and washings were washed with saturated aqueous NH4Cl (10 mL).  
The aqueous layer was backwashed with CH2Cl2 (2 x 5 mL), and the combined organics 
were dried (MgSO4), filtered, and concentrated under reduced pressure.  The residue was 
purified by flash chromatography eluting with EtOAc/Hexane (1:3) to give 158 mg 
(63%) of amide 2.38 as a viscous colorless oil.  1H NMR (500 MHz, DMSO, 120 °C) 
δ 7.67 (d, J = 8.0 Hz, 1H), 7.65 (d, J = 9.9 Hz, 1 H), 7.55 (t, J = 7.6 Hz, 1 H), 7.39 (t, J = 
7.6 Hz, 1 H), 6.02 (t, J = 7.3 Hz, 1 H), 5.77 (dddd, J = 17.1, 10.4, 6.7, 6.7 Hz, 1 H), 5.12 
(d, J = 17.1 Hz, 1 H), 5.02 (d, J = 10.2 Hz, 1 H), 4.03 (d, J = 18.4 Hz, 1 H), 3.80 (s, 3 H), 
3.78 (comp, 1 H), 2.81 (comp, 3 H), 2.08 (s, 3 H); 13C NMR (125 MHz, DMSO, 120 °C) 
δ 169.2, 167.4, 138.0, 134.3, 131.5, 130.5, 128.8, 127.6, 126.9, 116.5, 80.1, 72.5, 54.3, 
51.4, 35.2, 32.4, 21.2; IR (neat) 1721, 1654, 1406, 1269, 913, 747 cm-1; mass spectrum 
(CI) m/z 286.1448 [C17H20NO3 (M+1) requires 286.1443].   
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NMR Assignments.  1H NMR (500 MHz, DMSO, 120 °C) δ 7.67 (d, J = 8.0 Hz, 
1H, C7-H or C10-H), 7.65 (d, J = 9.9 Hz, 1 H, ), 7.55 (t, J = 7.6 Hz, 1 H, C9-H), 7.39 (t, 
J = 7.6 Hz, 1 H, C8-H), 6.02 (t, J = 7.3 Hz, 1 H, C1-H), 5.77 (dddd, J = 17.1, 10.4, 6.7, 
6.7 Hz, 1 H, C3-H), 5.12 (d, J = 17.1 Hz, 1 H, C4-H), 5.02 (d, J = 10.2 Hz, 1 H, C4-H), 
4.03 (d, J = 18.4 Hz, 1 H, C11-H), 3.80 (s, 3 H, C17-H), 3.78 (comp, 1 H, C11-H), 2.81 
(comp, 3 H, C2-H and C13-H), 2.08 (s, 3 H, C15-H); 13C NMR (125 MHz, DMSO, 120 
°C) δ 169.2 (C14), 167.4 (C16), 138.0, 134.3, 131.5, 130.5, 128.8, 127.6, 126.9, 116.5 
(C1), 80.1 (C12), 72.5 (C13), 54.3 (17), 51.4 (C1), 35.2 (C11), 32.4 (C2), 21.2 (C15). 
Alternate procedure for  2.38.  (JDSIII-266a).  Propargyl amine (0.07 mL, 56 
mg, 1.02 mmol) was added to a solution of freshly distilled methyl formyl benzoate 
(2.34) (153 mg, 0.93 mmol) in CH2Cl2 (3 mL) containing 4 Å powdered molecular sieves 
(~500 mg) and the reaction was stirred for 12 h at room temperature. The reaction was 
filtered through a pad of that was washed with CH2Cl2 (3 x 5 mL), and the filtrate was 
concentrated under reduced pressure.  The residue was dissolved in CH2Cl2 (2.3 mL), and 
freshly distilled acetyl chloride (0.07 mL, 77 mg, 0.98 mmol) was added and the reaction 
was stirred for 1 h at room temperature.  The reaction was then cooled to -78 °C, freshly 
prepared allylzinc bromide (2.1 M in THF, 0.55 mL, 1.15 mmol) was added and the 
reaction was stirred for 1 h at -78 ºC.  The reaction was partitioned between sat. NH4Cl (5 
mL) and CH2Cl2 (5 mL).  The organic phase was removed, and aqueous phase washed 
with CH2Cl2 (2 x 5 mL).  The combined organics were dried (MgSO4), filtered, and 
concentrated under reduced pressure.  The residue was purified by flash chromatography 






























(2.42).  (JDSIV-127a).   The Hoveyda-Grubbs II catalyst (12 mg, 0.018 mmol) was 
added to a solution of amide 2.38 (77 mg, 0.26 mmol) and freshly distilled styrene (0.46 
mL, 42 mg, 4.01 mmol) in CH2Cl2 (11 mL) and the reaction was heated under reflux for 
24 h.  The reaction was cooled to rt and DMSO (0.25 mL) was added.  The reaction was 
stirred for 20 h and then concentrated under reduced pressure.  The residue was quickly 
purified by flash chromatography eluting with EtOAc/Hexane (1:1) to give a brownish 
oil, which was immediately dissolved in THF (11 mL). NaHMDS (2M in THF, 0.26 mL, 
0.52 mmol)  was added, and the reaction was stirred for 5 min upon which sat. aqueous 
NH4Cl (5 mL) was added.  The organic phase was removed, and the aqueous layer was 
washed with Et2O (2 x 5 mL).  The combined organic layers were dried (MgSO4), 
filtered, and concentrated under reduced pressure.  The residue was purified by flash 
chromatography eluting with EtOAc/Hexane (3:7) to give 52 mg (58%) of a mixture 
(18:1) of amides 2.42 and 2.41 as an amorphous solid.  1H NMR (400 MHz, CDCl3) 
δ 7.99 (dd, J = 7.9, 1.0 Hz, 1H), 7.49 (td, J = 7.5, 1.4 Hz, 1H), 7.41-7.20 (comp, 7H), 
6.79 (d, J = 16.4 Hz, 1H), 6.49 (d, J = 16.4 Hz, 1H), 6.24 (m, 1H), 5.72 (d, J = 6.2 Hz, 
1H), 4.46 (d, J = 17.4 Hz, 1H), 4.43 (d, J = 18.1 Hz, 1H), 3.88 (d, J = 17.4 Hz, 1H), 3.84 
(d, J = 18.1 Hz, 1H), 3.11-3.06 (m, 1H), 2.98 (dd, J = 18.3, 5.8 Hz, 1H);  13C NMR (100 
MHz, CDCl3) δ 192.0, 169.9, 142.0, 137.8, 136.6, 134.3, 133.4, 131.4, 129.6, 129.6, 
129.4, 128.6, 128.5, 128.1, 127.2, 127.2, 126.0, 123.8, 55.0, 51.8, 41.4, 26.9; IR (neat) 
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2358, 1680, 1641, 1596, 1410, 1247, 957 cm-1; mass spectrum (CI) m/z 330.1492 
[C22H20NO2 (M+1) requires 330.1494]. 
NMR Assignments.  1H NMR (400 MHz, CDCl3) δ 7.99 (dd, J = 7.9, 1.0 Hz, 1H, 
C2-H), 7.49 (td, J = 7.5, 1.4 Hz, 1H, Ar-H), 7.20-7.41 (comp, 7H, Ar-H), 6.79 (d, J = 
16.4 Hz, 1H, C15-H), 6.49 (d, J = 16.4 Hz, 1H, C16-H), 6.24 (m, 1H, C7-H), 5.72 (d, J = 
6.2 Hz, 1H, C9-H), 4.46 (d, J = 17.4 Hz, 1H, C11-H or C13-H), 4.43 (d, J = 18.1 Hz, 1H, 
C11-H or C13-H), 3.88 (d, J = 17.4 Hz, 1H, C11-H or C13-H), 3.84 (d, J = 18.1 Hz, 1H, 
C11-H or C13-H), 3.06-3.11 (m, 1H, C8-H), 2.98 (dd, J = 18.3, 5.8 Hz, 1H, C8-H);  13C 
NMR (100 MHz, CDCl3) δ 192.0 (C14), 169.9 (C12), 142.0, 137.8, 136.6, 134.3, 133.4, 
131.4, 129.6, 129.6, 129.4, 128.6, 128.5, 128.1, 127.2, 127.2, 126.0, 123.8, 55.0 (C7 or 


















54a).  A mixture containing 2-bromobenzaldehyde (2.28) (0.1 mL, 16 mg, 0.86 mmol), 
propargyl amine (0.06 mL, 48 mg, 0.87 mmol) and activated 4 Å molecular sieves (~ 500 
mg) in CH2Cl2 (2.2 mL) was stirred for 12 h at room temperature.  Freshly distilled acetyl 
chloride (0.07 mL, 77 mg, 0.98 mmol) was added, and the reaction was stirred for 1 h.  
The reaction was then cooled to –78 °C, freshly prepared allylzinc bromide (1.7 M in 
THF, 0.75 mL, 1.27 mmol) was added, and the reaction was stirred for 1 h.  The dry ice 
bath was removed, and the reaction was filtered thru a Celite pad that was washed with 
CH2Cl2 (3 x 5 mL). The combined filtrate and washings were washed with saturated 
aqueous NH4Cl (10 mL).  The aqueous layer was backwashed with CH2Cl2 (2 x 5 mL), 
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and the combined organics were dried (MgSO4), filtered, and concentrated under reduced 
pressure.  The residue was purified by flash chromatography eluting with EtOAc/Hexane 
(1:3) to give 257 mg (98%) of amide 2.47 as a viscous colorless oil.  1H NMR (500 MHz, 
DMSO, 130 °C) δ 7.62 (d, J = 8.2 Hz, 1 H), 7.61 (d, J = 8.2 Hz, 1 H), 7.41 (t, J = 8.2 Hz, 
1 H), 7.24 (t, J = 8.2 Hz, 1 H), 5.76 (ddt, J = 17.0, 10.2, 6.7 Hz, 1 H), 5.67 (s, 1 H), 5.12 
(d, J = 17.0 Hz, 1 H), 5.02 (d, J = 10.2 Hz, 1 H), 4.00 (d, J = 18.5 Hz, 1 H), 3.80 (d, J = 
18.5 Hz, 1 H), 2.75-2.87 (comp, 3 H), 2.16 (s, 1 H); 13C NMR (125 MHz, DMSO, 130 
°C) δ 168.9, 137.0, 134.0, 132.5, 129.3, 128.9, 126.9, 124.4, 116.6, 79.8, 72.2, 57.3, 34.7, 
32.3, 21.0; IR (neat) 1650, 1406, 1173, 1028, 918, 750, 665 cm-1; mass spectrum (CI) m/z 
[C15H16BrNO (M+1) requires].   
NMR Assignments.  1H NMR (500 MHz, DMSO, 130 °C) δ 7.62 (d, J = 8.2 Hz, 
1 H, C7-H or C10-H), 7.61 (d, J = 8.2 Hz, 1 H, C7-H or C10-H), 7.41 (t, J = 8.2 Hz, 1 H, 
C9-H), 7.24 (t, J = 8.2 Hz, 1 H, C8-H), 5.76 (ddt, J = 17.0, 10.2, 6.7 Hz, 1 H, C3-H), 5.67 
(s, 1 H, C1-H), 5.12 (d, J = 17.0 Hz, 1 H, C4-H), 5.02 (d, J = 10.2 Hz, 1 H, C4-H), 4.00 
(d, J = 18.5 Hz, 1 H, C11-H), 3.80 (d, J = 18.5 Hz, 1 H, C11-H), 2.75-2.87 (comp, 3 H, 
C2-H and C13-H), 2.16 (s, 1 H, C15-H); 13C NMR (125 MHz, DMSO, 130 °C) δ 168.9 
(C14), 137.0, 134.0, 132.5, 129.3, 128.9, 126.9, 124.4, 116.6 (C4), 79.8 (C12), 72.2 



















Methyl 2-((E)-N-(1-(pyr idin-3-yl)but-3-enyl)but-2-enamido)acetate (2.59).  
(JDSIV-87a).  Allylzinc bromide (1.9 M in THF, 0.63 mL, 1.20 mmol) was added to a 
solution of imine 2.58 (177 mg, 0.99 mmol) in THF (5 mL) at -78 °C.  The reaction was 
stirred for 5 min at -78 °C, whereupon crotonyl chloride (0.14 mL, 153 mg, 1.46 mmol) 
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was added.  The reaction was stirred for 3 h warming to room tempurature and then 
quenched with NH4Cl (5 mL).  The organic phase was removed, and the aqueous layer 
was extracted with CH2Cl2 (3 x 5 mL).  The combined organic layers were dried 
(MgSO4), filtered, and concentrated under reduced pressure.  The residue was purified by 
flash chromatography eluting with EtOAc to give 170 mg (59%) of amide 2.59 as a 
viscous yellowish oil. 1H NMR (500 MHz, DMSO, 130 °C) δ 8.56 (d, J = 1.7 Hz, 1 H), 
8.45 (d, J = 4.7 Hz, 1 H), 7.75 (d, J = 7.7 Hz, 1 H), 7.31 (dd, J = 7.7, 4.7 Hz, 1 H), 6.71 
(dq, J = 14.3, 6.8 Hz, 1 H)  6.37 (d, J = 14.3 Hz, 1 H), 5.77 (ddt, J = 17.0, 10.3, 6.6 Hz, 1 
H)  5.53-5.57 (m, 1H), 5.13 (dd, J = 17.2, 1.4 Hz, 1 H), 5.03 (d, J = 10.3 Hz, 1 H), 4.03 
(d, J = 17.7 Hz, 1 H), 3.97 (d, J = 17.7 Hz, 1 H), 3.50 (s, 3 H), 2.72-2.84 (comp, 2 H), 
1.83 (dd, J = 6.8, 1.1 Hz, 3 H);  13C NMR (125 MHz, DMSO, 130 °C) δ 169.1, 166.3, 
149.2, 148.1, 140.4, 135.0, 134.3, 134.2, 122.6, 122.4, 117.0, 55.9, 51.1, 44.8, 34.3, 16.9; 
IR (neat) 2953, 1748, 1660, 1621, 1434, 1207, 1179, 1064, 963, 925, 824, 715; mass 
spectrum (CI) m/z 289.1552 [C16H21N2O3 (M+1) requires 289.1552]. 
NMR Assignments. 1H NMR (500 MHz, DMSO, 130 °C) δ 8.56 (d, J = 1.7 Hz, 
1 H, C5-H), 8.45 (d, J = 4.7 Hz, 1 H, C9-H), 7.75 (d, J = 7.7 Hz, 1 H, C7-H), 7.31 (dd, J 
= 7.7, 4.7 Hz, 1 H, C8-H), 6.71 (dq, J = 14.3, 6.8 Hz, 1 H, C15-H)  6.37 (d, J = 14.3 Hz, 
1 H, C14-H), 5.77 (ddt, J = 17.0, 10.3, 6.6 Hz, 1 H, C3-H)  5.53-5.57 (m, 1H, C1-H), 
5.13 (dd, J = 17.2, 1.4 Hz, 1 H, C4-H), 5.03 (d, J = 10.3 Hz, 1 H, C4-H), 4.03 (d, J = 17.7 
Hz, 1 H, C10-H), 3.97 (d, J = 17.7 Hz, 1 H, C10-H), 3.50 (s, 3 H, C12-H), 2.72-2.84 
(comp, 2 H, C2-H), 1.83 (dd, J = 6.8, 1.1 Hz, 3 H, C16-H);  13C NMR (125 MHz, DMSO, 
130 °C) δ 169.1 (C11), 166.3 (C13), 149.2 (C5 or C9), 148.1 (C5 or C9), 140.4, 135.0, 




















   2-Allyl-3-(2-bromophenyl)-2,3,4,4a,8,8a-hexahydroisoquinolin-1(7H)-one 
(2.69).  (JDSIII-278a). TMSOTf (15.5 µL, 19 mg, 0.086 mmol) was added to a solution 
of 2-bromobenzaldehyde (0.1 mL, 158 mg, 0.86 mmol) and bis(trimethylsilyl)allylamine 
(0.22 mL, 179 mg, 0.89 mmol) in CH2Cl2 (2.2 mL), and the reaction was stirred for 30 
min at rt. Pentadienylsilane 2.67420  (303 mg, 2.16 mmol) and freshly distilled acryloyl 
chloride (85 µL, 94 mg, 1.05 mmol) were then added and the reaction stirred for 22 h.  
The reaction was partitioned between CH2Cl2 (5 mL) and saturated aqueous NaHCO3 (5 
mL).  The organic phase was removed, and the aqueous layer was washed with CH2Cl2 (3 
x 4 mL).  The combined organic layers were dried (MgSO4), filtered, and concentrated 
under reduced pressure.  The residue was purified by flash chromatography eluting with 
EtOAc/Hexane (3:17) to give 251 mg (84%) of amide 2.69 as a clear oil.  1H NMR (500 
MHz, CDCl3) δ 7.51 (d, J = 7.6 Hz, 1 H), 7.29 (t, J = 7.6 Hz, 1 H), 7.16 (d, J = 7.6 Hz, 1 
H), 7.11 (t, J = 7.6 Hz, 1 H), 5.74-5.66 (comp, 2 H), 5.55-5.52 (m, 1 H), 5.08 (d, J = 10.0 
Hz, 1 H), 4.97 (dd, J = 10.1, 5.4 Hz, 1 H), 4.87 (d, J = 17.2 Hz, 1 H), 4.66 (dd, J = 14.8, 
4.2 Hz, 1 H), 2.94 (dd, J = 14.8, 7.7 Hz, 1 H), 2.7 (d, J = 10.9 Hz, 1 H), 2.56-2.55 (m, 1 
H), 2.21-2.08 (comp, 4 H), 1.85-1.77 (m, 1 H), 1.64-1.56 (m, 1 H); 13C NMR (125 MHz, 
CDCl3) δ 174.9, 141.2, 133.8, 133.0, 129.7, 129.2, 128.9, 128.8, 128.8, 123.5, 118.9, 
60.4, 47.6, 42.0, 35.5, 32.6, 25.9, 23.6; IR (neat) 2933, 1651, 1568, 1410, 1338, 1283, 
1188, 1024, 925, 760 cm-1; Mass spectrum (CI) m/z 346.0799 [C18H20BrNO (M+1) 
requires 346.0807], 348.0784.  
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NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 7.51 (d, J = 7.6 Hz, 1 H, C12-
H), 7.29 (t, J = 7.6 Hz, 1 H, C14-H), 7.16 (d, J = 7.6 Hz, 1 H, C15-H), 7.11 (t, J = 7.6 Hz, 
1 H, C13-H), 5.74-5.66 (comp, 2 H, C5-H and C17-H), 5.55-5.52 (m, 1 H, C6-H), 5.08 
(d, J = 10.0 Hz, 1 H, C18-H), 4.97 (dd, J = 10.1, 5.4 Hz, 1 H, C9-H), 4.87 (d, J = 17.2 
Hz, 1 H, C18-H), 4.66 (dd, J = 14.8, 4.2 Hz, 1 H, C16-H), 2.94 (dd, J = 14.8, 7.7 Hz, 1 H, 
C16-H), 2.7 (d, J = 10.9 Hz, 1 H, C2-H), 2.56-2.55 (m, 1 H, C7-H), 2.21-2.08 (comp, 4 
H, C3-H, C4-H, and C8-H), 1.77-1.85 (m, 1 H, C3-H), 1.64-1.56 (m, 1 H, C8-H); 13C 
NMR (125 MHz, CDCl3) δ 174.9 (C1), 141.2 (C10), 133.8 (C12 or C17), 133.0 (C12 or 
C17), 129.7, 129.2, 128.9, 128.8, 128.8, 123.5 (C11), 118.9 (C18), 60.4 (C9), 47.6 (C16), 




























one (2.71). (JDSIII-279a).  TMSOTf (12 µL, 55 mg, 0.066 mmol) was added to a 
solution of  3,4-dimethoxybenzaldehyde (2.66) (111 mg, 0.67 mmol) and 
bis(trimethylsilyl)allylamine (0.17 mL, 139 mg, 0.69 mmol) in CH2Cl2 (1.7 mL), and the 
reaction was stirred for 30 min at rt.  Freshly distilled acryloyl chloride (65 µL, 72 mg, 
0.80 mmol) and pentadienylsilane 2.67 ( 214 mg, 1.53 mmol) and were then added, and 
the reaction was stirred for 24 h at room temperature.  The reaction was partitioned 
between CH2Cl2 (5 mL) and saturated aqueous NaHCO3 (5 mL).  The organic phase was 
removed, and the aqueous layer was extracted with CH2Cl2 (2 x 5 mL).  The combined 
organic layers were dried (MgSO4), filtered, and concentrated under reduced pressure.  
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The residue was purified by flash chromatography eluting with EtOAc/Hexane (2:3) to 
give 172 mg (78 %) of amide 2.71 (6:1 mixture of diastereomers) as a viscous colorless 
oil. 1H NMR (400 MHz, CDCl3, major diastereomer) δ 6.82 (d, J = 8.2 Hz, 1 H), 6.74 
(dd, J = 8.2, 2.0 Hz, 1 H), 6.66 (d, J = 1.7 Hz, 1 H), 5.78-5.65 (comp, 2 H), 5.58-5.54 (m, 
1H), 5.08 (dd, J = 10.2, 1.0 Hz, 1 H), 4.89 (dd, J = 17.1, 1.0 Hz, 1 H), 4.62 (dd, J = 15.0, 
4.4 Hz, 1 H), 4.42 (dd, J = 10.9, 4.8 Hz, 1 H), 3.88 (s, 3 H), 3.86 (s, 3 H), 3.07 (dd, J = 
15.0, 1.0 Hz, 1 H), 2.72-2.68 (m, 1 H), 2.58-2.52 (m, 1 H), 2.24-2.14 (comp, 3 H), 2.12-
2.04 (comp, 2 H), 1.89-1.74 (comp, 2 H);  13C NMR (100 MHz, CDCl3, major 
diastereomer) δ 174.2, 149.5, 148.8, 134.2, 133.2, 128.7, 128.1, 119.6, 117.3, 111.3, 
109.8, 61.3, 56.1, 56.1, 46.5, 41.5, 37.1, 32.3, 25.5, 23.3; IR (neat) 2934, 1634, 1516, 
1442, 1410, 1262, 1138, 1027, 928; Mass spectrum (CI) m/z 328.1913 [C20H26NO3 
(M+1) requires 328.1913]. 
NMR Assignments. 1H NMR (400 MHz, CDCl3, major diastereomer) δ 6.82 (d, 
J = 8.2 Hz, 1 H, C15-H), 6.74 (dd, J = 8.2, 2.0 Hz, 1 H, C14-H), 6.66 (d, J = 1.7 Hz, 1 H. 
C11-H), 5.78-5.65 (comp, 2 H, C19-H and C5-H, or C19-H and C6-H), 5.58-5.54 (m, 
1H, C5-H or C6-H), 5.08 (dd, J = 10.2, 1.0 Hz, 1 H, C20-H), 4.89 (dd, J = 17.1, 1.0 Hz, 1 
H, C20-H), 4.89 (dd, J = 15.0, 4.4 Hz, 1 H, C18-H), 4.42 (dd, J = 10.9, 4.8 Hz, 1 H, C9-
H), 3.88 (s, 3 H, C16-H or C17-H), 3.86 (s, 3 H, C16-H or C17-H) 3.07 (dd, J = 15.0, 
1.0, Hz, 1 H, C18-H), 2.72-2.68 (m, 1 H, C2-H or C7-H), 2.58-2.52 (m, 1 H, C2-H or C7-
H), 2.14-2.24 (comp, 3 H), 2.04-2.12 (comp, 2 H), 1.74-1.89 (comp, 2 H);  13C NMR 
(100 MHz, CDCl3, major diastereomer) δ 174.2 (C1), 149.5 (C12 or C13), 148.8 (C12 or 
C13), 134.2, 133.2, 128.7, 128.1, 119.6, 117.3, 111.3, 109.8, 61.3 (C9), 56.1 (C16), 56.1 




























(2.72). (JDSIV-107a).  LiAlH4 (63 mg, 1.66 mmol) was added to a solution of 2.71 (172 
mg, 0.52 mmol) in THF (10 mL).  The reaction was heated under reflux for 4 h and then 
cooled to rt. H2O (2 mL) and 6 M NaOH (2 mL) were added sequentially, and the 
reaction was filtered through Celite.  The organic layer was removed and washed with sat 
NaCl (10 mL), dried (MgSO4), filtered and concentrated.  The residue was purified by 
flash chromatography eluting with EtOAc/Hexane (1:19) to give 126 mg (76 %) of amide 
2.72 as a viscous oil. 1H NMR (400 MHz, CDCl3) δ 6.90 (dd, J = 1.7 Hz, 1 H), 6.82 (dd, 
J = 8.2, 1.7 Hz, 1 H), 6.78 (d, J = 8.2 Hz, 1 H), 5.74 (dddd, J = 17.5,10.2, 7.7, 4.6 Hz, 1 
H), 5.60-5.66 (comp, 2 H), 5.10 (d, J = 17.5 Hz, 1H), 5.03 (d, J = 10.2, Hz, 1 H), 3.88 (s, 
3 H), 3.86 (s, 3 H), 3.13 (ddt (J = 14.4, 4.3, 2.0 Hz, 1 H), 3.03-3.00 (comp, 1 H), 2.98 
(dd, J = 11.3, 2.7 Hz, 1 H), 2.39 (dd, J = 14.4, 7.5 Hz 1 H), 2.33 (dd, J = 11.8, 3.1 Hz 1 
H), 2.20-2.09 (comp, 4 H), 1.85-1.80 (m, 1 H), 1.69 (dt, J = 13.7, 3.6, 1 H), 1.60-1.52 
(comp, 2 H);  13C NMR (100 MHz, CDCl3) δ 149.9, 148.7, 138.6, 137.0, 132.1, 127.5, 
120.3, 116.9, 111.7, 111.0, 69.1, 59.5, 58.6, 56.7, 56.7, 40.9, 36.2, 35.0, 27.1, 23.9; IR 
(neat) 2933, 1591, 1514, 1261, 1235, 1134, 1030, 920, 807; mass spectrum (CI) m/z 
314.2114 [C20H28NO2 (M+1) requires 314.2120]. 
NMR Assignments.  1H NMR (400 MHz, CDCl3) δ 6.90 (dd, J = 1.7 Hz, 1 H, 
C11-H), 6.82 (dd, J = 8.2, 1.7 Hz, 1 H, C14-H), 6.78 (d, J = 8.2 Hz, 1 H, C15-H), 5.74 
(dddd, J = 17.5,10.2, 7.7, 4.6 Hz, 1 H, C19-H), 5.66-5.60 (comp, 2 H, C5-H and C6-H), 
5.10 (d, J = 17.5 Hz, 1H, C20-H), 5.03 (d, J = 10.2, Hz, 1 H, C20-H), 3.88 (s, 3 H, C16-H 
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or C17-H), 3.86 (s, 3 H, C16-H or C17-H), 3.13 (ddt, J = 14.4, 4.3, 2.0 Hz, 1 H), 3.03-
3.00 (comp, 1 H), 2.98 (dd, J = 11.3, 2.7 Hz, 1 H), 2.39 (dd, J = 14.4, 7.5 Hz 1 H), 2.33 
(dd, J = 11.8, 3.1 Hz 1 H), 2.20-2.09 (comp, 4 H), 1.85-1.80 (m, 1 H), 1.69 (dt, J = 13.7, 
3.6, 1 H), 1.60-1.52 (comp, 2 H, (C8-H);  13C NMR (100 MHz, CDCl3) δ 149.9 (C12 or 
C13), 148.7, (C12 or C13), 138.6, 137.0, 132.1, 127.5, 120.3, 116.9, 111.7, 111.0, 69.1 
(C9), 59.5 (C18), 58.6 (C1), 56.7 (C16 or C17), 56.7 (C16 or C17), 40.9 (C8), 36.2 (C2 



















Epoxy isoindolones 2.76. (JDSII-161a).  TMSOTf (21 µL, 26 mg, 0.12 mmol) 
was added to a solution of furfural (0.1 mL, 116 mg, 1.21 mmol) and 
bis(trimethylsilyl)allylamine (0.31 mL, 253 mg, 1.26 mmol) in CH2Cl2 (3.0 mL) and the 
reaction was stirred for 30 min.  Freshly distilled acetyl chloride (0.12 mL, 132 mg, 1.48 
mmol) and silyl enol ether 2.74421 (411 mg, 2.60 mmol) were added and the reaction was 
stirred for 6 h.  The reaction was then partitioned between CH2Cl2 (5 mL) and saturated 
aqueous NaHCO3 (5 mL).  The organic phase was removed, and the aqueous layer was 
washed with CH2Cl2 (3 x 4 mL).  The combined organic layers were dried (MgSO4), 
filtered, and concentrated under reduced pressure.  The residue was dissolved in toluene 
(35 mL) and heated under reflux for 18 h. The reaction was cooled to room temperature 
and concentrated under reduced pressure.  The residue was purified by flash 
chromatography eluting with Et2O/Hexane (gradient elution 3:1 to 100% Et2O) followed 
by EtOAc to give 139 mg (49%) of amide 2.76 as a dark yellowish oil along with 52 mg 
(~19%) of an unclean diastereomer.  1H NMR (500 MHz, CDCl3) δ 9.90 (s, 1 H), 6.41 (d, 
J = 5.9 Hz, 1 H), 6.27 (d, J = 5.9 Hz, 1 H), 5.73 (dddd, J = 17.0, 10.3, 5.9, 5.9 Hz, 1 H), 
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5.25 (d, J = 17.0 Hz ), 5.21 (d, J = 10.3 Hz, 1 H), 5.06 (d, J = 3.9 Hz, 1 H), 4.34 (t, J = 
6.1 Hz, 1 H), 4.27 (dd, J = 15.9, 4.0 Hz, 1H), 3.61 (dd, J = 15.9, 6.5 Hz, 1 H), 2.96 (d, J = 
6.1 Hz, 2 H), 2.53 (dd, J = 8.8, 3.9 Hz, 1 H), 2.20 (d, J = 11.7 Hz, 1 H), 1.60 (dd, J = 
11.7, 8.8 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 198.4, 174.0, 137.5, 132.1, 131.4, 
118.1, 92.0, 79.0, 54.5, 45.9, 44.4, 43.9, 28.3; IR (neat) 2951, 2735, 1721, 1688, 1440, 
1348, 1253, 1045, 946, 700 cm-1; mass spectrum (CI) m/z 234.1131 [C13H15NO3 (M+1) 
requires 234.1130]. 
NMR Assignments. 33: 1H NMR (500 MHz, CDCl3) δ 9.90 (s, 1 H, C10-H), 
6.41 (d, J = 5.9 Hz, 1 H, C5-H), 6.27 (d, J = 5.9 Hz, 1 H, C6-H), 5.73 (dddd, J = 17.0, 
10.3, 5.9, 5.9 Hz, 1 H, C12-H), 5.25 (d, J = 17.0 Hz, 1 H, C13-H ), 5.21 (d, J = 10.3 Hz, 1 
H, C13-H), 5.06 (d, J = 3.9 Hz, 1 H, C4-H), 4.34 (t, J = 6.1 Hz, 1 H, C8-H), 4.27 (dd, J = 
15.9, 4.0 Hz, 1H, C11-H), 3.61 (dd, J = 15.9, 6.5 Hz, 1 H, C11-H), 2.96 (d, J = 6.1 Hz, 2 
H, C9-H), 2.53 (dd, J = 8.8, 3.9 Hz, 1 H, C2-H), 2.20 (d, J = 11.7 Hz, 1 H, C3-H), 1.60 
(dd, J = 11.7, 8.8 Hz, 1 H,C3-H); 13C NMR (100 MHz, CDCl3) δ 198.4 (C10), 174.0 
(C1), 137.5 (C5), 132.1 (C12), 131.4 (C6), 118.1 (C13), 92.0 (C7), 79.0 (C4), 54.5 (C8), 















N-Allyl-N-(1-(2-bromophenyl)-2-formylethyl)acetamides (2.86). (JDSI-245a).  
TMSOTf (15.5 µL, 19 mg, 0.086 mmol) was added to a solution of  2-
bromobenzaldehyde (0.1 mL, 158 mg, 0.86 mmol) and bis(trimethylsilyl)allylamine (0.22 
mL, 179 mg, 0.89 mmol) in CH2Cl2 (2.2 mL), and the reaction was stirred for 1 h at rt.  
The reaction was cooled to 0 ºC and silyl enol ether 2.74 (420 mg, 2.66 mmol) and 
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freshly distilled acetyl chloride (0.07 mL, 77 mg, 0.98 mmol) were then added, and the 
reaction was stirred for 10 min.  The ice bath was removed and the reaction was stirred 
for 40 h at rt.  The reaction was concentrated under reduced pressure.  The residue was 
purified by flash chromatography eluting with EtOAc/Hexane (1:1) to give 207 mg 
(77%) of amide 2.86 as a brownish solid, mp = 56-58 ºC.  1H NMR (500 MHz, DMSO, 
100 °C) δ 9.66 (s, 1 H), 7.64 (d, J = 7.8 Hz, 1H), 7.54 (d J = 7.8 Hz, 1H), 7.40 (t, J = 7.8 
Hz, 1H), 7.26 (t, J = 7.8 Hz, 1H), 6.02 (br, 1H), 5.52-5.45 (m, 1H), 4.94-4.92 (comp, 2H), 
3.81 (dd, J = 17.2, 5.2 Hz, 2H), 3.73 (dd, J = 17.2, 5.7 Hz), 3.24-3.19 (m, 1H), 3.10 (dd, J 
= 16.4, 7.6 Hz, 1H), 2.08 (s, 3H); 13C NMR (125 MHz, DMSO, 130 °C) δ 199.2, 169.3, 
137.1, 134.0, 132.5, 129.2, 129.0, 127.0, 124.0, 115.3, 52.7, 46.2, 44.9, 21.0; IR (neat) 
1720, 1645, 1405, 1024, 913, 749 cm-1;  mass spectrum (CI) m/z 310.0446 [C14H16BrNO2 
(M+1) requires 310.0443] 312.0426. 
NMR Assignments.  1H NMR (500 MHz, DMSO, 100 °C) δ 9.66 (t, J = 1.7 Hz, 
C3-H), 7.62 (dd, J = 7.7, 1.2 Hz, 1H, C6-H), 7.52 (dd, J = 7.8, 1.4 Hz, 1H, C9-H), 7.39 
(td, J = 7.6, 1.0 Hz, 1H, C7-H), 7.25 (td, J = 7.6, 1.5 Hz 1H, C8-H), 6.04 (br s, 1H, C1-
H), 5.48-5.40 (m, 1H, C11-H), 4.90 (comp, 2H, C12-H), 3.80-3.68 (comp, 2H, C10-H), 
3.20 (br s, 1H, C2-H), 3.09-3.04 (m, 1H, C2-H), 2.05 (s, 3H, C14-H); 13C NMR (125 
MHz, DMSO, 100 °C) δ 199.5 (C3), 169.5 (C13), 137.1 (C4), 134.1, 132.6, 129.3, 129.2, 

















2.87   
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N-Allyl-N-(2-formyl-1-(2-iodophenyl)ethyl)acetamide (2.87). (JDSII-158A). 
TMSOTf (23 µL, 28 mg, 0.13 mmol) was added to a solution of  2-iodobenzaldehyde 
(2.85) (300 mg, 1.29 mmol) and bis(trimethylsilyl)allylamine (0.33 mL, 269 mg, 1.33 
mmol) in CH2Cl2 (3.2 mL), and the reaction was stirred for 30 min at room temperature.  
Silyl enol ether 2.74421  (401 mg, 2.54 mmol) and freshly distilled acetyl chloride (0.11 
mL, 121 mg, 1.55 mmol) were then added, and the reaction was stirred for 24 h at room 
temperature.  The reaction was then partitioned between CH2Cl2 (5 mL) and saturated 
aqueous NaHCO3 (5 mL).  The organic phase was removed, and the aqueous phase was 
washed with CH2Cl2 (2 x 5 mL).  The combined organic layers were dried (MgSO4), 
filtered, and concentrated under reduced pressure.  The reaction was concentrated under 
reduced pressure.  The residue was purified by flash chromatography eluting with 
EtOAc/Hexane (1:1) to give 326 mg (70%) of amide 2.87 as viscous light brown oil.  1H 
NMR (500 MHz, DMSO, 100 °C) δ 9.65 (t, J = 1.8 Hz, 1 H), 7.90 (dd, J = 7.8, 1.3 Hz, 1 
H), 7.46 (dd, J = 7.8, 1.6 Hz, 1 H), 7.41 (td, J = 7.8, 1.3 Hz, 1 H), 7.06 (td, J =  7.8, 1.8 
Hz, 1 H), 5.82 (s, 1 H),  5.42 (ddt, J = 16.4, 10.9, 5.6 Hz, 1 H), 4.92-4.90 (comp, 2 H), 
3.77 (dd, J = 17.2, 5.6 Hz, 1 H), 3.67 (dd, J = 17.2, 5.6 Hz, 1 H), 3.17 (s, 1H), 3.06 (dd, J 
= 16.3, 7.5 Hz, 1 H), 2.06 (s, 3 H); 13C NMR (125 MHz, DMSO, 100 °C) δ 199.5, 169.6, 
140.1, 139.5, 134.1, 129.3, 128.9, 127.8, 115.6, 100.9, 56.8, 45.3, 21.3; IR (CDCl3) 2931, 
2837, 1722, 1644, 1464, 1404, 1255, 1224, 1177, 1011, 925, 753 cm-1; mass spectrum 
(CI) m/z 358.0305 [C14H16INO2 (M+1) requires 358.0304]. 
NMR Assignments.  1H NMR (400 MHz, DMSO, 100 °C) δ 9.65 (t, J = 1.8 Hz, 
1 H, C3-H), 7.90 (dd, J = 7.8, 1.3 Hz, 1 H, C6-H), 7.46 (dd, J = 7.8, 1.6 Hz, 1 H, C9-H), 
7.41 (td, J = 7.8, 1.3 Hz, 1 H, C8-H), 7.06 (td, J =  7.8, 1.8 Hz, 1 H, C7-H), 5.82 (s, 1 H, 
C1-H),  5.42 (ddt, J = 16.4, 10.9, 5.6 Hz, 1 H, C11-H), 4.92-4.90 (comp, 2 H, C12-H), 
3.77 (dd, J = 17.2, 5.6 Hz, 1 H, C10-H), 3.67 (dd, J = 17.2, 5.6 Hz, 1 H, C10-H), 3.17 (s, 
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1H, C2-H), 3.06 (dd, J = 16.3, 7.5 Hz, 1 H, C2-H), 2.06 (s, 3 H, C14-H); 13C 
NMR (125 MHz, DMSO, 100 °C) δ 199.5 (C3), 169.6 (C13), 140.1, 139.5, 134.1, 129.3, 
























yl)ethanone (2.89).  (JDSIII-161a).  Sarcosine (84 mg, 0.95 mmol) was added to a 
solution of 2.86 (166 mg, 0.54 mmol) in toluene (1 mL).  The reaction was heated under 
reflux for 3 h.  The reaction was cooled to room temperature and then was partitioned 
between water (5 mL) and CH2Cl2 (5 mL).  The organic layer was removed and the 
aqueous layer was washed with CH2Cl2 (2 x 5 mL).  The combined organic layers were 
dried (MgSO4), filtered and concentrated under reduced pressure. The residue was 
purified by flash chromatography eluting with MeOH/EtOAc (1:3) to give 118 mg (65%) 
of 2.89 as a brownish gum.  1H NMR (500 MHz, DMSO, 130 °C) δ 7.54 (d, J = 7.9 Hz, 1 
H), 7.33-7.27 (comp, 2 H), 7.14 (t, J = 7.0 Hz, 1 H), 4.97 (dd, J = 12.8, 4.8 Hz, 1 H), 4.20 
(br, 1 H),  3.14 (br, 1 H), 2.88-2.84  (m, 1 H), 2.50-2.47 (m, 1 H), 2.38 (br, 1 H), 2.30 (s, 
3 H), 2.27-2.23 (comp, 2 H), 1.94-1.84 (comp, 4 H), 1.51-1.38 (comp, 2 H); 13C 
NMR (125 MHz, DMSO, 130 °C) δ 168.4, 143.1, 131.9, 127.6, 127.5, 125.8, 120.2, 61.0, 
54.2, 37.9, 32.6, 27.3, 20.8; IR (neat) 1648, 1413, 1243, 1023, 757 cm-1; mass spectrum 
(CI) m/z  337.0912 [C16H21BrN2O (M+1) requires 337.0915] 339.0902. 
NMR Assignments.  1H NMR (500 MHz, DMSO, 130 °C) δ 7.54 (d, J = 7.9 Hz, 
1 H, C3-H), 7.33-7.27 (comp, 2 H, C5 and C6-H), 7.14 (t, J = 7.0 Hz, 1 H, C4-H), 4.97 
(dd, J = 12.8, 4.8 Hz, 1 H, C7-H), 4.20 (br, 1 H, C11-H),  3.14 (br, 1 H, C11-H), 2.88-
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2.84  (m, 1 H, C9 or C13-H), 2.50-2.47 (m, 1 H, C9 or C13-H), 2.38 (br, 1 H, C9 or C13-
H), 2.30 (s, 3 H, C14-H), 2.27-2.23 (comp, 2 H, C8 and C15-H), 1.94-1.84 (comp, 4 H, 
C15-H and C8-H), 1.51-1.38 (comp, 2 H, C12-H); 13C NMR (125 MHz, DMSO, 130 
°C) δ 168.4 (C15), 143.1 (C1), 131.9, 127.6, 127.5, 125.8, 120.2 (C2), 61.0, 54.2, 37.9, 
























yl)ethanone (2.90). (JDSII-146a).   Sarcosine (95 mg, 1.07 mmol) was added to a 
solution of 2.87 (237 mg, 0.66 mmol) in toluene (10 mL).  The reaction was heated under 
reflux for 5 h.  The reaction was cooled to room temperature and then was partitioned 
between water (10 mL) and CH2Cl2 (10 mL).  The organic layer was removed and the 
aqueous layer was washed with CH2Cl2 (3 x 5 mL).  The combined organic layers were 
dried (MgSO4), filtered and concentrated under reduced pressure. The residue was 
purified by flash chromatography eluting with MeOH/EtOAc (1:3) to give 151 mg (59%) 
of 2.90 as a brownish white gum.   1H NMR (500 MHz, DMSO, 140 °C) δ 7.80 (d, J = 
7.6 Hz, 1 H), 7.35 (t, J = 7.6 Hz, 1 H), 7.23 (d, J = 7.6 Hz, 1 H), 6.96 (t, J = 7.6 Hz, 1 H), 
4.79 (dd, J = 12.6, 4.6 Hz, 1 H), 4.26 (br, 1 H),  3.14 (s, 1 H), 2.87  (t, J = 7.8 Hz, 1 H), 
2.80 (s,1 H), 2.44-2.35 (m, 1 H), 2.31 (s, 3 H), 2.29-2.22 (comp, 2 H), 1.95-1.90 (m, 1 H), 
1.83 (s, 3 H), 1.47-1.38 (comp, 2 H); 13C NMR (125 MHz, DMSO, 140 
°C) δ 168.0, 145.8, 138.6, 128.2, 127.9, 125.0, 111.0, 96.0, 61.1, 54.2, 38.8, 37.8, 32.8, 
27.3, 20.9; IR (CH2Cl2) 2941, 2779, 2359, 1649, 1410, 1242, 1010, 756 cm-1; mass 
spectrum (CI) m/z  385.0777 [C16H21IN2O (M+1) requires 385.0777]. 
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NMR Assignments. 1H NMR (500 MHz, DMSO, 140 °C) δ 7.80 (d, J = 7.6 Hz, 
1 H, C11-H), 7.35 (t, J = 7.6 Hz, 1 H, C13-H), 7.23 (d, J = 7.6 Hz, 1 H, C14-H), 6.96 (t, J 
= 7.6 Hz, 1 H, C12-H), 4.79 (dd, J = 12.6, 4.6 Hz, 1 H, C8-H), 4.26 (br, 1 H, C1-H),  3.14 
(s, 1 H, C1-H), 2.87  (t, J = 7.8 Hz, 1 H, C2-H, C4-H, or C6-H), 2.80 (s,1 H, C2-H, C4-H, 
or C6-H), 2.44-2.35 (m, 1 H, C2-H, C4-H, or C6-H), 2.31 (s, 3 H, C16-H), 2.29-2.22 
(comp, 2 H, C2-H, C4-H, or C6-H), 1.95-1.95 (m, 1 H, C7-H), 1.83 (s, 3 H, C5-H), 1.47-
1.38 (comp, 2 H, C5-H); 13C NMR (125 MHz, DMSO, 140 °C) δ 168.0 (C15) 145.8 

























5(1H,3H,6H)-yl)ethanone (2.91). (JDSIII-120a).  N-methyl hydroxylamine 
hydrochloride (70 mg, 0.84 mmol) and Et3N (0.24 mL, 174 mg, 1.72 mmol) were added 
to a solution of 2.86 (166 mg, 0.54 mmol) in toluene (10 mL).  The reaction was heated 
to reflux for 5 h.  The reaction was cooled to rt and then concentrated under reduced 
pressure.  The residue was then partitioned between water (5 mL) and CH2Cl2 (5 mL).  
The organic phase was removed, and the aqueous layer was washed with CH2Cl2 (3 x 5 
mL).  The combined organic layers were dried (MgSO4), filtered, and concentrated under 
reduced pressure.  The residue was purified by flash chromatography eluting with EtOAc 
to give 166 mg (91%) of amide 2.91 as a orangish gum.  1H NMR (500 MHz, DMSO, 
130 °C) δ 7.55 (d, J = 7.9 Hz, 1 H), 7.34 (t, J = 7.1 Hz, 1 H), 7.28 (d, J = 7.1 Hz, 1 H), 
7.16 (t, J = 7.3 Hz, 1 H), 5.04 (dd, J = 12.9, 5.0 Hz, 1 H), 4.10 (br, 1 H), 4.04 (t, J = 8.3 
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Hz, 1 H), 3.46 (dd, J = 8.7, 5.0 Hz, 1H), 3.26 (br, 1 H), 3.00-3.06 (m, 1 H), 2.99-2.91 (m, 
1 H) 2.58 (s, 3 H), 2.20 (dt, J = 13.7, 5.2 Hz, 1 H) 1.86 (s, 3 H) 1.59 (app q, J = 12.7 Hz, 
1 H); 13C NMR (100 MHz, CDCl3, mixture of rotomers, major rotomer reported) δ 172.2, 
143.1, 134.0, 130.0, 129.6, 127.0, 122.0, 69.1, 65.3, 57.1, 44.5, 43.4, 40.3, 33.8, 22.6; IR 
(neat) 1651, 1417, 1361, 1253, 1026, 998, 967, 917, 757, 726, 642 cm-1; mass spectrum 
(CI) m/z 339.0705 [C15H19BrN2O2 (M+1) requires 339.0708] 341.0692.  
NMR Assignments.  1H NMR (500 MHz, DMSO, 130 °C) δ 7.55 (d, J = 7.9 Hz, 
1 H,  C3-H), 7.34 (t, J = 7.1 Hz, 1 H, C5-H), 7.28 (d, J = 7.1 Hz, 1 H, C6-H), 7.16 (t, J = 
7.3 Hz, 1 H, C4-H), 5.04 (dd, J = 12.9, 5.0 Hz, 1 H, C7-H), 4.10 (br, 1 H, C11-H), 4.04 
(t, J = 8.3 Hz, 1 H, C12-H), 3.46 (dd, J = 8.7, 5.0 Hz, 1H, C12-H), 3.26 (br, 1 H, C11-H), 
3.00-3.06 (m, 1 H, C9 or C10-H), 2.99-2.91 (m, 1 H, C9 or C10-H) 2.58 (s, 3 H, C13-H), 
2.20 (dt, J = 13.7, 5.2 Hz, 1 H, C8-H) 1.86 (s, 3 H, C15-H) 1.59 (app q, J = 12.7 Hz, 1 H, 
C8-H); 13C NMR (100 MHz, CDCl3, mixture of rotomers, major rotomer 
reported) δ 172.2 (C14), 143.1 (C1), 134.0, 130.0, 129.6, 127.0, 122.0 (C2), 69.1, 65.3, 


















N-Allyl-N-(1-(2-bromopyr idin-3-yl)-2-formylethyl)acetamide (2.93). (JDSIII-
65a)  TMSOTf (18 µL, 22 mg, 0.099 mmol) was added to a solution of 2-bromo-3-
formyl pyridine192 (188 mg, 1.01 mmol) and bis(trimethylsilyl)allylamine (0.26 mL, 212 
mg, 1.05 mmol) in CH2Cl2 (2.5 mL), and the reaction was stirred for 3.5 h at rt.  Silyl 
enol ether 2.74 (361 mg, 2.29 mmol) and freshly distilled acetyl chloride (0.9 mL, 99 mg, 
1.26 mmol) were then added, and the reaction was stirred for 31 h at room temperature.  
The reaction was then partitioned between CH2Cl2 (5 mL) and saturated aqueous 
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NaHCO3 (5 mL).  The organic phase was removed, and the aqueous layer was washed 
with CH2Cl2 (3 x 5 mL).  The combined organic layers were dried (MgSO4), filtered, and 
concentrated under reduced pressure.  The residue was purified by flash chromatography 
eluting with EtOAc/Hexane (3:1) to give 178 mg (56%) of amide 2.93 as a brownish 
gum.  1H NMR (400 MHz, CDCl3) δ 9.76 (s, 1 H), 8.32 (dd, J = 4.8, 2.0 Hz, 1 H), 7.77 
(dd, J = 7.7, 2.0 Hz, 1 H), 7.29 (dd, J = 7.7, 4.9 Hz, 1 H), 5.88 (dd, J = 8.5m 6.5 Hz, 1 H), 
5.65-5.56 (m, 1 H), 5.10-5.03 (comp, 2H), 3.80 (d, J = 5.5 Hz, 1 H), 3.42 (ddd,  J = 16.6, 
8.5, 2.0 Hz, 1 H), 3.07 (ddd, J = 16.6, 6.5, 1.4 Hz, 1 H), 2.13 (s, 3 H); 13C NMR (100 
MHz, CDCl3) δ 199.6, 172.3, 150.1, 145.3, 138.8, 135.9, 133.9, 123.6, 118.5, 54.3, 50.8, 
46.5, 23.2; IR (neat) 2360, 1719, 1643, 1561, 1401, 1256, 1178, 1051, 914, 742 cm-1; 
Mass spectrum (CI) m/z 311.0397 [C13H15BrN2O2 (M+1) requires 311.0395] 313.0379.   
NMR Assignments.  1H NMR (400 MHz, CDCl3) δ 9.76 (s, 1 H, C1-H), 8.32 
(dd, J = 4.8, 2.0 Hz, 1 H, C6-H), 7.77 (dd, J = 7.7, 2.0 Hz, 1 H, C8-H), 7.29 (dd, J = 7.7, 
4.9 Hz, 1 H, C7-H), 5.88 (dd, J = 8.5 6.5 Hz, 1 H, C3-H), 5.65-5.56 (m, 1 H, C10-H), 
5.10-5.03 (comp, 2H, C11-H), 3.80 (d, J = 5.5 Hz, 1 H, C9-H), 3.42 (ddd,  J = 16.6, 8.5, 
2.0 Hz, 1 H, C2-H), 3.07 (ddd, J = 16.6, 6.5, 1.4 Hz, 1 H, C2-H), 2.13 (s, 3 H, C13-H); 
13C NMR (100 MHz, CDCl3) δ 199.6 (C1), 172.3 (C12), 150.1 (C6), 145.3 (C5), 138.8, 


















Methyl 3-(N-allylacetamido)-3-phenylpropanoate (2.104). (JDSI-84b).   A 
mixture containing freshly distilled benzaldehyde (0.2 mL, 209 mg, 1.97 mmol), 
allylamine (0.15 mL, 114 mg, 2.0 mmol) and activated 4 Å molecular sieves (~500 mg) 
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in CH2Cl2 (5 mL) was stirred for 2 h at room temperature.  The reaction was cooled to 0 
°C and silyl ketene acetal 2.103422 (0.380 g, 2.02 mmol) and acetyl chloride (0.15 ml, 166 
mg, 2.11 mmol) was added and the reaction stirred for 30 minutes, whereupon the ice 
bath was removed. The reaction was stirred for 18 h at room temperature and then was 
filtered through a pad of Celite that was washed with CH2Cl2 (3 x 5 mL), and the filtrate 
was concentrated under reduced pressure.  The residue was purified by flash 
chromatography eluting with EtOAc/Hexane (gradient elution 1:3 to 1:1) to give 104 mg 
(20%) of 2.104 as a viscous yellowish oil. 1H NMR (400 MHz, mixture of rotomers) δ 
7.39-7.22 (comp, 5 H), 6.25 (t, J = 8.0 Hz, 0.6 H), 5.77-5.67 (m, 0.3 H), 5.59-5.48 (comp, 
1 H), 5.08-4.95 (comp, 2 H), 4.16-4.11 (m, 0.4 H) 3.77-3.68 (comp, 2 H), 3.64 (s, 2 H), 
3.33 (dd J = 15.8, 7.0 Hz, 0.4 H), 3.11-2.95 (comp, 2 H), 2.39 (s, 1 H), 2.10 (s, 2 H);  13C 
NMR (100 MHz, mixture of rotomers) δ 172.2, 172.1, 171.9, 139.6, 139.3, 135.4, 135.2, 
129.8, 129.5, 129.0, 128.8, 128.7, 127.5, 117.8, 117.0, 58.3, 54.3, 52.9, 52.8, 48.6, 46.1, 
37.9, 37.1, 23.2, 22.9; IR (neat) 3460, 2952, 2359, 2243, 1964, 1738, 1650, 1497, 1408, 
1259, 1163, 984 cm-1;  mass spectrum (CI) m/z 262.1441 [C15H19NO3 (M+1) requires 
262.1443]. 
NMR assignments. 1H NMR (400 MHz, mixture of rotomers) δ 7.39-7.22 (comp, 
5 H, Ar-H), 6.25 (t, J = 8.0 Hz, 0.6 H, C1-H), 5.77-5.67 (m, 0.3 H, C10-H), 5.59-5.48 
(comp, 1 H, C10-H), 5.08-4.95 (comp, 2 H, C11-H), 4.16-4.11 (m, 0.4 H, C9-H) 3.77-
3.68 (comp, 2 H, C9 and C4-H), 3.64 (s, 2 H, C4-H), 3.33 (dd J = 15.8, 7.0 Hz, 0.4 H, 
C2-H), 3.11-2.95 (comp, 2 H, C2-H), 2.39 (s, 1 H, C13-H), 2.10 (s, 2 H, C13-H);  13C 
NMR (100 MHz, mixture of rotomers) δ 172.2 (C3 or C12), 172.1 (C3 or C12), 171.9 
(C3 or C12), 139.6, 139.3, 135.4, 135.2, 129.8, 129.5, 129.0, 128.8, 128.7, 127.5, 117.8 
(C11), 117.0 (C11), 58.3 (C1), 54.3 (C1), 52.9 (C4), 52.8 (C4), 48.6 (C9), 46.1 (C9), 37.9 
(C2), 37.1 (C2), 23.2 (C13), 22.9 (C13). 
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Alternative procedure for  2.104. (JDSI-155a)  Acetyl chloride (0.1 mL, 110 
mg, 1.41 mmol) was added to a solution of imine 2.17 (179 mg, 1.24 mmol) and silyl 
ketene acetal 2.103 (491 mg, 2.61 mmol) in CH2Cl2 (3.5 mL) at -78 ºC.  The reaction was 
stirred at -78 ºC for 15 min, whereupon the cold bath was removed and TMSOTf (22 µL, 
27 mg, 0.12 mmol) was added.  The reaction was stirred for 18 h at room temperature.  
The reaction was then partitioned between CH2Cl2 (5 mL) and saturated aqueous 
NaHCO3 (5 mL).  The organic phase was removed, and the aqueous layer was washed 
with CH2Cl2 (3 x 5 mL).  The combined organic layers were dried (MgSO4), filtered, and 
concentrated under reduced pressure.  The residue was purified by flash chromatography 
eluting with EtOAc/Hexane (gradient elution 1:3 to 1:1) to give 171 mg (52%) of 2.104 



















Methyl 3-(N-allylacetamido)-3-(2-bromophenyl)propanoate (2.106). (JDSI-
274A). TMSOTf (15.5 µL, 19 mg, 0.086 mmol) was added to a solution of  2-
bromobenzaldehyde (0.1 mL, 158 mg, 0.86 mmol) and bis(trimethylsilyl)allylamine (0.22 
mL, 179 mg, 0.89 mmol) in CH3CN (2.2 mL), and the reaction was stirred for 30 min at 
room temperature.  Freshly distilled acetyl chloride (70 µL, 77 mg, 0.98 mmol) and silyl 
ketene acetal 2.105423  (292 mg, 2.05 mmol) and were then added, and the reaction was 
stirred for 3 h at room temperature.  The reaction was partitioned between CH2Cl2 (5 mL) 
and saturated aqueous NaHCO3 (5 mL).  The organic phase was removed, and the 
aqueous layer was extracted with CH2Cl2 (2 x 5 mL).  The combined organic layers were 
dried (MgSO4), filtered, and concentrated under reduced pressure.  The residue was 
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purified by flash chromatography eluting with EtOAc/Hexane (1:1) to give 230 mg 
(78%) of amide 2.106 as a colorless, viscous oil.  1H NMR (500 MHz, DMSO, 100 °C) δ 
7.61 (dd, J = 7.8, 1.1 Hz, 1 H), 7.54 (dd, J = 7.8, 1.6 Hz, 1 H), 7.38 (dt, J = 7.8, 1.1 Hz, 1 
H), 7.24 (dt, J = 7.8, 1.6 Hz), 5.93 (br, 1 H), 5.48-5.40 (m, 1 H), 4.87 (comp, 2 H), 3.78 
(dd, J = 17.1, 5.2 Hz, 1 H), 3.64 (dd, J = 17.1, 5.7 Hz, 1 H), 3.54 (s, 3 H), 3.10 (s, 1 H), 
3.00 (dd, J = 15.6, 6.7 Hz, 1 H), 2.07 (s, 3 H); 13C NMR (125 MHz, DMSO, 100 
°C) δ 169.8, 169.2, 137.0, 134.1, 132.6, 129.2, 128.8, 127.1, 124.3, 115.2, 54.2, 50.7, 
46.3, 35.7, 21.1; IR (neat) 3066, 2951, 1737, 1650, 1436, 1405, 1257, 1163, 754 cm-1; 
mass spectrum (CI) m/z 340.0546 [C15H18BrNO3 (M+1) requires 340.0548], 342.059.  
NMR Assignments. 1H NMR (500 MHz, DMSO, 100 °C) δ 7.61 (dd, J = 7.8, 1.1 
Hz, 1 H, C7-H), 7.54 (dd, J = 7.8, 1.6 Hz, 1 H, C10-H), 7.38 (dt, J = 7.8, 1.1 Hz, 1 H, C9-
H), 7.24 (dt, J = 7.8, 1.6 Hz, 1 H, C8-H), 5.93 (bs, 1 H, C1-H), 5.48-5.40 (m, 1 H, C12-
H), 4.87 (comp, 2 H, C13-H), 3.78 (dd, J = 17.1, 5.2 Hz, 1 H, C11-H), 3.64 (dd, J = 17.1, 
5.7 Hz, 1 H, C11-H), 3.54 (s, 3 H, C4-H), 3.10 (br s, 1 H, C2-H), 3.00 (dd, J = 15.6, 6.7 
Hz, 1 H, C2-H), 2.07 (s, 3 H, C15-H); 13C NMR (125 MHz, DMSO, 100 °C) δ 169.8 (C3 
or C14), 169.2 (C3 or C14), 137.0 (C5), 134.1 (C12), 132.6 (C7), 129.2 (C8, C9, or C10), 
128.8 (C8, C9, or C10), 127.1 (C8, C9, or C10), 124.3 (C6), 115.2 (C13), 54.2 (C4), 50.7 
















1-Allyl-6-(2-bromophenyl)-5,5-dimethylpiper idine-2,4-dione (2.110). (JDSII-
55a).  NaHMDS (2.0 M in THF, 0.53 mL, 1.06 mmol) was added to a solution of amide 
2.109 (187 mg, 0.51 mmol) in THF (17 mL) and the reaction was heated under reflux for 
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17 h.  The reaction was cooled to room temperature the reaction was washed sequentially 
with saturated aqueous NH4Cl (10 mL) and saturated NaCl (10 mL).  The organic phase 
was then dried (MgSO4), filtered, and concentrated under reduced pressure.  The residue 
was purified by flash chromatography eluting with EtOAc/Hex (1:3) to give 137 mg 
(80%) of 2.110 as a white solid, mp 133.5-135 °C.  1H NMR (400 MHz, CDCl3) δ 7.57 
(dd, J = 7.9, 1.7 Hz, 1 H), 7.27 (t, J = 7.9 Hz, 1 H), 7.16 (dt, J = 7.9, 1.7 Hz, 1 H), 6.79 
(dd, J = 7.9, 1.4 Hz, 1 H), 5.83-5.73 (m, 1 H), 5.34 (d, J = 17.1 Hz, 1 H), 5.28 (d, J = 9.9 
Hz, 1 H), 5.04 (s, 1 H), 4.69 (dd, J = 14.5, 4.6 Hz, 1 H), 3.64 (d, J = 21.2 Hz, 1 H), 3.49 
(d, J = 21.2 Hz, 1 H), 3.04 (dd, J = 14.5, 8.7 Hz, 1 H), 1.45 (s, 3 H), 0.92 (s, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 207.0, 166.7, 138.1, 134.2, 132.5, 130.8, 129.4, 127.7, 126.0, 
121.0, 67.7, 50.5, 48.9, 45.3, 26.4, 19.6; IR (neat) 3422, 2980, 2359, 1721, 1656, 1465, 
1282, 922, 758 cm-1; mass spectrum (CI) m/z 336.0599 [C16H18BrNO2 (M+1) requires 
336.0599], 338.0578. 
NMR Assignments.  1H NMR (400 MHz, CDCl3) δ 7.57 (dd, J = 7.9, 1.7 Hz, 1 
H, C8-H), 7.27 (t, J = 7.9 Hz, 1 H, C10-H), 7.16 (dt, J = 7.9, 1.7 Hz, 1 H, C9-H), 6.79 
(dd, J = 7.9, 1.4 Hz, 1 H, C11-H), 5.83-5.73 (m, 1 H, C15-H), 5.34 (d, J = 17.1 Hz, 1 H, 
C16-H), 5.28 (d, J = 9.9 Hz, 1 H, C16-H), 5.04 (s, 1 H, C5-H), 4.69 (dd, J = 14.5, 4.6 Hz, 
1 H, C14-H), 3.64 (d, J = 21.2 Hz, 1 H, C2-H), 3.49 (d, J = 21.2 Hz, 1 H, C2-H), 3.04 
(dd, J = 14.5, 8.7 Hz, 1 H, C14-H), 1.45 (s, 3 H, C12-H or C13-H), 0.92 (s, 3 H, C12-H 
or C13-H); 13C NMR (100 MHz, CDCl3) δ 207.0 (C3), 166.7 (C1), 138.1 (C6), 134.2 
(C8), 132.5 (C15), 130.8 (C9, C10, or C11), 129.4 (C9, C10, or C11), 127.7 (C9, C10, or 
C11), 126.0 (C7) (C9, C10, or C11), 121.0 (C16), 67.7, 50.5, 48.9, 45.3, 26.4 (C12 or 





















Methyl 3-(N-allylacetamido)-3-(2-bromopyr idin-3-yl)-2,2-dimethyl- 
propanoate (2.111). (JDSII-204a).  TMSOTf (14 µL, 17 mg, 0.077 mmol) was added to 
a solution of  2-bromopyridine-3-carbaldehyde (2.92)192 (149 mg, 0.80 mmol) and 
bis(trimethylsilyl)allylamine (0.20 mL, 163 mg, 0.81 mmol) in CH3Cl2 (2 mL), and the 
reaction was stirred for 3.5 h at room temperature.  Freshly distilled acetyl chloride (0.06 
mL, 66 mg, 0.84 mmol) and silyl ketene acetal 2.105  (0.33 mL, 283 mg, 1.62 mmol) and 
were then added, and the reaction was stirred for 5 h at room temperature.  The reaction 
was partitioned between CH2Cl2 (5 mL) and saturated aqueous NaHCO3 (5 mL).  The 
organic phase was removed, and the aqueous layer was extracted with CH2Cl2 (3 x 4 
mL).  The combined organic layers were dried (MgSO4), filtered, and concentrated under 
reduced pressure.  The residue was purified by flash chromatography eluting with 
EtOAc/Hexane (1:1) to give 206 mg (69%) of amide 2.111 as a white solid, mp 91-92 °C.  
1H NMR (400 MHz, CDCl3) δ 8.29 (dd, J = 4.7, 2.0 Hz, 1 H), 7.96 (dd, J = 7.9, 2.0 Hz, 1 
H), 7.38 (dd, J = 7.9, 4.7 Hz, 1 H), 6.01 (s, 1 H), 5.34 (ddt, J = 16.6, 10.1, 5.4 Hz, 1 H ), 
4.91 (d, J = 10.1 Hz, 1 H), 4.87 (d, J = 16.6 Hz, 1 H), 3.96 (dd, J = 17.7, 5.4 Hz, 1 H), 
3.71 (dd, J = 17.7, 5.4 Hz, 1H), 3.62 (s, 3 H), 2.16 (s, 3 H), 1.44 (s, 3 H), 1.32 (s, 3 H); 
13C NMR (100 MHz, CDCl3) δ 177.5, 172.8, 149.9, 147.3, 139.9, 136.0, 134.4, 123.0, 
118.0, 63.9, 53.0, 51.6, 48.7, 27.5, 25.4, 23.6; IR (neat) 2984, 2239, 1731, 1659, 1405, 
1252, 1127, 1053, 922, 743 cm-1; mass spectrum (CI) m/z 369.0813 [C16H21BrN2O3 
(M+1) requires 369.0814], 371.0795.  
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NMR Assignments. 1H NMR (400 MHz, CDCl3) δ 8.29 (dd, J = 4.7, 2.0 Hz, 1 H, 
C10-H), 7.96 (dd, J = 7.9, 2.0 Hz, 1 H, C8-H), 7.38 (dd, J = 7.9, 4.7 Hz, 1 H, C9-H), 6.01 
(s, 1 H, C1-H), 5.34 (ddt, J = 16.6, 10.1, 5.4 Hz, 1 H, C13-H ), 4.91 (d, J = 10.1 Hz, 1 H, 
C14-H), 4.87 (d, J = 16.6 Hz, 1 H, C14-H), 3.96 (dd, J = 17.7, 5.4 Hz, 1 H, C12-H), 3.71 
(dd, J = 17.7, 5.4 Hz, 1H, C12-H), 3.62 (s, 3 H, C14-H ), 2.16 (s, 3 H, C16-H), 1.44 (s, 3 
H, C5-H or C6-H), 1.32 (s, 3 H, C5-H or C6-H); 13C NMR (100 MHz, CDCl3) δ 177.5 
(C3), 172.8 (C15), 149.9 (C10), 147.3 (C11), 139.9 (C7, C8, or C13) , 136.0 (C7, C8, or 
C13), 134.4 (C7, C8, or C13), 123.0 (C9), 118.0 (C14), 63.9 (C1), 53.0 (C2, C4, or C12), 
51.6 (C2, C4, or C12), 48.7 (C2, C4, or C12), 27.5 (C5, C6, or C16), 25.4 (C5, C6, or 


















1-Allyl-6-(2-bromopyridin-3-yl)-5,5-dimethylpiper idine-2,4-dione (2.112). 
(JDSII-123a).  NaHMDS (1.3 M in THF, 0.55 mL, 0.72 mmol) was added to a solution 
of amide 2.111 (119 mg, 0.32 mmol) in THF (13 mL) and the reaction was heated under 
reflux for 13 h.  The reaction was cooled to room temperature and then washed with 
saturated aqueous NH4Cl (10 mL).  The aqueous phase was backwashed with CH2Cl2 (2 
x 5 mL).  The combined organics were then washed with saturated NaCl (5 mL), dried 
(MgSO4), filtered, and concentrated under reduced pressure.  The residue was purified by 
flash chromatography eluting with EtOAc/Hex (1:1) to give 97 mg (89%) of 2.112 as a 
white solid, mp 156-157 °C.  1H NMR (400 MHz, CDCl3) δ 8.34 (dd, J = 4.6, 1.9 Hz, 1 
H), 7.26 (dd, J = 7.7, 4.6 Hz, 1 H), 7.11 (dd, J = 7.7, 1.9 Hz, 1 H), 5.81-5.71 (m, 1 H), 
5.37 (d, J = 17.1 Hz, 1 H),  5.31 (d, J = 9.9 Hz, 1 H), 5.01 (s, 1 H), 4.68 (dd, J = 14.5, 4.9 
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Hz, 1 H), 3.66 (d, J = 21.2 Hz, 1 H), 3.47 (d, J = 21.2 Hz, 1 H), 3.09 (dd, J = 14.5, 8.7 
Hz, 1 H), 1.47 (s, 3 H), 0.97 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 206.5, 166.5, 151.0, 
145.5, 136.3, 135.9, 132.2, 124.6, 121.6, 67.3, 50.7, 49.2, 45.4, 39.2, 26.3, 19.7; IR (neat) 
2980, 2359, 1723, 1651, 1462, 1404, 1280, 1048, 934, 743 cm-1; mass spectrum (CI) m/z 
337.0548 [C15H17BrN2O2 (M+1) requires 337.0552], 339.0536. 
NMR Assignments.  1H NMR (400 MHz, CDCl3) δ 8.34 (dd, J = 4.6, 1.9 Hz, 1 
H, C12-H), 7.26 (dd, J = 7.7, 4.6 Hz, 1 H, C10-H), 7.11 (dd, J = 7.7, 1.9 Hz, 1 H, C11-
H), 5.81-5.71 (m, 1 H, C14-H), 5.37 (d, J = 17.1 Hz, 1 H, C15-H),  5.31 (d, J = 9.9 Hz, 1 
H, C15-H), 5.01 (s, 1 H, C7-H), 4.68 (dd, J = 14.5, 4.9 Hz, 1 H, C13-H), 3.66 (d, J = 21.2 
Hz, 1 H, C2-H), 3.47 (d, J = 21.2 Hz, 1 H, C2-H), 3.09 (dd, J = 14.5, 8.7 Hz, 1 H, C13-
H), 1.47 (s, 3 H, C5 or C6-H), 0.97 (s, 3 H, C5 or C6-H); 13C NMR (100 MHz, CDCl3) δ 
206.5 (C3), 166.5, (C1), 151.0 (12), 145.5 (C8), 136.3 (C9, C10, or C14), 135.9 (C9, 
C10, or C14), 132.2 (C9, C10, or C14), 124.6 (C11), 121.6 (C15), 67.3 (C7), 50.7 (C2 or 



















Methyl 3-(N-allylacetamido)-3-(2-iodophenyl)propanoate (2.126). (JDSII-
66a).  TMSOTf (8.5 µL, 10 mg, 0.047 mmol) was added to a solution of  2-
iodobenzaldehyde (112 mg, 0.48 mmol) and bis(trimethylsilyl)allylamine (0.12 mL, 92 
mg, 0.49 mmol) in CH2Cl2 (1.2 mL), and the reaction was stirred for 1 h at room 
temperature.  The reaction was cooled to 0 ºC and silyl ketene acetal 2.105  (205 mg, 1.40 
mmol) and freshly distilled acetyl chloride (40 µL, 44 mg, 0.56 mmol) and were then 
added, and the reaction was stirred for 10 min 0 ºC.  The cold bath was then removed and 
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the reaction stirred for 4 h at room temperature.  The reaction was partitioned between 
CH2Cl2 (5 mL) and saturated aqueous NaHCO3 (5 mL).  The organic phase was removed, 
and the aqueous layer was extracted with CH2Cl2 (3 x 4 mL).  The combined organic 
layers were dried (MgSO4), filtered, and concentrated under reduced pressure.  The 
residue was purified by flash chromatography eluting with EtOAc/Hexane (1:1) to give 
112 mg (60%) of amide 2.126 as a yellowish solid: mp 72-74 °C.  1H NMR (500 MHz, 
DMSO, 100 °C) 7.90 (dd, J = 7.8, 1.3 Hz, 1 H), 7.48 (dd, J = 7.8, 1.6 Hz, 1 H), 7.4 (dt, J 
= 7.8, 1.1 Hz, 1 H), 7.05 (dt, J = 7.8, 1.6 Hz, 1 H), 5.72 (br, 1 H), 5.49-5.41 (m, 1 H), 
4.90-4.88 (comp, 2 H), 3.78 (dd, J = 17.1, 5.4 Hz, 1 H), 3.61 (dd, J = 17.1, 5.9 Hz, 1 H), 
3.54 (s, 3 H), 3.07 ( s, 1 H), 2.98 (dd, J = 15.8, 6.6 Hz, 1 H), 2.08 (s, 3 H); 13C 
NMR (125 MHz, DMSO, 100 °C) δ 169.7, 169.4, 140.0, 139.5, 134.2, 129.2, 128.4, 
127.7, 115.4, 101.1, 58.7, 50.7, 46.6, 35.9, 21.3; IR (neat) 3061, 2950, 1738, 1650, 1404, 
1256, 1012, 754 cm-1; mass spectrum (CI) m/z 388.0412 [C15H18INO3 (M+1) requires 
388.0410].  
NMR Assignments.  1H NMR (500 MHz, DMSO, 100 °C) 7.90 (dd, J = 7.8, 1.2 
Hz, 1 H, C7-H), 7.48 (dd, J = 7.8, 1.6 Hz, 1 H, C10-H), 7.4 (dt, J = 7.8, 1.2 Hz, 1 H, C9-
H), 7.05 (dt, J = 7.8, 1.6 Hz, 1 H, C8-H), 5.72 (br, 1 H, C1-H), 5.49-5.41 (m, 1 H, C12-
H), 4.90-4.88 (comp, 2 H, C13-H), 3.78 (dd, J = 17.1, 5.4 Hz, 1 H, C11-H), 3.61 (dd, J = 
17.1, 5.9 Hz, 1 H, C11-H), 3.54 (s, 3 H, C4-H), 3.07 ( br, 1 H, C2-H), 2.98 (dd, J = 15.8, 
6.6 Hz, 1 H, C2-H), 2.08 (s, 3 H, C15-H); 13C NMR (125 MHz, DMSO, 100 °C) δ 169.7 
(C1 or C14), 169.4 (C1 or C14), 140.0 (C5), 139.5 (C7), 134.2 (C12), 129.2 (C8, C9, or 
C10), 128.4 (C8, C9, or C10), 127.7 (C8, C9, or C10), 115.4 (C13), 101.1 (C6), 58.7 




















(2.127). (JDSII-86a).  TMSOTf (10 µL, 12 mg, 0.033 mmol) was added to a solution of  
2-iodobenzaldehyde (133 mg, 0.60 mmol) and bis(trimethylsilyl)allylamine (0.15 mL, 
122 mg, 0.61 mmol) in CH2Cl2 (1.5 mL), and the reaction was stirred for 1 h at room 
temperature.  The reaction was cooled to 0 ºC and silyl ketene acetal 2.105  (0.35 mL, 
300 mg, 1.72 mmol) and freshly distilled acetyl chloride (0.08 mL, 88 mg, 1.12 mmol) 
and were then added, and the reaction was stirred for 10 min 0 ºC.  The cold bath was 
then removed and the reaction stirred for 18 h at room temperature.  The reaction was 
partitioned between CH2Cl2 (5 mL) and saturated aqueous NaHCO3 (5 mL).  The organic 
phase was removed, and the aqueous layer was extracted with CH2Cl2 (3 x 4 mL).  The 
combined organic layers were dried (MgSO4), filtered, and concentrated under reduced 
pressure.  The residue was purified by flash chromatography eluting with EtOAc/Hexane 
(1:3) to give 159 mg (67%) of amide 2.127 as a white solid: mp 100-101 °C.  1H NMR 
(400 MHz, CDCl3) δ 7.92 (dd, J = 7.7, 1.0 Hz, 1 H), 7.47 (dd, J = 7.7, 1.2 Hz, 1 H), 7.28 
(dt, J = 7.7, 1.0 Hz, 1 H) 6.94 (dt, J = 7.7, 1.2 Hz, 1 H), 6.14 (s, 1 H), 5.16-5.06 (m, 1 H), 
4.82-4.78 (comp, 2 H), 3.88-3.60 (comp, 2 H), 3.59 (s, 3 H), 2.16 (s, 3 H), 1.44 (s, 3 H), 
1.32 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 178.0, 172.7, 141.8, 141.5, 135.0, 130.5, 
130.3, 128.7, 117.3, 104.8, 67.7, 52.9, 50.8, 49.4, 27.3, 25.6, 23.8; IR (neat) 3437, 2979, 
1729, 1657, 1392, 1249, 1147, 1013, 752 cm-1; mass spectrum (CI) m/z 416.0725 
[C17H22NO3 (M+1) requires 416.0723]. 
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NMR Assignments.  1H NMR (400 MHz, CDCl3) δ 7.92 (dd, J = 7.7, 1.0 Hz, 1 
H, C9-H), 7.47 (dd, J = 7.7, 1.2 Hz, 1 H, C12-H), 7.28 (dt, J = 7.7, 1.0 Hz, 1 H, C11-H) 
6.94 (dt, J = 7.7, 1.2 Hz, 1 H, C10-H), 6.14 (s, 1 H, C1-H), 5.16-5.06 (m, 1 H, C14-H), 
4.82-4.78 (comp, 2 H, C15-H), 3.88-3.60 (comp, 2 H, C13-H), 3.59 (s, 3 H, C14-H), 2.16 
(s, 3 H, C17-H), 1.44 (s, 3 H, C5 or C6-H), 1.32 (s, 3 H, C5-H or C6-H); 13C 
NMR (100 MHz, CDCl3) δ 178.0 (C3), 172.7 (C16), 141.8 (C7 or C9), 141.5 (C7 or C9), 
135.0 (C14), 130.5 (C10, C11, or C12), 130.3 (C10, C11, or C12), 128.7 (C10, C11, or 
C12), 117.3 (C15), 104.8 (C8), 67.7 (C1), 52.9 (C2, C4, or C13), 50.8 (C2, C4, or C13), 


















(2.131). (JDSII-89A).  NaHMDS (214 mg, 1.17 mmol) was added to a solution of 2.127 
(159 mg, 0.38 mmol) in THF (15 mL) and the reaction was heated under reflux for 19 h.  
The reaction was cooled to room temperature and washed with concentrated aqueous 
NH4Cl (10 mL). The organic phase was removed and then dried (MgSO4), filtered, and 
concentrated.  The residue was purified by flash chromatography eluting with 
EtOAc/Hexane (1:3) to give 133 mg (91%) of 2.131 as a white solid, mp 146-146.5 °C. 
1H NMR (400 MHz, CDCl3) δ 7.85 (d, J = 7.7 Hz, 1 H), 7.30 (t, J = 7.7 Hz, 1 H), 7.00 (t, 
J = 7.7 Hz, 1 H), 6.74 (d, J = 7.7 Hz, 1 H), 5.85-5.75 (m, 1 H), 5.41 (d, J = 17.1 Hz, 1 H), 
5.29 (d, J = 10.3 Hz, 1 H), 4.86 (s, 1 H), 4.66 (dd, J = 14.6, 3.2 Hz, 1 H), 3.64 (d, J = 21.2 
Hz, 1 H), 3.49 (d, J = 21.2 Hz, 1 H), 3.05 (dd, J = 14.7, 8.5 Hz, 1 H), 1.46 (s, 3 H), 0.94 
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(s, 3 H); 13C NMR (100 MHz, CDCl3) δ 207.0, 166.5, 141.1, 141.0, 132.5, 131.1, 130.3, 
127.1, 121.0, 102.7, 72.7, 50.7, 48.9, 45.3, 26.5, 19.9; IR (neat) 3077, 2979, 1723, 1651, 
1468, 1381, 1333, 1282, 1182, 1010, 932, 756 cm-1; mass spectrum (CI) m/z 384.0462 
[C16H18INO2 (M+1) requires 384.0461]. 
NMR Assignments.  1H NMR (400 MHz, CDCl3) δ 7.85 (d, J = 7.7 Hz, 1 H, C8-
H)), 7.30 (t, J = 7.7 Hz, 1 H, C10-H), 7.00 (t, J = 7.7 Hz, 1 H, C9-H), 6.74 (d, J = 7.7 Hz, 
1 H, C11-H), 5.85-5.75 (m, 1 H, C15-H), 5.41 (d, J = 17.1 Hz, 1 H, C16-H), 5.29 (d, J = 
10.3 Hz, 1 H, C16-H), 4.86 (s, 1 H, C5-H), 4.66 (dd, J = 14.6, 3.2 Hz, 1 H, C14-H), 3.64 
(d, J = 21.2 Hz, 1 H, C2-H), 3.49 (d, J = 21.2 Hz, 1 H, C2-H), 3.05 (dd, J = 14.7, 8.5 Hz, 
1 H, C14-H), 1.46 (s, 3 H, C12-H or C13-H), 0.94 (s, 3 H, C12-H or C13-H); 13C NMR 
(100 MHz, CDCl3) δ 207.0 (C3), 166.5 (C1), 141.1 (C6 or C8), 141.0 (C6 or C8), 132.5 
(C15), 131.1 (C9, C10, or C11), 130.3 (C9, C10, or C11), 127.1 (C9, C10, or C11), 121.0 



















Methyl 3-(N-(prop-2-ynyl)acetamido)-3-(2-bromophenyl)propanoate (2.137). 
(JDSII-247a).  Acetyl chloride (0.04 mL, 44 mg, 0.56 mmol), TMSOTf (8 µL, 10 mg, 
0.044 mmol), and silyl ketene acetal 2.105 (534 mg, 3.75 mmol) were sequentially added 
to a solution of imine 2.135 (101 mg, 0.46 mmol) in CH3CN (1.1 mL) and the reaction 
was stirred for 1.5 h at room temperature.  The reaction was then partitioned between 
CH2Cl2 (5 mL) and saturated aqueous NaHCO3 (5 mL).  The organic phase was removed, 
and the aqueous phase was washed with CH2Cl2 (3 x 5 mL).  The combined organics 
were dried (MgSO4), filtered, and concentrated under reduced pressure.  The residue was 
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purified by flash chromatography eluting with EtOAc/Hexane (2:3) to give 115 mg 
(74%) of amide 2.137 as a yellowish, viscous oil.   1H NMR (500 MHz, DMSO, 130 °C) 
δ 7.62 (d, J = 8.0 Hz,  1 H), 7.57 (d, J = 8.0 Hz, 1 H), 7.40 (t, J = 8.0 Hz, 1 H), 7.26 (t, J 
= 8.0 Hz, 1 H), 5.90 (s, 1 H), 4.04 (d, J = 18.6 Hz, 1 H), 3.78 (d, J = 18.6 Hz, 1 H), 3.56 
(s, 3 H), 3.22 (dd, J = 16.0, 8.6 Hz, 1 H), 3.03 (dd, J = 16.0, 6.4 Hz, 1 H), 2.76 (s, 1 H), 
2.17 (s, 3 H); 13C NMR (125 MHz, DMSO, 130 °C) δ 169.5, 168.9, 136.4, 132.6, 129.1, 
128.6, 127.0, 124.1, 79.5, 72.5, 54.7, 50.7, 35.4, 32.9, 20.9; IR 2117, 1738, 1659, 1434, 
1409, 1256, 1160, 1026 cm-1; mass spectrum (CI) m/z 338.0387 [C15H17BrNO3 (M+1) 
requires 338.0392], 340. 0370.   
NMR assignments.  1H NMR (500 MHz, DMSO, 130 °C) δ 7.62 (d, J = 8.0 Hz,  
1 H, C7-H or C10-H), 7.57 (d, J = 8.0 Hz, 1 H, C7-H or C10-H), 7.40 (t, J = 8.0 Hz, 1 H, 
C8-H or C9-H), 7.26 (t, J = 8.0 Hz, 1 H, C8-H or C9-H), 5.90 (s, 1 H, C1-H), 4.04 (d, J = 
18.6 Hz, 1 H, C11-H), 3.78 (d, J = 18.6 Hz, 1 H, C11-H), 3.56 (s, 3 H, C4-H), 3.22 (dd, J 
= 16.0, 8.6 Hz, 1 H, C2-H), 3.03 (dd, J = 16.0, 6.4 Hz, 1 H, C2-H), 2.76 (s, 1 H, C13-H), 
2.17 (s, 3 H, C15-H); 13C NMR (125 MHz, DMSO, 130 °C) δ 169.5 (C3 or C14), 168.9 
(C3 or C14), 136.4, 132.6, 129.1, 128.6, 127.0, 124.1, 79.5 (C12), 72.5 (C-13), 54.7 (C1 




















Methyl 3-(N-(prop-2-ynyl)acetamido)-3-(2-iodophenyl)propanoate (2.138). 
(JDSII-301a)   Acetyl chloride (0.09 mL, 99 mg, 1.27 mmol), TMSOTf (19 µL, 23 mg, 
0.10 mmol), and silyl ketene acetal 2.105 (347 mg, 2.44 mmol) were sequentially added 
to a solution of imine 2.136 (282 mg, 1.05 mmol) in CH3CN (2.5 mL) and the reaction 
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was stirred for 2.5 h at room temperature.  The reaction was then partitioned between 
CH2Cl2 (5 mL) and saturated aqueous NaHCO3 (5 mL).  The organic phase was removed, 
and the aqueous layer was washed with CH2Cl2 (3 x 5 mL).  The combined organic layers 
were dried (MgSO4), filtered, and concentrated under reduced pressure.  The residue was 
purified by flash chromatography eluting with EtOAc/Hexane (2:3) to give 235 mg 
(58%) of amide 2.138 as a viscous, yellowish oil.   1H NMR (500 MHz, DMSO, 130 °C) 
δ 7.91 (d, J = 7.8 Hz,  1 H), 7.51 (d, J = 7.8 Hz, 1 H), 7.43 (t, J = 7.8 Hz, 1 H), 7.07 (t, J 
= 7.8 Hz, 1 H), 5.72 (s, 1 H), 4.04 (d, J = 18.6 Hz, 1 H), 3.71 (d, J = 18.6 Hz, 1 H), 3.56 
(s, 3 H), 3.21 (dd, J = 16.0, 8.8 Hz, 1 H), 3.02 (dd, J = 16.0, 6.5 Hz, 1 H), 2.79 (s, 1 H), 
2.18 (s, 3 H); 13C NMR (125 MHz, DMSO, 130 °C) δ 169.4, 169.0, 139.6, 139.5, 129.2, 
128.0, 127.6, 100.7, 79.5, 72.6, 59.0, 50.6, 35.6, 32.9, 21.1; IR 1738, 1651, 1435, 1406, 
1255, 1159, 1013, 754, 657 cm-1; mass spectrum (CI) m/z 386.0255 [C15H17INO3 (M+1) 
requires 386.0253].   
NMR Assignments.  1H NMR (500 MHz, DMSO, 130 °C) δ 7.91 (d, J = 7.8 Hz,  
1 H, C7-H), 7.51 (d, J = 7.8 Hz, 1 H, C10-H), 7.43 (t, J = 7.8 Hz, 1 H, C9-H), 7.07 (t, J = 
7.8 Hz, 1 H, C8-H), 5.72 (s, 1 H, C1-H), 4.04 (d, J = 18.6 Hz, 1 H, C11-H), 3.71 (d, J = 
18.6 Hz, 1 H, C11-H), 3.56 (s, 3 H, C4-H), 3.21 (dd, J = 16.0, 8.8 Hz, 1 H, C2-H), 3.02 
(dd, J = 16.0, 6.5 Hz, 1 H, C2-H), 2.79 (s, 1 H, C13-H), 2.18 (s, 3 H, C15-H); 13C NMR 
(125 MHz, DMSO, 130 °C) δ 169.4 (C3 or C14), 169.0 (C3 or C14), 139.6, 139.5 (C5), 
129.2, 128.0, 127.6, 100.7 (C6), 79.5 (C12), 72.6 (C13), 59.0 (C1 or C4), 50.6 (C1 or 






























(2.140).  TMSOTf (6.5 µL, 8 mg, 0.036 mmol) was added to a solution of  4-
bromoindole-3-carboxaldehyde 2.139203, 204 (140 mg, 0.37 mmol) and bis(trimethylsilyl)-
allylamine (0.10 mL, 82 mg, 0.40 mmol) in CH2Cl2 (1 mL), and the reaction was stirred 
for 3 h at room temperature.  Silyl ketene acetal 1.105 (135 mg, 0.95 mmol) and freshly 
distilled acetyl chloride (35 µL, 39 mg, 0.49 mmol) were then added, and the reaction 
was stirred for 4 h at room temperature.  The reaction was partitioned between CH2Cl2 (5 
mL) and saturated aqueous NaHCO3 (5 mL).  The organic phase was removed, and the 
aqueous layer was extracted with CH2Cl2 (2 x 5 mL).  The combined organic layers were 
dried (MgSO4), filtered, and concentrated under reduced pressure.  The residue was 
purified by flash chromatography eluting with EtOAc/Hexane (1:1) to give 149 mg 
(75%) of amide 2.140 as a white solid, mp 134.5–136 °C.  1H NMR (500 MHz, DMSO, 
130 °C) δ 7.95 (d, J = 7.8 Hz, 1 H), 7.95 (s, 1 H), 7.77 (d, J = 8.2 Hz, 2 H), 7.45 (d, J = 
7.8 Hz, 1 H), 7.36 (d, J = 8.2 Hz, 2 H), 7.23 (t, J = 8.2 Hz, 1 H ), 6.41 (s, 1 H), 5.31 
(dddd, J = 15.8, 10.2, 5.3, 5.3 Hz, 1 H), 4.72 (d, J = 17.1 Hz, 1 H), 4.65 (d, J = 10.2 Hz, 
1H), 3.86 (dd, J = 17.3, 5.3 Hz 1 H), 3.70 (dd, J = 17.3, 5.3 Hz, 1 H), 3.54 (s, 3 H), 3.18 
(dd,  J = 15.3, 9.3 Hz, 1 H), 3.00 (dd, J = 15.3, 5.9 Hz, 1 H), 2.34 (s, 3 H), 2.03 (s, 3 H); 
13C NMR (125 MHz, DMSO, 130 °C) δ 169.8, 169.3, 145.1, 135.5, 134.2 133.7, 129.5, 
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127.6, 127.4, 125.9, 125.3, 119.7, 114.7, 112.7, 112.1, 50.5, 47.2, 46.0, 36.4, 21.4, 20.2; 
IR (neat) 1736, 1644, 1411, 1374, 1258, 1174, 675, 574 cm-1; mass spectrum (CI) m/z 
533.0754 [C24H26BrN2O5S (M+1) requires 533.0746], 535.0731. 
NMR Assignments.  1H NMR (500 MHz, DMSO, 130 °C) δ 7.95 (d, J = 7.8 Hz, 
1 H, C9-H), 7.95 (s, 1 H, C5-H), 7.77 (d, J = 8.2 Hz, 2 H, C19-H), 7.45 (d, J = 7.8 Hz, 1 
H, C11-H), 7.36 (d, J = 8.2 Hz, 2 H, C20-H), 7.23 (t, J = 8.1 Hz, 1 H, C10-H), 6.41 (s, 1 
H, C1-H), 5.31 (ddt, J = 15.8, 10.2, 5.3 Hz, 1 H, C14-H), 4.72 (d, J = 17.1 Hz, 1 H, C15-
H), 4.65 (d, J = 10.2 Hz, 1H, C15-H), 3.86 (dd, J = 17.3, 5.3 Hz 1 H, C13-H), 3.70 (dd, J 
= 17.3, 5.3 Hz, 1 H, C13-H), 3.54 (s, 3 H, C4-H), 3.18 (dd,  J = 15.3, 9.3 Hz, 1 H, C2-H), 
3.00 (dd, J = 15.3, 5.9 Hz, 1 H, C2-H), 2.34 (s, 3 H, C22-H), 2.03 (s, 3 H, C17-H); 13C 
NMR (125 MHz, DMSO, 130 °C) δ 169.8 (C3 or C16), 169.3 (C3 or C16), 145.1 (C21), 
135.5, 134.2 133.7, 129.5 (C19), 127.6, 127.4, 125.9 (C20), 125.3, 119.7, 114.7, 112.7, 
112.1, 50.5 (C4), 47.2 (C1 or C13), 46.0 (C1 or C13), 36.4 (C2), 21.4 (C17 or C22), 20.2 




























































yl)acetate (2.141) and methyl 2-((Z)-9-acetyl-2,6,9,10-tetrahydro-2-
tosylazocino[3,4,5-cd]indol-10-yl)acetate (2.142). Pd(OAc)2 (2 mg, 0.001 mmol), PPh3 
(6 mg, 0.025 mmol), and Et3N (0.06 mL, 43 mg, 0.43 mmol) were added to a solution of 
amide 2.140 (0.057 mg, 0.11 mmol) in CH3CN (4.2 mL) and the reaction was heated to 
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125 ºC in a microwave reactor for 30 min.  The reaction was cooled to rt and 
concentrated under reduced pressure.  The residue was purified by flash chromatography 
eluting with EtOAc/Hexane (1:1) to give 6 mg (12%) of enamine 2.142 as a yellowish 
gum and 40 mg (83%) of amide 2.141 as a brownish solid.  Recrystallization of 2.141 via 
slow evaporation from benzene provided large colorless prisms, mp = 170-172 ºC.  2.142 
(minor): 1H NMR (500 MHz, DMSO, 130 ºC) δ 7.74 (d, J = 8.3 Hz, 2 H), 7.73 (d, J = 
8.3 Hz, 1 H), 7.65 (s, 1 H), 7.34 (d, J = 8.3 Hz, 2 H), 7.21 (t, J = 7.4 Hz, 1 H), 7.05 (d, J = 
7.4 Hz, 1 H), 6.45 (d, J = 9.1 Hz, 1 H), 5.94 (t, J = 7.1 Hz, 1 H), 5.34-5.29 (m, 1 H), 3.65 
(dd, J = 7.5, 3.7 Hz, 2 H), 3.53 (s, 3 H), 3.31 (dd, J = 15.7, 6.4 Hz, 1 H), 3.10 (dd, J = 
15.7, 7.7 Hz, 1 H), 2.33 (s, 3H), 2.00 (s, 3H);  13C NMR (125 MHz, DMSO, 130 
ºC) δ 169.8, 168.8, 144.6, 134.8, 134.2, 132.1, 129.3, 128.2, 127.2, 125.8, 125.2, 124.3, 
123.2, 119.8, 115.1, 111.0, 50.4, 49.9, 38.6, 31.2, 22.2, 20.1; IR (neat) 2950, 1737, 1642, 
1425, 1368, 1290, 1175, 1091, 912, 743 cm-1; mass spectrum (CI) m/z 453.1482 
[C24H25N2O5S (M+1) requires 453.1484].  2.141 (major):  1H NMR (500 MHz, DMSO, 
130 ºC) δ 7.88 (d, J = 8.3 Hz, 1 H), 7.78 (s, 1 H), 7.77 (d, J = 8.3 Hz, 2 H), 7.37 (d, J = 
8.3 Hz, 2 H), 7.34 (t, J = 8.3 Hz, 1 H), 7.12 (d, J = 7.5 Hz, 1 H), 6.92 (d, J = 10.9 Hz, 1 
H), 5.99 (ddd, J = 10.5, 10.5, 6.9 Hz, 1 H), 5.84 (m, 1 H), 4.34 (br, 1 H), 3.82 (br, 1 H), 
3.37 (s, 3 H), 2.96 (dd, J = 15.0, 9.8 Hz, 1 H), 2.88 (dd, J = 15.0, 4.7 Hz, 1 H), 2.34 (s, 
3H), 2.14 (s, 3H);  13C NMR (125 MHz, DMSO, 130 ºC) δ 169.4, 168.1, 144.8, 135.2, 
134.1, 133.5, 129.4, 128.6, 127.1, 126.6, 126.5, 125.9, 124.3, 124.1, 118.2, 112.5, 50.5, 
50.1, 41.3, 40.6, 20.9, 20.1; IR (neat) 1736, 1638, 1419, 1371, 1307, 1259, 1176, 1149, 
1091, 731 cm-1; mass spectrum (CI) m/z 453.1487 [C24H25N2O5S (M+1) requires 
453.1484]. 
NMR Assignments. 2.142: 1H NMR (500 MHz, DMSO, 130 ºC) δ 7.74 (d, J = 
8.3 Hz, 2 H, C19-H), 7.73 (d, J = 8.3 Hz, 1 H, C11-H), 7.65 (s, 1 H, C5-H), 7.34 (d, J = 
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8.3 Hz, 2 H, C20-H), 7.21 (t, J = 7.4 Hz, 1 H, C10-H), 7.05 (d, J = 7.4 Hz, 1 H, C9-H), 
6.45 (d, J = 9.1 Hz, 1 H, C13-H), 5.94 (t, J = 7.1 Hz, 1 H, C1-H), 5.34-5.29 (m, 1 H, 
C14-H), 3.65 (dd, J = 7.5, 3.7 Hz, 2 H, C14-H), 3.53 (s, 3 H, C4-H), 3.31 (dd, J = 15.7, 
6.4 Hz, 1 H, C2-H), 3.10 (dd, J = 15.7, 7.7 Hz, 1 H, C2-H), 2.33 (s, 3H, C22-H), 2.00 (s, 
3H, C17-H);  13C NMR (125 MHz, DMSO, 130 ºC) δ 169.8 (C4 or C16), 168.8 (C4 or 
C16), 144.6, 134.8, 134.2, 132.1, 129.3 (C20), 128.2, 127.2, 125.8 (C19), 125.2, 124.3, 
123.2, 119.8, 115.1, 111.0, 50.4 (C1 or C4), 49.9 (C1 or C4), 38.6 (C2), 31.2 (C15), 22.2 
(C17 or C22), 20.1 (C17 or C22).  2.141:  1H NMR (500 MHz, DMSO, 130 ºC) δ 7.88 (d, 
J = 8.3 Hz, 1 H, C11-H), 7.78 (s, 1 H, C5-H), 7.77 (d, J = 8.3 Hz, 2 H, C19-H), 7.37 (d, J 
= 8.3 Hz, 2 H, C20-H), 7.34 (t, J = 8.3 Hz, 1 H, C10-H), 7.12 (d, J = 7.5 Hz, 1 H, C9-H), 
6.92 (d, J = 10.7 Hz, 1 H, C15-H), 5.99 (dt, J = 10.7, 6.9 Hz, 1 H, C14-H), 5.84 (m, 1 H, 
C1-H), 4.34 (br, 1 H, C13-H), 3.82 (br, 1 H, C13-H), 3.37 (s, 3 H, C4-H), 2.96 (dd, J = 
15.0, 9.8 Hz, 1 H, C2-H), 2.88 (dd, J = 15.0, 4.7 Hz, 1 H, C2-H), 2.34 (s, 3H, C22), 2.14 
(s, 3H, C17-H);  13C NMR (125 MHz, DMSO, 130 ºC) δ 169.4 (C3 or C16), 168.1 (C3 or 
C16), 144.8 (C21), 135.2, 134.1, 133.5, 129.4 (C20), 128.6, 127.1, 126.6, 126.5, 125.9 
(C19), 124.3, 124.1, 118.2, 112.5 (C11), 50.5 (C1 or C4), 50.1 (C1 or C4), 41.3 (C2 or 




















(2.149).  (JDSII-96a).  TMSOTf (23.0 µL, 28 mg, 0.13 mmol) was added to a solution of 
2-vinylbenzaldehyde424 (172 mg, 1.30 mmol) and bis(trimethylsilyl)allylamine (0.33 mL, 
269 mg, 1.34 mmol) in CH2Cl2 (3.2 mL), and the reaction was stirred for 30 min at room 
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temperature.  Silyl ketene acetal 1.105 (0.53 mL, 455 mg, 2.60 mmol) and freshly 
distilled acetyl chloride (0.11 mL, 121 mg, 1.55 mmol) were then added, and the reaction 
was stirred for 19 h at room temperature.  The reaction was partitioned between CH2Cl2 
(5 mL) and saturated aqueous NaHCO3 (5 mL).  The organic phase was removed, and the 
aqueous layer was extracted with CH2Cl2 (2 x 5 mL).  The combined organic layers were 
dried (MgSO4), filtered, and concentrated under reduced pressure.  The residue was 
purified by flash chromatography eluting with EtOAc/Hexane (1:3) to give 328 mg 
(80%) of amide 2.149 as a viscous yellowish oil.  1H NMR (400 MHz, CDCl3) δ 7.47 (d, 
J = 7.5 Hz, 1 H), 7.38 (d, J = 7.9 Hz, 1 H), 7.26 (t, J = 7.5 Hz, 1H), 7.20 (dt, J = 7.9, 1.5 
Hz, 1H), 7.04 (dd, J = 17.1, 10.9 Hz, 1 H), 6.36 (s, 1 H), 5.57 (dd, J = 17.1, 1.7 Hz, 1 H), 
5.32 (dd, J = 10.9, 1.7 Hz, 1 H), 5.07-4.98 (m, 1 H), 4.80 (dd, J = 7.5, 1.4 Hz, 1 H), 4.77 
(dd, J = 14.2, 1.4 Hz, 1 H), 3.79-3.78 (comp, 2 H), 3.57 (s, 3 H), 2.11 (s, 3 H), 1.45 (s, 3 
H), 1.33 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 178.3, 173.1, 140.4, 136.2, 136.1, 
135.4, 128.8, 128.5, 128.2, 127.8, 117.6, 117.1, 58.9, 52.8, 50.6, 48.5, 27.5, 24.9, 23.5; 
IR (neat) 2981, 1729, 1651, 1456, 1396, 1252, 1147, 918, 779 cm-1; mass spectrum (CI) 
m/z 316.1912 [C19H25NO3 (M+1) requires 316.1913]. 
NMR Assignments.  1H NMR (400 MHz, CDCl3) δ 7.47 (d, J = 7.5 Hz, 1 H, C9-
H), 7.38 (d, J = 7.9 Hz, 1 H, C12-H), 7.26 (t, J = 7.5 Hz, 1H, C11-H), 7.20 (dt, J = 7.9, 
1.5 Hz, 1H, C10-H), 7.04 (dd, J = 17.1, 10.9 Hz, 1 H, C13-H), 6.36 (s, 1 H, C1-H), 5.57 
(dd, J = 17.1, 1.7 Hz, 1 H, C14-H), 5.32 (dd, J = 10.9, 1.7 Hz, 1 H, C14-H), 5.07-4.98 
(m, 1 H, C16-H), 4.80 (dd, J = 7.5, 1.4 Hz, 1 H, C17-H), 4.77 (dd, J = 14.2, 1.4 Hz, 1 H, 
C17-H), 3.78-3.79 (comp, 2 H, C15-H), 3.57 (s, 3 H, C4-H), 2.11 (s, 3 H, C19-H), 1.45 
(s, 3 H, C5 or C6-H), 1.33 (s, 3 H, C5 or C6-H); 13C NMR (100) MHz, CDCl3) δ 178.3 
(C3), 173.1 (C18), 140.4, 136.2 , 136.1, 135.4, 128.8, 128.5, 128.2, 127.8, 117.6 (C14 or 
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C17), 117.1 (C14 or C17), 58.9 (C1), 52.8 (C4), 50.6 (C2 or C15), 48.5 (C2 or C15), 27.5 

















1-Allyl-5,5-dimethyl-6-(2-vinylphenyl)piper idine-2,4-dione (2.151). (JDSII-
99A).   NaHMDS (540 mg, 2.95 mmol) was added to a solution of 2.149 (308 mg, 0.98 
mmol) in THF (38 mL) and the reaction was stirred for 2 h at room temperature.  
Saturated aqueous NH4Cl (15 mL) and H2O (15 mL) were then added.  The organic phase 
was removed and the aqueous layer was extracted with CH2Cl2 (2 x 10 mL).  The 
combined organics were washed with saturated aqueous NaCl (20 mL), dried (MgSO4), 
filtered, and concentrated under reduced pressure.  The residue was purified by flash 
chromatography eluting with EtOAc/Hexane (3:7) to give 240 mg (86%) of 2.151 as a 
light brownish solid. 1H NMR (400 MHz, CDCl3) δ  7.43 (dd, J = 7.5, 1.7 Hz, 1 H), 7.29-
7.21 (comp, 2 H), 6.99 (dd, J = 17.1, 10.9 Hz, 1 H), 6.74 (dd, J = 7.7, 1.2 Hz, 1 H), 
(dddd, J = 17.1, 9.9, 8.9, 4.4 Hz, 1H), 5.64 (dd, J = 17.1, 1.0 Hz, 1 H), 5.42 (dd, J = 10.9, 
1.4 Hz, 1 H), 5.28 (d, J = 9.9 Hz, 1 H), 5.23 (d, J = 17.1 Hz, 1 H),  4.80 (ddt, J = 14.7, 
4.4, 1.7 Hz, 1 H), 4.74 (s, 1 H), 3.63 (d, J = 21.2 Hz, 1 H), 3.5 (d, J = 21.2 Hz, 1 H), 2.96 
(dd, J = 14.7, 8.9 Hz, 1 H), 1.42 (s, 3 H), 0.80 (s, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 207.3, 166.9, 139.2, 135.9, 135.1, 133.3, 129.7, 129.5, 128.1, 125.8, 120.6, 
119.5, 64.2, 50.7, 48.5, 45.4, 26.6, 20.3; IR (neat) 2979, 1723, 1650, 1463, 1282, 931, 
755 cm-1; Mass spectrum (CI) m/z 284.1658 [C18H21NO2 (M+1) requires 284.1651]. 
NMR Assignments.  1H NMR (400 MHz, CDCl3) δ  7.43 (dd, J = 7.5, 1.7 Hz, 1 
H, C8-H), 7.29-7.21 (comp, 2 H, C9-H & C10-H), 6.99 (dd, J = 17.1, 10.9 Hz, 1 H, C12-
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H), 6.74 (dd, J = 7.7, 1.2 Hz, 1 H, C11-H), (dddd, J = 17.1, 9.9, 8.9, 4.4 Hz, 1H, C17-H), 
5.64 (dd, J = 17.1, 1.2 Hz, 1 H, 13-H), 5.42 (dd, J = 10.9, 1.2 Hz, 1 H, C13-H), 5.28 (d, J 
= 9.9 Hz, 1 H, C18-H), 5.23 (d, J = 17.1 Hz, 1 H, C18-H),  4.80 (ddt, J = 14.7, 4.4, 1.7 
Hz, 1 H, C16-H), 4.74 (s, 1 H, C5-H), 3.63 (d, J = 21.2 Hz, 1 H, C2-H), 3.5 (d, J = 21.2 
Hz, 1 H, C2-H), 2.96 (dd, J = 14.7, 8.9 Hz, 1 H, C18-H), 1.42 (s, 3 H, C14-H or C15-H), 
0.80 (s, 3 H, C14-H or C15-H); 13C NMR (100 MHz, CDCl3) δ 207.3 (C3), 166.9 (C1), 
139.2, 135.9, 135.1, 133.3, 129.7, 129.5, 128.1, 125.8, 120.6 (C13 or C18), 119.5 (C13 or 

















  1,1-Dimethyl-1,12b-dihydrobenzo[c]pyr ido[1,2-a]azepine-2,4(3H,6H)-dione 
(2.133).  (JDSII-101a).  Grubbs II catalyst (4 mg, 0.0053 mmol) was added to a solution 
of 2.151 (76 mg, 0.27 mmol) in CH2Cl2 (10 mL), and the reaction was heated under 
reflux for 22 h.  The reaction was then cooled to room temperature and concentrated 
under reduced pressure.  The residue was purified by flash chromatography eluting with 
EtOAc/Hex (2:3) to give 55 mg (80%) of 2.133 as a brownish amorphous solid.  1H NMR 
(400 MHz, CDCl3) δ  7.29-7.24 (comp, 2 H), 7.15 (dt, J = 8.2, 4.2 Hz, 1 H) 6.97 (d, J = 
7.9 Hz, 1 H), 6.60 (d, J = 12.3 Hz, 1 H), 5.95 (dt, J = 12.3, 3.4 Hz, 1 H), 5.30 (d, J = 19.2 
Hz, 1 H), 4.57 (s, 1 H), 3.85 (d, J = 19.2 Hz, 1 H), 3.32 (d, J = 20.5 Hz, 1 H), 3.17 (d, J = 
20.5 Hz, 1 H), 1.45 (s, 3 H), 1.30 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 209.4, 166.6, 
137.4, 136.1, 132.2, 130.3, 129.9, 128.8, 127.6, 125.3, 65.2, 49.2, 47.8, 47.0, 26.2, 21.5; 
IR (neat) 3426, 2974, 2244, 1722, 1660, 1462, 1376, 1310, 1269,1181, 952, 734 cm-1; 
mass spectrum (CI) m/z 256.1328 [C16H17NO2 (M+1) requires 256.1337]. 
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NMR Assignments. .  1H NMR (400 MHz, CDCl3) δ  7.29-7.24 (comp, 2 H, C8-
H & C10-H), 7.15 (dt, J = 8.2, 4.2 Hz, 1 H, C9-H) 6.97 (d, J = 7.9 Hz, 1 H, C7-H), 6.60 
(d, J = 12.3 Hz, 1 H, C12-H), 5.95 (dt, J = 12.3, 3.4 Hz, 1 H, C13-H), 5.30 (d, J = 19.2 
Hz, 1 H, C14-H), 4.57 (s, 1 H, C5-H), 3.85 (d, J = 19.2 Hz, 1 H, C14-H), 3.32 (d, J = 
20.5 Hz, 1 H, C2-H), 3.17 (d, J = 20.5 Hz, 1 H, C2-H), 1.45 (s, 3 H, C15-H or C16-H), 
1.30 (s, 3 H, C15-H or C16-H); 13C NMR (100 MHz, CDCl3) δ 209.4 (C3), 166.6 (C1), 
137.4, 136.1, 132.2, 130.3, 129.9, 128.8, 127.6, 125.3, 65.2, 49.2, 47.8, 47.0, 26.2 (C15 


















    14,14a-Dihydrobenzo[f]pyr ido[1,2-d][1,2,3]tr iazolo[1,5-a][1,4]diazepine-
11,13(9H,12H)-dione (2.155).  (JDSIV-228a).    A mixture containing propargyl amine 
(0.06 mL, 48 mg, 0.87 mmol), 2-azidobenzaldehyde (2.154)208 (116 mg, 0.79 mmol),  
activated 4 Å molecular sieves (~500 mg) in CH3CN (2 mL) was stirred for 12 h.  Freshly 
distilled acetyl chloride (0.07 mL, 77 mg, 0.98 mmol) and silyl ketene acetal 2.105 (286 
mg, 2.01 mg) were added, and the reaction was stirred for 28 h.  The reaction was then 
filtered thru celite washing with CH2Cl2 (3 x 5 mL), and the combined filtrate washings 
were concentrated under reduced pressure.  The residue was purified by flash 
chromatography eluting with EtOAc to give 181 mg (76%) of triazole 2.155 as a viscous 
colorless oil.  1H NMR (500 MHz, DMSO, 130 °C) δ 7.94 (d, J = 7.9 Hz, 1 H), 7.91 (s, 1 
H), 7.63 (t, J = 7.9 Hz, 1 H), 7.58 (d, J = 7.3 Hz, 1 H), 7.51 (t, J = 7.3 Hz, 1 H), 5.84 (s, 1 
H), 5.21 (d, J = 15.5 Hz, 1 H), 4.28 (d, J = 15.5 Hz, 1H), 3.43 (s, 3 H), 2.41 (dd,  J = 
15.3, 6.1 Hz, 1 H), 2.21 (s, 3 H), 1.80 (m, 1 H); 13C NMR (125 MHz, DMSO, 130 
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°C) δ 168.7, 168.1, 134.1, 132.2, 132.1, 131.0, 129.4, 128.5, 122.6, 55.1, 50.4, 38.0, 36.6, 
20.8; IR (neat) 1738, 1650, 1500, 1411, 1305, 1234, 1168, 980, 767 cm-1; mass spectrum 
(CI) m/z 301.1304 [C15H17N4O3 (M+1) requires 301.1301].  
NMR Assignments.  1H NMR (500 MHz, DMSO, 130 °C) δ 7.94 (d, J = 7.9 Hz, 
1 H, C7-H or C10-H ), 7.91 (s, 1 H, C13-H), 7.63 (t, J = 7.9 Hz, 1 H, C8-H or C9-H), 
7.58 (d, J = 7.3 Hz, 1 H, C7-H or C10-H), 7.51 (t, J = 7.3 Hz, 1 H, C8-H or C9-H), 5.84 
(s, 1 H, C1-H), 5.21 (d, J = 15.5 Hz, 1 H, C11-H), 4.28 (d, J = 15.5 Hz, 1H. C11-H), 3.43 
(s, 3 H, C4-H), 2.41 (dd,  J = 15.3, 6.1 Hz, 1 H, C2-H), 2.21 (s, 3 H, C15-H), 1.80 (m, 1 
H, C2-H); 13C NMR (125 MHz, DMSO, 130 °C) δ 168.7 (C3 or C14), 168.1 (C3 or 
C14), 134.1, 132.2, 132.1, 131.0, 129.4, 128.5, 122.6, 55.1 (C1 or C10), 50.4 (C11 or 




















(E)-tert-Butyl 5-(N-allylacetamido)-5-phenylpent-2-enoate (2.165). (JDSI-
166b).  Acetyl chloride (90 µL, 99 mg, 1.27 mmol) was added to a solution of imine 2.17 
(159 mg, 1.10 mmol) and silyl ketene acetal 2.162 (380 mg, 1.48 mmol) in CH2Cl2 (3 
mL) at −78 °C.  The reaction was stirred for 15 min, whereupon the cold bath was 
removed. The reaction was stirred for 18 h at room temperature and then was 
concentrated under reduced pressure.  The residue was purified by flash chromatography 
eluting with EtOAc/Hexane (gradient elution 1:3 to 1:1) to give 114 mg (31%) of amide 
2.165 as a viscous yellowish oil.  1H NMR (500 MHz, DMSO, 100 °C) δ 7.35-7.32 
(comp, 4 H), 7.30-7.26 (m, 1 H), 6.73-6.67 (m, 1 H), 5.82 (d, J = 15.8 Hz, 1 H), 5.65 (br, 
1 H) 5.50 (ddt, J = 16.2, 10.7, 5.6 Hz, 1 H),  4.99-4.92 (comp, 2 H), 3.83-3.78 (m, 1 H), 
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3.72-3.69 (m, 1 H), 2.89-2.83 (comp, 2 H), 2.04 (s, 3 H), 1.42 (s 9 H); 13C NMR (125 
MHz, DMSO, 100 °C) δ 169.6, 164.2, 143.6, 138.9, 134.6, 127.8, 127.3, 126.9, 124.3, 
115.5, 79.1, 55.6, 45.8, 32.5, 27.4, 21.3; IR (neat) 3411, 3063, 2977, 2932, 2245, 1956, 
1816, 1711, 1648, 1407, 1150, 981, 920, 701 cm-1; mass spectrum (CI) m/z 330.2069 
[C20H27BrNO3 (M+1) requires 330.2069]. 
NMR Assignments.  1H NMR (500 MHz, DMSO, 100 °C) δ 7.35-7.32 (comp, 4 
H, Ar-H), 7.30-7.26 (m, 1 H, Ar-H), 6.73-6.67 (m, 1 H, C3-H), 5.82 (d, J = 15.8 Hz, 1 H, 
C4-H), 5.65 (br s, 1 H, C1-H) 5.50 (ddt, J = 16.2, 10.7, 5.6 Hz, 1 H, C15-H),  4.99-4.92 
(comp, 2 H, C16-H), 3.83-3.78 (m, 1 H, C14-H), 3.72-3.69 (m, 1 H, C14-H), 2.89-2.83 
(comp, 2 H, C2-H), 2.04 (s, 3 H, C18-H), 1.42 (s 9 H, C7-H); 13C NMR (125 MHz, 
DMSO, 100 °C) δ 169.6 (C17), 164.2 (C5), 143.6 (C3), 138.9 (C8), 134.6 (C15), 127.8 
(C10 & C12 or C9 & C13) , 127.3 (C10 & C12 or C9 & C13), 126.9 (C11), 124.3 (C4), 

















































2.175 2.175a  
Methyl 2-(N-allyl-N-((2,5-dihydro-5-oxofuran-2-yl)(2-iodophenyl) methyl) 
carbamoyl) acetate (2.XX). (JDSII-192a and JDSII-192d).  A mixture containing 2-
iodobenzaldehyde (223 mg, 0.96 mmol), allylamine (0.08 mL, 61 mg, 1.07 mmol) and 
activated 4 Å molecular sieves (~500 mg) in CH2Cl2 (2 mL) was stirred for 13 h at room 
temperature.  The reaction was cooled to 0 °C and methyl malonyl chloride (0.13 mL, 
165 mg, 1.21 mmol) and silyloxy furan 2.174 (0.35 mL, 325 mg, 2.08 mmol) were added 
and the reaction was stirred for 15 min at 0 ºC.  The ice bath was removed, and the 
reaction was stirred at room temperature for 23 h.  The reaction was filtered through a 
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pad of Celite washing with CH2Cl2 (3 x 5 mL) and then concentrated under reduced 
pressure.  The residue was purified by flash chromatography eluting with EtOAc/Hex 
(gradient elution 2:3 to 1:1) to give 72 mg (16%) of 2.175 as a viscous yellowish oil and 
110 mg of a mixture of 2.175a and a side product resulting from the acylation of allyl 
amine by methyl malonyl chloride.  The mixture containg 2.175a was further purified by 
flash chromatography eluting with EtOAc/Hex (3:7) to give 54 mg (12%) of 2.175 as 
whitish gum.  2.175: 1H NMR (400 MHz, CDCl3) δ 8.06 (dd, J = 7.9, 1.4 Hz, 1 H), 7.92 
(dd, J = 7.9, 1.0 Hz, 1 H), 7.66 (dd, J = 5.5, 1.5 Hz, 1 H), 7.46 (dt, J = 7.9, 1.0 Hz, 1 H), 
7.08 (dt, J = 7.9, 1.4 Hz, 1 H),  6.12 (dd, J = 5.5, 2.0 Hz, 1 H), 6.00 (s, 1 H), 5.67 (d, J = 
1.7 Hz, 1 H), 5.17-5.27 (m, 1 H), 4.90 (s, 1 H), 4.86 (d, J = 6.5 Hz, 1 H), 3.89 (dd, J = 
17.6, 5.3 Hz, 1 H), 3.78-3.74 (comp, 1 H), 3.74 (s, 3 H), 3.53 (d, J = 15.4 Hz, 1 H), 3.36 
(d, J = 15.4 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 173.5, 169.3, 168.3, 156.3, 141.3, 
139.9, 134.0, 132.0, 131.4, 129.9, 121.7, 118.6, 103.2, 86.3, 62.8, 53.4, 50.2, 42.4; IR 
(neat) 2954, 2360, 1757, 1653, 1403, 1157, 1017, 909, 668 cm-1; mass spectrum (CI) m/z 
456.0307 [C18H18INO5 (M+1) requires 456.0308].  2.175a: 1H NMR (400 MHz, CDCl3) 
δ 7.90 (dd, J = 7.9, 1.0 Hz, 1 H), 7.77 (dd, J = 5.8, 1.7 Hz, 1 H), 7.64 (dd, J = 7.9, 1.4 Hz, 
1 H), 7.40 (dt, J = 7.9, 1.0 Hz, 1 H), 7.05 (dt, J = 7.9, 1.4 Hz, 1 H),  6.18 (dd, J = 5.8, 2.0 
Hz, 1 H), 5.76 (d, J = 8.9 Hz, 1 H), 5.51-5.41 (comp, 1 H), 5.42 (d, J = 8.9 Hz, 1H), 5.09 
(d, J = 4.1 Hz, 1 H), 5.05 (d, J = 11.6 Hz, 1 H), 3.84-3.82 (comp, 2 H), 3.78 (s, 3 H), 3.61 
(d, J = 16.1 Hz, 1 H), 3.50 (d, J = 16.1 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 173.4, 
169.3, 168.0, 156.7, 141.4, 138.7, 133.7, 131.4, 130.9, 129.5, 122.7, 119.3, 103.1, 82.7, 
65.8, 53.6, 49.7, 42.3; IR (neat) 2952, 1788, 1755, 1654, 1435, 1160, 1014, 942, 753 cm-
1; mass spectrum (CI) m/z 456.0310 [C18H18INO5 (M+1) requires 456.0308]. 
NMR Assignments. 2.175: 1H NMR (400 MHz, CDCl3) δ 8.06 (dd, J = 7.9, 1.4 
Hz, 1 H, C8-H), 7.92 (dd, J = 7.9, 1.0 Hz, 1 H, C11-H), 7.66 (dd, J = 5.5, 1.5 Hz, 1 H, 
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C3-H), 7.46 (dt, J = 7.9, 1.0 Hz, 1 H, C10-H), 7.08 (dt, J = 7.9, 1.4 Hz, 1 H, C9-H),  6.12 
(dd, J = 5.5, 2.0 Hz, 1 H, C4-H), 6.00 (s, 1 H, C1-H), 5.67 (d, J = 1.7 Hz, 1 H, C2-H), 
5.27-5.17 (m, 1 H, C13-H), 4.90 (br, 1 H, C14-H), 4.86 (d, J = 6.5 Hz, 1 H, C14-H), 3.89 
(dd, J = 17.6, 5.3 Hz, 1 H, C12-H), 3.74-3.78 (comp, 1 H, C12-H), 3.74 (s, 3 H, C18-H), 
3.53 (d, J = 15.4 Hz, 1 H, C16-H), 3.36 (d, J = 15.4 Hz, 1 H, C16-H); 13C 
NMR (100 MHz, CDCl3) δ 173.5 (C5), 169.3 (C15 or C17), 168.3 (C15 or C17), 156.3 
(C3), 141.3, 139.9, 134.0, 132.0, 131.4, 129.9, 121.7 (C4), 118.6 (C14), 103.2 (C7), 
86.3(C2), 62.8, 53.4, 50.2, 42.4. 2.175a: 1H NMR (400 MHz, CDCl3) δ 7.90 (dd, J = 7.9, 
1.0 Hz, 1 H, C8-H), 7.77 (dd, J = 5.8, 1.7 Hz, 1 H, C3-H), 7.64 (dd, J = 7.9, 1.4 Hz, 1 H, 
C11-H), 7.40 (dt, J = 7.9, 1.0 Hz, 1 H, C10-H), 7.05 (dt, J = 7.9, 1.4 Hz, 1 H, C9-H),  
6.18 (dd, J = 5.8, 2.0 Hz, 1 H, C4-H), 5.76 (d, J = 8.9 Hz, 1 H, C1 or C2), 5.51-5.41 
(comp, 1 H, C13-H), 5.42 (d, J = 8.9 Hz, 1H, C1 or C2), 5.09 (d, J = 4.1 Hz, 1 H, C14-
H), 5.05 (d, J = 11.6 Hz, 1 H, C14-H), 3.84-3.82 (comp, 2 H, C12-H), 3.78 (s, 3 H, C18-
H), 3.61 (d, J = 16.1 Hz, 1 H, C16-H), 3.50 (d, J = 16.1 Hz, 1 H, C16-H); 13C 
NMR (100 MHz, CDCl3) δ 173.4 (C5), 169.3 (C15 or C17), 168.0 (C15 or C17), 156.7 
(C3), 141.4, 138.7, 133.7, 131.4, 130.9, 129.5, 122.7 (C4), 119.3 (C14), 103.1 (C7), 82.7 


































(4.26). (JDSIV-233a). A solution of methylamine (~1.9 M in THF, 0.5 mL, 0.95 mmol) 
was added to a mixture of piperonal (0.92 mg, 0.61 mmol) in THF (1 mL) containing 
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activated 3 Å molecular sieves (8-12 mesh, ~750 mg), and the reaction was stirred for 18 
h. In a separate flask, a solution of piperonyl chloride357 (728 mg, 4.27 mmol) in THF (6 
mL) was added dropwise over 2 h to a suspension of magnesium turnings (170 mg) in 
THF (2.5 mL) at 0 °C, and the reaction was stirred for 3 h at 0 °C.  A solution of the 
Grignard reagent thus prepared (0.4 M in THF, 3.5 mL, 1.40 mmol) was added to the 
mixture of the imine, and the reaction was heated under reflux for 20 h.  The mixture was 
cooled to –78 °C, and diacetoxyacetyl chloride (4.25)359 (358 mg, 1.83 mmol) was added.  
The reaction was stirred for 2.5 h at –78 °C.  The cold bath was removed, and the mixture 
was partitioned between CH2Cl2 (5 mL) and sat. NaHCO3 (5 mL).  The organic phase was 
removed, and the aqueous layer was washed with CH2Cl2 (3 x 4 mL).  The combined 
organic layers were dried (MgSO4), filtered, and concentrated under reduced pressure.  
The residue was purified by flash chromatography eluting with EtOAc/Hexane (3:7) to 
give 173 mg (61%) of amide 4.26 as a pale yellow solid, mp 141–142.5 °C. 1H NMR 
(500 MHz, DMSO, 130 °C) δ 6.95 (s, 1 H), 6.88 (s, 1 H), 6.84 (comp, 2 H), 6.77 (d, J = 
1.4 Hz, 1 H), 6.74 (d, J = 7.9 Hz, 1 H), 6.70 (dd, J = 7.9, 1.5 Hz, 1 H ), 5.97 (d, J = 1.5 
Hz 2 H), 5.91 (s, 2 H), 5.63 (br, 1 H), 3.26 (dd, J = 14.3, 6.1 Hz, 1H), 3.10 (dd, J = 14.3, 
9.5 Hz, 1 H), 2.74 (s, 3 H), 2.04 (s, 6 H); 13C NMR (125 MHz, DMSO, 130 °C) δ 167.4, 
167.3, 162.8, 147.0, 146.6 146.1, 145.1, 132.1, 131.0, 121.2, 120.2, 108.4, 107.3, 107.3 
107.2, 100.3, 99.9, 83.9, 57.5, 35.0, 28.4, 19.3, 19.2; IR (neat) 1767, 1668, 1490, 1441, 
1246, 1198, 1038, 924 cm-1; mass spectrum (CI) m/z 458.1453 [C23H24BrNO9 (M+1) 
requires 458.1451]. 
NMR Assignments. 1H NMR (500 MHz, DMSO, 130 °C) δ 6.95 (s, 1 H, C19-
H), 6.88 (s, 1 H, C2-H or C10-H), 6.84 (comp, 2 H, C5-H and C6-H or C13-H and C14-
H), 6.77 (d, J = 1.4 Hz, 1 H, C2-H or C10-H ), 6.74 (d, J = 7.9 Hz, 1 H, C5-H, C6-H, 
C13-H, C14-H), 6.70 (dd, J = 7.9, 1.5 Hz, 1 H, C5-H, C6-H, C13-H, or C14-H), 5.97 (d, 
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J = 1.5 Hz, 2 H, C15-H or C16-H), 5.91 (s, 2 H, C15-H or C16-H ), 5.63 (br, 1 H, C7-H), 
3.26 (dd, J = 14.3, 6.1 Hz, 1H, C8-H), 3.10 (dd, J = 14.3, 9.5 Hz, 1 H, C8-H), 2.74 (s, 3 
H, C17-H), 2.04 (s, 6 H, C21-H and C23-H); 13C NMR (125 MHz, DMSO, 130 
°C) δ 167.4 (C20 or C22), 167.3 (C20 or C22), 162.8 (C18), 147.0 (C3, C4, C11, or 
C12), 146.6 (C3, C4, C11, or C12), 146.1 (C3, C4, C11, or C12), 145.1 (C3, C4, C11, or 
C12), 132.1 (C1 or C9), 131.0 (C1 or C9), 121.2 (C6 or C14), 120.2 (C6 or 14), 108.4 
(C2, C5, C10, or C13), 107.3 (C2, C5, C10, or C13), 107.3, (C2, C5, C10, or C13),  
107.2 (C2, C5, C10, or C13), 100.3, (C15 or C16), 99.9 (C15 or C16), 83.9 (C19), 57.5 
























(±)- Roelactamine (±-4.11). (JDSIV-251a).  A solution of conc. HCl/MeOH 
(2:1, 5 mL) was added to amide 4.26 and the reaction was stirred for 8 h at room 
temperature.  The reaction was diluted with CH2Cl2 (5 mL) and carefully quenched with 
2 M Na2CO3 (10 mL) and sat. NaHCO3 (5 mL).  The organic phase was removed, and the 
aqueous layer was washed with CH2Cl2 (3 x 5 mL).  The combined organic layers were 
dried (MgSO4), filtered, and concentrated under reduced pressure.  The residue was 
purified by flash chromatography eluting with EtOAc/Hexane (2:3) to give 58 mg (68%) 
of 4.11 as a white foam.  1H NMR (400 MHz, CDCl3,) δ 6.75 (s, 1 H), 6.73 (s, 1 H), 6.69 
(s, 1 H), 6.46 (s, 1 H), 5.93 (d, J = 1.4 Hz, 1 H), 5.89 (d, J = 1.4 Hz, 1 H), 5.87 (d, J = 1.4 
Hz, 1 H), 5.85 (d, J = 1.4 Hz, 1 H), 4.39 (dd, J = 4.2, 2.6 Hz, 1 H), 4.25 (s, 1 H), 3.33 (dd, 
J = 17.3, 4.2 Hz, 1 H), 3.10 (s, 3 H), 2.95 (dd, J = 17.3, 2.6 Hz, 1 H);  13C NMR (100 
MHz, CDCl3) δ 173.6, 148.1, 148.0, 147.4, 147.0, 135.1, 130.3, 130.2, 127.0, 112.2, 
110.0, 107.0, 106.3, 102.1, 101.9, 61.5, 57.4, 34.8, 33.3; IR (neat) 2895, 1661, 1504, 
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1482, 1228, 1038, 941, 873 cm-1;  mass spectrum (CI) m/z 338.1026 [C19H16NO5 (M+1) 
requires 338.1028].  
NMR Assignments.  1H NMR (400 MHz, CDCl3,) δ 6.75 (s, 1 H, C10-H), 6.73 
(s, 1 H, C6-H), 6.69 (s, 1 H, C2-H), 6.46 (s, 1 H. C15-H), 5.93 (d, J = 1.4 Hz, 1 H, C8-
H), 5.89 (d, J = 1.4 Hz, 1 H, C8-H), 5.87 (d, J = 1.4 Hz, 1 H, C17-H), 5.85 (d, J = 1.4 Hz, 
1 H, C17-H), 4.39 (dd, J = 4.2, 2.6 Hz, 1 H, C12-H), 4.25 (s, 1 H, C4-H), 3.33 (dd, J = 
17.3, 4.2 Hz, 1 H, C13-H), 3.10 (s, 3 H, C19-H), 2.95 (dd, J = 17.3, 2.6 Hz, 1 H, C13-H);  
13C NMR (100 MHz, CDCl3) δ 173.6 (C18), 148.1 (C1 or C9), 148.0 (C1 or C9), 147.4 
(C7), 147.0 (C16), 135.1 (C3), 130.3 (C5), 130.2 (C11), 127.0 (C14), 112.2 (C15), 110.0 
(C2), 107.0 (C10), 106.3 (C6), 102.1 (C8), 101.9 (C17), 61.5 (C12), 57.4 (C4), 34.8 


















1H NMR Data 
Synthetic 
1H NMR Data 
Literature 
13C NMR Data 
Synthetic 
13C NMR Data 
6.75 (s) 6.75 (s) 172.3 172.6 
6.73 (s) 6.73 (s) 147.1 147.1 
6.69 (s) 6.69 (s) 147.1 147.0 
6.46 (s) 6.46 (s) 146.4 146.4 
5.93 (d, J = 1.4 Hz) 5.93 (d, J = 1.4 Hz) 146.0 146.0 
5.89 (d, J =1.4 Hz) 5.89 (d, J = 1.4. Hz) 134.2 134.1 
5.87 (d, J = 1.4 Hz) 5.87 (d, J = 1.4 Hz) 129.4 129.3 
5.85 (d, J = 1.4 Hz) 5.85 (d, J = 1.4 Hz) 129.3 129.2 
4.39 (dd, J = 4.2, 
2.6 Hz) 
4.39 (dd, J = 4.2, 
2.6 Hz) 
126.0 126.0 
4.25 (s) 4.25 (s) 111.2 111.2 
3.33 (dd, J = 17.3, 
4.2 Hz) 
3.33 (dd, J = 17.3, 
4.2 Hz) 
109.1 109.0 
3.10 (s) 3.10 (s) 106.1 106.0 
2.95 (dd, J = 17.3, 
2.6 Hz) 
2.95 (dd, J = 17.3, 
2.6 Hz) 
105.3 105.3 
  101.3 101.1 
  100.9 100.9 
  60.7 60.5 
  56.5 56.4 
  33.9 33.8 































N-Allyl-1-phenyl-2-vinylbut-3-en-1-amine (4.60) and (E)-N-allyl-1-
phenylhexa-3,5-dien-1-amine (4.61).  (JDSV-106a).  n-BuLi (0.4 mL, 2.3 M in hexane, 
0.94 mmol) was added to a solution of 1,4-pentadiene (0.1 mL, 66 mg, 0.97 mmol) in 
THF (0.5 mL) at -78 ºC.  The reaction was stirred at -78 ºC for 15 min, whereupon the 
bath was replaced with a 0 ºC bath.  The reaction was stirred for an additional 30 min at 0 
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ºC.  A solution of AlCl3 (140 mg, 1.05 mmol) in Et2O (1 mL) was then added and the 
reaction was stirred for 1 h at 0 ºC.  The pentadienyl Al reagent 4.58 thus prepared was 
added to a solution of imine 4.59 (112 mg, 0.77 mmol) in CH2Cl2 (2 mL) and the reaction 
was stirred for 18 h at room temperature.  H2O (3 mL) and 6 M NaOH (4 mL) where 
added, and the mixture was filtered through a pad of Celite washing with CH2Cl2 (3 x 5 
mL).  The layers were separated, and the aqueous phase was washed with CH2Cl2 (2 x 5 
mL).  The combined organics were dried (MgSO4), filtered and concentrated under 
reduced pressure.  The residue was purified by flash chromatography eluting with 
EtOAc/hexane (1:9 to 1:3) to give 116 mg (70%) of amine 4.60 and 4 mg (2%) of amine 
4.61 as colorless oils.  4.60: 1H NMR (400 MHz, CDCl3) δ 7.33-7.21 (comp, 5H), 5.87-
5.72 (comp, 2 H), 5.59 (ddd, J = 17.8, 10.8, 7.2 Hz, 1 H), 5.19-5.03 (comp, 4 H), 4.95-
4.89 (comp, 2 H), 3.58 (d, J = 7.9 Hz, 1 H), 3.08 (ddt, J = 14.3, 5.2, 1.7 Hz, 1 H), 3.02 
(dt, J = 7.8, 7.8 Hz, 1 H), 2.94 (ddt, J = 14.3, 6.8, 1.0 Hz, 1H) ;  13C NMR (100 MHz, 
CDCl3) δ 141.4, 138.1, 137.7, 136.8, 128.3, 127.9, 127.0, 117.4, 116.0, 115.6, 65.1, 55.1, 
49.7; IR (neat) 3078, 2977, 2817, 1642, 1453, 1111, 994, 917, 700 cm-1; mass spectrum 
(CI) m/z 214.2601 [C15H20N (M+1) requires 214.1596]. 
NMR Assignments.  4.60:  1H NMR (400 MHz, CDCl3) δ 7.33-7.21 (comp, 5H, 
Ar-H), 5.87 -5.72 (comp, 2 H, C12-H and C3-H or C5-H), 5.59 (ddd, J = 17.8, 10.8, 7.2 
Hz, 1 H, C3-H or C5-H), 5.19-5.03 (comp, 4 H, C3-H, C5-H, or C12-H), 4.95-4.89 
(comp, 2 H, C3-H, C5-H, or C12-H ), 3.58 (d, J = 7.9 Hz, 1 H, C1-H), 3.08 (ddt, J = 
14.3, 5.2, 1.7 Hz, 1 H, C11-H), 3.02 (dt, J = 7.9, 7.9 Hz, 1 H, C2-H), 2.94 (ddt, J = 14.3, 
6.8, 1.0 Hz, 1H, C11-H);  13C NMR (100 MHz, CDCl3) δ 141.4 (C3 or C5), 138.1 (C12), 
137.7 (C3 or C5), 136.8 (C7), 128.3 (C8 or C9), 127.9 (C8 or C9), 127.0 (C10), 117.4 






































N-Allyl-N-(1-phenyl-2-vinylbut-3-enyl)acetamide (4.65) and N-allyl-N-((E)-1-
phenylhexa-3,5-dienyl)acetamide (4.66).  (JDSV-195a).  n-BuLi (0.4 mL, 2.3 M in 
hexane, 0.94 mmol) was added to a solution of 1,4-pentadiene (0.1 mL, 66 mg, 0.97 
mmol) in THF (0.5 mL) at -78 ºC.  The reaction was stirred at -78 ºC for 15 min, 
whereupon the bath was replaced with a 0 ºC bath.  The reaction was stirred for an 
additional 30 min at 0 ºC.  A solution of AlCl3 (140 mg, 1.05 mmol) in Et2O (1 mL) was 
added, and the reaction was stirred for 1 h at 0 ºC.  In a separate flask freshly distilled 
acetyl chloride (0.06 mL, 66 mg, 0.84 mmol) was added to a solution of imine 4.17 (111 
mg, 0.77 mmol) in CH2Cl2 (2 mL) and the reaction was stirred for 1 h upon which the 
solution of pentadienyl Al 4.58 was added.  The reaction was stirred at rt for 3 h.  The 
reaction was partitioned between CH2Cl2 (5 mL) and sat. NH4Cl (5 mL).  The organic 
phase was removed, and the aqueous layer was washed with CH2Cl2 (2 x 5 mL).  The 
combined organic layers were dried (MgSO4), filtered and concentrated under reduced 
pressure.  The residue was purified by flash chromatography eluting with EtOAc/hexane 
(1:3) to give 164 mg (84%) of a mixture (~1:1) of amides 4.65 and 4.66 as a colorless oil.  
1H NMR (400 MHz, CDCl3) δ 7.40-7.22 (comp, 10 H), 6.26 (dt, J = 17.0, 10.1 Hz, 1 H), 
6.15 (dd, J = 15.2, 10.1 Hz, 1 H), 5.79 (dt, J = 17.5, 8.8 Hz, 1 H), 5.69-5.42 (comp, 5 H), 
5.30 (dddd, J = 15.6, 10.4, 5.2, 5.2 Hz, 1 H), 5.18-4.94 (comp, 8 H), 4.86-4.82 (m, 2H), 
3.87-3.79 (comp, 4 H), 3.71 (dd, J  = 16.8, 5.9 Hz, 1 H), 2.86-2.72 (comp, 2 H), 2.05 (s, 3 
H), 2.00 (s, 3 H);  13C NMR (100 MHz, CDCl3) δ 169.3, 139.3, 138.0, 137.7, 137.5, 
136.2, 134.7, 134.4, 132.2, 130.7, 130.4, 128.6, 127.5, 127.3, 127.2, 126.6, 126.5, 115.6, 
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115.2, 115.1, 114.9, 114.6, 46.8, 39.7, 33.1, 21.2, 21.1; IR (neat) 2976, 1644, 1452, 1406, 
1316, 1250, 1176, 1003, 918, 701 cm-1; mass spectrum (CI) m/z 256.1696 [C17H22NO 























227).  A mixture containing indole-3-carboxaldehyde 2.97 (224 mg, 0.74 mmol), 
allylamine (0.15 mL, 114 mg, 2.0 mmol) and activated 4 Å molecular sieves (~500 mg) 
in CH2Cl2 (3 mL) was stirred for 20 h at room temperature.  The reaction was filtered 
through a pad of Celite that was washed with CH2Cl2 (3 x 5 mL) and the filtrate was 
concentrated under reduced pressure to give 246 mg (97%) of 4.98 as an orangish brown 
oil.  1H NMR (400 MHz, CDCl3) δ 8.44 (s, 1 H), 8.35 (d, J = 7.9 Hz, 1 H), 7.96 (d, J = 
7.9 Hz, 1 H), 7.83 (s, 1 H), 7.78 (d, J = 8.2 Hz, 2 H), 7.36 (t, J = 7.9 Hz, 1 H), 7.29 (t, J = 
7.9 Hz, 1 H), 7.23 (d, J = 8.2 Hz, 2 H), 6.09 (dddd, J = 17.1, 10.3, 5.5, 4.8 Hz, 1 H) 5.27 
(d, J = 17.1 Hz, 1 H), 5.23 (d, J = 10.3 Hz, 1 H), 4.25 (d, J = 5.8 Hz, 1 H), 2.34 (s, 3 H);  
13C NMR (100 MHz, CDCl3) δ 154.9, 145.2, 136.0, 135.3, 134.6, 129.9, 129.5, 127.9, 
126.8, 125.4, 124.0, 123.0, 120.5, 115.6, 113.1, 63.9, 21.4; IR (neat) 1647, 1445, 1268, 
1175, 1126, 1099, 983, 750 cm-1; mass spectrum (CI) m/z 339.1167 [C19H18N2O2S (M+1) 
requires 339.11671]. 
NMR Assignments.  1H NMR (400 MHz, CDCl3) δ 8.44 (s, 1 H, C8-H), 8.35 (d, J = 7.9 
Hz, 1 H, C7-H), 7.96 (d, J = 7.9 Hz, 1 H, C4-H), 7.83 (s, 1 H, C1-H), 7.78 (d, J = 8.2 Hz, 
2 H, C13-H), 7.36 (t, J = 7.9 Hz, 1 H, C6-H), 7.29 (t, J = 7.9 Hz, 1 H, C5-H), 7.23 (d, J = 
8.2 Hz, 2 H, C14-H), 6.09 (dddd, J = 17.1, 10.3, 5.5, 4.8 Hz, 1 H, C10-H) 5.27 (d, J = 
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17.1 Hz, 1 H, C11-H), 5.23 (d, J = 10.3 Hz, 1 H, C11-H), 4.25 (d, J = 5.8 Hz, 1 H, C9-
H), 2.34 (s, 3 H, C16-H);  13C NMR (100 MHz, CDCl3) δ 154.9 (C8), 145.2 (C15), 136.0, 
135.3, 134.6, 129.9, 129.5, 127.9, 126.8, 125.4, 124.0, 123.0, 120.5, 115.6, 113.1, 63.9 




















































N-Allyl-1-(1-tosyl-1H-indol-3-yl)-2-vinylbut-3-en-1-amine (4.100) and (E)-N-
allyl-1-(1-tosyl-1H-indol-3-yl)hexa-3,5-dien-1-amine (4.101). (JDSV-120a and JDSV-
120b).  n-BuLi (0.4 mL, 2.3 M in hexane, 0.94 mmol) was added to a solution of 1,4-
pentadiene (0.1 mL, 66 mg, 0.97 mmol) in THF (0.5 mL) at -78 ºC.  The reaction was 
stirred at -78 ºC for 15 min, whereupon the bath was replaced with a 0 ºC bath.  The 
reaction was stirred for an additional 30 min at 0 ºC.  A solution of AlCl3 (135 mg, 1.01 
mmol) in Et2O (1 mL) was added and the reaction was stirred for 1 h at 0 ºC.  The 
pentadienyl Al reagent 4.58 thus prepared was added to a solution of imine 4.98 (228 mg, 
0.67 mmol) in CH2Cl2 (2 mL) and the reaction was stirred for 20 h at rt.  The reaction was 
partitioned between 3 M NaOH (4 mL) and CH2Cl2 (5 mL).  The layers organic phase 
was removed, and the aqueous layer was washed with CH2Cl2 (3 x 5 mL).  The combined 
organic layers were dried (MgSO4), filtered and concentrated under reduced pressure.  
The residue was purified by flash chromatography eluting with EtOAc/hexane (1:4) to 
give 235 mg (85%) of amine 4.100 and 10 mg (3%) of amine 4.101 as colorless gums.  
4.100: 1H NMR (500 MHz, CDCl3) δ  7.97 (d, J = 8.3 Hz, 1 H), 7.71-7.66 (comp, 3 H), 
7.43 (s, 1 H), 7.28 (td, J = 7.8, 1.1 Hz 1 H), 7.20 (t, J = 7.8 Hz, 1 H), 7.17 (d, J = 8.0 Hz, 
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1 H), 5.82-5.70 (comp, 2 H), 5.63 (ddd, J = 17.4, 10.0, 7.6 Hz, 1 H), 5.14 (dd, J = 10.2, 
1.5 Hz, 1 H), 5.09 (d, J = 17.1 Hz, 1 H), 5.03-5.02 (m, 1 H), 5.00-4.99 (m, 1 H), 4.88-
4.86 (m, 1 H), 4.85-4.84 (m, 1 H), 3.88 (d, J = 7.6 Hz, 1 H), 3.15 (app q, J = 7.6 Hz, 1 H), 
3.10 (ddt, J = 14.1, 5.1, 1.7 Hz, 1 H), 2.96 (ddt, J = 14.1, 5.7,  1.1 Hz, 1 H), 2.32 (s, 3 H), 
1.59 (br, 1 H);  13C NMR (100 MHz, CDCl3) δ 144.7, 137.8, 137.7, 136.8, 135.7, 135.2, 
130.4, 139.7, 126.7, 124.9, 124.6, 123.3, 123.0, 120.8, 117.7, 116.3, 115.8, 113.9, 57.8, 
53.7, 49.9, 21.5; IR (neat) 3333, 2977, 1446, 1367, 1175, 1121, 1094, 918, 747, 670 cm-1; 
mass spectrum (CI) m/z 407.1794 [C24H27N2O2S (M+1) requires 407.1793].  4.101: 1H 
NMR (400 MHz, CDCl3) δ 7.98 (d, J = 8.2 Hz, 1 H), 7.72 (d, J = 8.5 Hz, 2 H), 7.65 (d, J 
= 7.9 Hz, 1 H), 7.46 (s, 1 H), 7.28 (t, J = 7.2 Hz, 1 H), 7.21 (td, J =  8.2, 1.0 Hz, 1 H) 7.20 
(d, J = 7.9 Hz, 2 H), 6.24 (dt, J = 17.1, 10.2 Hz, 1 H), 6.08 (dd, J = 15.0, 10.6 Hz, 1 H), 
5.83 (dddd, J = 16.7, 10.3, 6.5, 5.5 Hz, 1 H), 5.55 (dt, J = 15.0, 7.52 Hz, 1 H), 5.11-4.99 
(comp, 4 H), 4.00 (t, J = 6.5 Hz, 1 H), 3.16 (ddt, J = 14.0, 5.5, 1.4 Hz, 1 H), 3.08 (ddt, J = 
14.0, 6.5 Hz, 1.4 Hz, 1 H), 2.56 (comp, 2 H) 2.33 (s, 3 H), 1.54 (s, 1 H);  13C NMR (100 
MHz, CDCl3) δ 144.7, 136.8, 136.7, 135.7, 135.2, 133.8, 130.7, 129.8, 129.8 129.7, 
126.7, 126.7, 124.7, 124.6, 123.7, 123.0, 120.3, 116.0, 115.9, 113.9, 54.3, 50.0, 39.3, 
21.5; IR (neat) 2922, 1642, 1598, 1446, 1367, 1174, 1120, 1004, 747, 688, 572 cm-1; 
mass spectrum (CI) m/z 407.1797 [C24H27N2O2S (M+1) requires 407.1793]. 
NMR Assignments. 4.100: 1H NMR (500 MHz, CDCl3) δ  7.97 (d, J = 8.3 Hz, 1 
H, C13-H), 7.71-7.66 (comp, 3 H, C10 and C16-H ), 7.43 (s, 1 H, C7-H), 7.28 (td, J = 
7.8, 1.1 Hz, 1 H, C12-H), 7.20 (t, J = 7.8 Hz, 1 H, C11-H), 7.17 (d, J = 8.0 Hz, 1 H, C17-
H), 5.82-5.70 (comp, 2 H, C3, C5, or C21-H), 5.63 (ddd, J = 17.4, 10.0, 7.6 Hz, 1 H, C3 
or C5-H), 5.14 (dd, J = 10.2, 1.5 Hz, 1 H, C4 or C6-H), 5.09 (d, J = 17.1 Hz, 1 H, C4 or 
C6-H), 5.03-5.02 (m, 1 H, C21-H), 5.00-4.99 (m, 1 H, C21-H), 4.88-4.86 (m, 1 H, C4 or 
C6-H), 4.85-4.84 (m, 1 H, C4 or C6-H), 3.88 (d, J = 7.6 Hz, 1 H, C1-H), 3.15 (app q, J = 
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7.6 Hz, 1 H, C2-H), 3.10 (ddt, J = 14.1, 5.1, 1.7 Hz, 1 H, C20-H), 2.96 (ddt, J = 14.1, 5.7,  
1.1 Hz, 1 H, C20-H), 2.32 (s, 3 H, C19-H), 1.59 (br, 1 H, NH);  13C NMR (100 MHz, 
CDCl3) δ 144.7 (C18), 137.8 (C3 or C5), 137.7 (C3 or C5), 136.8 (C21), 135.7 (C14 or 
C15), 135.2 (C14 or C15), 130.4 (C3), 129.7 (C17), 126.7 (C16), 124.9 (C7), 124.6 
(C12), 123.3 (C8), 123.0 (C5), 120.8 (C4), 117.7 (C4 or C6), 116.3 (C22), 115.8 (C4 or 
C6), 113.9 (C7), 57.8 (C1), 53.7 (C2), 49.9 (C20), 21.5 (C19) 4.101:  1H NMR (400 
MHz, CDCl3) δ 7.98 (d, J = 8.2 Hz, 1 H, C13-H), 7.72 (d, J = 8.5 Hz, 2 H, C16-H), 7.65 
(d, J = 7.9 Hz, 1 H, C10-H), 7.46 (s, 1 H, C7-H), 7.28 (t, J = 7.2 Hz, 1 H, C11-H or C12-
H), 7.21 (td, J =  8.2, 1.0 Hz, 1 H, C11-H or C12-H) 7.20 (d, J = 7.9 Hz, 2 H, C17-H), 
6.24 (dt, J = 17.1, 10.2 Hz, 1 H, C5-H), 6.08 (dd, J = 15.0, 10.6 Hz, 1 H, C4-H), 5.83 
(dddd, J = 16.7, 10.3, 6.5, 5.5 Hz,1 H, C21-H), 5.55 (dt, J = 15.0, 7.52 Hz, 1 H, C3-H), 
5.11-4.99 (comp, 4 H, C6-H and C22-H), 4.00 (t, J = 6.5 Hz, 1 H, C1-H), 3.16 (ddt, J = 
14.0, 5.5, 1.4 Hz, 1 H, C20-H), 3.08 (ddt, J = 14.0, 6.5 Hz, 1.4 Hz, 1 H, C20-H), 2.56 
(comp, 2 H, C2-H) 2.33 (s, 3 H, C19-H), 1.54 (s, 1 H, NH);  13C NMR (100 MHz, CDCl3) 
δ 144.7, 136.8, 136.7, 135.7, 135.2, 133.8, 130.7, 129.8 (C17), 129.8 (C17) 129.7, 126.7 
(C16), 126.7 (C16), 124.7, 124.6, 123.7, 123.0, 120.3, 116.0, 115.9, 113.9, 54.3 (C1), 






























ethanamine (4.116).  (JDSV-228).  A mixture containing indole-3-carboxaldehyde 2.97 
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(225 mg, 0.75 mmol), amine 4.115 (260 mg, 0.77 mmol), triethylamine (0.11 mL, 80 mg, 
0.79 mmol) and activated 4 Å molecular sieves (~500 mg) in CH2Cl2 (3 mL) was stirred 
for 22 h at room temperature.  The stirred was stopped and Et2O (8 mL) was added and 
the reaction was allowed to sit for 5 min.  The reaction was filtered through a pad of 
Celite that was washed with Et2O (3 x 5 mL) and the filtrate was concentrated under 
reduced pressure to give 434 mg (99%) of 4.116 as an orangish brown oil.  1H NMR (400 
MHz, CDCl3) δ 8.45 (s, 1 H), 8.34 (d, J = 7.9 Hz, 1 H), 7.97 (d, J = 7.9 Hz, 1 H), 7.81 (s, 
1 H), 7.74 (d, J = 8.5 Hz, 2 H), 7.64-7.61 (comp, 4 H), 7.39-7.28 (comp, 4 H), 7.27-7.23 
(comp, 5 H), 7.17 (d, J = 8.5 Hz, 2 H), 3.96 (t, J = 5.4 Hz, 2 H), 3.78 (t, J = 5.4 Hz, 2 H), 
2.31 (s, 3 H), 0.97 (s, 9 H);  13C NMR (100 MHz, CDCl3) δ 155.8, 145.2, 135.6, 135.5, 
134.8, 133.6, 129.9, 129.6, 129.5, 128.1, 127.5, 126.8, 125.5, 124.0, 123.2, 120.8, 113.2, 
64.1, 63.2, 26.7, 21.5, 19.1; IR (neat) 2929, 1644, 1445, 1268, 1176, 1112, 979, 703 cm-1; 
mass spectrum (CI) m/z 581.2296 [C34H36N2O3SSi (M+1) requires 581.2294]. 
NMR Assignments.  1H NMR (400 MHz, CDCl3) δ 8.45 (s, 1 H, C8-H), 8.34 (d, 
J = 7.9 Hz, 1 H, C7-H), 7.97 (d, J = 7.9 Hz, 1 H, C4-H), 7.81 (s, 1 H, C1-H), 7.74 (d, J = 
8.5 Hz, 2 H, C17-H), 7.64-7.61 (comp, 4 H, Ar-H), 7.39-7.28 (comp, 4 H, Ar-H), 7.27-
7.23 (comp, 5 H, Ar-H), 7.17 (d, J = 8.5 Hz, 2 H, C18-H), 3.96 (t, J = 5.4 Hz, 2 H, C10-































yl)methylene)ethanamine (4.117). (JDSV-229).  A mixture containing indole-3-
carboxaldehyde 2.114 (220 mg, 0.77 mmol), amine 4.115 (263 mg, 0.78 mmol), 
triethylamine (0.11 mL, 80 mg, 0.79 mmol) and activated 4 Å molecular sieves (~500 
mg) in CH2Cl2 (3 mL) was stirred for 22 h at room temperature.  The stirring was stopped 
and Et2O (8 mL) was added and the reaction was allowed to sit for 5 min.  The reaction 
was filtered through a pad of Celite that was washed with Et2O (3 x 5 mL) and the filtrate 
was concentrated under reduced pressure to give 438 mg (100%) of 4.117 as an orangish 
brown oil.  1H NMR (400 MHz, CDCl3) δ 8.45 (s, 1 H), 8.34 (d, J = 7.9 Hz, 1 H), 7.98 (d, 
J = 7.9 Hz, 1 H), 7.88-7.85 (m, 2 H), 7.82 (s, 1 H), 7.64-7.61 (comp, 4 H), 7.52 (td, J = 
7.5, 1.4 Hz, 1 H), 7.43-7.29 (comp, 6 H), 7.27-7.23 (comp, 4 H), 3.96 (t, J = 5.2 Hz, 2 H), 
3.78 (t, J = 5.2 Hz, 2 H), 0.97 (s, 9 H);  13C NMR (100 MHz, CDCl3) δ 155.7, 137.8, 
135.6, 135.5, 134.0, 133.6, 129.5, 129.4, 129.3, 128.1, 127.5, 126.7, 125.6, 124.1, 123.2, 
120.9, 113.2, 64.1, 63.2, 26.7, 19.1; IR (neat) 2929, 1644, 1446, 1379, 1268, 1176, 1112, 
979, 727, 702 cm-1; mass spectrum (CI) m/z 567.2142 [C33H34N2O3SSi (M+1) requires 
567.2138]. 
NMR Assignments.  1H NMR (400 MHz, CDCl3) δ 8.45 (s, 1 H, (C8-H), 8.34 (d, 
J = 7.9 Hz, 1 H, C7-H), 7.98 (d, J = 7.9 Hz, 1 H, C4-H), 7.88-7.85 (m, 2 H, C17-H), 7.82 
(s, 1 H, C1-H), 7.64-7.61 (comp, 4 H, Ar-H), 7.52 (td, J = 7.5, 1.4 Hz, 1 H, C19-H), 7.43-
7.29 (comp, 6 H, Ar-H), 7.27-7.23 (comp, 4 H, Ar-H), 3.96 (t, J = 5.2 Hz, 2 H, C10-H), 


































































diphenyl-silanyloxy)-ethyl]-amine (4.119) and ([1-(1-Benzenesulfonyl-1H-indol-3-yl)-
hexa-3,5-dienyl]-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-amine (4.121). (JDSV-
188a and JDSV-188b).  n-BuLi (0.45 mL, 2.1 M in hexane, 0.94 mmol) was added to a 
solution of 1,4-pentadiene (0.1 mL, 66 mg, 0.97 mmol) in THF (0.5 mL) at -78 ºC.  The 
reaction was stirred at -78 ºC for 15 min, whereupon the bath was replaced with a 0 ºC 
bath.  The reaction was stirred for an additional 30 min at 0 ºC.  A solution AlCl3 (134 
mg, 1.0 mmol) in Et2O (1 mL) was added and the reaction was stirred for 1 h at 0 ºC.  
The pentadienyl Al reagent 4.58 thus prepared was then added to a solution of imine 
4.117 (382 mg, 0.67 mmol) in CH2Cl2 (2 mL) and the reaction was stirred for 25 h at rt.  
The reaction was partitioned between 3 M NaOH (6 mL) and CH2Cl2 (5 mL).  The layers 
organic phase was removed, and the aqueous layer was washed with CH2Cl2 (3 x 5 mL).  
The combined organic layers were dried (MgSO4), filtered and concentrated under 
reduced pressure.  The residue was purified by flash chromatography eluting with 
EtOAc/hexane (1:9 to 1:4) to give 301 mg (70%) of amine 4.119 and 10 mg (9%) of 
amine 4.121 as colorless gums.  4.119: 1H NMR (500 MHz, CDCl3) δ 7.97 (d, J = 8.0 
Hz, 1 H), 7.79-7.77 (m, 2H), 7.69 (d, J = 8.0 Hz, 1 H), 7.67-7.64 (comp, 4 H), 7.46 (td, J 
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= 7.5, 1.4 Hz, 1 H), 7.44-7.40 (comp, 3 H), 7.38-7.33 (comp, 6 H), 7.28 (t, J = 8.0 Hz, 1 
H), 7.17 (t, J = 8.0 Hz, 1 H), 5.77 (ddd, J = 17.1, 10.3, 8.8 Hz, 1 H), 5.62 (ddd, J = 17.4, 
10.0, 7.3 Hz, 1 H), 5.13 (d, J = 10.3 Hz, 1 H), 5.11 (d, J = 17.1 Hz, 1 H), 4.85-4.81 
(comp, 2 H), 3.84 (d, J = 7.6 Hz, 1 H), 3.69-3.62 (comp, 2 H), 3.15 (app q, 7.8 Hz, 1 H), 
2.55-2.46 (comp, 2 H), 2.20 (br, 1 H), 1.05 (s, 9 H); 13C NMR (125 MHz, CDCl3) 
δ 138.1, 137.8, 137.7, 135.8, 135.61, 135.57, 133.7, 133.6, 130.3, 129.68, 129.66, 129.0, 
127.66, 127.65, 126.6, 124.8, 124.6, 123.9, 123.1, 121.0, 117.8, 116.2, 113.8, 630, 58.5, 
54.0, 49.3, 26.9, 19.2; IR (neat) 2930, 1446, 1369, 1175, 1112, 919, 745 cm-1; mass 
spectrum (CI) m/z  635.2766 [C38H42N2O3SSi (M+1) requires 635.2764].  4.121: 1H 
NMR (400 MHz, CDCl3) δ 8.22 (d, J = 8.5 Hz, 1 H), 7.72-7.69 (comp, 4 H), 4.66-7.64 
(comp, 3 H),  7.52 (s, 1 H), 7.20-7.18 (comp, 6 H), 7.12-7.08 (m, 1 H), 7.00 (t, J = 7.5 
Hz, 1 H), 6.65-6.57 (comp, 2 H), 6.16 (dt, J = 17.0, 10.3 Hz, 1 H), 5.96 (dd, J = 15.1, 
10.8 Hz, 1 H), 5.44 (dt, J = 15.1, 7.5 Hz, 1 H), 4.96 (d, J = 17.0, 4.87 (d, J = 10.3 Hz, 1 
H), 3.74 (t, J = 6.5 Hz, 1 H), 3.58-3.55 (comp, 2 H), 2.47-2.39 (comp, 2 H), 2.36 (t, J = 
7.2 Hz, 2 H), 1.11 (s, 9 H); 13C NMR (100 MHz, CDCl3) δ 138.7, 137.2, 136.5, 135.9, 
135.8, 134.02, 133.95, 133.8, 13.1, 131.2, 130.1, 129.2, 128.9, 128.1, 128.0, 127.9, 127.8, 
127.6, 126.8, 126.6, 125.7, 124.9, 124.0, 123.3, 121.1, 115.7, 114.2, 63.7, 55.3, 49.3, 
39.9, 27.0, 19.3. 
NMR Assignments.  4.119: 1H NMR (500 MHz, CDCl3) δ 7.97 (d, J = 8.0 Hz, 1 
H, C13-H), 7.79-7.77 (m, 2H, C23-H), 7.69 (d, J = 8.0 Hz, 1 H, C10-H), 7.67-7.64 
(comp, 4 H, Ar-H), 7.46 (td, J = 7.5, 1.4 Hz, 1 H, C25-H), 7.44-7.40 (comp, 3 H, Ar-H), 
7.38-7.33 (comp, 6 H, Ar-H), 7.28 (t, J = 8.0 Hz, 1 H, C12-H), 7.17 (t, J = 8.0 Hz, 1 H, 
C11-H), 5.77 (ddd, J = 17.1, 10.3, 8.8 Hz, 1 H, C3 or C5-H), 5.62 (ddd, J = 17.4, 10.0, 
7.3 Hz, 1 H, C3 or C5-H), 5.13 (d, J = 10.3 Hz, 1 H, C4 or C6-H), 5.11 (d, J = 17.1 Hz, 1 
H, C4 or C6-H), 4.85-4.81 (comp, 2 H, C4 or C6-H), 3.84 (d, J = 7.6 Hz, 1 H, C1-H), 
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3.69-3.62 (comp, 2 H, C16-H), 3.15 (app q, 7.8 Hz, 1 H, C2-H), 2.55-2.46 (comp, 2 H, 
C15-H), 2.20 (br, 1 H, NH), 1.05 (s, 9 H, C18); 13C NMR (125 MHz, CDCl3) δ 138.1 
(C22), 137.8 (C3 or C5), 137.7 (C3 or C5), 135.8, 135.61, 135.57, 133.7, 133.6 (C35), 
130.3, 129.68, 129.66, 129.0 (C24), 127.66, 127.65, 126.6 (C23), 124.8, 124.6, 123.9 
(C12), 123.1 (C11), 121.0 (C10), 117.8 (C4 or C6), 116.2 (C4 or C6), 113.8 (C13), 63.0 








































4.122   
Allyl-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-{1-[1-(toluene-4-sulfonyl)-1H-
indol-3-yl]-2-vinyl-but-3-enyl}-amine (4.122). (JDSV-219a).  Allyl bromide (0.23 mL, 
321 mg, 2.65 mmol) was added to a suspension of amine 4.118 (349 mg, 0.54 mmol) and 
K2CO3 (237 mg, 1.71 mmol) in DMSO (1 mL).  The reaction was heated to 60 ºC for 18 
h and the reaction was cooled to rt.  The mixture was partitioned between H2O (10 mL) 
and EtOAc (10 mL).  The organic layer was removed and the aqueous layer was washed 
with EtOAc (2 x 5 mL).  The combined organic layers were dried (MgSO4), filtered and 
concentrated under reduced pressure.  The residue was purified by flash chromatography 
eluting with EtOAc/hexane (1:19) to give 321 mg (84%) of amine 4.122 as colorless 
glass.  1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 8.2 Hz, 1 H), 7.77-7.67 (comp, 6 H), 
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7.51 (d, J = 7.9 Hz, 1 H), 7.45-7.36 (comp, 7 H), 7.29-7.27 (m, 1 H), 7.14-7.19 (comp, 3 
H), 5.95 (ddd, J = 17.4, 10.4, 7.4 Hz, 1 H), 5.70 (dddd, J = 17.8, 10.3, 7.8, 4.4 Hz, 1 H), 
5.44 (ddd, J = 17.4, 10.4, 7.4 Hz, 1 H), 5.06-4.95 (comp, 4 H), 4.83 (d, J = 16.7 Hz, 1 H), 
4.74 (d, J = 10.3 Hz, 1 H), 3.99 (d, J = 10.2 Hz, 1 H), 3.72-3.67 (comp, 2 H), 3.31-3.19 
(comp, 2 H), 2.78-2.69 (comp, 2 H), 2.36 (comp, 1H), 2.31 (s, 3 H), 1.05 (s, 9 H);  13C 
NMR (100 MHz, CDCl3) δ 144.7, 139.7, 138.2, 137.3, 135.6, 135.0, 134.7, 133.8, 133.6, 
132.2, 129.7, 129.6, 129.6, 127.7, 127.6, 126.7, 124.7, 124.5, 123.0, 120.4, 119.9, 116.5, 
116.1, 115.0, 113.6, 63.4, 59.7, 54.6, 52.0, 50.7, 26.8, 21.5, 19.1; IR (neat) 2929, 1445, 
1370, 1175, 1112, 1094, 914, 809, 743, 703, 571 cm-1; mass spectrum (CI) m/z  689.3228 
[C42H49N2O3SSi (M+1) requires 689.3229].   
NMR Assignments.  1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 8.2 Hz, 1 H, 
C13-H), 7.7-7.67 (comp, 6 H, Ar-H), 7.51 (d, J = 7.9 Hz, 1 H, C10-H), 7.34-7.36 (comp, 
7 H, Ar-H), 7.29-7.27 (m, 1 H, Ar-H), 7.19-7.14 (comp, 3 H, Ar-H), 5.95 (ddd, J = 17.4, 
10.4, 7.4 Hz, 1 H, C3-H or C5-H), 5.70 (dddd, J = 17.8, 10.3, 7.8, 4.4 Hz, 1 H, C21-H), 
5.44 (ddd, J = 17.4, 10.4, 7.4 Hz, 1 H, C3-H or C5-H), 5.06-4.95 (comp, 4 H, C4 or C6-
H, and C22-H), 4.83 (d, J = 16.7 Hz, 1 H, C4 or C6-H), 4.74 (d, J = 10.3 Hz, 1 H, C4 or 
C6-H), 3.99 (d, J = 10.2 Hz, 1 H, C1-H), 3.72-3.67 (comp, 2 H, C24-H), 3.31-3.19 
(comp, 2 H, C20-H), 2.78-2.69 (comp, 2 H, C23-H), 2.36 (comp, 1H, C2-H), 2.31 (s, 3 
H, C19-H), 1.05 (s, 9 H, C30-H);  13C NMR (100 MHz, CDCl3) δ 144.7 (C18), 139.7, 
138.2, 137.3, 135.6, 135.0, 134.7, 133.8, 133.6, 132.2, 129.7, 129.6, 129.6, 127.7, 127.6, 
126.7, 124.7, 124.5, 123.0, 120.4, 119.9, 116.5 (C4, C6, or C22), 116.1 (C4, C6, or C22), 
115.0 (C4, C6, or C22), 113.6 (C13), 63.4 (C24), 59.7 (C1), 54.6 (C20), 52.0 (C23), 50.7 










































diphenyl-silanyloxy)-ethyl]-amine (4.123).  (JDSV-220a).  Allyl bromide (0.23 mL, 
321 mg, 2.65 mmol) was added to a suspension of amine 4.119 (333 mg, 0.52 mmol) and 
K2CO3 (243 mg, 1.76 mmol) in DMSO (1 mL) and the reaction was heated at 60 ºC for 
18 h.  The reaction was cooled to rt and partitioned between H2O (10 mL) and EtOAc (10 
mL).  The organic layer was removed and the aqueous layer was washed with EtOAc (2 x 
5 mL).  The combined organic layers were dried (MgSO4), filtered and concentrated 
under reduced pressure.  The residue was purified by flash chromatography eluting with 
EtOAc/hexane (1:19) to give 301 mg (85%) of amine 4.123 as colorless gum.  1H NMR 
(400 MHz, CDCl3) δ  7.84 (d, J = 8.2 Hz, 1 H), 7.79 (dd, J = 8.5, 1.0 Hz, 2 H), 7.51 (t, J 
= 8.2 Hz, 2 H), 7.47-7.35 (comp, 9 H), 7.29 (t, J = 8.0 Hz, 1 H), 7.18 (t, J = 7.2 Hz, 1 H), 
5.94 (ddd, J = 17.4, 10.3, 7.3 Hz, 1 H), 5.70 (dddd, J = 17.8, 10.9, 7.9, 4.6 Hz, 1 H), 5.44 
(ddd, J = 17.4, 10.3, 7.5 Hz, 1 H), 5.05-4.95 (comp, 4 H), 4.82 (d, J = 17.4 Hz, 1 H), 4.72 
(d, J = 10.3 Hz, 1 H), 3.99 (d, J = 10.6 Hz, 1 H), 3.73-3.64 (comp, 2 H), 3.30-3.19 (comp, 
2 H), 2.78-2.68 (comp, 2 H), 2.36 (comp, 1H), 1.05 (s, 9 H);  13C NMR (100 MHz, 
CDCl3) δ 139.7, 138.2, 137.9, 137.2, 135.6, 134.8, 133.8, 133.7, 133.6, 132.2, 129.6, 
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129.6, 129.1, 127.7, 127.7, 126.6, 124.6, 124.5, 123.2, 120.5, 120.2, 116.6, 116.1, 115.0, 
113.6, 63.4, 59.7, 54.6, 52.0, 50.7, 26.9, 19.1; IR (neat) 2929, 2856, 1641, 1447, 1370, 
1176, 1112, 964, 914, 743, 685, 597, 571 cm-1; Mass Spectrum (CI) m/z 675.3075 
[C41H47N2O3S (M+1) requires 675.3077] 607.   
NMR Assignments.  .  1H NMR (400 MHz, CDCl3) δ  7.84 (d, J = 8.2 Hz, 1 H, 
C13-H), 7.79 (dd, J = 8.5, 1.0 Hz, 2 H, Ar-H), 7.51 (t, J = 8.2 Hz, 2 H, Ar-H), 7.47-7.35 
(comp, 9 H, Ar-H), 7.29 (t, J = 8.0 Hz, 1 H, C11-H or C12-H), 7.18 (t, J = 7.2 Hz, 1 H, 
C11-H or C12-H), 5.94 (ddd, J = 17.4, 10.3, 7.3 Hz, 1 H, C3-H or C5-H), 5.70 (dddd, J = 
17.8, 10.9, 7.9, 4.6 Hz, 1 H, C20-H), 5.44 (ddd, J = 17.4, 10.3, 7.5 Hz, 1 H, C3-H or C5-
H), 5.05-4.95 (comp, 4 H, C4 or C6-H, C21-H), 4.82 (d, J = 17.4 Hz, 1 H, C4 or C6-H), 
4.72 (d, J = 10.3 Hz, 1 H, C4 or C6-H), 3.99 (d, J = 10.6 Hz, 1 H, C1-H), 3.64-3.73 
(comp, 2 H, C23-H), 3.30-3.19 (comp, 2 H, C19-H), 2.78-2.68 (comp, 2 H, C22-H), 2.36 
(comp, 1H, C2-H), 1.05 (s, 9 H, C29-H);  13C NMR (100 MHz, CDCl3) δ 139.7, 138.2, 
137.9, 137.2, 135.6, 134.8, 133.8, 133.7, 133.6, 132.2, 129.6, 129.6, 129.1 (C17), 127.66, 
127.64, 126.6 (C16), 124.6, 124.5, 123.2, 120.5, 120.2, 116.6 (C3, C5, or C20), 116.1 
(C3, C5, or C20), 115.0 (C3, C5, or C20), 113.6 (C13), 63.4 (C23), 59.7 (C1), 54.6 

























































ethanol (4.126). (JDSV-).  4.126a: 1H NMR (600 MHz, CDCl3) δ 7.98 (d, J = 8.3 Hz, 1 
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H), 7.80 (d, J = 7.7 Hz, 2 H), 7.60 (d, J = 7.6 Hz, 1 H), 7.50 (t, J = 7.7 Hz, 1 H), 7.44 (s, 1 
H), 7.40 (t, J = 7.7 Hz, 2 H), 7.31 (t, J = 7.6 Hz, 1 H), 7.24 (t, J = 7.7 Hz, 1 H), 6.24 
(comp, 2 H), 5.84-5.78 (m, 1 H), 5.59-5.52 (m, 1 H), 5.19-5.11 (comp, 3 H), 5.00 (d, J = 
10.3 Hz, 1 H), 4.20-4.16 (m, 1 H), 3.52-3.44 (comp, 2 H), 3.22-3.13 (comp, 2 H), 2.77-
2.59 (comp, 4 H), 2.30 (br, 1 h); 13C NMR (150 MHz, CDCl3) δ 138.0, 136.7, 136.4, 
135.4, 133.8, 133.3, 131.6, 130.9, 129.2, 126.7, 125.0, 127.8, 123.5, 122.1, 120.1, 117.9, 
115.9, 113.9, 58.7, 56.3, 53.4, 51.2, 32.2; mass spectrum (CI) m/z 437.1893 
[C25H28N2O3S (M+1) requires 437.1899]. 
NMR Assignments. 4.126a: 1H NMR (600 MHz, CDCl3) δ 7.98 (d, J = 8.3 Hz, 1 
H, C13-H), 7.80 (d, J = 7.7 Hz, 2 H, C16-H), 7.60 (d, J = 7.6 Hz, 1 H, C10-H), 7.50 (t, J 
= 7.7 Hz, 1 H, C18-H), 7.44 (s, 1 H, C7-H), 7.40 (t, J = 7.7 Hz, 2 H, C17-H), 7.31 (t, J = 
7.6 Hz, 1 H, C12-H), 7.24 (t, J = 7.7 Hz, 1 H, C11-H), 6.24-6.12 (comp, 2 H, C4 and C5-
H), 5.84-5.78 (m, 1 H, C20-H), 5.59-5.52 (m, 1 H, C3-H), 5.19-5.11 (comp, 3 H, C6 and 
C21-H), 5.00 (d, J = 10.3 Hz, 1 H, C6-H), 4.20-4.16 (m, 1 H, C1-H), 3.52-3.44 (comp, 2 
H, C23-H), 3.22-3.13 (comp, 2 H, C19-H), 2.77-2.59 (comp, 4 H, C2 and C22-H), 2.30 
(br, 1 h, OH); 13C NMR (150 MHz, CDCl3) δ 138.0 (C15), 136.7 (C5), 136.4 (C20), 
135.4 (C14), 133.8 (C18), 133.3 (C4), 131.6 (C3), 130.9 (C9), 129.2 (C17), 126.7 (C16), 
125.0 (C12), 124.8 (C7), 123.5 (C11), 122.1 (C8), 120.1 (C10), 117.9 (C21), 115.9 (C6), 


































indol-3-yl)-2-vinylbut-3-en-1-amine (4.127). (JDSVI-199a).  A solution of alcohol 
4.126 (9.08g, 20.8 mmol), TBS-Cl (4.0g, 26.5 mmol), and imidazole (2.02g, 29.7 mmol) 
in DMF (100 mL) was stirred for 3 h at room temperature.  The reaction was partitioned 
between H2O (250 mL) and Et2O (250 mL).  The aqueous layer was backwashed with 
Et2O (3 x 100 mL), and the combined organics were dried (MgSO4), filtered, and 
concentrated under reduced pressure.  The residue was crystallized from MeOH (~100 
mL) to give 10.669g of 4.127 as an off-white solid, mp = 85.5-87.5 ºC.  1H NMR (600 
MHz, CDCl3) δ 7.96 (d, J = 8.2 Hz, 1 H), 7.78 (d, J = 8.5 Hz, 1 H), 7.59 (d, J = 8.2 Hz, 1 
H), 7.49 (t, J = 7.6 Hz, 1 H), 7.40 (s, 1 H), 7.38 (t, J = 7.6 Hz, 1 H), 7.27 (t, J = 8.2 Hz, 1 
H), 7.20 (t, J = 8.2 Hz, 1 H), 5.97 (ddd, J = 17.5, 10.3, 7.5 Hz, 1 H), 5.74 (dddd, J = 17.7, 
10.2, 7.7, 4.5 Hz, 1 H), 5.47 (ddd, J = 17.3, 10.3, 7.5 Hz, 1 H), 5.08-5.03 (comp, 4 H), 
4.84 (dt, J = 17.3, 1.3 Hz, 1 H), 4.73 (d, J = 10.3 Hz, 1 H), 4.03 (d, J = 10.4 Hz, 1 H), 
3.67-3.60 (comp, 2 H), 3.38 (ap q, J = 7.4 Hz, 1H), 3.27-3.23 (m, 1 H), 2.73 (dd, J = 
14.5, 7.7 Hz, 1 H), 2.70 (ddd, J = 13.2, 7.2, 6.1 Hz, 1 H), 2.35 (dt, J = 6.6, 13.2 Hz, 1 H), 
0.88 (s, 9H), 0.03 (s, 6 H); 13C NMR (150 MHz, CDCl3) δ 139.8, 138.3, 138.1, 137.4, 
134.9, 133.7, 132.3, 129.1, 126.7, 124.7, 124.6, 123.2, 120.6, 120.4, 116.6, 116.1, 115.0, 
 370 
113.6, 63.0, 59.9, 54.7, 52.3, 50.9, 26.0, 18.3, -5.3; IR (neat) 2928, 1447, 1370, 1176, 
1119, 1094, 914, 834 cm-1; mass spectrum (CI) m/z 551.2765 [C31H42N2O3SSi (M+1) 
requires 551.2764]. 
NMR Assignments. 1H NMR (600 MHz, CDCl3) δ 7.96 (d, J = 8.2 Hz, 1 H, C13-
H), 7.78 (d, J = 8.5 Hz, 1 H, C16-H), 7.59 (d, J = 8.2 Hz, 1 H, C10-H), 7.49 (t, J = 7.6 
Hz, 1 H, C18-H), 7.40 (s, 1 H, C7-H), 7.38 (t, J = 7.6 Hz, 1 H, C17-H), 7.27 (t, J = 8.2 
Hz, 1 H, C12-H), 7.20 (t, J = 8.2 Hz, 1 H, C11-H), 5.97 (ddd, J = 17.5, 10.3, 7.5 Hz, 1 H, 
C3 or C5-H), 5.74 (dddd, J = 17.7, 10.2, 7.7, 4.5 Hz, 1 H, C20-H), 5.47 (ddd, J = 17.3, 
10.3, 7.5 Hz, 1 H, C3 or C5-H), 5.08-5.03 (comp, 4 H, C21-H and C4 or C6-H), 4.84 (dt, 
J = 17.3, 1.3 Hz, 1 H, C4 or C6-H), 4.73 (d, J = 10.3 Hz, 1 H, C4 or C6-H), 4.03 (d, J = 
10.4 Hz, 1 H, C1-H), 3.67-3.60 (comp, 2 H, C23-H), 3.38 (ap q, J = 7.4 Hz, 1H, C2-H), 
3.27-3.23 (m, 1 H, C19-H), 2.73 (dd, J = 14.5, 7.7 Hz, 1 H, C19-H), 2.70 (ddd, J = 13.2, 
7.2, 6.1 Hz, 1 H, C22-H), 2.35 (dt, J = 6.6, 13.2 Hz, 1 H, C22-H), 0.88 (s, 9H, C26-H), 
0.03 (s, 6 H, C24-H); 13C NMR (150 MHz, CDCl3) δ 139.8 (C3 or C5), 138.3 (C3 or C5), 
138.1 (C15), 137.4 (C20), 134.9 (C14), 133.7 (C18), 132.3 (C9), 129.1 (C17), 126.7 
(C16), 124.7 (C12), 124.6 (C7), 123.2 (C11), 120.6 (C10), 120.4 (C8), 116.6 (C21), 
116.1 (C4 or C6), 115.0 (C4 or C6), 113.6 (C13), 63.0 (C23), 59.9 (C1), 54.7 (C19), 52.3 







































enyl)-1-(phenylsulfonyl)-1H-indol-2-yl)-2-oxoacetate (4.131).  (JDSVI-49c).  Indole 
4.127 (262 mg, 0.47 mmol) was azeotroped from benzene (3 x ~10 mL), and then 
dissolved in THF (3 mL) and cooled to -78 ºC.  LDA (1 M in THF/hexane, 1.0 mL, 1.0 
mmol) was then added, and the reaction was stirred for 15 min at -78 ºC.  The -78 ºC bath 
was exchanged for a 0 ºC bath, and the reaction was stirred for 3 h at 0 ºC.  The reaction 
was then cooled to -78 ºC and dimethyl oxalate (122 mg, 1.03 mmol) was added as a 
solution in THF (1 mL).  The reaction was stirred for 2.5 h over which the bath 
temperature warmed to 0 ºC.  The reaction was then partitioned between CH2Cl2 (10 mL) 
and saturated aqueous NH4Cl (15 mL). The organic phase was removed, and the aqueous 
layer was extracted with CH2Cl2 (2 x 5 mL). The combined organics were dried 
(MgSO4), filtered, and concentrated under reduced pressure.  The residue was purified by 
flash chromatography eluting with EtOAc/Hexane (1:3) to give 19 mg (7%) of 4.127 and 
202 mg (66%) of 4.131 as a yellow gum.1H NMR (600 MHz, CDCl3) δ 8.00 (d, J = 8.4 
Hz, 1 H), 7.86 (d, J = 8.0 Hz, 1 H), 7.54 (d, J = 7.5 Hz, 2 H), 7.44-7.38 (comp, 2 H), 7.28 
(t, J = 8.0 Hz, 2 H), 7.21 (t, J = 7.5 Hz, 1 H), 5.86 (ddd, J = 17.3, 10.4, 7.2 Hz, 1 H), 
5.71-5.64 (m, 1 H), 5.47 (ddd, J = 17.1, 10.4, 8.1 Hz, 1 H), 5.02-4.97 (comp, 4 H), 4.68 
(d, J = 17.1 Hz, 1 H), 4.54 (d, J = 10.4 Hz, 1 H), 4.18 (d, J = 9.09 Hz, 1 H), 3.96 (s, 1 H), 
3.56-3.50 (comp, 3 H), 3.26 (dd, J = 14.8, 5.1 Hz, 1 H), 2.86 (dd, J = 14.8, 7.2 Hz, 1 H), 
2.67 (dt, J = 13.5, 6.7 Hz, 1 H), 2.48 (dt, J = 13.5, 6.7 Hz, 1 H), 0.848 (s, 9 H), -0.01 (s, 3 
H), -0.02 (s, 3 H); 13C NMR (150 MHz, CDCl3) δ 178.9, 160.9, 139.2, 137.4, 137.1, 
136.1, 135.5, 134.1, 133.5, 133.0, 130.3, 128.9, 127.8, 127.0, 124.9, 124.4, 116.8, 115.9, 
115.8, 115.2, 61.6, 60.7, 54.1, 63.3, 51.9, 49.4, 25.9, 18.3, -5.3, -5.4; IR (neat) 2926, 
1763, 1742, 1698, 1447, 1370, 1174, 1088, 1048, 836 cm-1; mass spectrum (CI) m/z 
637.2759 [C34H44N2O6SSi (M+1) requires 637.2768]. 
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NMR Assignments.  1H NMR (600 MHz, CDCl3) δ 8.00 (d, J = 8.4 Hz, 1 H, 
C13-H), 7.86 (d, J = 8.0 Hz, 1 H, C10-H), 7.54 (d, J = 7.5 Hz, 2 H, C19-H), 7.44-7.38 
(comp, 2 H, C12 and C21-H), 7.28 (t, J = 8.0 Hz, 2 H, C20-H), 7.21 (t, J = 7.5 Hz, 1 H, 
C11-H), 5.86 (ddd, J = 17.3, 10.4, 7.2 Hz, 1 H, C3 or C5-H), 5.71-5.64 (m, 1 H, C23-H), 
5.47 (ddd, J = 17.1, 10.4, 8.1 Hz, 1 H, C3 or C5-H), 5.02-4.97 (comp, 4 H, C24-H and C4 
or C6-H), 4.68 (d, J = 17.1 Hz, 1 H, C4 or C6-H), 4.54 (d, J = 10.4 Hz, 1 H, C4 or C6-H), 
4.18 (d, J = 9.09 Hz, 1 H, C1-H), 3.96 (s, 1 H, C17-H), 3.56-3.50 (comp, 3 H, C2 and 
C26-H), 3.26 (dd, J = 14.8, 5.1 Hz, 1 H, C22-H), 2.86 (dd, J = 14.8, 7.2 Hz, 1 H, C22-H), 
2.67 (dt, J = 13.5, 6.7 Hz, 1 H, C25-H), 2.48 (dt, J = 13.5, 6.7 Hz, 1 H, C25-H), 0.848 (s, 
9 H, C29-H), -0.01 (s, 3 H, C27-H), -0.02 (s, 3 H, C27-H); 13C NMR (150 MHz, CDCl3) 
δ 178.9 (C15), 160.9 (C16), 139.2 (C3 or C5), 137.4 (C23), 137.1, 136.1 (C3 or C5), 
135.5, 134.1 (C21), 133.5, 133.0, 130.3, 128.9 (C20), 127.8 (C12), 127.0, 124.9 (C10), 
124.4 (C11), 116.8 (C3, C5, or C23), 115.9 (C3 or C5), 115.8 (C3, C5, or C23), 115.2 
(C13), 61.6 (C26), 60.7 (C1), 54.1 (C22), 53.3 (C17), 51.9 (C25), 49.4 (C2), 25.9 (C29), 









































enyl)-1-(phenylsulfonyl)-1H-indol-2-yl)-2-hydroxypropanoate (4.139).  (JDSVI-29).  
Indole 4.127 (318 mg, 0.58 mmol) was azeotroped from benzene (3 x ~10 mL), and then 
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dissolved in THF (4 mL) and cooled to -78 ºC.  LDA (1 M in THF/hexane, 1.1 mL, 1.1 
mmol) was then added, and the reaction was stirred for 10 min at -78 ºC.  The -78 ºC bath 
was exchanged for a 0 ºC bath, and the reaction was stirred for 2 h at 0 ºC.  The reaction 
was then cooled to -78 ºC and methyl pyruvate (0.2 mL, 226 mg, 2.21 mmol) was then 
added.  The reaction was stirred for 2 h over which the reaction warmed to 5 ºC.  The 
reaction was then partitioned between Et2O (5 mL) and saturated aqueous NH4Cl (5 mL). 
The organic phase was removed, and the aqueous layer was extracted with CH2Cl2 (2 x 5 
mL). The combined organics were dried (MgSO4), filtered, and concentrated under 
reduced pressure.  The residue was purified by flash chromatography eluting with 
EtOAc/Hexane (gradient elution, 1:19 to 1:9) to give 84 mg (26%) of 4.127, 135 mg 
(35%) of 4.139 (major diastereomer), and 95 mg (25%) of 4.139 (minor diastereomer).  
Major diastereomer : 1H NMR (500 MHz, C6D6) δ 10.14 (s, 1 H), 7.99-7.96 (comp, 3 
H), 7.30-7.28 (m, 1 H), 6.94-6.91 (comp, 2 H), 6.71 (t, J = 7.4 Hz, 1 H), 6.63 (t, J = 7.4, 1 
H), 6.06-5.98 (m, 1 H), 5.89 (ddd, J = 17.7, 10.4, 7.6 Hz, 1 H), 5.30 (ddd, J = 16.9, 10.0, 
8.7 Hz, 1 H), 5.07, (d, J = 17.7 Hz, 1 H), 5.03-5.00 (comp, 2 H), 4.91 (d, J = 16.9 Hz, 1 
H), 4.80 (d, J = 17.1 Hz, 1 H), 4.51 (d, J = 7.6 Hz, 1 H), 4.40 (dd, J = 10.0, 1.8 Hz, 1 H), 
3.96-3.87 (comp, 2 H), 3.81-3.77 (comp, 3 H), 3.62 (s, 1 H), 3.37 (dt, J = 6.5, 13.0 Hz, 1 
H), 2.92-2.87 (m, 1 H), 2.40 (s, 3 H), 0.97 (s, 9 H), 0.69 (s, 3 H), 0.65 (s, 3 H); 13C NMR 
(125 MHz, C6C6) δ 174.6, 142.8, 142.6, 139.0, 138.1, 136.9, 133.1, 131.6, 128.6, 127.7, 
125.1, 124.4, 123.7, 119.6, 115.9, 115.3, 115.2, 77.7, 61.6, 61.3, 54.5, 51.8, 51.6, 27.4, 
26.2, 18.5, -5.3, -5.4; IR (neat) 3070, 2950, 1755, 1728, 1448, 1376, 1176, 1116, 916, 
836 cm-1 mass spectrum (CI) m/z 653.3081 [C35H48N2O6SSi (M+1) requires 653.3081].  
Minor  Diastereomer : 1H NMR (600 MHz, CDCl3) δ 10.77 (br, 1 H), 7.72 (d, J = 7.6 
Hz, 2 H), 7.68-7.66 (m, 1 H), 7.46-7.42 (comp,  2 H), 7.33-7.30 (m, 2 H), 7.17-7.11 
(comp, 2 H), 6.05 (ap dt. J = 10.0, 17.6 Hz, 1 H), 5.93 (ddt, J = 17.2, 10.3, 7.0 Hz, 1 H), 
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5.83 (ddd, J = 17.4, 10.3, 7.9 Hz, 1 H), 5.22 (d, J = 10.3 Hz, 1 H), 5.18 (d, J = 17.4 Hz, 1 
H), 5.07 (d, J = 17.2 Hz, 1 H), 5.05 (d, J = 17.6 Hz, 1 H), 5.01 (d, J = 10.3 Hz, 1 H), 4.84 
(dd, J = 10.0 Hz,  1 H), 4.07 (d, J = 7.4 Hz, 1 H), 3.87 (ap q, J = 7.9 Hz, 1 H), 3.79-3.73 
(comp, 2 H), 3.47 (dd, J = 14.9, 5.6 Hz, 1 H), 3.67 (s, 3 H), 3.35-3.28 (m, 1 H), 2.98-2.86 
(comp, 2 H), 2.01 (s, 3 H), 0.88 (s, 9 H), 0.05 (s, 3 H), 0.04 (s, 3 H); 13C NMR (150 MHz, 
CDCl3) δ 172.2, 142.1, 140.9, 139.2, 138.4, 136.2, 133.3, 132.3, 130.8, 128.7, 127.0, 
125.0, 123.3, 122.3, 119.9, 115.5, 115.3, 115.0, 77.4, 60.9, 60.1, 52.9, 51.9, 51.1, 50.2, 
30.3, 26.0, 18.3, -5.38, -5.41; IR (neat) 3072, 2950, 1738, 1637, 1448, 1361, 1255, 1117, 
1098, 914, 836 cm-1 mass spectrum (CI) m/z 653.3083 [C35H48N2O6SSi (M+1) requires 
653.3081]. 
NMR Assignments.  Major diastereomer : 1H NMR (500 MHz, C6D6) δ 10.14 
(s, 1 H, OH), 7.99-7.96 (comp, 3 H, C13 and C20-H), 7.30-7.28 (m, 1 H, C10-H), 6.94-
6.91 (comp, 2 H, C11 and C12-H), 6.71 (t, J = 7.4 Hz, 1 H, C21-H), 6.63 (t, J = 7.4, 1 H, 
C22-H), 6.06-5.98 (m, 1 H, C24-H), 5.89 (ddd, J = 17.7, 10.4, 7.6 Hz, 1 H, C3 or C5-H), 
5.30 (ddd, J = 16.9, 10.0, 8.7 Hz, 1 H, C3 or C5-H), 5.07, (d, J = 17.7 Hz, 1 H. C4 or C6-
H), 5.03-5.00 (comp, 2 H, C4 or C6-H and C25-H), 4.91 (d, J = 16.9 Hz, 1 H, C4 or C6-
H), 4.80 (d, J = 17.1 Hz, 1 H, C24-H), 4.51 (d, J = 7.6 Hz, 1 H, C1-H), 4.40 (dd, J = 10.0, 
1.8 Hz, 1 H, C4 or C6-H), 3.96-3.87 (comp, 2 H, C2 and C23-H), 3.81-3.77 (comp, 3 H, 
C23 and C27-H), 3.62 (s, 1 H, C17-H), 3.37 (dt, J = 6.5, 13.0 Hz, 1 H, C26-H), 2.92-2.87 
(m, 1 H, C26-H), 2.40 (s, 3 H, C18-H), 0.97 (s, 9 H, C30-H), 0.69 (s, 3 H, C28-H), 0.65 
(s, 3 H, C28-H); 13C NMR (125 MHz, C6C6) δ 174.6 (C16), 142.8 (C3 or C5), 142.6 
(C19), 139.0 (C14), 138.1 (C3 or C5), 136.9 (C7), 133.1 (C24), 131.6 (C9), 128.6 (C21), 
127.7 (C20), 125.1 (C11 or C12), 124.4 (C8), 123.7 (C11 or C12), 119.6 (C25), 115.9 
(C13), 115.3 (C4 or C6), 115.2 (C4 or C6), 77.7 (C15), 61.6 (C1), 61.3 (C27), 54.5 
(C23), 51.8 (C17), 51.6 (C3 and C26), 27.4 (C18), 26.2 (C30), 18.5 (C29), -5.3 (C28), -
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5.4 (C28).  Minor  Diastereomer : 1H NMR (600 MHz, CDCl3) δ 10.77 (br, 1 H, OH), 
7.72 (d, J = 7.6 Hz, 2 H, C20-H), 7.68-7.66 (m, 1 H, C13-H), 7.46-7.42 (comp, 2 H, C10 
and C22-H), 7.33-7.30 (m, 2 H, C21-H), 7.17-7.11 (comp, 2 H, C11 and C12-H), 6.05 
(ap dt. J = 10.0, 17.6 Hz, 1 H, C3 or C5-H), 5.93 (ddt, J = 17.2, 10.3, 7.0 Hz, 1 H, C24-
H), 5.83 (ddd, J = 17.4, 10.3, 7.9 Hz, 1 H, C3 or C5-H), 5.22 (d, J = 10.3 Hz, 1 H, C25-
H), 5.18 (d, J = 17.4 Hz, 1 H, C4 or C6-H), 5.07 (d, J = 17.2 Hz, 1 H, C25-H), 5.05 (d, J 
= 17.6 Hz, 1 H, C4 or C6-H), 5.01 (d, J = 10.3 Hz, 1 H, C4 or C6-H), 4.84 (dd, J = 10.0 
Hz,  1 H, C4 or C6-H), 4.57 (d, J = 7.4 Hz, 1 H, C1-H), 3.87 (ap q, J = 7.9 Hz, 1 H, C2-
H), 3.79-3.73 (comp, 2 H, C27-H), 3.47 (dd, J = 14.9, 5.6 Hz, 1 H, C23-H), 3.67 (s, 3 H, 
C17-H), 3.35-3.28 (m, 1 H, C23-H), 2.98-2.86 (comp, 2 H, C26-H), 2.01 (s, 3 H, C18-H), 
0.88 (s, 9 H, C30-H), 0.05 (s, 3 H, C28-H), 0.04 (s, 3 H, C28-H); 13C NMR (150 MHz, 
CDCl3) δ 172.2 (C16), 142.1 (C7), 140.9 (C3 or C5), 139.2 (C19), 138.4 (C3 or C5), 
136.2 (C14), 133.3 (C22), 132.3 (C24), 130.8 (C9), 128.7 (C21), 127.0 (C20), 125.0 
(C11), 123.3 (C12), 122.3 (C8), 119.9 (C10), 115.5 (C4 or C6), 115.3 (C4 or C6), 115.0 
(C13), 77.4 (C15), 60.9 (C1), 60.1 (C27), 52.9 (C24), 51.9 (C17), 51.1 (C2), 50.2 (C26), 





































(phenylsulfonyl)-1H-indol-2-yl)ethanol (4.161).  (JDSVI-158b and JDSVI-158c).  
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Indole 4.127 (1.239g, 2.25 mmol) was azeotroped from benzene (3 x ~10 mL), and then 
dissolved in THF (10 mL) and cooled to -78 ºC.  LDA (1 M in THF, 4.5 mL, 4.5 mmol) 
was then added, and the reaction was stirred for 15 min at -78 ºC.  The -78 ºC bath was 
exchanged for a 0 ºC bath, and the reaction was stirred for 2 h at 0 ºC.  The reaction was 
then cooled to -78 ºC and acetaldehyde (0.5 mL, 392 mg, 8.91 mmol) was added.  The 
reaction was stirred for 2 h over which the reaction warmed to 0 ºC.  The reaction was 
then partitioned between Et2O (10 mL) and saturated aqueous NH4Cl (15 mL). The 
organic phase was removed, and the aqueous layer was extracted with CH2Cl2 (2 x 10 
mL). The combined organics were dried (MgSO4), filtered, and concentrated under 
reduced pressure.  The residue was purified by flash chromatography eluting with 
EtOAc/Hexane (gradient elution, 1:19 to 1:9) to give 293 mg (23%) of 4.127, 444 mg 
(33%) of 4.161 (major diastereomer), and 418 mg (31%) of 4.161 (minor diastereomer).  
Major diastereomer : 1H NMR (600 MHz, DMSO) δ 7.98 (d, J = 8.4 Hz, 1 H), 7.91 (br, 
1 H), 7.69 (d, J = 7.4 Hz, 2 H), 7.60 (t, J = 7.4 Hz, 1 H), 7.46 (t,  J = 7.4 Hz, 2 H), 7.22 (t, 
J = 7.6 Hz, 1 H), 7.15 (t, J = 7.6 Hz, 1 H), 5.91.-5.89 (m, 1 H), 5.76-5.70 (m, 1 H), 5.64-
5.62 (m, 1 H), 5.53-5.47 (m, 1 H), 5.40-5.37 (m, 1 H), 5.07 (d, J = 17.1 Hz, 1 H), 5.02 (d, 
J = 10.5 Hz, 1 H), 4.98 (d, J = 17.7 Hz, 1 H), 4.95 (d, J = 10.3 Hz, 1 H), 4.79-4.76 (m, 1 
H), 4.59 (d, J = 16.0 Hz, 1 H), 4.43-4.41 (m, 1 H), 3.61-3.53 (comp, 2 H), 3.50-3.46 (m, 
1 H), 3.33-3.30 (m, 1 H), 3.02-2.98 (dd, J = 14.9, 7.0 Hz, 1 H), 2.58 (t, J = 6.7 Hz, 1 H), 
1.55 (d, J = 6.5 Hz, 3 H), 0.79 (s, 9 H), -0.08 (s, 3 H), -0.09 (s, 3 H); 13C NMR (150 
MHz, DMSO) δ 142.1, 140.6, 138.8, 137.2, 136.7, 136.4, 134.1, 130.1, 129.2, 126.0, 
124.3, 123.2, 122.7, 116.5, 114.8, 114.0, 62.5, 61.2, 60.6, 54.0, 51.9, 49.8, 25.7, 24.8, 
17.8, -5.5.   Minor  diastereomer : 1H NMR (600 MHz, DMSO) δ 8.00 (d, J = 8.4 Hz, 1 
H), 7.87 (br, 1 H), 7.66 (d, J = 7.4 Hz, 2 H), 7.59 (t, J = 7.4 Hz, 1H), 7.45 (t, J = 7.4 Hz, 1 
H), 7.24 (t, J = 7.6 Hz, 1 H), 7.16 (t, J = 7.6 Hz, 1 H), 5.88-5.86 (m, 1 H), 5.66-5.64 (m, 1 
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H), 5.50-5.40 (comp, 2 H), 5.05-4.94 (comp, 1 H), 4.73 (br, 1 H), 4.66 (d, J = 17.2 Hz, 1 
H), 4.58 (d, J = 10.1 Hz, 1 H), 3.62-3.66 (m, 1 H), 3.50-3.45 (comp, 2 H), 3.30-3.27 (m, 
1 H), 2.94-2.91 (m, 1 H), 2.54-2.52 (comp, 2 H), 1.50 (d, J = 6.5 Hz, 3 H), 0.81 (2, 9 H), 
-0.06 (s, 3 H), -0.07 (s, 3 H); 13C NMR (150 MHz, DMSO) δ 142.4, 140.4, 138.4, 137.3, 
136.9, 136.4, 134.1, 130.5, 129.2, 126.1, 124.3, 123.4, 122.7, 115.9, 115.1, 115.0, 114.9, 
62.9, 61.3, 60.2, 54.0, 51.6, 49.2, 25.7, 25.6, 17.8, -5.4;        
NMR Assignments.  Major  diastereomer : 1H NMR (600 MHz, DMSO) δ 7.98 
(d, J = 8.4 Hz, 1 H, C13-H), 7.91 (br, 1 H, C10-H), 7.69 (d, J = 7.4 Hz, 2 H, C18-H), 
7.60 (t, J = 7.4 Hz, 1 H, C20-H), 7.46 (t,  J = 7.4 Hz, 2 H, C19-H), 7.22 (t, J = 7.6 Hz, 1 
H, C11-H), 7.15 (t, J = 7.6 Hz, 1 H, C12-H), 5.91.-5.89 (m, 1 H, C3 or C5-H), 5.76-5.70 
(m, 1 H, C22-H), 5.64-5.62 (m, 1 H, C15-H), 5.53-5.47 (m, 1 H, C3 or C5-H), 5.40-5.37 
(m, 1 H, OH), 5.07 (d, J = 17.1 Hz, 1 H, C23-H), 5.02 (d, J = 10.5 Hz, 1 H, C23-H), 4.98 
(d, J = 17.7 Hz, 1 H, C4 or C6-H), 4.95 (d, J = 10.3 Hz, 1 H, C4 or C6-H), 4.79-4.76 (m, 
1 H, C1-H), 4.59 (d, J = 16.0 Hz, 1 H, C4 or C6-H), 4.43-4.41 (m, 1 H, C4 or C6-H), 
3.61-3.53 (comp, 2 H, C2 and C25-H), 3.50-3.46 (m, 1 H, C25-H), 3.33-3.30 (m, 1 H, 
C21-H), 3.02-2.98 (dd, J = 14.9, 7.0 Hz, 1 H, C21-H), 2.58 (t, J = 6.7 Hz, 2 H, C24-H), 
1.55 (d, J = 6.5 Hz, 3 H, C16-H), 0.79 (s, 9 H, C28-H), -0.08 (s, 3 H, C26-H), -0.09 (s, 3 
H, C26-H); 13C NMR (150 MHz, DMSO) δ 142.1 (C7), 140.6 (C3 or C5), 138.8 (C3 or 
C5), 137.2 (C17), 136.7 (C14), 136.4 (C22), 134.1 (C20), 130.1 (C9), 129.2 (C19), 126.0 
(C18), 124.3 (C12), 123.2 (C11), 122.7 (C8), 116.5 (C23), 114.8 (C4 or C6), 114.0 (C4 
or C6), 62.5 (C15), 61.2 (C25), 60.6 (C1), 54.0 (C21), 51.9 (C24), 49.8 (C2), 25.7 (C28), 
24.8 (C16), 17.8 (C27), -5.5 (C26).  Minor diastereomer : 1H NMR (600 MHz, DMSO) 
δ 8.00 (d, J = 8.4 Hz, 1 H, C13-H), 7.87 (br, 1 H, C10-H), 7.66 (d, J = 7.4 Hz, 2 H, C18-
H), 7.59 (t, J = 7.4 Hz, 1H, C20-H), 7.45 (t, J = 7.4 Hz, 2 H, C19-H), 7.24 (t, J = 7.6 Hz, 
1 H, C12-H), 7.16 (t, J = 7.6 Hz, 1 H, C11-H), 5.88-5.86 (m, 1 H, C3 or C5-H), 5.66-5.64 
 378 
(comp, 2 H, C15 and C22-H), 5.50-5.40 (comp, 2 H, OH and C3 or C5-H ), 5.05-4.94 
(comp, 4 H, C23-H and C4 or C6-H), 4.73 (br, 1 H, C1-H), 4.66 (d, J = 17.2 Hz, 1 H, C4 
or C6-H), 4.58 (d, J = 10.1 Hz, 1 H, C4 or C6-H), 3.62-3.66 (m, 1 H, C2-H), 3.50-3.45 
(comp, 2 H, C25-H), 3.30-3.27 (m, 1 H, C21-H), 2.94-2.91 (m, 1 H, C21-H), 2.54-2.52 
(comp, 2 H, C24-H), 1.50 (d, J = 6.5 Hz, 3 H, C16-H), 0.81 (2, 9 H, C28-H), -0.06 (s, 3 
H, C26-H), -0.07 (s, 3 H, C26-H); 13C NMR (150 MHz, DMSO) δ 142.4 (C7), 140.4 (C3 
or C5), 138.4 (C3 or C5), 137.3 (C14), 136.9 (C17), 136.4 (C22), 134.1 (C20), 130.5 
(C9), 129.2 (C19), 126.1 (C18), 124.3 (C12), 123.4 (C11), 122.7 (C8), 115.9 (C23), 
115.1 (C13), 115.0 (C4 or C6), 114.9 (C4 or C6), 62.9 (C15), 61.3 (C25), 60.2 (C1), 54.0 



































1H-indol-3-yl)-2-vinylbut-3-en-1-amine (4.162).  (JDSVII-26a).  Tf2O (0.28 mL, 469 
mg, 1.66 mmol) and Hunig’s base (0.7 mL, 519 mg, 4.02 mmol) were added in rapid 
succession to a solution of indole alcohol 4.161 (833 mg, 1.40 mmol) in CH2Cl2 (7 mL) 
at -78 ºC.  The reaction was stirred for 15 min at -78 ºC and then partitioned between 1M 
NaOH (10 mL) and CH2Cl2 (10 mL).  The organic phase was removed, and the aqueous 
layer was extracted with CH2Cl2 (2 x 5 mL). The combined organic layers were dried 
(MgSO4), filtered, and concentrated under reduced pressure.  The residue was purified by 
flash chromatography eluting with EtOAc/Hexane (1:49) to give 536 mg (66%) of 4.162 
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as a colorless oil.  1H NMR (600 MHz, CDCl3) δ 8.23 (d, J = 8.0 Hz, 1 H), 7.83 (d, J = 8 
Hz, 1 H), 7.62-7.60 (m, 2 H), 7.45 (t, J = 7.5 Hz, 1 H), 7.33-7.28 (comp, 3 H), 7.21 (dt, J 
= 8.0 Hz, 1 H), 6.95 (dd, J = 17.7, 11.4 Hz, 1 H), 5.74 (ddd, J = 17.5, 9.9, 7.5 Hz, 1 H), 
5.68 (dddd, J = 17.5, 10.3, 7.4, 5.0 Hz, 1 H), 5.61 (dd, J = 11.4, 1.7 Hz, 1 H), 5.44 (ddd, J 
= 17.4, 10.3, 7.5 Hz, 1 H), 5.35 (dd, J = 17.7, 1.7 Hz, 1 H), 5.05-4.98 (comp, 4 H), 6.21 
(d, J = 17.4 Hz, 1 H), 4.60 (d, J = 10.3 Hz, 1 H), 4.15 (d, J = 9.5 Hz, 1 H), 3.63 (ap q, J = 
7.6 Hz, 1 H), 3.55-3.49 (comp, 2 H), 3.29 (dd, J = 14.6, 5.0 Hz, 1 H), 2.84 (dd, J = 14.6, 
7.4 Hz, 1 H), 2.67 (td, J = 13.6, 7.0 Hz, 1 H), 2.42 (ddd, J = 13.6, 7.3, 5.9 Hz, 1H), 0.85 
(s, 9 H), -0.02 (s, 6 H); 13C NMR (150 MHz, CDCl3) δ 139.6, 138.19, 138.17, 137.4, 
136.9, 136.7, 133.5, 130.5, 128.7, 128.1, 136.6, 124.8, 123.4, 123.1, 121.8, 121.4, 116.4, 
115.5, 115.4, 115.3, 61.8, 60.9, 54.1, 52.0, 49.3, 25.9, 18.3, -5.31, -5.33; IR (neat) 2928, 
1448, 1375, 1252, 1175, 1090, 988, 916, 836, 751 cm-1; mass spectrum (CI) m/z 
577.2920 [C33H44N2O3SSi (M+1) requires 577.2920]. 
NMR Assignments. 1H NMR (600 MHz, CDCl3) δ 8.23 (d, J = 8.0 Hz, 1 H, C13-
h), 7.83 (d, J = 8 Hz, 1 H, C10-H), 7.62-7.60 (m, 2 H, C18-H), 7.45 (t, J = 7.5 Hz, 1 H, 
C20-H), 7.33-7.28 (comp, 3 H, C12 and C19-H), 7.21 (dt, J = 8.0 Hz, 1 H, C11-H), 6.95 
(dd, J = 17.7, 11.4 Hz, 1 H, C15-H), 5.74 (ddd, J = 17.5, 9.9, 7.5 Hz, 1 H, C3 or C5-H), 
5.68 (dddd, J = 17.5, 10.3, 7.4, 5.0 Hz, 1 H, C21-H), 5.61 (dd, J = 11.4, 1.7 Hz, 1 H, 
C16-H), 5.44 (ddd, J = 17.4, 10.3, 7.5 Hz, 1 H, C3 or C5-H ), 5.35 (dd, J = 17.7, 1.7 Hz, 
1 H, C16-H), 5.05-4.98 (comp, 4 H, C4 or C6-H and C23-H), 6.21 (d, J = 17.4 Hz, 1 H, 
C4 or C6-H), 4.60 (d, J = 10.3 Hz, 1 H, C4 or C6-H), 4.15 (d, J = 9.5 Hz, 1 H, C1-H), 
3.63 (ap q, J = 7.6 Hz, 1 H, C2-H), 3.55-3.49 (comp, 2 H, C24-H), 3.29 (dd, J = 14.6, 5.0 
Hz, 1 H, C21-H), 2.84 (dd, J = 14.6, 7.4 Hz, 1 H, C21-H), 2.67 (td, J = 13.6, 7.0 Hz, 1 H, 
C24-H), 2.42 (ddd, J = 13.6, 7.3, 5.9 Hz, 1H, C24-H), 0.85 (s, 9 H, C28-H), -0.02 (s, 6 H, 
C26-H); 13C NMR (150 MHz, CDCl3) δ 139.6 (C3 or C5), 138.19 (C3 or C5), 138.17 
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(C17), 137.4 (C14), 136.9 (C9), 136.7 (C22), 133.5 (C20), 130.5 (C7), 128.7 (C19), 
128.1 (C15), 126.6 (C18), 124.8 (C12), 123.4 (C11), 123.1 (C10), 121.8 (C16), 121.4 (8), 
116.4 (C23), 115.5 (C4 or C6), 115.4 (C4 or C6), 115.3 (C13), 61.8 (C25), 60.9 (C1), 

































tetrahydro-1H-pyr ido[3,2-c]carbazole (4.169).  (JDSVII-27a).  A solution of tetraene 
4.162 (536 mg, 0.93 mmol) in toluene (50 mL) was placed under vacuum and backfilled 
with N2 three times.  The Hoveyda-Grubbs II catalyst (29 mg, 0.046 mmol) was added 
and the reaction was heated under reflux for 3 h.  The reaction was then cooled to room 
temperature and concentrated under reduced pressure.  The residue was purified by flash 
chromatography eluting with EtOAc/Hexane (gradient elution 1:49 to 1:19) to give 338 
mg (69%) of tetracylce 4.169 as a yellowish gum.  1H NMR (500 MHz, CDCl3) δ 8.12 (d, 
J = 8.4 Hz, 1 H), 7.98 (d, J = 7.9 Hz, 1 H), 7.74-7.72 (m, 2 H), 7.47 (t, J = 7.5 Hz, 1 H), 
7.36 (t, J = 7.5 Hz, 2 H), 7.25 (t, J = 7.9 Hz, 1 H), 7.19 (t, J = 7.9 Hz, 1 H), 7.11 (dd, J = 
9.9, 3.5 Hz, 1 H), 6.02 (ddd, J = 9.9, 2.7, 1.2 Hz, 1 H), 5.95-5.93 (m, 1 H), 5.65-5.62 (m, 
1 H), 4.18 (d, J = 16.5 Hz, 1 H), 3.89-3.78 (comp, 2 H), 3.58-3.53 (m, 1 H), 3.44-3.40 
(m, 1 H), 3.38-3.33 (m, 1 H), 2.60 (ap t, J = 6.6 Hz, 1 H), 0.82 (s, 9 H), -0.04 (2, 3 H), -
0.08 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 138.1, 136.8, 135.1, 133.6, 132.8, 129.0, 
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128.6, 128.0, 126.5, 126.0, 124.6, 123.9, 121.2, 120.8, 118.7, 114.6, 63.2, 62.8, 50.6, 
49.7, 32.5, 25.9, 18.3, -5.3, -5.4; IR (neat) 2928, 1447, 1370, 1184, 1172, 1092, 835, 724 
cm-1; mass spectrum (CI) m/z 521.2301 [C29H36N2O3SSi (M+1) requires 521.2294]. 
NMR Assignments.  1H NMR (500 MHz, CDCl3) δ 8.12 (d, J = 8.4 Hz, 1 H, 
C14-H), 7.98 (d, J = 7.9 Hz, 1 H, C11-H), 7.74-7.72 (m, 2 H, C17-H), 7.47 (t, J = 7.5 Hz, 
1 H, C19-H), 7.36 (t, J = 7.5 Hz, 2 H, C18-H), 7.25 (t, J = 7.9 Hz, 1 H, C13-H), 7.19 (t, J 
= 7.9 Hz, 1 H, C12-H), 7.11 (dd, J = 9.9, 3.5 Hz, 1 H, C6-H), 6.02 (ddd, J = 9.9, 2.7, 1.2 
Hz, 1 H, C7-H), 5.95-5.93 (m, 1 H, C3-H), 5.65-5.62 (m, 1 H, C2-H), 4.18 (d, J = 16.5 
Hz, 1 H, C1-H), 3.89-3.78 (comp, 2 H, C21-H), 3.58-3.53 (m, 1 H, C5-H), 3.44-3.40 (m, 
1 H, C5-H), 3.38-3.33 (m, 1 H, C2-H), 2.60 (ap t, J = 6.6 Hz, 1 H, C20-H), 0.82 (s, 9 H, 
C24-H), -0.04 (2, 3 H, C22-H), -0.08 (s, 3 H, C22-H); 13C NMR (125 MHz, CDCl3) 
δ 138.1 (C16), 136.8 (C15), 135.1 (C10), 133.6 (C19), 132.8 (C7), 129.0 (C18), 128.6 
(C8), 128.0 (C3), 126.5 (C17), 126.0 (C4), 124.6 (C13), 123.9 (C12), 121.2 (C11), 120.8 
(C9), 118.7 (C6), 114.6 (C14), 63.2 (C1), 62.8 (C21), 50.6 (C5), 49.7 (C20), 32.5 (C2), 




















37a).  10% Pd/C (4 mg) was added to a solution of 4.174 (143 mg, 0.37 mmol) in MeOH 
(15 mL) and the reaction was placed under an atmosphere of H2.  The reaction was then 
stirred for 15 h at room temperature under a balloon of H2.  The reaction was opened to 
atmosphere and conc. HCl (0.6 mL) was added.  The reaction stirred for 1 h and then 
filtered through filter paper that was washed with MeOH (3 x 5 mL).  The filtrate was 
then partitioned between 2 M NaOH (10 mL) and CH2Cl2 (10 mL).  The organic phase 
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was removed and the aqueous phase was washed with CH2Cl2 (4 x 10 mL).  The 
combined organics were dried, filtered, and concentrated under reduced pressure to give 
115 mg of crude 4.179.  MsCl (30 µL, 44 mg, 0.39 mmol) was added to a solution of the 
crude 4.179 and Et3N (0.07 mL, 51 mg, 0.5 mmol) in THF (1 mL) at -10 ºC.  The 
reaction was stirred for 1 h at -10 ºC and then a solution of KOt-Bu (160 mg, 1.42 mmol) 
in THF (1 mL) was added.  The reaction was stirred for 2 h over which the bath 
temperature rose to 0 ºC.  The reaction was partitioned between saturated aqueous NH4Cl 
(5 mL) and CH2Cl2 (5 mL).  The organic phase was removed and the aqueous phase was 
washed with CH2Cl2 (3 x 5 mL).  The combined organics were dried (MgSO4), filtered, 
and concentrated under reduced pressure.  The residue was purified by flash 
chromatography (basic Al2O3) eluting with EtOAc/hexane (gradient elution, 1:19 to 1:9) 
to give 35 mg (37%) of 4.180 as a orangish gum.  1H NMR (600 MHz, CDCl3) δ 7.59 (d, 
J = 7.5 Hz, 1 H), 7.54 (d, J = 7.5 Hz, 1 H), 7.31 (td, J = 7.5, 1.3 Hz, 1 H), 7.19 (td, J = 
7.5, 1.0 Hz, 1 H), 5.80 (ddt, J = 10.0, 3.7, 2.2 Hz, 1 H), 5.69 (ddt, J = 10.0, 5.5, 2.7 Hz, 1 
H), 3.74 (dd, J = 19.2, 2.2 Hz, 1H), 3.61 (td, J = 9.1, 5.1 Hz, 1 H), 3.33 (dd, J = 19.2, 2.7 
Hz, 1 H), 3.11 (ddd, J = 10.9, 9.1, 5.1 Hz, 1 H), 2.98 (ddd, J = 13.2, 3.7, 2.3 Hz, 1 H)   
2.68 (td, J = 13.2, 5.4 Hz, 1 H), 2.46 (ddd, J = 13.3, 10.9, 5.01 Hz, 1 H), 2.40-2.37 
(comp, 2 H), 2.13 (ddt, J = 12.7, 5.0, 2.3 Hz, 1 H), 1.93 (ddd, J = 13.3, 9.1, 5.1 Hz, 1 H), 
1.30-1.25 (m, 1 H); 13C NMR (150 MHz, CDCl3) δ 186.1, 153.8, 146.1, 128.3, 127.6, 
125.3, 123.2, 119.7, 71.5, 63.1, 51.2, 48.5, 31.2, 31.0, 30.9, 30.7;  mass spectrum (CI) m/z 
251.15423 [C17H18N2 (M+1) requires 251.1545]. 
NMR Assignments.  1H NMR (600 MHz, CDCl3) δ 7.59 (d, J = 7.5 Hz, 1 H 
(C13-H), 7.54 (d, J = 7.5 Hz, 1 H, C16-H), 7.31 (td, J = 7.5, 1.3 Hz, 1 H, C15-H), 7.19 
(td, J = 7.5, 1.0 Hz, 1 H, C14-H), 5.80 (ddt, J = 10.0, 3.7, 2.2 Hz, 1 H, C4-H), 5.69 (ddt, J 
= 10.0, 5.5, 2.7 Hz, 1 H, C5-H), 3.74 (dd, J = 19.2, 2.2 Hz, 1H, C7-H), 3.61 (td, J = 9.1, 
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5.1 Hz, 1 H, C8-H), 3.33 (dd, J = 19.2, 2.7 Hz, 1 H, C7-H), 3.11 (ddd, J = 10.9, 9.1, 5.1 
Hz, 1 H, C8-H), 2.98 (ddd, J = 13.2, 3.7, 2.3 Hz, 1 H, C2-H)   2.68 (td, J = 13.2, 5.4 Hz, 
1 H, C2-H), 2.46 (ddd, J = 13.3, 10.9, 5.01 Hz, 1 H, C9-H), 2.40-2.37 (comp, 2 H, C4 
and C10-H), 2.13 (ddt, J = 12.7, 5.0, 2.3 Hz, 1 H, C3-H, C3-H), 1.93 (ddd, J = 13.3, 9.1, 
5.1 Hz, 1 H, C9-H), 1.30-1.25 (m, 1 H, C3-H); 13C NMR (150 MHz, CDCl3) δ 186.1 
(C1), 153.8 (C17), 146.1 (C12), 128.3 (C5), 127.7 (C6), 127.5 (C15),  125.3 (C14), 123.2 
(C13), 119.7 (C16), 71.5 (C11), 63.1 (C10), 51.2 (C8), 48.5 (C7), 31.2 (C3), 31.0 (C2), 







2-Methylenebutan-1-amine hydrochloride (4.188). (JDSVII-42a).  NaBH4 
(7.1g, 0.19 mol) was added in portions to a solution of 2-ethylactolein (18.5 mL, 15.89 g, 
0.19 mol) in Et2O (125 mL) and MeOH (35 mL) at 0 ºC.  The reaction was stirred for 1 h 
at 0 ºC and then for 1 h at room temperature.  The reaction was partitioned between H2O 
(200 mL) and Et2O (100 mL).  The aqueous layer was backwashed with Et2O (3 x 100 
mL) and the combined organics were dried (MgSO4), filtered, and concentrated by 
distillation to give 15.6 g of 4.190 as an ~78% solution in Et2O.  The crude 4.190 was 
dissolved in Et2O (200 mL) and cooled to 0 ºC.  PBr3 (13.5 mL, 38.88 g, 0.14 mol) was 
added dropwise and the reaction was warmed to room temperature and stirred for 15 h.  
The reaction was then cooled to 0 ºC and ice water (100 mL) was slowly added.  
Additional H2O (100 mL) and Et2O was then added and the phases were separated.  The 
organic phase was washed sequentially with H2O (50 mL), saturated aqueous NaHCO3 
(50 mL), and saturated aqueous NaCl (2 x 50 mL).  The organics were then dried 
(MgSO4), filtered, and concentrated by distillation to give 23.1g of 4.191 as an ~70% 
solution in Et2O.  The crude 4.191 was added to LiHMDS (1.44 M in hexane) at -40 ºC.  
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The reaction was warmed to room temperature and then heated under reflux for 24 h.  
The reaction was cooled to room temperature and filtered through a pad of celite that was 
washed with pentane (3 x 20 mL).  The filtrate was concentrated under reduced pressure, 
and the residue was diluted with pentane (100 mL).  The suspension was then filtered 
through a pad of celite that was washed with pentane (3 x 20 mL).  The filtrate was 
concentrated under reduced pressure and the crude bis(silyl)amine was added dropwise to 
a solution of HCl in MeOH/Et2O (prepared from AcCl (35 mL) and MeOH (100 mL) in 
Et2O (100 mL) at 0 ºC.  The reaction was warmed to room temperature and stirred for 15 
h and then the reaction was concentrated under reduced pressure. The residue was 
crystallized from EtOH (~15 mL) to give 5.268g (22%) of 4.192 as a white waxy solid, 
mp = 158-159 ºC.  1H NMR (400 MHz, CDCl3) δ 8.49 (s, 3 H), 5.22 (s, 1 H), 5.11 (s, 1 
H), 3.59 (s, 2 H), 2.17 (q, J = 7.4 Hz, 2 H), 1.08 (t, J = 7.4 Hz, 1 H); 13C NMR (100 
MHz, CDCl3) δ 142.3, 113.2, 43.7, 26.7, 11.6;  IR (neat) 3409, 2971, 1603, 1515, 1458, 
1378, 909, 736 cm-1; mass spectrum (CI) m/z 86.0973 [C5H11N (M+1) requires 86.0970]. 
NMR Assignments.  1H NMR (400 MHz, CDCl3) δ 8.49 (s, 3 H, NH), 5.22 (s, 1 
H, C5-H), 5.11 (s, 1 H, C5-H), 3.59 (s, 2 H, C1-H), 2.17 (q, J = 7.4 Hz, 2 H, C3-H), 1.08 
(t, J = 7.4 Hz, 1 H, C4-H); 13C NMR (100 MHz, CDCl3) δ 142.3 (C2), 113.2 (C5), 43.7 






























amine (4.194).  (JDSVII-58b).  1H NMR (600 MHz, CDCl3) δ 7.99 (d, J = 8.3 Hz, 1 H), 
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7.82-7.80 (m, 2 H), 7.70 (d, J = 7.8 Hz, 1 H), 7.49 (t, J = 7.5 Hz, 1 H), 7.42 (s, 1 H), 7.38 
(t, J = 7.5 Hz, 2 H), 7.29 (t, J = 7.8 Hz, 1 H), 7.20 (t, J = 7.8 Hz, 1 H), 5.75 (ddd, J = 
17.1, 10.2, 8.7 Hz, 1 H), 5.65-5.59 (m, 1 H), 5.14 (dd, J = 10.2, 1.7 Hz, 1 H), 5.09 (d, J = 
17.1 Hz, 1 H), 4.83 (d, J = 1.1 Hz, 1 H), 4.82-4.80 (m, 1 H), 4.77 (s, 1 H), 4.74 (s, 1 H), 
3.82 (d, J = 7.7 Hz, 1 H), 3.14 (app q, J = 7.7 Hz, 1 H), 3.02 (d, J = 14.3 Hz, 1 H), 2.91 
(d, J = 14.3 Hz, 1 H), 1.97 (dq, J = 23.1, 7.4 Hz, 1 H), 1.92 (dq, J = 23.1, 7.4 Hz, 1 H), 
1.61 (s, 1 H), 0.93 (t, J = 7.4 Hz, 1 H); 13C NMR (150 MHz, CDCl3) δ 149.4, 138.2, 
137.79, 137.78, 135.8, 133.6, 130.4, 129.0, 126.6, 124.9, 124.7, 123.8, 123.1, 121.0, 
117.7, 116.2, 113.9, 108.9, 57.7, 53.7, 52.0, 27.0, 12.2;  IR (neat) 3073, 2964, 1446, 
1368, 1176, 1120, 918, 747 cm-1; mass spectrum (CI) m/z 421.1949 [C25H28N2O2S (M+1) 
requires 421.1950].     
NMR Assignments.  1H NMR (600 MHz, CDCl3) δ 7.99 (d, J = 8.3 Hz, 1 H, 
C18-H), 7.82-7.80 (m, 2 H, C21-H), 7.70 (d, J = 7.8 Hz, 1 H, C15-H), 7.49 (t, J = 7.5 Hz, 
1 H, C23-H), 7.42 (s, 1 H, C12-H), 7.38 (t, J = 7.5 Hz, 2 H, C22-H), 7.29 (t, J = 7.8 Hz, 1 
H, C17-H), 7.20 (t, J = 7.8 Hz, 1 H, C16-H), 5.75 (ddd, J = 17.1, 10.2, 8.7 Hz, 1 H, C3 or 
C5-H), 5.65-5.59 (m, 1 H, C3 or C5-H), 5.14 (dd, J = 10.2, 1.7 Hz, 1 H, C4 or C6-H), 
5.09 (d, J = 17.1 Hz, 1 H, C4 or C6-H), 4.83 (d, J = 1.1 Hz, 1 H, C4 or C6-H), 4.82-4.80 
(m, 1 H, C4 or C6-H), 4.77 (s, 1 H, C9-H), 4.74 (s, 1 H, C9-H), 3.82 (d, J = 7.7 Hz, 1 H, 
C1-H), 3.14 (app q, J = 7.7 Hz, 1 H, C2-H), 3.02 (d, J = 14.3 Hz, 1 H, C7-H), 2.91 (d, J = 
14.3 Hz, 1 H, C7-H), 1.97 (dq, J = 23.1, 7.4 Hz, 1 H, C10-H), 1.92 (dq, J = 23.1, 7.4 Hz, 
1 H, C10-H), 1.61 (s, 1 H, NH), 0.93 (t, J = 7.4 Hz, 1 H, C11-H); 13C NMR (150 MHz, 
CDCl3) δ 149.4 (C8), 138.2 (C20), 137.79 (C3 or C5), 137.78 (C3 or C5), 135.8 (C19), 
133.6 (C23), 130.4 (C14), 129.0 (C22), 126.6 (C21), 124.9 (C12), 124.7 (C17), 123.8 
(C13), 123.1 (C16), 121.0 (C15), 117.7 (C4 or C6), 116.2 (C4 or C6), 113.9 (C18), 108.9 


































(phenylsulfonyl)-1H-indol-3-yl)-2-vinylbut-3-en-1-amine (4.196). (JDSVII-64a).  A 
solution of amino alcohol 4.190 (2.823g, 6.07 mmol), TBS-Cl (1.24g, 8.22 mmol), and 
imidazole (0.704g, 10.3 mmol) in DMF (30 mL) was stirred for 4.5 h at room 
temperature.  The reaction was partitioned between H2O (100 mL) and Et2O (100 mL).  
The organic phase was removed and the aqueous phase was washed with Et2O (2 x 100 
mL).  The combined organic phases were washed with saturated aqueous NaCl (100 mL), 
dried (MgSO4), filtered and concentrated under reduced pressure.  The residue was 
crystallized from a minimal volume of aqueous MeOH to give 2.995 g (85%) of 4.196 as 
a white solid (mp = 58-59.5 ºC).  1H NMR (600 MHz, CDCl3) δ 7.98 (d, J = 8.3 Hz, 1 H), 
7.82-7.80 (m, 2 H), 7.59 (7.7 Hz, 1 H), 7.50 (t, J = 7.5 Hz, 1 H), 7.40 (s, 1 H), 7.38 (t, J = 
7.5 Hz, 2 H), 7.29 (t, J = 7.7 Hz, 1 H), 7.21 (t, J = 7.7 Hz, 1 H), 6.06 (ddd, J = 17.5, 10.4, 
7.4 Hz, 1 H), 5.43 (ddd, J = 17.5, 10.3, 7.4, Hz, 1 H), 5.12-5.07 (comp, 2 H), 4.84-4.82 
(comp, 3 H), 4.70 (d, J = 10.3 Hz, 1 H), 4.07 (d, J = 10.9 Hz, 1 H), 3.71-3.62 (comp, 2 
H), 3.40 (dt, J = 10.3, 7.4 Hz, 1 H), 3.12 (d, J = 13.9 Hz, 1 H), 2.76 (dt, J = 13.2, 6.7 Hz, 
1 H), 2.62 (d, J = 13.9 Hz, 1 H), 2.30 (dt, J = 13.2, 6.5 Hz,  1 H), 2.03 (dq, J = 23.2, 7.4 
Hz, 1 H), 2.00 (dq, J = 23.2, 7.4 Hz, 1 H), 0.98 (t, J = 7.4 Hz, 3 H), 0.90 (s, 9 H), 0.059 
(s, 3 H), 0.056 (s, 3 H); 13C NMR (150 MHz, DCl3) δ 149.6, 139.9, 138.4, 138.1, 134.9, 
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133.7, 132.5, 129.1, 126.7, 124.7, 124.6, 123.2, 120.7, 120.1, 116.0, 115.1, 113.7, 110.8, 
62.9, 59.6, 57.3, 52.3, 50.9, 26.5, 26.0, 18.4, 12.2, -5.30, -5.31;  IR (neat) 2928, 1446, 
1370, 1255, 1176, 1095, 835 cm-1; mass spectrum (CI) m/z 579.3087 [C33H46N2O3SSi 
(M+1) requires 579.3077].     
NMR Assignments.  1H NMR (600 MHz, CDCl3) δ 7.98 (d, J = 8.3 Hz, 1 H, 
C13-H), 7.82-7.80 (m, 2 H, C16-H), 7.59 (7.7 Hz, 1 H, C10-H), 7.50 (t, J = 7.5 Hz, 1 H, 
C18-H), 7.40 (s, 1 H, C7-H), 7.38 (t, J = 7.5 Hz, 2 H, C17-H), 7.29 (t, J = 7.7 Hz, 1 H, 
C12-H), 7.21 (t, J = 7.7 Hz, 1 H, C11-H), 6.06 (ddd, J = 17.5, 10.4, 7.4 Hz, 1 H, C3 or 
C5-H), 5.43 (ddd, J = 17.5, 10.3, 7.4, Hz, 1 H, C3 or C5-H), 5.12-5.07 (comp, 2 H, C4 or 
C6-H), 4.84-4.82 (comp, 3 H, C23-H and C4 or C6-H), 4.70 (d, J = 10.3 Hz, 1 H, C4 or 
C6-H), 4.07 (d, J = 10.9 Hz, 1 H, C1-H), 3.71-3.62 (comp, 2 H, C25-H), 3.40 (dt, J = 
10.3, 7.4 Hz, 1 H, C2-H), 3.12 (d, J = 13.9 Hz, 1 H, C19-H), 2.76 (dt, J = 13.2, 6.7 Hz, 1 
H, C24-H), 2.62 (d, J = 13.9 Hz, 1 H, C19-H), 2.30 (dt, J = 13.2, 6.5 Hz,  1 H, C24-H), 
2.03 (dq, J = 23.2, 7.4 Hz, 1 H, C21-H), 2.00 (dq, J = 23.2, 7.4 Hz, 1 H, C21-H), 0.98 (t, 
J = 7.4 Hz, 3 H, C22-H), 0.90 (s, 9 H, C28-H), 0.059 (s, 3 H, C26-H), 0.056 (s, 3 H, C36-
H); 13C NMR (150 MHz, DCl3) δ 149.6 (C20), 139.9 (C3 or C5), 138.4 (C3 or C5), 138.1 
(C15), 134.9 (C14), 133.7 (C18), 132.5 (C9), 129.1 (C17), 126.7 (C16), 124.7 (C7), 
124.6 (C12), 123.2 (C11), 120.7 (C10), 120.1 (C8), 116.0 (C4 or C6), 115.1 (C4 or C6), 
113.7 (C13), 110.8 (C23), 62.9 (C25), 59.6 (C1), 57.3 (C19), 52.3 (C24), 50.9 (C2), 26.5 








































vinylbut-3-enyl)-1-(phenylsulfonyl)-1H-indol-2-yl)ethanol (4.197). (JDSVII-84a).  
Indole 4.196 (1.356 g, 2.35 mmol) was azeotroped from benzene (3 x ~10 mL), and then 
dissolved in THF (11 mL) and cooled to -78 ºC.  LDA (1 M in THF/hexane, 4.7 mL, 4.7 
mmol) was then added, and the reaction was stirred for 15 min at -78 ºC.  The -78 ºC bath 
was exchanged for a 0 ºC bath, and the reaction was stirred for 2 h at 0 ºC.  The reaction 
was then cooled to -78 ºC and freshly distilled acetaldehyde (0.5 mL, 392 mg, 8.91 
mmol) was added.  The reaction was stirred for 2 h over which the reaction warmed to 0 
ºC.  The reaction was then partitioned between Et2O (10 mL) and saturated aqueous 
NH4Cl (15 mL). The organic phase was removed, and the aqueous layer was extracted 
with CH2Cl2 (2 x 10 mL). The combined organics were dried (MgSO4), filtered, and 
concentrated under reduced pressure.  The residue was purified by flash chromatography 
eluting with EtOAc/Hexane (gradient elution, 1:49 to 1:19 to 1:9) to give 441 mg (32%) 
of 4.196, 576 mg (39%) of 4.197 (major diastereomer) as a colorless oil, and 259 mg 
(17%) of 4.197 (minor diastereomer) as colorless oil.  Major diastereomer : 1H NMR 
(600 MHz, DMSO) δ 7.99 (d, J = 8.2 Hz, 1 H), 7.90-7.88 (m, 1 H), 7.69 (d, J = 7.5 Hz, 2 
H), 7.56 (t, J = 7.5 Hz, 1 H), 7.45 (d, J = 7.5 Hz, 1 H), 7.22 (t, J = 7.7 Hz, 1 H), 7.16 (t, J 
= 7.7 Hz, 1 H), 6.04-6.00 (m, 1 H), 5.56-5.53 (m, 1 H), 5.46-5.40 (m, 1 H), 5.27 (d, J = 
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4.7 Hz, 1 H), 5.05 (d, J = 17.5 Hz, 1 H), 5.00 (d, J = 10.3 Hz, 1 H), 4.84 (s, 1 H), 4.71 (s, 
1 H), 4.65 (d, J = 9.3 Hz, 1 H), 4.56 (d, J = 16.7 Hz, 1 H), 4.43 (d, J = 9.4 Hz, 1 H), 3.70 
(app q, J = 8.3 Hz, 1 H), 3.52 (t, J = 6.8 Hz, 1 H), 3.14 (d, J = 13.8 Hz, 1 H), 2.75 (d, J = 
13.8 Hz, 1 H), 2.61 (dt, J = 13.4, 6.8 Hz, 1 H), 2.44 (dt, J = 13.4, 6.8 Hz, 1 H), 2.01 (dq, J 
= 14.9, 7.4 Hz, 1 H), 1.91 (dq, J = 14.9, 7.4 Hz, 1 H), 1.57 (d, J = 6.6 Hz, 3 H), 0.86 (t, J 
= 7.4 Hz, 1 H), 0.81 (s, 9 H), -0.06 (s, 6 H); 13C NMR (150 MHz, DMSO) δ 150.0, 142.4, 
140.9, 138.4, 137.0, 136.5, 134.1, 130.2, 129.1, 126.1, 124.3, 123.4, 123.3, 122.2, 114.8, 
114.6, 114.3, 109.9, 62.5, 61.2, 60.9, 57.6, 52.2, 49.1, 25.72, 25.71, 24.7, 17.8, 11.9, -5.5;  
IR (neat) 3551, 2930, 1447, 1362, 1254, 1174, 1092, 835 cm-1; mass spectrum (CI) m/z 
623.3331 [C35H50N2O4SSi (M+1) requires 579.3077].    Minor  diastereomer : 1H NMR 
(600 MHz, DMSO) δ 8.02 (d, J = 8.3 Hz, 1 H), 7.86-7.84 (m, 1 H), 7.63 (d, J = 7.5 Hz, 2 
H), 7.58 (t, J = 7.5 Hz, 1 H), 7.43 (t, J = 7.5 Hz, 1 H), 7.24 (t, J = 7.3 Hz, 1 H), 7.17 (t, J 
= 7.3 Hz, 1 H), 6.01 (ddd, J = 17.2, 10.3, 6.9 Hz, 1 H), 5.69 (br, 1 H), 5.45-5.39 (comp, 2 
H), 5.08 (d, J = 17.2 Hz, 1 H), 5.03 (d, J = 10.3 Hz, 1 H), 4.75 (m, 1 H), 4.71 (s, 1 H), 
4.68 (d, J = 17.4 Hz, 1 H), 4.65 (s, 1 H), 4.57 (d, J = 10.3 Hz, 1 H), 3.74-3.72 (m, 1 H), 
3.50-3.42 (comp, 2 H), 3.08 (d, J = 13.8 Hz, 1 H), 2.61 (d, J = 13.8 Hz, 1 H), 2.52-2.47 
(m, 1 H), 2.35 (dt, J = 12.6, 5.8 Hz, 1 H), 1.99 (dq, J = 15.1, 7.2 Hz, 1 H), 1.88 (dq, J = 
15.1, 7.2 Hz, 1 H), 1.48 (d, J = 5.4 Hz, 1 H), 0.83 (t, J = 7.2 Hz, 3 H), 0.82 (s, 9 H), -0.05 
(s, 3 H), -0.06 (s, 3 H);  13C NMR (150 MHz, DMSO) δ 150.4, 142.8, 140.7, 138.1, 
136.9, 136.5, 134.0, 131.0, 129.1, 126.1, 124.2, 123.5, 122.2, 115.4, 115.1, 114.7, 109.4, 
63.1, 61.3, 60.0, 57.5, 51.9, 48.4, 26.1, 25.8, 25.6, 17.9, 11.8, -5.41, -5.42;  IR (neat) 
3555, 2929, 1448, 1362, 1173, 1091, 914, 836 cm-1; mass spectrum (CI) m/z 623.3333 
[C35H50N2O4SSi (M+1) requires 623.3339].     
NMR Assignments.  Major diastereomer : 1H NMR (600 MHz, DMSO) δ 7.99 
(d, J = 8.2 Hz, 1 H, C13-H), 7.90-7.88 (m, 1 H, C10-H), 7.69 (d, J = 7.5 Hz, 2 H, C18-
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H), 7.56 (t, J = 7.5 Hz, 1 H, C20-H), 7.45 (d, J = 7.5 Hz, 2 H, C19-H), 7.22 (t, J = 7.7 Hz, 
1 H, C12-H), 7.16 (t, J = 7.7 Hz, 1 H, C11-H), 6.04-6.00 (m, 1 H, C3 or C5-H), 5.56-5.53 
(m, 1 H, C15-H), 5.46-5.40 (m, 1 H, C3 or C5-H), 5.27 (d, J = 4.7 Hz, 1 H, OH), 5.05 (d, 
J = 17.5 Hz, 1 H, C4 or C6-H), 5.00 (d, J = 10.3 Hz, 1 H, C4 or C6-H), 4.84 (s, 1 H, C25-
H), 4.71 (s, 1 H, C25-H), 4.65 (d, J = 9.3 Hz, 1 H, C1-H), 4.56 (d, J = 16.7 Hz, 1 H, C4 
or C6-H), 4.43 (d, J = 9.4 Hz, 1 H, C4 or C6-H), 3.70 (app q, J = 8.3 Hz, 1 H, C2-H), 
3.52 (t, J = 6.8 Hz, 1 H, C27-H), 3.14 (d, J = 13.8 Hz, 1 H, C21-H), 2.75 (d, J = 13.8 Hz, 
1 H, C21-H), 2.61 (dt, J = 13.4, 6.8 Hz, 1 H, C26-H), 2.44 (dt, J = 13.4, 6.8 Hz, 1 H, 
C26-H), 2.01 (dq, J = 14.9, 7.4 Hz, 1 H, C23-H), 1.91 (dq, J = 14.9, 7.4 Hz, 1 H, C23-H), 
1.57 (d, J = 6.6 Hz, 3 H, C16-H), 0.86 (t, J = 7.4 Hz, 1 H, C25-H), 0.81 (s, 9 H, C28-H), -
0.06 (s, 6 H, C26-H); 13C NMR (150 MHz, DMSO) δ 150.0 (C22), 142.4 (C7), 140.9 (C3 
or C5), 138.4 (C3 or C5), 137.0 (C17), 136.5 (C14), 134.1 (C20), 130.2 (C9), 129.1 
(C18), 126.1 (C19), 124.3 (C12), 123.4 (C10), 123.3 (C11), 122.2 (C8), 114.8 (C13), 
114.6 (C4 or C6), 114.3 (C4 or C6), 109.9 (C25), 62.5 (C15), 61.2 (C27), 60.9 (C1), 57.6 
(C21), 52.2 (C26), 49.1 (C2), 25.72 (C23), 25.71 (C30), 24.7 (C16), 17.8 (C29), 11.9 
(C24), -5.5 (C28).  Minor  diastereomer : 1H NMR (600 MHz, DMSO) δ 8.02 (d, J = 8.3 
Hz, 1 H, C13-H), 7.86-7.84 (m, 1 H, C10-H), 7.63 (d, J = 7.5 Hz, 2 H, C18-H), 7.58 (t, J 
= 7.5 Hz, 1 H, C20-H), 7.43 (t, J = 7.5 Hz, 2 H, C19-H), 7.24 (t, J = 7.3 Hz, 1 H, C12-H), 
7.17 (t, J = 7.3 Hz, 1 H, C11-H), 6.01 (ddd, J = 17.2, 10.3, 6.9 Hz, 1 H, C3 or C5-H), 
5.69 (br, 1 H, C15-H), 5.45-5.39 (comp, 2 H, C3 or C5-H and OH), 5.08 (d, J = 17.2 Hz, 
1 H, C4 or C6-H), 5.03 (d, J = 10.3 Hz, 1 H, C4 or C6-H), 4.75 (m, 1 H, C1-H), 4.71 (s, 1 
H, C25-H), 4.68 (d, J = 17.4 Hz, 1 H, C4 or C6-H), 4.65 (s, 1 H, C25-H), 4.57 (d, J = 
10.3 Hz, 1 H, C4 or C6-H), 3.74-3.72 (m, 1 H, C2-H), 3.50-3.42 (comp, 2 H, C27-H), 
3.08 (d, J = 13.8 Hz, 1 H, C21-H), 2.61 (d, J = 13.8 Hz, 1 H, C21-H), 2.52-2.47 (m, 1 H, 
C26-H), 2.35 (dt, J = 12.6, 5.8 Hz, 1 H, C26-H), 1.99 (dq, J = 15.1, 7.2 Hz, 1 H, C23-H), 
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1.88 (dq, J = 15.1, 7.2 Hz, 1 H, C23-H), 1.48 (d, J = 5.4 Hz, 1 H, C16-H), 0.83 (t, J = 7.2 
Hz, 3 H, C24-H), 0.82 (s, 9 H, C30-H), -0.05 (s, 3 H, C28-H), -0.06 (s, 3 H, C28-H);  13C 
NMR (150 MHz, DMSO) δ 150.4 (C22), 142.8 (C7), 140.7 (C3 or C5), 138.1 (C3 or C5), 
136.9 (C17), 136.5 (C14), 134.0 (C20), 131.0 (C9), 129.1 (C19), 126.1 (C18), 124.2 
(C12), 123.5 (C10 and C11), 122.2 (C8), 115.4 (C13), 115.1 (C4 or C6), 114.7 (C4 or 
C6), 109.4 (C25), 63.1 (C15), 61.3 (C27), 60.0 (C1), 57.5 (C21), 51.9 (C26), 48.4 (C2), 







































26a).  Tf2O (0.27 mL, 453 mg, 1.60 mmol) and Hunig’s base (0.7 mL, 519 mg, 4.02 
mmol) were added in rapid succession to a solution of indole alcohol 4.197 (835 mg, 1.34 
mmol) in CH2Cl2 (7 mL) at -78 ºC.  The reaction was stirred for 20 min at -78 ºC and 
then partitioned between 1M NaOH (10 mL) and CH2Cl2 (10 mL).  The organic phase 
was removed, and the aqueous layer was extracted with CH2Cl2 (2 x 5 mL). The 
combined organic layers were dried (MgSO4), filtered, and concentrated under reduced 
pressure.  The residue was purified by flash chromatography eluting with EtOAc/Hexane 
(1:49) to give 656 mg (80%) of 4.198 as a colorless oil.  1H NMR (600 MHz, CDCl3) 
δ 8.24 (d, J = 7.7 Hz, 1 H), 7.77 (d, J = 7.7 Hz, 1 H), 7.60-7.58 (m, 2 H), 7.45 (t, J = 7.5 
Hz, 1 H), 7.32-7.25 (comp, 3 H), 7.21 (t, J = 7.7 Hz, 1 H), 6.96 (dd, J = 17.7, 11.4 Hz, 1 
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H), 5.92 (ddd, J = 16.8, 10.8, 7.4 Hz, 1 H), 5.59 (dd, J = 11.4, 1.8 Hz, 1 H), 5.35 (ddd, J 
= 17.3, 10.3, 7.4 Hz, 1 H), 5.31 (dd, J = 17.7, 1.8 Hz, 1 H), 5.10-5.06 (comp, 2 H), 4.84 
(s, 1 H), 4.73 (s, 1 H), 4.71 (d, J = 17.3 Hz, 1 H), 4.54 (d, J = 10.3 Hz, 1 H), 4.14 (d, J = 
10.7 Hz, 1 H), 3.70 (dt, J = 10.7, 7.4 Hz, 1 H), 3.56-3.51 (m, 1 H), 3.48-3.44 (m, 1 H), 
3.15 (d, J = 14.0 Hz, 1 H), 2.74 (ddd, J = 13.1, 8.4, 6.5 Hz, 1 H), 2.65 (d, J = 14.0 Hz, 1 
H), 2.23 (ddd, J = 13.1, 7.8, 5.0 Hz, 1 H), 2.00 (dq, J = 15.1, 7.5 Hz, 1 H), 1.91 (dq, J 
=15.1, 7.5 Hz, 1 H), 0.94 (t, J = 7.4 Hz, 3 H), 0.86 (s, 9 H), -0.011 (s, 3 H), -0.014 (s, 3 
H); 13C NMR (150 MHz, CDCl3) δ 149.7, 139.8, 138.2, 138.1, 137.8, 136.9, 133.5, 
128.7, 128.1, 126.6, 124.7, 123.5, 122.9, 122.1, 120.7, 115.5, 115.34, 115.33, 110.0, 61.6, 
60.7, 57.3, 52.2, 48.7, 26.5, 26.0, 18.3, 12.1, -5.30, -5.31; IR (neat) 2928, 1448, 1374, 
1253, 1175, 1091, 987, 916, 836, 751 cm-1; mass spectrum (CI) m/z 605.3246 
[C35H48N2O3SSi (M+1) requires 605.3233]. 
NMR Assignments. 1H NMR (600 MHz, CDCl3) δ 8.24 (d, J = 7.7 Hz, 1 H, C13-
H), 7.77 (d, J = 7.7 Hz, 1 H, C10-H), 7.60-7.58 (m, 2 H, C18-H), 7.45 (t, J = 7.5 Hz, 1 H, 
C20-H), 7.32-7.25 (comp, 3 H, C19 and C12-H), 7.21 (t, J = 7.7 Hz, 1 H, C11-H), 6.96 
(dd, J = 17.7, 11.4 Hz, 1 H, C15-H), 5.92 (ddd, J = 16.8, 10.8, 7.4 Hz, 1 H, C3 or C5-H), 
5.59 (dd, J = 11.4, 1.8 Hz, 1 H, C16-H), 5.35 (ddd, J = 17.3, 10.3, 7.4 Hz, 1 H, C3 or C5-
H), 5.31 (dd, J = 17.7, 1.8 Hz, 1 H, C16-H), 5.10-5.06 (comp, 2 H, C4 or C6-H), 4.84 (s, 
1 H, C25-H), 4.73 (s, 1 H, C25-H), 4.71 (d, J = 17.3 Hz, 1 H, C4 or C6-H), 4.54 (d, J = 
10.3 Hz, 1 H, C4 or C6-H), 4.14 (d, J = 10.7 Hz, 1 H, C1-H), 3.70 (dt, J = 10.7, 7.4 Hz, 1 
H, C2-H), 3.56-3.51 (m, 1 H, C27-H), 3.48-3.44 (m, 1 H, C27-H), 3.15 (d, J = 14.0 Hz, 1 
H, C21-H), 2.74 (ddd, J = 13.1, 8.4, 6.5 Hz, 1 H, C26-H), 2.65 (d, J = 14.0 Hz, 1 H, C21-
H), 2.23 (ddd, J = 13.1, 7.8, 5.0 Hz, 1 H, C26-H), 2.00 (dq, J = 15.1, 7.5 Hz, 1 H, C23-
H), 1.91 (dq, J =15.1, 7.5 Hz, 1 H, C23-H), 0.94 (t, J = 7.4 Hz, 3 H, C24-H), 0.86 (s, 9 H, 
C30-H), -0.011 (s, 3 H, C28-H), -0.014 (s, 3 H, C28-H); 13C NMR (150 MHz, CDCl3) 
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δ 149.7 (C22), 139.8 (C3 or C5), 138.2 (C17), 138.1 (C3 or C5), 137.8 (C14), 136.9 (C9), 
133.5 (C20), 128.7 (C19), 128.1 (C15), 126.6 (C18), 124.7 (C12), 123.5 (C11), 122.9 
(C10), 122.1 (C16), 120.7 (C8), 115.5 (C3 or C5), 115.34 (C3, C5 or C13), 115.33 (C3, 
C5, or C10), 110.0 (C25), 61.6 (C27), 60.7 (C1), 57.3 (C21), 52.2 (C26), 48.7 (C2), 26.5 













































carboxylate (4.202) and methyl 2-ethyl-3a,4,11,12-tetrahydro-1H-indolizino[8,1-
cd]carbazole-6-carboxylate (4.202a).  (JDSVII-100a and JDSVII-100b).  Pentacycle 
4.201 (70 mg, 0.25 mmol) was azeotroped from benzene (3 x ~10 mL), and then 
dissolved in THF (3 mL) and cooled to -78 ºC.  LDA (1 M in THF/hexane, 0.75 mL, 0.75 
mmol) was then added, and the reaction was stirred for 1 h over which the reaction 
warmed to -20 ºC, and stirring was then continued at -20 ºC for 1 h.  The reaction was 
then cooled to -78 ºC and methyl cyanoformate (0.09 mL, 96 mg, 1.13 mmol) was added.  
The reaction was stirred for 1 h at -78 ºC.  The reaction was then partitioned between 
CH2Cl2 (5 mL) and saturated aqueous NH4Cl (5 mL). The organic phase was removed, 
and the aqueous layer was extracted with CH2Cl2 (3 x 5 mL). The combined organics 
were dried (MgSO4), filtered, and concentrated under reduced pressure.  The residue was 
purified by flash chromatography eluting with EtOAc/Hexane (3:97) to give 35 mg 
(41%) of 4.202 as a viscous oil and 26 mg (30%) of a mixture (5:1) of 4.202a and 4.202.  
4.198:  1H NMR (600 MHz, CDCl3) δ 9.07 (s, 1 H), 7.52 (d, J = 7.5 Hz, 1 H), 7.08 (td, J 
= 7.5, 1.3 Hz, 1 H), 6.83 (td, J = 7.5, 1.0 Hz, 1 H), 6.75 (d, J = 7.5 Hz, 1 H), 5.51 (d, J = 
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1.5 Hz, 1 H), 3.75 (s, 3 H), 3.70 (d, J = 18.5 Hz, 1 H), 3.39 (ddd, J = 9.0, 9.0, 5.5 Hz, 1 
H) 3.20 (d, J = 18.5 Hz, 1 H), 2.92 (ddd, J = 10.8, 9.0, 4.7 Hz, 1 H), 2.81 (d, J = 9.8 Hz, 1 
H), 2.71 (dd, J = 15.6, 5.5 Hz, 1 H), 2.56-2.50 (comp, 2 H), 2.06 (dd, J = 15.6, 12.8 Hz, 1 
H), 1.99-1.96 (comp, 2 H), 1.91 (ddd, J = 13.3, 9.0, 4.7 Hz, 1 H), 1.05 (t, J = 7.5 Hz, 1 
H); 13C NMR (150 MHz, CDCl3) δ 169.1, 165.3, 144.2, 138.9, 138.2, 127.3, 123.1, 
121.2, 120.8, 109.2, 95.0, 63.4, 55.0, 51.5, 51.0, 49.8, 40.7, 29.3, 28.1, 27.3, 12.3; IR 
(neat) 3354, 2963, 1677, 1606, 1463, 1283, 1233, 1215, 1163, 747 cm-1; mass spectrum 
(CI) m/z  336.1845 [C21H24N2O2 (M+1) requires 337.1910].  4.202a:  1H NMR (600 
MHz, CDCl3) δ 7.71 (d, J = 7.5 Hz, 1 H), 7.62 (dd, J = 7.5, 1.0 Hz, 1 H), 7.16 (td, J = 
7.5, 1.4 Hz, 1 H), 7.00 (dt, J = 7.5, 1.0 Hz, 1 H), 5.91 (s, 1 H), 5.47 (d, J = 1.5 Hz, 1 H), 
3.91 (s, 3 H), 3.69 (d, J = 18.3 Hz, 1 H), 3.32 (ddd, J = 9.1, 9.1, 4.9 Hz, 1 H), 3.17 (d, J = 
18.3 Hz, 1 H), 2.91 (ddd, J = 10.6, 9.0, 5.2 Hz, 1 H), 2.75 (d, J = 9.5 Hz, 1 H), 2.55-2.50 
(comp, 2 H), 2.41 (ddd, J = 13.1, 10.6, 4.9 Hz, 1 H), 1.99-1.94 (comp, 2 H), 1.94-1.91 
(m, 1 H), 1.84 (ddd, J = 13.1, 9.1, 5.2 Hz, 1 H), 1.05 (t, J = 7.5 Hz, 1 H); 13C NMR (150 
MHz, CDCl3) δ 153.0, 143.4, 140.5, 139.5, 139.1, 127.1, 123.7, 123.0, 120.9, 114.8, 
111.3, 64.2, 51.7, 51.3, 50.3, 39.7, 29.9, 27.4, 27.3, 12.3; IR (neat) 2961, 1715, 1603, 
1475, 1380, 1303, 1211, 754 cm-1; mass spectrum (CI) m/z 336.1841 [C21H24N2O2 (M+1) 
requires 336.1838] 337.1913. 
NMR Assignments.  4.202: 1H NMR (600 MHz, CDCl3) δ 9.07 (s, 1 H, N-H), 
7.52 (d, J = 7.5 Hz, 1 H, C13-H), 7.08 (td, J = 7.5, 1.3 Hz, 1 H, C14-H), 6.83 (td, J = 7.5, 
1.0 Hz, 1 H, C15-H), 6.75 (d, J = 7.5 Hz, 1 H, C16-H), 5.51 (d, J = 1.5 Hz, 1 H, C5-H), 
3.75 (s, 3 H, C19-H), 3.70 (d, J = 18.5 Hz, 1 H, C7-H), 3.39 (ddd, J = 9.0, 9.0, 5.5 Hz, 1 
H, C8-H) 3.20 (d, J = 18.5 Hz, 1 H, C7-H), 2.92 (ddd, J = 10.8, 9.0, 4.7 Hz, 1 H, C8-H), 
2.81 (d, J = 9.8 Hz, 1 H, C11-H), 2.71 (dd, J = 15.6, 5.5 Hz, 1 H, C3-H), 2.56-2.50 
(comp, 2 H, C9 and C4-H), 2.06 (dd, J = 15.6, 12.8 Hz, 1 H, C3-H), 1.99-1.96 (comp, 2 
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H, C20-H), 1.91 (ddd, J = 13.3, 9.0, 4.7 Hz, 1 H, C9-H), 1.05 (t, J = 7.5 Hz, 1 H, C21-H); 
13C NMR (150 MHz, CDCl3) δ 169.1 (C18), 165.3 (C1), 144.2 (C17), 138.9 (C6), 138.2 
(C12), 127.3 (C14), 123.1 (C13), 121.2 (C5), 120.8 (C15), 109.2 (C16), 95.0 (C2), 63.4 
(C11), 55.0 (C10), 51.5 (C7), 51.0 (C19), 49.8 (C8), 40.7 (C9), 29.3 (C3), 28.1 (C4), 27.3 
(C20), 12.3 (C21).  4.202a:  1H NMR (600 MHz, CDCl3) δ 7.71 (d, J = 7.5 Hz, 1 H, C16-
H), 7.62 (dd, J = 7.5, 1.0 Hz, 1 H, C13-H), 7.16 (td, J = 7.5, 1.4 Hz, 1 H, C15-H), 7.00 
(dt, J = 7.5, 1.0 Hz, 1 H, C14-H), 5.91 (s, 1 H, C2-H), 5.47 (d, J = 1.5 Hz, 1 H, C5-H), 
3.91 (s, 3 H, C19-H), 3.69 (d, J = 18.3 Hz, 1 H, C7-H), 3.32 (ddd, J = 9.1, 9.1, 4.9 Hz, 1 
H, C8-H), 3.17 (d, J = 18.3 Hz, 1 H, C7-H), 2.91 (ddd, J = 10.6, 9.0, 5.2 Hz, 1 H, C8-H), 
2.75 (d, J = 9.5 Hz, 1 H, C11-H), 2.55-2.50 (comp, 2 H, C3 and C4-H), 2.41 (ddd, J = 
13.1, 10.6, 4.9 Hz, 1 H, C9-H), 1.99-1.94 (comp, 2 H, C20-H), 1.94-1.91 (m, 1 H, C3-H), 
1.84 (ddd, J = 13.1, 9.1, 5.2 Hz, 1 H, C9-H), 1.05 (t, J = 7.5 Hz, 1 H, C21-H); 13C NMR 
(150 MHz, CDCl3) δ 153.0 (C18), 143.4, 140.5, 139.5, 139.1, 127.1 (C15), 123.7 (C14), 
123.0 (C13), 120.9 (C5), 114.8 (C16), 111.3 (C2), 64.2 (C11), 51.7 (C10), 51.3 (C7), 
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